|
Code
|
Display
|
Definition
|
Comments
|
|
ARCHIVE
|
Archive
|
Archive
device
|
|
|
AR
|
Autorefraction
|
Autorefraction
device
|
|
|
AS
|
Angioscopy
|
Angioscopy
device
|
|
|
AU
|
Audio
|
Audio
object
|
|
|
BDUS
|
Ultrasound
Bone
Densitometry
|
Ultrasound
Bone
Densitometry
(modality)
|
|
|
BI
|
Biomagnetic
imaging
|
Biomagnetic
imaging
device
|
|
|
BMD
|
Bone
Mineral
Densitometry
|
Bone
Mineral
Densitometry
by
X-Ray
(modality),
including
dual-energy
X-Ray
absorptiometry
(DXA)
and
morphometric
X-Ray
absorptiometry
(MXA)
|
|
|
CAD
|
Computer
Assisted
Detection/Diagnosis
|
Computer
Assisted
Detection/Diagnosis
device
|
|
|
CAPTURE
|
Image
Capture
|
Image
Capture
Device,
includes
video
capture
|
|
|
CD
|
Color
flow
Doppler
|
Color
flow
Doppler
|
|
|
CF
|
Cinefluorography
|
Cinefluorography
|
|
|
COMP
|
Computation
Server
|
Computation
Server;
includes
radiotherapy
planning
|
|
|
CP
|
Culposcopy
|
Culposcopy
|
|
|
CR
|
Computed
Radiography
|
Computed
Radiography
device
|
|
|
CS
|
Cystoscopy
|
Cystoscopy
|
|
|
CT
|
Computed
Tomography
|
Computed
Tomography
device
|
|
|
DD
|
Duplex
Doppler
|
Duplex
Doppler
|
|
|
DF
|
Digital
fluoroscopy
|
Digital
fluoroscopy
|
|
|
DG
|
Diaphanography
|
Diaphanography
device
|
|
|
DM
|
Digital
microscopy
|
Digital
microscopy
|
|
|
DOCD
|
Document
Digitizer
Equipment
|
Equipment
that
digitized
hardcopy
documents
and
imported
them
|
|
|
DS
|
Digital
Subtraction
Angiography
|
Digital
Subtraction
Angiography
|
|
|
DSS
|
Department
System
Scheduler
|
Department
System
Scheduler,
workflow
manager;
includes
RIS
|
|
|
DX
|
Digital
Radiography
|
Digital
Radiography
device
|
|
|
EC
|
Echocardiography
|
Echocardiography
|
|
|
ECG
|
Electrocardiography
|
Electrocardiography
device
|
|
|
EPS
|
Cardiac
Electrophysiology
|
Cardiac
Electrophysiology
device
|
|
|
ES
|
Endoscopy
|
Endoscopy
device
|
|
|
F
|
Female
|
Female
sex
|
|
|
FA
|
Fluorescein
angiography
|
Fluorescein
angiography
|
|
|
FC
|
Female
changed
to
Male
|
Female
sex
changed
to
Male
sex
|
|
|
FILMD
|
Film
Digitizer
|
Film
Digitizer
|
|
|
FP
|
Female
Pseudohermaphrodite
|
Female
Pseudohermaphrodite
|
|
|
FS
|
Fundoscopy
|
Fundoscopy
|
|
|
GM
|
General
Microscopy
|
General
Microscopy
device
|
|
|
H
|
Hermaphrodite
|
Hermaphrodite
|
|
|
HC
|
Hard
Copy
|
Hard
Copy
|
|
|
HD
|
Hemodynamic
Waveform
|
Hemodynamic
Waveform
acquisition
device
|
|
|
IO
|
Intra-oral
Radiography
|
Intra-oral
Radiography
device
|
|
|
IVOCT
|
Intravascular
Optical
Coherence
Tomography
|
An
acquisition
device,
process
or
method
that
performs
intravascular
optical
coherence
tomography
|
|
|
IVUS
|
Intravascular
Ultrasound
|
Intravascular
Ultrasound
device
|
|
|
KER
|
Keratometry
|
Keratometry
device
|
|
|
KO
|
Key
Object
Selection
|
Key
Object
Selection
object
|
|
|
LEN
|
Lensometry
|
Lensometry
device
|
|
|
LOG
|
Procedure
Logging
|
Procedure
Logging
device;
includes
cath
lab
logging
|
|
|
LP
|
Laparoscopy
|
Laparoscopy
|
|
|
LS
|
Laser
surface
scan
|
Laser
surface
scan
device
|
|
|
M
|
Male
|
Male
sex
|
|
|
MA
|
Magnetic
resonance
angiography
|
Magnetic
resonance
angiography
|
|
|
MC
|
Male
changed
to
Female
|
Male
sex
changed
to
Female
sex
|
|
|
MCD
|
Media
Creation
Device
|
A
device
that
creates
DICOM
PS3.10
interchange
media;
e.g.
a
CD
creator
that
is
managed
by
the
Media
Creation
Management
Service
Class
|
|
|
MEDIM
|
Portable
Media
Importer
Equipment
|
Equipment
that
retrieved
and
imported
objects
from
interchange
Media
|
|
|
MG
|
Mammography
|
Mammography
device
|
|
|
MP
|
Male
Pseudohermaphrodite
|
Male
Pseudohermaphrodite
|
|
|
MR
|
Magnetic
Resonance
|
Magnetic
Resonance
device
|
|
|
MS
|
Magnetic
resonance
spectroscopy
|
Magnetic
resonance
spectroscopy
|
|
|
NEARLINE
|
Nearline
|
Instances
need
to
be
retrieved
from
relatively
slow
media
such
as
optical
disk
or
tape
|
|
|
NM
|
Nuclear
Medicine
|
Nuclear
Medicine
device
|
|
|
OAM
|
Ophthalmic
Axial
Measurements
|
Measurements
of
the
axial
length
of
the
eye,
which
are
done
by
various
devices
|
|
|
OCT
|
Optical
Coherence
Tomography
|
Modality
device
that
uses
an
interferometric,
non-invasive
optical
tomographic
technique
to
image
2D
slices
and
3D
volumes
of
tissue
using
visible
and
near
visible
frequencies
|
|
|
OFFLINE
|
Offline
|
Instances
need
to
be
retrieved
by
manual
intervention
|
|
|
ONLINE
|
Online
|
Instances
are
immediately
available
|
|
|
OP
|
Ophthalmic
photography
|
Ophthalmic
photography
modality
|
|
|
OPM
|
Ophthalmic
Mapping
|
Modality
device
that
measures
corneal
topography,
corneal
or
retinal
thickness,
and
other
similar
parameters
that
are
typically
displayed
as
maps
|
|
|
OPR
|
Ophthalmic
Refraction
|
Modality
device
that
measures
the
refractive
characteristics
of
the
eye
|
|
|
OPT
|
Ophthalmic
Tomography
|
Tomography
of
the
eye
acquired
by
a
modality
that
is
based
on
light
and
optical
principles.
Tomography
based
on
other
principles,
such
as
ultrasound,
is
excluded
|
|
|
OPV
|
Ophthalmic
Visual
Field
|
Modality
device
that
measures
visual
fields
and
perform
visual
perimetry
|
|
|
OSS
|
Optical
Survace
Scanner
|
An
acquisition
device,
process
or
method
that
performs
optical
surface
scanning
|
|
|
OT
|
Other
Modality
|
Other
Modality
device
|
|
|
PR
|
Presentation
State
|
Presentation
State
object
|
|
|
PRINT
|
Hard
Copy
Print
Server
|
Hard
Copy
Print
Server;
includes
printers
with
embedded
DICOM
print
server
|
|
|
PT
|
Positron
emission
tomography
|
Positron
emission
tomography
(PET)
device
|
|
|
PX
|
Panoramic
X-Ray
|
Panoramic
X-Ray
device
|
|
|
REG
|
Registration
|
Registration
|
|
|
RF
|
Radiofluoroscopy
|
Radiofluoroscopy
device
|
|
|
RG
|
Radiographic
imaging
|
Radiographic
imaging
(conventional
film/screen)
|
|
|
RT
|
Radiation
Therapy
Device
|
Radiation
Therapy
Device;
includes
linear
accelerator,
proton
therapy
|
|
|
RTDOSE
|
Radiotherapy
Dose
|
Radiotherapy
Dose
|
|
|
RTIMAGE
|
Radiotherapy
Image
|
Radiotherapy
Imaging
device;
includes
portal
imaging
|
|
|
RTPLAN
|
Radiotherapy
Plan
|
Radiotherapy
Plan
|
|
|
RTRECORD
|
Radiotherapy
Treatment
Record
|
Radiotherapy
Treatment
Record
|
|
|
RTSTRUCT
|
Radiotherapy
Structure
Set
|
Radiotherapy
Structure
Set
|
|
|
SEG
|
Segmentation
|
Segmentation
|
|
|
SM
|
Slide
Microscopy
|
Slide
Microscopy
|
|
|
SMR
|
Stereometric
Relationship
|
Stereometric
image
pairing
modality
|
|
|
SR
|
Structured
Report
Document
|
Structured
Report
Document
|
|
|
SRF
|
Subjective
Refraction
|
Subjective
Refraction
device
|
|
|
ST
|
Single-photon
emission
computed
tomography
|
Single-photon
emission
computed
tomography
(SPECT)
device
|
|
|
TG
|
Thermography
|
Thermography
device
|
|
|
U
|
Unknown
Sex
|
Unknown
Sex
|
|
|
UNAVAILABLE
|
Unavailable
|
Instances
cannot
be
retrieved
|
|
|
US
|
Ultrasound
|
Ultrasound
device
|
|
|
VA
|
Visual
Acuity
|
Visual
Acuity
device
|
|
|
VF
|
Videofluorography
|
Videofluorography
|
|
|
VIDD
|
Video
Tape
Digitizer
Equipment
|
Equipment
that
digitizes
video
tape
and
imports
it
|
|
|
WSD
|
Workstation
|
Workstation
|
|
|
XA
|
X-Ray
Angiography
|
X-Ray
Angiography
device
|
|
|
XC
|
External-camera
Photography
|
External-camera
Photography
device
|
|
|
109001
|
Digital
timecode
(NOS)
|
A
signal
transmitted
for
the
purpose
of
interchange
of
the
current
time,
not
specific
to
any
source
or
methodology
|
|
|
109002
|
ECG-based
gating
signal,
processed
|
A
signal
that
is
generated
for
each
detection
of
a
heart
beat
|
|
|
109003
|
IRIG-B
timecode
|
A
signal
transmitted
by
the
Inter-Range
Instrumentation
Group
for
the
purpose
of
synchronizing
time
clocks
|
|
|
109004
|
X-Ray
Fluoroscopy
On
Signal
|
A
signal
that
indicated
that
X-Ray
source
has
been
activated
for
fluoroscopy
use
|
|
|
109005
|
X-Ray
On
Trigger
|
A
signal
that
indicated
that
the
X-Ray
source
has
been
activated
for
image
recording
|
|
|
109006
|
Differential
signal
|
An
electrical
signal
derived
from
two
electrodes
|
|
|
109007
|
His
bundle
electrogram
|
An
electrophysiological
recording
from
the
HIS
nerve
bundle
|
|
|
109008
|
Monopole
signal
|
An
electrical
signal
from
one
electrode
relative
to
an
indifferent
potential
|
|
|
109009
|
Pacing
(electrical)
stimulus,
voltage
|
The
voltage
stimulus
during
cardiac
pacing
|
|
|
109010
|
Radio
frequency
ablation,
power
|
The
power
injected
during
RF
ablation
procedure
|
|
|
109011
|
Voltage
measurement
by
basket
catheter
|
Electrophysiological
signals
acquired
using
a
multi-splined
catheter
each
equipped
with
multiple
electrodes
|
|
|
109012
|
Voltage
measurement
by
mapping
catheter
|
Electrophysiological
signals
acquired
using
a
steerable
catheter
|
|
|
109013
|
Voltage
measurement,
NOS
|
A
voltage
measurement
not
otherwise
specified
|
|
|
109014
|
35%
of
thermal
CO
|
A
signal
point
that
is
35%
of
the
peak
thermal
cardiac
output
signal
|
|
|
109015
|
70%
of
thermal
CO
|
A
signal
point
that
is
70%
of
the
peak
thermal
cardiac
output
signal
|
|
|
109016
|
A
wave
peak
pressure
|
The
peak
pressure
of
each
heart
beat
in
the
atrium
caused
by
the
atrial
contraction
|
|
|
109017
|
A
wave
pressure,
average
|
The
average
of
several
A
wave
pressure
measurements
|
|
|
109018
|
Beat
detected
(accepted)
|
An
identified
cardiac
beat
used
in
the
determination
of
a
measurement
|
|
|
109019
|
Beat
detected
(rejected)
|
An
identified
cardiac
beat
not
used
in
the
determination
of
a
measurement
|
|
|
109020
|
Diastolic
pressure,
average
|
The
average
of
several
diastolic
pressure
measurements
|
|
|
109021
|
Diastolic
pressure
nadir
|
The
lowest
pressure
value
excluding
any
undershoot
artifact
|
|
|
109022
|
End
diastole
|
The
moment
at
the
end
of
the
diastolic
phase
of
the
cardiac
cycle
|
|
|
109023
|
End
of
expiration
|
The
moment
at
the
end
of
respiratory
expiration
|
|
|
109024
|
End
of
inspiration
|
The
moment
at
the
end
of
respiratory
inspiration
|
|
|
109025
|
Max
dp/dt
|
The
maximum
positive
rate
of
change
of
pressure
|
|
|
109026
|
Max
neg
dp/dt
|
The
maximum
negative
rate
of
change
of
pressure
|
|
|
109027
|
Mean
blood
pressure
|
The
average
blood
pressure
value,
generally
over
2
or
more
seconds
|
|
|
109028
|
Peak
of
thermal
cardiac
output
bolus
|
The
peak
change
in
blood
temperature
during
a
thermal
cardiac
output
measurement
|
|
|
109029
|
Start
of
expiration
|
The
moment
respiratory
expiration
begins
|
|
|
109030
|
Start
of
inspiration
|
The
moment
of
respiratory
inspiration
begins
|
|
|
109031
|
Start
of
thermal
cardiac
output
bolus
|
The
first
discernible
blood
temperature
change
following
the
injectate
during
a
thermal
cardiac
output
measurement
|
|
|
109032
|
Systolic
pressure,
average
|
The
average
of
several
systolic
blood
pressure
measurements
|
|
|
109033
|
Systolic
peak
pressure
|
The
highest
systolic
blood
pressure
value
excluding
any
overshoot
artifact
|
|
|
109034
|
V
wave
peak
pressure
|
The
peak
pressure
of
each
heart
beat
in
the
atrium
caused
by
the
filling
of
the
atrium
|
|
|
109035
|
V
wave
pressure,
average
|
The
average
of
several
V
wave
pressure
measurements
|
|
|
109036
|
Valve
close
|
The
moment
at
which
a
heart
valve
closes
|
|
|
109037
|
Valve
open
|
The
moment
at
which
a
heart
valve
opens
|
|
|
109038
|
Ablation
off
|
The
moment
when
RF
ablation
current
is
turned
off
|
|
|
109039
|
Ablation
on
|
The
moment
when
RF
ablation
current
is
turned
on
|
|
|
109040
|
HIS
bundle
wave
|
The
moment
in
the
cardiac
cycle
when
the
HIS
bundle
nerves
depolarize
|
|
|
109041
|
P
wave
|
The
surface
electrocardiogram
of
the
atrial
contraction
|
|
|
109042
|
Q
wave
|
The
first
negative
deflection
of
the
electrocardiogram
caused
by
ventricular
depolarization
|
|
|
109043
|
R
wave
|
The
first
positive
deflection
the
electrocardiogram
caused
by
ventricular
depolarization
|
|
|
109044
|
S
wave
|
The
first
negative
deflection
after
the
R
wave
|
|
|
109045
|
Start
of
atrial
contraction
|
The
beginning
of
the
atrial
contraction
|
|
|
109046
|
Start
of
atrial
contraction
(subsequent)
|
The
beginning
of
the
second
atrial
contraction
of
two
consecutive
beats
|
|
|
109047
|
Stimulation
at
rate
1
interval
|
The
stimulation
interval
during
cardiac
stimulation
first
used
in
a
pacing
train
|
|
|
109048
|
Stimulation
at
rate
2
interval
|
The
stimulation
interval
different
from
the
first
stimulation
interval
used
in
a
pacing
train
|
|
|
109049
|
Stimulation
at
rate
3
interval
|
A
stimulation
interval
different
from
and
subsequent
to
the
second
interval
in
a
pacing
train
|
|
|
109050
|
Stimulation
at
rate
4
interval
|
Describes
a
stimulation
interval
different
from
and
subsequent
to
the
third
interval
in
a
pacing
train
|
|
|
109051
|
T
wave
|
The
electrocardiogram
deflection
caused
by
ventricular
repolarization
|
|
|
109052
|
V
wave
|
The
peak
pressure
of
each
heart
beat
monitored
in
the
atrium
caused
by
the
filling
of
the
atrium
|
|
|
109053
|
V
wave
of
next
beat
|
The
second
V
wave
measurement
of
two
consecutive
beats
|
|
|
109054
|
Patient
State
|
A
description
of
the
physiological
condition
of
the
patient
|
|
|
109055
|
Protocol
Stage
|
The
exercise
level
during
a
progressive
cardiac
stress
test
|
|
|
109056
|
Stress
Protocol
|
A
series
of
physiological
challenges
designed
to
progressively
increase
the
work
of
the
heart
|
|
|
109057
|
Catheterization
Procedure
Phase
|
A
subpart
of
a
cardiac
catheterization
procedure
|
|
|
109058
|
Contrast
Phase
|
The
subpart
of
a
cardiac
catheterization
procedure
in
which
a
radio-opaque
contrast
medium
is
injected
into
the
patient
|
|
|
109059
|
Physiological
challenges
|
Physical
changes
administered
to
a
patient
in
order
to
elicit
an
physiological
response
|
|
|
109060
|
Procedure
Step
Number
|
Enumeration
of
a
subpart
of
a
catheterization
procedure
|
|
|
109061
|
EP
Procedure
Phase
|
A
subpart
of
an
electrophysiological
procedure
|
|
|
109063
|
Pulse
train
definition
|
A
means
of
defining
a
series
of
cardiac
stimulation
pulses
|
|
|
109070
|
End
of
systole
|
End
of
the
contraction
phase
of
the
cardiac
cycle
|
|
|
109071
|
Indicator
mean
transit
time
|
Time
for
a
median
particle
to
travel
from
point
of
injection
to
point
of
detection
|
|
|
109072
|
Tau
|
The
time
constant
of
isovolumic
pressure
fall
|
|
|
109073
|
V
max
myocardial
|
Maximum
velocity
of
myocardial
contractility
|
|
|
109080
|
Real
time
acquisition
|
Total
time
for
the
acquisition
is
shorter
than
cardiac
cycle,
no
gating
is
applied;
see
Cardiac
Synchronization
Technique
(0018,9037)
|
|
|
109081
|
Prospective
gating
|
Certain
thresholds
have
been
set
for
a
gating
window
that
defines
the
acceptance
of
measurement
data
during
the
acquisition;
see
Cardiac
Synchronization
Technique
(0018,9037)
|
|
|
109082
|
Retrospective
gating
|
Certain
thresholds
have
been
set
for
a
gating
window
that
defines
the
acceptance
of
measurement
data
after
the
acquisition;
see
Cardiac
Synchronization
Technique
(0018,9037)
|
|
|
109083
|
Paced
|
There
is
a
constant
RR
interval,
which
makes
thresholding
not
required;
see
Cardiac
Synchronization
Technique
(0018,9037);
e.g.
Pacemaker
|
|
|
109091
|
Cardiac
Stress
State
|
Imaging
after
injection
of
tracer
during
increased
cardiac
workload
or
increased
myocardial
blood
flow,
achieved
by
either
exercise
or
pharmacologic
means
|
|
|
109092
|
Reinjection
State
|
Imaging
after
injection
of
additional
tracer
under
resting
conditions
|
|
|
109093
|
Redistribution
State
|
Imaging
after
allowing
a
moderate
amount
of
time
for
tracer
to
move
from
its
initial
sites
of
uptake.
Example:
For
Thallium
imaging
this
would
correspond
to
imaging
2-6
hours
after
injection
|
|
|
109094
|
Delayed
Redistribution
State
|
Imaging
after
allowing
an
extended
amount
of
time
for
tracer
to
move
from
its
initial
sites
of
uptake.
Example:
For
Thallium
imaging
this
would
correspond
to
imaging
more
than
6
hours
after
injection
|
|
|
109095
|
Peak
stress
state
|
Peak
cardiac
stress
state
|
|
|
109096
|
Recovery
state
|
Recovery
from
cardiac
stress
|
|
|
109101
|
Acquisition
Equipment
|
Equipment
that
originally
acquired
the
data
stored
within
composite
instances;
e.g.
a
CT,
MR
or
Ultrasound
modality
|
|
|
109102
|
Processing
Equipment
|
Equipment
that
has
processed
composite
instances
to
create
new
composite
instances;
e.g.
a
3D
Workstation
|
|
|
109103
|
Modifying
Equipment
|
Equipment
that
has
modified
existing
composite
instances
(without
creating
new
composite
instances);
e.g.
a
QA
Station
or
Archive
|
|
|
109104
|
De-identifying
Equipment
|
Equipment
that
has
modified
an
existing
composite
instance
to
remove
patient
identifying
information
|
|
|
109105
|
Frame
Extracting
Equipment
|
Equipment
that
has
processed
composite
instances
to
create
new
composite
instances
by
extracting
selected
frames
from
the
original
instance
|
|
|
109106
|
Enhanced
Multi-frame
Conversion
Equipment
|
Equipment
that
has
processed
composite
instances
to
create
new
composite
instances
by
converting
classic
single
frame
images
to
enhanced
multi-frame
image,
or
vice
versa
and
updating
other
instances
to
maintain
referential
integrity
|
|
|
109110
|
Voice
|
The
sound
of
a
human's
speech,
recorded
during
a
procedure
|
May
include
the
patient's
voice,
or
the
voice
of
staff
present
in
the
room,
or
an
operator's
voice
(whether
for
the
purpose
of
recording
a
narrative
accompanying
a
procedure
or
not).
|
|
109111
|
Operator's
narrative
|
The
voice
of
a
device
operator,
recorded
during
a
procedure
|
|
|
109112
|
Ambient
room
environment
|
The
ambient
sound
recorded
during
a
procedure,
which
may
or
may
not
include
voice
and
other
types
of
sound
|
|
|
109113
|
Doppler
audio
|
The
Doppler
waveform
recorded
as
an
audible
signal
|
|
|
109114
|
Phonocardiogram
|
The
sound
of
the
human
heart
beating
|
Such
as
might
be
recorded
from
an
electronic
stethoscope.
|
|
109115
|
Physiological
audio
signal
|
Any
sound
made
by
the
human
body
|
May
include
the
sound
of
the
heart,
but
also
sound
from
other
organs,
such
as
bowel
sounds
or
bruits
from
vessels,
or
sounds
of
respiration.
Not
intended
to
include
voice.
|
|
109116
|
Arterial
Pulse
Waveform
|
A
digitized
signal
from
the
patient
arterial
system
collected
through
pulse
oximetry
or
other
means
|
|
|
109117
|
Respiration
Waveform
|
A
digitized
signal
from
the
patient
respiratory
system
representing
respiration
|
|
|
109120
|
On
admission
to
unit
|
The
occasion
on
which
a
procedure
was
performed
on
admission
to
a
specialist
unit;
e.g.
intensive
care
|
|
|
109121
|
On
discharge
|
The
occasion
on
which
a
procedure
was
performed
on
discharge
from
hospital
as
an
in-patient
|
|
|
109122
|
On
discharge
from
unit
|
The
occasion
on
which
a
procedure
was
performed
on
discharge
from
a
specialist
unit;
e.g.
intensive
care
|
|
|
109123
|
Pre-intervention
|
The
occasion
on
which
a
procedure
was
performed
immediately
prior
to
non-surgical
intervention;
e.g,
percutaneous
angioplasty,
biopsy
|
|
|
109124
|
Post-intervention
|
The
occasion
on
which
a
procedure
was
performed
immediately
after
to
non-surgical
intervention;
e.g,
percutaneous
angioplasty,
biopsy
|
|
|
109125
|
At
last
appointment
|
The
occasion
on
which
a
procedure
was
performed
at
the
most
recent
outpatient
visit
|
|
|
109132
|
Joint
position
method
|
The
active
or
passive
joint
positioning
during
acquisition
|
|
|
109133
|
Physical
force
|
A
physical
force
applied
during
acquisition
|
|
|
109134
|
Prior
to
voiding
|
Prior
to
voiding
|
|
|
109135
|
Post
voiding
|
Post
voiding
|
|
|
109136
|
Neutral
musculoskeletal
position
|
Neutral
musculoskeletal
position
|
|
|
109200
|
America
Kennel
Club
|
America
Kennel
Club
|
|
|
109201
|
America's
Pet
Registry
Inc.
|
America's
Pet
Registry
Inc
|
|
|
109202
|
American
Canine
Association
|
American
Canine
Association
|
|
|
109203
|
American
Purebred
Registry
|
American
Purebred
Registry
|
|
|
109204
|
American
Rare
Breed
Association
|
American
Rare
Breed
Association
|
|
|
109205
|
Animal
Registry
Unlimited
|
Animal
Registry
Unlimited
|
|
|
109206
|
Animal
Research
Foundation
|
Animal
Research
Foundation
|
|
|
109207
|
Canadian
Border
Collie
Association
|
Canadian
Border
Collie
Association
|
|
|
109208
|
Canadian
Kennel
Club
|
Canadian
Kennel
Club
|
|
|
109209
|
Canadian
Livestock
Records
Association
|
Canadian
Livestock
Records
Association
|
|
|
109210
|
Canine
Federation
of
Canada
|
Canine
Federation
of
Canada
|
|
|
109211
|
Continental
Kennel
Club
|
Continental
Kennel
Club
|
|
|
109212
|
Dog
Registry
of
America
|
Dog
Registry
of
America
|
|
|
109213
|
Federation
of
International
Canines
|
Federation
of
International
Canines
|
|
|
109214
|
International
Progressive
Dog
Breeders'
Alliance
|
International
Progressive
Dog
Breeders'
Alliance
|
|
|
109215
|
National
Kennel
Club
|
National
Kennel
Club
|
|
|
109216
|
North
American
Purebred
Dog
Registry
|
North
American
Purebred
Dog
Registry
|
|
|
109217
|
United
All
Breed
Registry
|
United
All
Breed
Registry
|
|
|
109218
|
United
Kennel
Club
|
United
Kennel
Club
|
|
|
109219
|
Universal
Kennel
Club
International
|
Universal
Kennel
Club
International
|
|
|
109220
|
Working
Canine
Association
of
Canada
|
Working
Canine
Association
of
Canada
|
|
|
109221
|
World
Kennel
Club
|
World
Kennel
Club
|
|
|
109222
|
World
Wide
Kennel
Club
|
World
Wide
Kennel
Club
|
|
|
109701
|
Overall
image
quality
evaluation
|
Evaluation
of
overall
image
quality
as
described
in
section
7.3.2
of
[IEC
62563-1]
|
|
|
109702
|
Grayscale
resolution
evaluation
|
Visual
verification
of
sufficient
grayscale
resolution
based
on
8
and
10-bit
markers
as
described
in
section
7.3.3
of
[IEC
62563-1]
|
|
|
109703
|
Luminance
response
evaluation
|
Visual
evaluation
of
luminance
response
using
the
TG18-CT
test
pattern
as
described
in
section
7.3.4
of
[IEC
62563-1]
|
|
|
109704
|
Luminance
uniformity
evaluation
|
Visual
detection
of
luminance
non-uniformities
as
described
in
section
7.3.5
of
[IEC
62563-1]
|
|
|
109705
|
Chromaticity
evaluation
|
Visual
verification
of
color
uniformity
as
described
in
section
7.3.6
of
[IEC
62563-1]
|
|
|
109706
|
Pixel
faults
evaluation
|
Visual
detection
of
defective
pixels
on
dark
(TG18-UN80)
and
bright
(TG18-UN10)
images
as
described
in
section
7.3.7
of
[IEC
62563-1]
|
|
|
109707
|
Veiling
glare
evaluation
|
Visual
evaluation
of
veiling
glare
by
looking
at
low
contrast
objects
on
2
test
patterns
as
described
in
section
7.3.8
of
[IEC
62563-1]
|
|
|
109708
|
Geometrical
image
evaluation
|
Visual
evaluation
of
geometry,
phase/clock
correction
and
clipping
as
described
in
section
7.3.9
of
[IEC
62563-1]
|
|
|
109709
|
Angular
viewing
evaluation
|
Visual
evaluation
of
viewing
angle
as
described
in
section
7.3.10
of
[IEC
62563-1]
|
|
|
109710
|
Clinical
evaluation
|
Visual
evaluation
of
the
appearance
of
clinical
images
as
described
in
section
7.3.11
of
[IEC
62563-1]
|
|
|
109801
|
TG18-QC
Pattern
|
AAPM
TG18-QC
Pattern
used
for
evaluation
of
resolution,
luminance,
distortion,
artifacts.
See
[AAPM
OR
03]
|
|
|
109802
|
TG18-BR
Pattern
|
AAPM
TG18-BR
Pattern
used
for
the
evaluation
of
the
display
of
low-contrast,
fine-detail
image
structures
See
[AAPM
OR
03]
|
|
|
109803
|
TG18-PQC
Pattern
|
AAPM
TG18-PQC
Pattern
used
for
evaluation
of
resolution,
luminance,
contrast
transfer
for
prints.
See
[AAPM
OR
03]
|
|
|
109804
|
TG18-CT
Pattern
|
AAPM
TG18-CT
Pattern
used
for
evaluation
of
luminance
response.
See
[AAPM
OR
03]
|
|
|
109805
|
TG18-LN8-01
Pattern
|
The
1st
image
in
the
AAPM
TG18-LN8
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109806
|
TG18-LN8-02
Pattern
|
The
2nd
image
in
the
AAPM
TG18-LN8
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109807
|
TG18-LN8-03
Pattern
|
The
3rd
image
in
the
AAPM
TG18-LN8
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109808
|
TG18-LN8-04
Pattern
|
The
4th
image
in
the
AAPM
TG18-LN8
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109809
|
TG18-LN8-05
Pattern
|
The
5th
image
in
the
AAPM
TG18-LN8
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109810
|
TG18-LN8-06
Pattern
|
The
6th
image
in
the
AAPM
TG18-LN8
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109811
|
TG18-LN8-07
Pattern
|
The
7th
image
in
the
AAPM
TG18-LN8
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109812
|
TG18-LN8-08
Pattern
|
The
8th
image
in
the
AAPM
TG18-LN8
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109813
|
TG18-LN8-09
Pattern
|
The
9th
image
in
the
AAPM
TG18-LN8
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109814
|
TG18-LN8-10
Pattern
|
The
10th
image
in
the
AAPM
TG18-LN8
set
used
for
DICOM
grayscale
calibration
series.
See
[AAPM
OR
03]
|
|
|
109815
|
TG18-LN8-11
Pattern
|
The
11th
image
in
the
AAPM
TG18-LN8
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109816
|
TG18-LN8-12
Pattern
|
The
12th
image
in
the
AAPM
TG18-LN8
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109817
|
TG18-LN8-13
Pattern
|
The
13th
image
in
the
AAPM
TG18-LN8
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109818
|
TG18-LN8-14
Pattern
|
The
14th
image
in
the
AAPM
TG18-LN8
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109819
|
TG18-LN8-15
Pattern
|
The
15th
image
in
the
AAPM
TG18-LN8
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109820
|
TG18-LN8-16
Pattern
|
The
16th
image
in
the
AAPM
TG18-LN8
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109821
|
TG18-LN8-17
Pattern
|
The
17th
image
in
the
AAPM
TG18-LN8
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109822
|
TG18-LN8-18
Pattern
|
The
18th
image
in
the
AAPM
TG18-LN8-
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109823
|
TG18-LN12-01
Pattern
|
The
1st
image
in
the
AAPM
TG18-LN12
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109824
|
TG18-LN12-02
Pattern
|
The
2
nd
image
in
the
AAPM
TG18-LN12
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109825
|
TG18-LN12-03
Pattern
|
The
3rd
image
in
the
AAPM
TG18-LN12
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109826
|
TG18-LN12-04
Pattern
|
The
4th
image
in
the
AAPM
TG18-LN12
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109827
|
TG18-LN12-05
Pattern
|
The
5th
image
in
the
AAPM
TG18-LN12
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109828
|
TG18-LN12-06
Pattern
|
The
6th
image
in
the
AAPM
TG18-LN12
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109829
|
TG18-LN12-07
Pattern
|
The
7th
image
in
the
AAPM
TG18-LN12
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109830
|
TG18-LN12-08
Pattern
|
The
8th
image
in
the
AAPM
TG18-LN12
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109831
|
TG18-LN12-09
Pattern
|
The
9th
image
in
the
AAPM
TG18-LN12
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109832
|
TG18-LN12-10
Pattern
|
The
10th
image
in
the
AAPM
TG18-LN12
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109833
|
TG18-LN12-11
Pattern
|
The
11th
image
in
the
AAPM
TG18-LN12
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109834
|
TG18-LN12-12
Pattern
|
The
12th
image
in
the
AAPM
TG18-LN12
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109835
|
TG18-LN12-13
Pattern
|
The
13th
image
in
the
AAPM
TG18-LN12
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109836
|
TG18-LN12-14
Pattern
|
The
14th
image
in
the
AAPM
TG18-LN12
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109837
|
TG18-LN12-15
Pattern
|
The
15th
image
in
the
AAPM
TG18-LN12
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109838
|
TG18-LN12-16
Pattern
|
The
16th
image
in
the
AAPM
TG18-LN12
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109839
|
TG18-LN12-17
Pattern
|
The
17th
image
in
the
AAPM
TG18-LN12
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109840
|
TG18-LN12-18
Pattern
|
The
18th
image
in
the
AAPM
TG18-LN12
set
used
for
DICOM
grayscale
calibration.
See
[AAPM
OR
03]
|
|
|
109841
|
TG18-UN10
Pattern
|
The
AAPM
TG18-UN10
Pattern
used
for
evaluation
of
luminance
and
color
uniformity,
and
angular
response.
See
[AAPM
OR
03]
|
|
|
109842
|
TG18-UN80
Pattern
|
The
AAPM
TG18-UN80
Pattern
used
for
evaluation
of
luminance
and
color
uniformity,
and
angular
response.
See
[AAPM
OR
03]
|
|
|
109843
|
TG18-UNL10
Pattern
|
The
AAPM
TG18-UNL10
Pattern
is
the
AAPM
TG-18
UN10
Pattern
with
added
defining
lines.
See
[AAPM
OR
03]
|
|
|
109844
|
TG18-UNL80
Pattern
|
The
AAPM
TG18-UNL80
Pattern
is
the
AAPM
TG-18
UN80
Pattern
with
added
defining
lines.
See
[AAPM
OR
03]
|
|
|
109845
|
TG18-AD
Pattern
|
The
AAPM
TG18-AD
Pattern
used
for
visual
evaluation
of
the
reflection
of
ambient
light
from
the
display.
See
[AAPM
OR
03]
|
|
|
109846
|
TG18-MP
Pattern
|
The
AAPM
TG18-MP
Pattern
used
for
evaluation
of
Luminance
response
(bit-depth
resolution).
See
[AAPM
OR
03]
|
|
|
109847
|
TG18-RH10
Pattern
|
The
AAPM
TG18-RH10
Pattern
used
for
LSF-line
spectra
function-(1k
and
2k)
evaluation
by
5
horizontal
lines
at
10%
luminance
level.
See
[AAPM
OR
03]
|
|
|
109848
|
TG18-RH50
Pattern
|
The
AAPM
TG18-RH50
Pattern
used
for
LSF-line
spectra
function-(1k
and
2k)
evaluation
by
5
horizontal
lines
at
50%
luminance
level.
See
[AAPM
OR
03]
|
|
|
109849
|
TG18-RH89
Pattern
|
The
AAPM
TG18-RH89
Pattern
used
for
LSF-line
spectra
function-(1k
and
2k)
evaluation
by
5
horizontal
lines
at
89%
luminance
level.
See
[AAPM
OR
03]
|
|
|
109850
|
TG18-RV10
Pattern
|
The
AAPM
TG18-RV10
Pattern
used
for
LSF-line
spectra
function-(1k
and
2k)
evaluation
by
5
vertical
lines
at
10%
luminance
level.
See
[AAPM
OR
03]
|
|
|
109851
|
TG18-RV50
Pattern
|
The
AAPM
TG18-RV50
Pattern
used
for
LSF-line
spectra
function-(1k
and
2k)
evaluation
by
5
vertical
lines
at
50%
luminance
level.
See
[AAPM
OR
03]
|
|
|
109852
|
TG18-RV89
Pattern
|
The
AAPM
TG18-RV89
Pattern
used
for
LSF-line
spectra
function-(1k
and
2k)
evaluation
by
5
vertical
lines
at
89%
luminance
level.
See
[AAPM
OR
03]
|
|
|
109853
|
TG18-PX
Pattern
|
The
AAPM
TG18-PX
Pattern
used
for
the
assessment
of
display
resolution.
See
[AAPM
OR
03]
|
|
|
109854
|
TG18-CX
Pattern
|
The
AAPM
TG18-CX
Pattern
used
to
assess
display
resolution
and
resolution
uniformity.
See
[AAPM
OR
03]
|
|
|
109855
|
TG18-LPH10
Pattern
|
The
AAPM
TG18-LPH10
Pattern
used
to
assess
display
resolution.
This
pattern
has
horizontal
bars
consisting
of
alternating
single-pixel-wide
lines
across
the
faceplate
of
display.
The
lines
have
a
12%
positive
contrast
against
10%
background
level
of
the
maximum
pixel
value.
See
[AAPM
OR
03]
|
|
|
109856
|
TG18-LPH50
Pattern
|
The
AAPM
TG18-LPH50
Pattern
used
to
assess
display
resolution.
This
pattern
has
horizontal
bars
consisting
of
alternating
single-pixel-wide
lines
across
the
faceplate
of
display.
The
lines
have
a
50%
positive
contrast
against
10%
background
level
of
the
maximum
pixel
value.
See
[AAPM
OR
03]
|
|
|
109857
|
TG18-LPH89
Pattern
|
The
AAPM
TG18-LPH89
Pattern
used
to
assess
display
resolution.
This
pattern
has
horizontal
bars
consisting
of
alternating
single-pixel-wide
lines
across
the
faceplate
of
display.
The
lines
have
a
12%
positive
contrast
against
89%
background
level
of
the
maximum
pixel
value.
See
[AAPM
OR
03]
|
|
|
109858
|
TG18-LPV10
Pattern
|
The
AAPM
TG18-LPV10
Pattern
used
to
assess
display
resolution.
This
pattern
has
vertical
bars
consisting
of
alternating
single-pixel-wide
lines
across
the
faceplate
of
display.
The
lines
have
a
12%
positive
contrast
against
10%
background
level
of
the
maximum
pixel
value.
See
[AAPM
OR
03]
|
|
|
109859
|
TG18-LPV50
Pattern
|
The
AAPM
TG18-LPV50
Pattern
used
to
assess
display
resolution.
This
pattern
has
vertical
bars
consisting
of
alternating
single-pixel-wide
lines
across
the
faceplate
of
display.
The
lines
have
a
12%
positive
contrast
against
50%
background
level
of
the
maximum
pixel
value.
See
[AAPM
OR
03]
|
|
|
109860
|
TG18-LPV89
Pattern
|
The
AAPM
TG18-LPV89
Pattern
used
to
assess
display
resolution.
This
pattern
has
vertical
bars
consisting
of
alternating
single-pixel-wide
lines
across
the
faceplate
of
display.
The
lines
have
a
12%
positive
contrast
against
89%
background
level
of
the
maximum
pixel
value.
See
[AAPM
OR
03]
|
|
|
109861
|
TG18-AFC
Pattern
|
The
AAPM
TG18-AFC
Pattern
used
to
assess
display
noise.
See
[AAPM
OR
03]
|
|
|
109862
|
TG18-NS10
Pattern
|
The
AAPM
TG18-NS10
Pattern
is
AAPM
TG18-RV10/RH10
with
only
difference
being
the
absence
of
the
single
line
at
the
center
of
the
measurement
area.
See
[AAPM
OR
03]
|
|
|
109863
|
TG18-NS50
Pattern
|
The
AAPM
TG18-NS50
Pattern
is
AAPM
TG18-RV50/RH50
with
only
difference
being
the
absence
of
the
single
line
at
the
center
of
the
measurement
area.
See
[AAPM
OR
03]
|
|
|
109864
|
TG18-NS89
Pattern
|
The
AAPM
TG18-NS89
Pattern
is
AAPM
TG18-RV89/RH89
with
only
difference
being
the
absence
of
the
single
line
at
the
center
of
the
measurement
area.
See
[AAPM
OR
03]
|
|
|
109865
|
TG18-GV
Pattern
|
The
TG18-GV
Pattern
used
to
assess
display
veiling.
See
[AAPM
OR
03]
|
|
|
109866
|
TG18-GVN
Pattern
|
The
TG18-GVN
Pattern
used
to
assess
display
veiling.
This
pattern
is
identical
to
AAPM
TG18-GV
Pattern
except
that
the
large-diameter
white
circle
is
replaced
with
a
black
circle,
creating
a
completely
black
pattern
except
for
the
presence
of
low-contrast
targets.
See
[AAPM
OR
03]
|
|
|
109867
|
TG18-GQ
Pattern
|
The
TG18-GQ
Pattern
used
for
quantitative
assessment
of
veiling
glare.
This
pattern
is
identical
to
TG18-GV
except
that
is
lacks
the
central
low-contrast
objects.
See
[AAPM
OR
03]
|
|
|
109868
|
TG18-GQN
Pattern
|
TG18-GQN
Pattern
used
for
the
quantitative
assessment
of
veiling
glare.
This
pattern
is
identical
to
AAPM
TG18-GQ
Pattern
except
that
the
large-diameter
white
circle
is
replaced
with
a
black
circle,
creating
a
completely
black
pattern
except
for
the
presence
of
low-contrast
targets.
See
[AAPM
OR
03]
|
|
|
109869
|
TG18-GQB
Pattern
|
The
TG18-GQB
Pattern
used
for
the
quantitative
assessment
of
veiling
glare.
This
pattern
is
identical
to
AAPM
TG18-GQ
Pattern
except
eliminating
the
central
black
circle.
See
[AAPM
OR
03]
|
|
|
109870
|
TG18-GA03
Pattern
|
The
TG18-GA03
Pattern
used
for
quantitative
assessment
of
veiling
glare.
This
pattern
is
identical
to
TG18-GQ
except
that
the
radius
of
the
central
black
circle
is
varied
as
r
=
3.
See
[AAPM
OR
03]
|
|
|
109871
|
TG18-GA05
Pattern
|
The
TG18-GA05
Pattern
This
pattern
is
identical
to
TG18-GQ
except
that
the
radius
of
the
central
black
circle
is
varied
as
r
=
5.
See
[AAPM
OR
03]
|
|
|
109872
|
TG18-GA08
Pattern
|
The
TG18-GA08
Pattern
used
for
quantitative
assessment
of
veiling
glare.
This
pattern
is
identical
to
TG18-GQ
except
that
the
radius
of
the
central
black
circle
is
varied
as
r
=
8.
See
[AAPM
OR
03]
|
|
|
109873
|
TG18-GA10
Pattern
|
The
TG18-GA10
Pattern
used
for
quantitative
assessment
of
veiling
glare.
This
pattern
is
identical
to
TG18-GQ
except
that
the
radius
of
the
central
black
circle
is
varied
as
r
=
10.
See
[AAPM
OR
03]
|
|
|
109874
|
TG18-GA15
Pattern
|
The
TG18-GA15
Pattern
used
for
quantitative
assessment
of
veiling
glare.
This
pattern
is
identical
to
TG18-GQ
except
that
the
radius
of
the
central
black
circle
is
varied
as
r
=
15
|
|
|
109875
|
TG18-GA20
Pattern
|
The
TG18-GA20
Pattern
used
for
quantitative
assessment
of
veiling
glare.
This
pattern
is
identical
to
TG18-GQ
except
that
the
radius
of
the
central
black
circle
is
varied
as
r
=
20.
See
[AAPM
OR
03]
|
|
|
109876
|
TG18-GA25
Pattern
|
The
TG18-GA25
Pattern
used
for
quantitative
assessment
of
veiling
glare.
This
pattern
is
identical
to
TG18-GQ
except
that
the
radius
of
the
central
black
circle
is
varied
as
r
=
25.
See
[AAPM
OR
03]
|
|
|
109877
|
TG18-GA30
Pattern
|
The
TG18-GA30
Pattern
used
for
quantitative
assessment
of
veiling
glare.
This
pattern
is
identical
to
TG18-GQ
except
that
the
radius
of
the
central
black
circle
is
varied
as
r
=
30.
See
[AAPM
OR
03]
|
|
|
109878
|
TG18-CH
Image
|
The
AAPM
TG18-CH
Image
is
a
reference
anatomical
PA
chest
image.
See
[AAPM
OR
03]
|
|
|
109879
|
TG18-KN
Image
|
The
AAPM
TG18-KN
Image
is
a
reference
anatomical
knee
image.
See
[AAPM
OR
03]
|
|
|
109880
|
TG18-MM1
Image
|
The
AAPM
TG18-MM1
Image
is
a
reference
anatomical
mammogram
image.
See
[AAPM
OR
03]
|
|
|
109881
|
TG18-MM2
Image
|
The
AAPM
TG18-MM2
Image
is
a
reference
anatomical
mammogram
image.
See
[AAPM
OR
03]
|
|
|
109901
|
OIQ
Pattern
|
The
IEC
OIQ
Pattern
is
used
as
an
alternative
to
the
TG18-QC
Pattern.
See
[IEC
62563-1]
|
|
|
109902
|
ANG
Pattern
|
The
IEC
ANG
Pattern
used
for
angular
viewing
evaluation.
See
[IEC
62563-1]
|
|
|
109903
|
GD
Pattern
|
The
IEC
GD
Pattern
used
for
geometrical
image
evaluation.
See
[IEC
62563-1]
|
|
|
109904
|
BN01
Pattern
|
The
IEC
BN01
Pattern
is
used
as
analternative
to
the
TG18-LN-01
Pattern,
to
avoid
the
use
of
a
cone
or
baffle
with
LCDs.
See
[IEC
62563-1]
|
|
|
109905
|
BN02
Pattern
|
The
IEC
BN02
Pattern
is
used
as
analternative
to
the
TG18-LN-02
Pattern,
to
avoid
the
use
of
a
cone
or
baffle
with
LCDs.
See
[IEC
62563-1]
|
|
|
109906
|
BN03
Pattern
|
The
IEC
BN03
Pattern
is
used
as
analternative
to
the
TG18-LN-03
Pattern,
to
avoid
the
use
of
a
cone
or
baffle
with
LCDs.
See
[IEC
62563-1]
|
|
|
109907
|
BN04
Pattern
|
The
IEC
BN04
Pattern
is
used
as
analternative
to
the
TG18-LN-04
Pattern,
to
avoid
the
use
of
a
cone
or
baffle
with
LCDs.
See
[IEC
62563-1]
|
|
|
109908
|
BN05
Pattern
|
The
IEC
BN05
Pattern
is
used
as
analternative
to
the
TG18-LN-05
Pattern,
to
avoid
the
use
of
a
cone
or
baffle
with
LCDs.
See
[IEC
62563-1]
|
|
|
109909
|
BN06
Pattern
|
The
IEC
BN06
Pattern
is
used
as
analternative
to
the
TG18-LN-06
Pattern,
to
avoid
the
use
of
a
cone
or
baffle
with
LCDs.
See
[IEC
62563-1]
|
|
|
109910
|
BN07
Pattern
|
The
IEC
BN07
Pattern
is
used
as
analternative
to
the
TG18-LN-07
Pattern,
to
avoid
the
use
of
a
cone
or
baffle
with
LCDs.
See
[IEC
62563-1]
|
|
|
109911
|
BN08
Pattern
|
The
IEC
BN08
Pattern
is
used
as
analternative
to
the
TG18-LN-08
Pattern,
to
avoid
the
use
of
a
cone
or
baffle
with
LCDs.
See
[IEC
62563-1]
|
|
|
109912
|
BN09
Pattern
|
The
IEC
BN09
Pattern
is
used
as
analternative
to
the
TG18-LN-09
Pattern,
to
avoid
the
use
of
a
cone
or
baffle
with
LCDs.
See
[IEC
62563-1]
|
|
|
109913
|
BN10
Pattern
|
The
IEC
BN10
Pattern
is
used
as
analternative
to
the
TG18-LN-10
Pattern,
to
avoid
the
use
of
a
cone
or
baffle
with
LCDs.
See
[IEC
62563-1]
|
|
|
109914
|
BN11
Pattern
|
The
IEC
BN11
Pattern
is
used
as
analternative
to
the
TG18-LN-11
Pattern,
to
avoid
the
use
of
a
cone
or
baffle
with
LCDs.
See
[IEC
62563-1]
|
|
|
109915
|
BN12
Pattern
|
The
IEC
BN12
Pattern
is
used
as
analternative
to
the
TG18-LN-12
Pattern,
to
avoid
the
use
of
a
cone
or
baffle
with
LCDs.
See
[IEC
62563-1]
|
|
|
109916
|
BN13
Pattern
|
The
IEC
BN13
Pattern
is
used
as
analternative
to
the
TG18-LN-13
Pattern,
to
avoid
the
use
of
a
cone
or
baffle
with
LCDs.
See
[IEC
62563-1]
|
|
|
109917
|
BN14
Pattern
|
The
IEC
BN14
Pattern
is
used
as
analternative
to
the
TG18-LN-14
Pattern,
to
avoid
the
use
of
a
cone
or
baffle
with
LCDs.
See
[IEC
62563-1]
|
|
|
109918
|
BN15
Pattern
|
The
IEC
BN15
Pattern
is
used
as
analternative
to
the
TG18-LN-15
Pattern,
to
avoid
the
use
of
a
cone
or
baffle
with
LCDs.
See
[IEC
62563-1]
|
|
|
109919
|
BN16
Pattern
|
The
IEC
BN16
Pattern
is
used
as
analternative
to
the
TG18-LN-16
Pattern,
to
avoid
the
use
of
a
cone
or
baffle
with
LCDs.
See
[IEC
62563-1]
|
|
|
109920
|
BN17
Pattern
|
The
IEC
BN17
Pattern
is
used
as
analternative
to
the
TG18-LN-17
Pattern,
to
avoid
the
use
of
a
cone
or
baffle
with
LCDs.
See
[IEC
62563-1]
|
|
|
109921
|
BN18
Pattern
|
The
IEC
BN18
Pattern
is
used
as
analternative
to
the
TG18-LN-18
Pattern,
to
avoid
the
use
of
a
cone
or
baffle
with
LCDs.
See
[IEC
62563-1]
|
|
|
109931
|
DIN
Grayscale
Pattern
|
Test
image
"Bild
2"
for
the
gray-scale
reproduction
of
imaging
devices.
See
[DIN
6868-57]
|
|
|
109932
|
DIN
Geometry
Pattern
|
Test
image
"Bild
3"
for
the
geometrical
imaging
properties
of
imaging
devices.
See
[DIN
6868-57]
|
|
|
109933
|
DIN
Resolution
Pattern
|
Test
image
"Bild
5"
for
displaying
the
spatial
and
contrast
resolution
as
well
as
the
line
structure
of
imaging
devices.
See
[DIN
6868-57]
|
|
|
109941
|
White
Pattern
|
An
alternative
to
AAPM
TG18-UN80,
specified
at
100%
of
maximum
pixel
value
|
|
|
109943
|
SMPTE
Pattern
|
A
standard
display
test
pattern.
See
[SMPTE
RP133].
A
pattern
is
available
at
http://www.dclunie.com/images/smpte.512.512.8.gif
|
|
|
109991
|
CRT
Display
|
A
Display
Device
that
displays
images
on
a
Cathode
Ray
Tube
|
|
|
109992
|
Liquid
Crystal
Display
|
A
Display
Device
that
displays
images
on
a
Liquid
Crystal
Display
|
|
|
109993
|
Plasma
Display
|
A
Display
Device
that
displays
images
on
a
Plasma
Display
|
|
|
109994
|
OLED
|
A
Display
Device
that
displays
images
on
an
Organic
Light
Emitting
Diode
based
display
|
|
|
109995
|
DLP
Rear
Projection
System
|
A
Display
Device
that
projects
images
on
a
surface
from
behind
using
a
Digital
Light
Processing
Projector
|
|
|
109996
|
DLP
Front
Projection
System
|
A
Display
Device
that
projects
images
on
a
surface
from
in
front
using
a
Digital
Light
Processing
Projector
|
|
|
109997
|
CRT
Rear
Projection
System
|
A
Display
Device
that
projects
images
on
a
surface
from
behind
using
a
Cathode
Ray
Tube
|
|
|
109998
|
CRT
Front
Projection
System
|
A
Display
Device
that
projects
images
on
a
surface
from
in
front
using
a
Cathode
Ray
Tube
|
|
|
109999
|
Other
Projection
System
|
A
Display
Device
that
projects
images
on
a
surface
from
an
unspecified
direction
using
an
unspecified
means
|
|
|
110001
|
Image
Processing
|
Image
processing
work
item
|
|
|
110002
|
Quality
Control
|
Quality
control
work
item
|
|
|
110003
|
Computer
Aided
Diagnosis
|
Computer
aided
diagnosis
work
item
|
|
|
110004
|
Computer
Aided
Detection
|
Computer
aided
detection
work
item
|
|
|
110005
|
Interpretation
|
Interpretation
work
item
|
|
|
110006
|
Transcription
|
Transcription
work
item
|
|
|
110007
|
Report
Verification
|
Report
verification
work
item
|
|
|
110008
|
Print
|
Print
work
item
|
|
|
110009
|
No
subsequent
Workitems
|
There
will
be
no
more
work
items
scheduled
|
|
|
110010
|
Film
|
Film
type
of
output
|
|
|
110011
|
Dictation
|
Dictation
type
of
output
|
|
|
110012
|
Transcription
|
Transcription
type
of
output
|
|
|
110013
|
Media
Import
|
The
procedure
to
read
DICOM
instances
from
DICOM
interchange
media,
coerce
identifying
attributes
into
the
local
namespace
if
necessary,
and
make
the
instances
available
|
|
|
110020
|
Sheet
Film
Digitized
|
Digitization
of
Sheet
Film
|
|
|
110021
|
Cine
Film
Digitized
|
Digitization
of
Cine
Film
|
|
|
110022
|
Video
Tape
Digitized
|
Digitization
of
Video
Tape
|
|
|
110023
|
Paper
Digitized
|
Digitization
of
pages
of
a
paper
document
(Units
may
be
specified
as
Pages,
Documents)
|
|
|
110024
|
CD
Imported
|
Importation
of
CD
|
|
|
110025
|
DVD
Imported
|
Importation
of
DVD
|
|
|
110026
|
MOD
Imported
|
Importation
of
MOD
|
|
|
110027
|
Studies
Imported
|
Importation
of
DICOM
Studies
|
|
|
110028
|
Instances
Imported
|
Importation
of
DICOM
Composite
Instances
|
|
|
110030
|
USB
Disk
Emulation
|
A
device
that
connects
using
the
USB
hard
drive
interface.
These
may
be
USB-Sticks,
portable
hard
drives,
and
other
technologies
|
|
|
110031
|
Email
|
Email
and
email
attachments
used
as
a
media
for
data
transport
|
|
|
110032
|
CD
|
CD-R,
CD-ROM,
and
CD-RW
media
used
for
data
transport
|
|
|
110033
|
DVD
|
DVD,
DVD-RAM,
and
other
DVD
formatted
media
used
for
data
transport
|
|
|
110034
|
Compact
Flash
|
Media
that
comply
with
the
Compact
Flash
standard
|
|
|
110035
|
Multi-media
Card
|
Media
that
comply
with
the
Multi-media
Card
standard
|
|
|
110036
|
Secure
Digital
Card
|
Media
that
comply
with
the
Secure
Digital
Card
standard
|
|
|
110037
|
URI
|
URI
Identifier
for
network
or
other
resource,
see
RFC
3968
|
|
|
110038
|
Paper
Document
|
Any
paper
or
similar
document
|
|
|
110100
|
Application
Activity
|
Audit
event:
Application
Activity
has
taken
place
|
|
|
110101
|
Audit
Log
Used
|
Audit
event:
Audit
Log
has
been
used
|
|
|
110102
|
Begin
Transferring
DICOM
Instances
|
Audit
event:
Storage
of
DICOM
Instances
has
begun
|
|
|
110103
|
DICOM
Instances
Accessed
|
Audit
event:
DICOM
Instances
have
been
created,
read,
updated,
or
deleted
|
|
|
110104
|
DICOM
Instances
Transferred
|
Audit
event:
Storage
of
DICOM
Instances
has
been
completed
|
|
|
110105
|
DICOM
Study
Deleted
|
Audit
event:
Entire
Study
has
been
deleted
|
|
|
110106
|
Export
|
Audit
event:
Data
has
been
exported
out
of
the
system
|
|
|
110107
|
Import
|
Audit
event:
Data
has
been
imported
into
the
system
|
|
|
110108
|
Network
Entry
|
Audit
event:
System
has
joined
or
left
network
|
|
|
110109
|
Order
Record
|
Audit
event:
Order
has
been
created,
read,
updated
or
deleted
|
|
|
110110
|
Patient
Record
|
Audit
event:
Patient
Record
has
been
created,
read,
updated,
or
deleted
|
|
|
110111
|
Procedure
Record
|
Audit
event:
Procedure
Record
has
been
created,
read,
updated,
or
deleted
|
|
|
110112
|
Query
|
Audit
event:
Query
has
been
made
|
|
|
110113
|
Security
Alert
|
Audit
event:
Security
Alert
has
been
raised
|
|
|
110114
|
User
Authentication
|
Audit
event:
User
Authentication
has
been
attempted
|
|
|
110120
|
Application
Start
|
Audit
event:
Application
Entity
has
started
|
|
|
110121
|
Application
Stop
|
Audit
event:
Application
Entity
has
stopped
|
|
|
110122
|
Login
|
Audit
event:
User
login
has
been
attempted
|
|
|
110123
|
Logout
|
Audit
event:
User
logout
has
been
attempted
|
|
|
110124
|
Attach
|
Audit
event:
Node
has
been
attached
|
|
|
110125
|
Detach
|
Audit
event:
Node
has
been
detached
|
|
|
110126
|
Node
Authentication
|
Audit
event:
Node
Authentication
has
been
attempted
|
|
|
110127
|
Emergency
Override
Started
|
Audit
event:
Emergency
Override
has
started
|
|
|
110128
|
Network
Configuration
|
Audit
event:
Network
configuration
has
been
changed
|
|
|
110129
|
Security
Configuration
|
Audit
event:
Security
configuration
has
been
changed
|
|
|
110130
|
Hardware
Configuration
|
Audit
event:
Hardware
configuration
has
been
changed
|
|
|
110131
|
Software
Configuration
|
Audit
event:
Software
configuration
has
been
changed
|
|
|
110132
|
Use
of
Restricted
Function
|
Audit
event:
A
use
of
a
restricted
function
has
been
attempted
|
|
|
110133
|
Audit
Recording
Stopped
|
Audit
event:
Audit
recording
has
been
stopped
|
|
|
110134
|
Audit
Recording
Started
|
Audit
event:
Audit
recording
has
been
started
|
|
|
110135
|
Object
Security
Attributes
Changed
|
Audit
event:
Security
attributes
of
an
object
have
been
changed
|
|
|
110136
|
Security
Roles
Changed
|
Audit
event:
Security
roles
have
been
changed
|
|
|
110137
|
User
security
Attributes
Changed
|
Audit
event:
Security
attributes
of
a
user
have
been
changed
|
|
|
110138
|
Emergency
Override
Stopped
|
Audit
event:
Emergency
Override
has
Stopped
|
|
|
110139
|
Remote
Service
Operation
Started
|
Audit
event:
Remote
Service
Operation
has
Begun
|
|
|
110140
|
Remote
Service
Operation
Stopped
|
Audit
event:
Remote
Service
Operation
has
Stopped
|
|
|
110141
|
Local
Service
Operation
Started
|
Audit
event:
Local
Service
Operation
has
Begun
|
|
|
110142
|
Local
Service
Operation
Stopped
|
Audit
event:
Local
Service
Operation
Stopped
|
|
|
110150
|
Application
|
Audit
participant
role
ID
of
software
application
|
|
|
110151
|
Application
Launcher
|
Audit
participant
role
ID
of
software
application
launcher,
i.e.,
the
entity
that
started
or
stopped
an
application
|
|
|
110152
|
Destination
Role
ID
|
Audit
participant
role
ID
of
the
receiver
of
data
|
|
|
110153
|
Source
Role
ID
|
Audit
participant
role
ID
of
the
sender
of
data
|
|
|
110154
|
Destination
Media
|
Audit
participant
role
ID
of
media
receiving
data
during
an
export
|
|
|
110155
|
Source
Media
|
Audit
participant
role
ID
of
media
providing
data
during
an
import
|
|
|
110180
|
Study
Instance
UID
|
ParticipantObjectID
type:
Study
Instance
UID
|
|
|
110181
|
SOP
Class
UID
|
ParticipantObjectID
type:
SOP
Class
UID
|
|
|
110182
|
Node
ID
|
ID
of
a
node
that
is
a
participant
object
of
an
audit
message
|
|
|
110190
|
Issuer
of
Identifier
|
System,
organization,
agency,
or
department
that
has
assigned
an
instance
identifier
(such
as
placer
or
filler
number,
patient
or
provider
identifier,
etc.)
|
|
|
110500
|
Doctor
canceled
procedure
|
Procedure
order
canceled
by
requesting
physician
or
other
authorized
physician
|
|
|
110501
|
Equipment
failure
|
Equipment
failure
prevented
completion
of
procedure
|
|
|
110502
|
Incorrect
procedure
ordered
|
Procedure
discontinued
due
to
incorrect
procedure
being
ordered
|
|
|
110503
|
Patient
allergic
to
media/contrast
|
Procedure
discontinued
due
to
patient
allergy
to
media/contrast
(reported
or
reaction)
|
|
|
110504
|
Patient
died
|
Procedure
discontinued
due
to
death
of
Patient
|
|
|
110505
|
Patient
refused
to
continue
procedure
|
Procedure
discontinued
due
to
patient
refusal
to
continue
procedure
|
|
|
110506
|
Patient
taken
for
treatment
or
surgery
|
Procedure
discontinued
due
to
patient
being
taken
for
treatment
or
surgery
|
|
|
110507
|
Patient
did
not
arrive
|
Patient
did
not
arrive
for
procedure
|
|
|
110508
|
Patient
pregnant
|
Procedure
discontinued
due
to
patient
pregnancy
(reported
or
determined)
|
|
|
110509
|
Change
of
procedure
for
correct
charging
|
Procedure
discontinued
to
restart
with
new
procedure
code
for
correct
charging
|
|
|
110510
|
Duplicate
order
|
Procedure
discontinued
due
to
duplicate
orders
received
for
same
procedure
|
|
|
110511
|
Nursing
unit
cancel
|
Procedure
order
canceled
by
nursing
unit
|
|
|
110512
|
Incorrect
side
ordered
|
Procedure
discontinued
due
to
incorrect
side
(laterality)
being
ordered
|
|
|
110513
|
Discontinued
for
unspecified
reason
|
Procedure
discontinued
for
unspecified
reason
|
|
|
110514
|
Incorrect
worklist
entry
selected
|
Procedure
discontinued
due
to
incorrect
patient
or
procedure
step
selected
from
modality
worklist
|
|
|
110515
|
Patient
condition
prevented
continuing
|
Patient
condition
prevented
continuation
of
procedure
|
|
|
110516
|
Equipment
change
|
Procedure
step
is
discontinued
to
change
to
other
equipment
or
modality
|
|
|
110518
|
Patient
Movement
|
A
movement
of
the
patient
affecting
test
quality
|
|
|
110519
|
Operator
Error
|
An
error
of
the
operator
affecting
test
quality
|
|
|
110521
|
Objects
incorrectly
formatted
|
One
or
more
of
the
objects
is
malformed
|
|
|
110522
|
Object
Types
not
supported
|
Receiving
System
is
unable
to
accept
the
object
type
|
|
|
110523
|
Object
Set
incomplete
|
One
or
more
objects
associated
with
the
object
set
is
missing
|
|
|
110524
|
Media
Failure
|
The
contents
of
the
Media
could
not
be
accessed
properly
|
|
|
110526
|
Resource
pre-empted
|
Procedure
discontinued
due
to
necessary
equipment,
staff
or
other
resource
becoming
(temporarily)
unavailable
to
the
procedure
|
|
|
110527
|
Resource
inadequate
|
Procedure
discontinued
due
to
necessary
equipment,
staff
or
other
resource
being
inadequate
to
complete
the
procedure
|
|
|
110528
|
Discontinued
Procedure
Step
rescheduled
|
A
new
Procedure
Step
has
been
scheduled
to
replace
the
Discontinued
Procedure
Step
|
|
|
110529
|
Discontinued
Procedure
Step
rescheduling
recommended
|
It
is
recommended
that
a
new
Procedure
Step
be
scheduled
to
replace
the
Discontinued
Procedure
Step
|
|
|
110700
|
Ventral
Diencephalon
|
Ventral
structures
of
the
diencephalon
that
cannot
readily
be
distinguished
on
MR
imaging,
including
the
hypothalamus,
mammillary
body,
subthalamic
nuclei,
substantia
nigra,
red
nucleus,
lateral
geniculate
nucleus,
medial
geniculate
nucleus,
zona
incerta,
cerebral
peduncle,
lenticular
fasciculus,
medial
lemniscus,
and
optic
tract.
See
http://neuromorphometrics.org:8080/Seg/html/segmentation/ventral%20diencephalon.html
|
|
|
110701
|
White
Matter
T1
Hypointensity
|
Area(s)
of
reduced
intensity
on
T1
weighted
images
relative
to
the
surrounding
white
matter.
These
may
be
indicative
of
age-related
or
neurodegenerative
white
matter
lesions,
and
may
be
co-located
with
areas
of
white
matter
T2
hyperintensity,
but
the
concept
is
specifically
confined
to
the
MR
appearance
on
T1
weighted
images
|
|
|
110702
|
White
Matter
T2
Hyperintensity
|
Area(s)
of
increased
intensity
on
T2
weighted
images
relative
to
the
surrounding
white
matter.
These
may
be
indicative
of
age-related
or
neurodegenerative
white
matter
lesions,
and
may
be
co-located
with
areas
of
white
matter
T1
hypointensity,
but
the
concept
is
specifically
confined
to
the
MR
appearance
on
T2
weighted
images
|
|
|
110703
|
superior
longitudinal
fasciculus
I
|
The
dorsal
component
of
the
SLF
originating
from
the
medial
and
dorsal
parietal
cortex
and
ending
in
the
dorsal
and
medial
part
of
the
frontal
lobe.
See
Makris
N,
et
al.
"Segmentation
of
Subcomponents
within
the
Superior
Longitudinal
Fascicle
in
Humans:
A
Quantitative,
In
Vivo,
DT-MRI
Study."
Cerebral
Cortex
15,
no.
6
(June
1,
2005):
854-69.
doi:10.1093/cercor/bhh186
|
|
|
110704
|
superior
longitudinal
fasciculus
II
|
The
major
component
of
the
SLF,
derived
from
the
caudal-inferior
parietal
region
corresponding
to
the
angular
gyrus
in
the
human
and
terminating
within
the
dorsolateral
frontal
region.
See
Makris
N,
et
al.
"Segmentation
of
Subcomponents
within
the
Superior
Longitudinal
Fascicle
in
Humans:
A
Quantitative,
In
Vivo,
DT-MRI
Study."
Cerebral
Cortex
15,
no.
6
(June
1,
2005):
854-69.
doi:10.1093/cercor/bhh186
|
|
|
110705
|
superior
longitudinal
fasciculus
III
|
The
ventral
component
of
the
SLF,
originating
from
the
supramarginal
gyrus
and
terminating
predominantly
in
the
ventral
premotor
and
prefrontal
areas.
See
Makris
N,
et
al.
"Segmentation
of
Subcomponents
within
the
Superior
Longitudinal
Fascicle
in
Humans:
A
Quantitative,
In
Vivo,
DT-MRI
Study."
Cerebral
Cortex
15,
no.
6
(June
1,
2005):
854-69.
doi:10.1093/cercor/bhh186
|
|
|
110706
|
Perilesional
White
Matter
|
White
matter
that
surrounds
a
lesion
of
interest;
e.g.
to
identify
the
otherwise
unclassified
white
matter
that
surrounds
a
tumor
to
be
surgically
resected
|
|
|
110800
|
Spin
Tagging
Perfusion
MR
Signal
Intensity
|
Signal
intensity
of
a
Spin
tagging
Perfusion
MR
image.
Spin
tagging
is
a
technique
for
the
measurement
of
blood
perfusion,
based
on
magnetically
labeled
arterial
blood
water
as
an
endogenous
tracer
|
|
|
110801
|
Contrast
Agent
Angio
MR
Signal
Intensity
|
Signal
intensity
of
a
Contrast
Agent
Angio
MR
image
|
|
|
110802
|
Time
Of
Flight
Angio
MR
Signal
Intensity
|
Signal
intensity
of
a
Time-of-flight
(TOF)
MR
image.
Time-of-flight
(TOF)
is
based
on
the
phenomenon
of
flow-related
enhancement
of
spins
entering
into
an
imaging
slice.
As
a
result
of
being
unsaturated,
these
spins
give
more
signal
that
surrounding
stationary
spins
|
|
|
110803
|
Proton
Density
Weighted
MR
Signal
Intensity
|
Signal
intensity
of
a
Proton
Density
Weighted
MR
image.
All
MR
images
have
intensity
proportional
to
proton
density.
Images
with
very
little
T1
or
T2
weighting
are
called
'PD-weighted'
|
|
|
110804
|
T1
Weighted
MR
Signal
Intensity
|
Signal
intensity
of
T1
Weighted
MR
image.
A
T1
Weighted
MR
image
is
created
typically
by
using
short
TE
and
TR
times
|
|
|
110805
|
T2
Weighted
MR
Signal
Intensity
|
Signal
intensity
of
a
T2
Weighted
MR
image.
T2
Weighted
image
contrast
state
is
approached
by
imaging
with
a
TR
long
compared
to
tissue
T1
(to
reduce
T1
contribution
to
image
contrast)
and
a
TE
between
the
longest
and
shortest
tissue
T2s
of
interest
|
|
|
110806
|
T2*
Weighted
MR
Signal
Intensity
|
Signal
intensity
of
a
T2*
Weighted
MR
image.
The
T2*
phenomenon
results
from
molecular
interactions
(spin
spin
relaxation)
and
local
magnetic
field
non-uniformities,
which
cause
the
protons
to
precess
at
slightly
different
frequencies
|
|
|
110807
|
Field
Map
MR
Signal
Intensity
|
Signal
intensity
of
a
Field
Map
MR
image.
A
Field
Map
MR
image
provides
a
direct
measure
of
the
B
0
inhomogeneity
at
each
point
in
the
image
|
|
|
110808
|
Fractional
Anisotropy
|
Coefficient
reflecting
the
fractional
anisotropy
of
the
tissues,
derived
from
a
diffusion
weighted
MR
image.
Fractional
anisotropy
is
proportional
to
the
square
root
of
the
variance
of
the
Eigen
values
divided
by
the
square
root
of
the
sum
of
the
squares
of
the
Eigen
values
|
|
|
110809
|
Relative
Anisotropy
|
Coefficient
reflecting
the
relative
anisotropy
of
the
tissues,
derived
from
a
diffusion
weighted
MR
image
|
|
|
110810
|
Volumetric
Diffusion
Dxx
Component
|
Dxx
Component
of
the
diffusion
tensor,
quantifying
the
molecular
mobility
along
the
X
axis
|
|
|
110811
|
Volumetric
Diffusion
Dxy
Component
|
Dxy
Component
of
the
diffusion
tensor,
quantifying
the
correlation
of
molecular
displacements
in
the
X
and
Y
directions
|
|
|
110812
|
Volumetric
Diffusion
Dxz
Component
|
Dxz
Component
of
the
diffusion
tensor,
quantifying
the
correlation
of
molecular
displacements
in
the
X
and
Z
directions
|
|
|
110813
|
Volumetric
Diffusion
Dyy
Component
|
Dyy
Component
of
the
diffusion
tensor,
quantifying
the
molecular
mobility
along
the
Y
axis
|
|
|
110814
|
Volumetric
Diffusion
Dyz
Component
|
Dyz
Component
of
the
diffusion
tensor,
quantifying
the
correlation
of
molecular
displacements
in
the
Y
and
Z
directions
|
|
|
110815
|
Volumetric
Diffusion
Dzz
Component
|
Dzz
Component
of
the
diffusion
tensor,
quantifying
the
molecular
mobility
along
the
Z
axis
|
|
|
110816
|
T1
Weighted
Dynamic
Contrast
Enhanced
MR
Signal
Intensity
|
Signal
intensity
of
a
T1
Weighted
Dynamic
Contrast
Enhanced
MR
image.
A
T1
Weighted
Dynamic
Contrast
Enhanced
MR
image
reflects
the
dynamics
of
diffusion
of
the
exogenous
contrast
media
from
the
blood
pool
into
the
extra
vascular
extracellular
space
(EES)
of
the
brain
at
a
rate
determined
by
the
blood
flow
to
the
tissue,
the
permeability
of
the
Brain
Blood
Barrier
(BBB),
and
the
surface
area
of
the
perfusing
vessels
|
|
|
110817
|
T2
Weighted
Dynamic
Contrast
Enhanced
MR
Signal
Intensity
|
Signal
intensity
of
a
T2
Weighted
Dynamic
Contrast
Enhanced
MR
image.
A
T2
Weighted
Dynamic
Contrast
Enhanced
MR
image
reflects
the
T2
of
tissue
decrease
as
the
Gd
contrast
agent
bolus
passes
through
the
brain
|
|
|
110818
|
T2*
Weighted
Dynamic
Contrast
Enhanced
MR
Signal
Intensity
|
Signal
intensity
of
a
T2*
Weighted
Dynamic
Contrast
Enhanced
MR
image.
A
T2*
Weighted
Dynamic
Contrast
Enhanced
MR
image
reflects
the
T2*
of
tissue
decrease
as
the
Gd
contrast
agent
bolus
passes
through
the
brain
|
|
|
110819
|
Blood
Oxygenation
Level
|
Signal
intensity
of
a
Blood
Oxygenation
Level
image.
BOLD
imaging
is
sensitive
to
blood
oxygenation
(but
also
to
cerebral
blood
flow
and
volume).
This
modality
is
essentially
used
for
detecting
brain
activation
(functional
MR)
|
|
|
110820
|
Nuclear
Medicine
Projection
Activity
|
Accumulated
decay
event
counts
in
a
nuclear
medicine
projection
image
|
|
|
110821
|
Nuclear
Medicine
Tomographic
Activity
|
Accumulated
decay
event
counts
in
a
Nuclear
Medicine
Tomographic
image
(including
PET)
|
|
|
110822
|
Spatial
Displacement
X
Component
|
Spatial
Displacement
along
axis
X
of
a
non-linear
deformable
spatial
registration
image.
The
X
axis
is
defined
in
reference
to
the
patient's
orientation,
and
is
increasing
to
the
left
hand
side
of
the
patient
|
|
|
110823
|
Spatial
Displacement
Y
Component
|
Spatial
Displacement
along
axis
Y
of
a
non-linear
deformable
spatial
registration
image.
The
Y
axis
is
defined
in
reference
to
the
patient's
orientation,
and
is
increasing
to
the
posterior
side
of
the
patient
|
|
|
110824
|
Spatial
Displacement
Z
Component
|
Spatial
Displacement
along
axis
Z
of
a
non-linear
deformable
spatial
registration
image.
The
Z
axis
is
defined
in
reference
to
the
patient's
orientation,
and
is
increasing
toward
the
head
of
the
patient
|
|
|
110825
|
Hemodynamic
Resistance
|
Measured
resistance
to
the
flow
of
blood;
e.g.
through
the
vasculature
or
through
a
heart
value
|
|
|
110826
|
Indexed
Hemodynamic
Resistance
|
Measured
resistance
to
the
flow
of
blood;
e.g.
through
the
vasculature
or
through
a
heart
value,
normalized
to
a
particular
indexed
scale
|
|
|
110827
|
Tissue
Velocity
|
Velocity
of
tissue
based
on
Doppler
measurements
|
|
|
110828
|
Flow
Velocity
|
Velocity
of
blood
flow
based
on
Doppler
measurements
|
|
|
110829
|
Flow
Variance
|
Statistical
variance
of
blood
velocity
relative
to
mean
|
|
|
110830
|
Elasticity
|
Scalar
value
related
to
the
elastic
properties
of
the
tissue
|
|
|
110831
|
Perfusion
|
Scalar
value
related
to
the
volume
of
blood
perfusing
into
tissue
|
|
|
110832
|
Speed
of
sound
|
Speed
of
sound
in
tissue
|
|
|
110833
|
Ultrasound
Attenuation
|
Reduction
in
strength
of
ultrasound
signal
as
the
wave
|
|
|
110834
|
RGB
R
Component
|
Red
component
of
a
true
color
image
(RGB)
|
|
|
110835
|
RGB
G
Component
|
Green
component
of
a
true
color
image
(RGB)
|
|
|
110836
|
RGB
B
Component
|
Blue
component
of
a
true
color
image
(RGB)
|
|
|
110837
|
YBR
FULL
Y
Component
|
Y
(Luminance)
component
of
a
YBR
FULL
image,
as
defined
in
JPEG
2000
|
|
|
110838
|
YBR
FULL
CB
Component
|
CB
(Blue
chrominance)
component
of
a
YBR
FULL
image,
as
defined
in
JPEG
2000
|
|
|
110839
|
YBR
FULL
CR
Component
|
CR
(Red
chrominance)
component
of
a
YBR
FULL
image,
as
defined
in
JPEG
2000
|
|
|
110840
|
YBR
PARTIAL
Y
Component
|
Y
(Luminance)
component
of
a
YBR
PARTIAL
image,
as
defined
in
JPEG
2000
|
|
|
110841
|
YBR
PARTIAL
CB
Component
|
CB
(Blue
chrominance)
component
of
a
YBR
PARTIAL
image,
as
defined
in
JPEG
2000
|
|
|
110842
|
YBR
PARTIAL
CR
Component
|
CR
(Red
chrominance)
component
of
a
YBR
PARTIAL
image,
as
defined
in
JPEG
2000
|
|
|
110843
|
YBR
ICT
Y
Component
|
Y
(Luminance)
component
of
a
YBR
ICT
image
(Irreversible
Color
Transform),
as
defined
in
JPEG
2000
|
|
|
110844
|
YBR
ICT
CB
Component
|
CB
(Blue
chrominance)
component
of
a
YBR
ICT
image
(Irreversible
Color
Transform),
as
defined
in
JPEG
2000
|
|
|
110845
|
YBR
ICT
CR
Component
|
CR
(Red
chrominance)
component
of
a
YBR
ICT
image
(Irreversible
Color
Transform),
as
defined
in
JPEG
2000
|
|
|
110846
|
YBR
RCT
Y
Component
|
Y
(Luminance)
component
of
a
YBR
RCT
image
(Reversible
Color
Transform),
as
defined
in
JPEG
2000
|
|
|
110847
|
YBR
RCT
CB
Component
|
CB
(Blue
chrominance)
component
of
a
YBR
RCT
image
(Reversible
Color
Transform),
as
defined
in
JPEG
2000
|
|
|
110848
|
YBR
RCT
CR
Component
|
CR
(Red
chrominance)
component
of
a
YBR
RCT
image
(Reversible
Color
Transform),
as
defined
in
JPEG
2000
|
|
|
110849
|
Echogenicity
|
The
ability
of
a
material
to
create
an
ultrasound
return
echo
|
|
|
110850
|
X-Ray
Attenuation
|
Decrease
in
the
number
of
photons
in
an
X-Ray
beam
due
to
interactions
with
the
atoms
of
a
material
substance.
Attenuation
is
due
primarily
to
two
processes,
absorption
and
scattering
|
|
|
110851
|
X-Ray
Attenuation
Coefficient
|
Coefficient
that
describes
the
fraction
of
a
beam
of
X-Rays
or
gamma
rays
that
is
absorbed
or
scattered
per
unit
thickness
of
the
absorber.
This
value
basically
accounts
for
the
number
of
atoms
in
a
cubic
cm
volume
of
material
and
the
probability
of
a
photon
being
scattered
or
absorbed
from
the
nucleus
or
an
electron
of
one
of
these
atoms
|
|
|
110852
|
MR
signal
intensity
|
Signal
intensity
of
an
MR
image,
not
otherwise
specified
|
|
|
110853
|
Binary
Segmentation
|
Binary
value
denoting
that
the
segmented
property
is
present
|
|
|
110854
|
Fractional
Probabilistic
Segmentation
|
Probability,
defined
as
a
percentage,
that
the
segmented
property
occupies
the
spatial
area
defined
by
the
voxel
|
|
|
110855
|
Fractional
Occupancy
Segmentation
|
Percentage
of
the
voxel
area
occupied
by
the
segmented
property
|
|
|
110856
|
Linear
Displacement
|
Spatial
dimension,
denoting
a
linear
displacement
|
|
|
110857
|
Photon
Energy
|
Dimension
denoting
the
energy
(frequency
or
wavelength)
of
photons
|
|
|
110858
|
Time
|
Dimension
used
to
sequence
events,
to
compare
the
duration
of
events
and
the
intervals
between
events
|
|
|
110859
|
Angle
|
Spatial
dimension,
denoting
an
angle
|
|
|
110860
|
Left-Right
Axis
|
A
spatial
dimension
axis
running
along
a
line
between
the
patient's
left
and
right
side
|
|
|
110861
|
Head-Foot
Axis
|
A
spatial
dimension
axis
running
along
a
line
between
the
patient's
head
and
foot
|
|
|
110862
|
Anterior-Posterior
Axis
|
A
spatial
dimension
axis
running
along
a
line
between
the
patient's
anterior
and
posterior
sides
|
|
|
110863
|
Apex-Base
Axis
|
A
spatial
dimension
axis
running
along
a
line
between
the
apex
and
base
of
an
organ,
object,
or
chamber
|
|
|
110864
|
Anterior-Inferior
Axis
|
A
spatial
dimension
axis
running
along
a
line
between
the
anterior
and
inferior
sides
of
an
organ,
object,
or
chamber
|
|
|
110865
|
Septum-Wall
Axis
|
A
spatial
dimension
axis
running
along
a
line
between
the
septum
and
wall
of
a
chamber
|
|
|
110866
|
Right
To
Left
|
Orientation
of
a
spatial
dimension
where
increasing
values
run
from
the
right
to
the
left
side
of
the
patient
|
|
|
110867
|
Left
To
Right
|
Orientation
of
a
spatial
dimension
where
increasing
values
run
from
the
left
to
the
right
side
of
the
patient
|
|
|
110868
|
Head
To
Foot
|
Orientation
of
a
spatial
dimension
where
increasing
values
run
from
the
head
to
the
foot
of
the
patient
|
|
|
110869
|
Foot
To
Head
|
Orientation
of
a
spatial
dimension
where
increasing
values
run
from
the
foot
to
the
head
of
the
patient
|
|
|
110870
|
Anterior
To
Posterior
|
Orientation
of
a
spatial
dimension
where
increasing
values
run
from
the
anterior
to
the
posterior
side
of
the
patient
|
|
|
110871
|
Posterior
To
Anterior
|
Orientation
of
a
spatial
dimension
where
increasing
values
run
from
the
posterior
to
the
anterior
side
of
the
patient
|
|
|
110872
|
Apex
To
Base
|
Orientation
of
a
spatial
dimension
where
increasing
values
run
from
the
apex
to
the
base
|
|
|
110873
|
Base
To
Apex
|
Orientation
of
a
spatial
dimension
where
increasing
values
run
from
the
base
to
the
apex
|
|
|
110874
|
Anterior
To
Inferior
|
Orientation
of
a
spatial
dimension
where
increasing
values
run
from
the
anterior
to
the
inferior
|
|
|
110875
|
Inferior
To
Anterior
|
Orientation
of
a
spatial
dimension
where
increasing
values
run
from
the
inferior
to
the
anterior
|
|
|
110876
|
Septum
To
Wall
|
Orientation
of
a
spatial
dimension
where
increasing
values
run
from
the
septum
of
a
chamber
to
the
opposite
wall
|
|
|
110877
|
Wall
To
Septum
|
Orientation
of
a
spatial
dimension
where
increasing
values
run
from
the
opposite
wall
to
the
septum
of
a
chamber
|
|
|
110901
|
Image
Position
(Patient)
X
|
The
x
coordinate
of
the
upper
left
hand
corner
(center
of
the
first
voxel
transmitted)
of
the
image,
with
respect
to
the
patient-based
coordinate
system
|
|
|
110902
|
Image
Position
(Patient)
Y
|
The
y
coordinate
of
the
upper
left
hand
corner
(center
of
the
first
voxel
transmitted)
of
the
image,
with
respect
to
the
patient-based
coordinate
system
|
|
|
110903
|
Image
Position
(Patient)
Z
|
The
z
coordinate
of
the
upper
left
hand
corner
(center
of
the
first
voxel
transmitted)
of
the
image,
with
respect
to
the
patient-based
coordinate
system
|
|
|
110904
|
Image
Orientation
(Patient)
Row
X
|
The
x
value
of
the
first
row
direction
cosine
with
respect
to
the
patient,
with
respect
to
the
patient-based
coordinate
system
|
|
|
110905
|
Image
Orientation
(Patient)
Row
Y
|
The
y
value
of
the
first
row
direction
cosine
with
respect
to
the
patient,
with
respect
to
the
patient-based
coordinate
system
|
|
|
110906
|
Image
Orientation
(Patient)
Row
Z
|
The
z
value
of
the
first
row
direction
cosine
with
respect
to
the
patient,
with
respect
to
the
patient-based
coordinate
system
|
|
|
110907
|
Image
Orientation
(Patient)
Column
X
|
The
x
value
of
the
first
column
direction
cosine
with
respect
to
the
patient,
with
respect
to
the
patient-based
coordinate
system
|
|
|
110908
|
Image
Orientation
(Patient)
Column
Y
|
The
y
value
of
the
first
column
direction
cosine
with
respect
to
the
patient,
with
respect
to
the
patient-based
coordinate
system
|
|
|
110909
|
Image
Orientation
(Patient)
Column
Z
|
The
z
value
of
the
first
column
direction
cosine
with
respect
to
the
patient,
with
respect
to
the
patient-based
coordinate
system
|
|
|
110910
|
Pixel
Data
Rows
|
Number
of
rows
in
the
pixel
data
of
the
image
|
|
|
110911
|
Pixel
Data
Columns
|
Number
of
columns
in
the
pixel
data
of
the
image
|
|
|
111001
|
Algorithm
Name
|
The
name
assigned
by
a
manufacturer
to
a
specific
software
algorithm
|
|
|
111002
|
Algorithm
Parameters
|
The
input
parameters
used
by
a
manufacturer
to
configure
the
behavior
of
a
specific
software
algorithm
|
|
|
111003
|
Algorithm
Version
|
The
software
version
identifier
assigned
by
a
manufacturer
to
a
specific
software
algorithm
|
|
|
111004
|
Analysis
Performed
|
The
type
of
correlation
applied
to
detection
results;
e.g.
temporal,
spatial
|
|
|
111005
|
Assessment
Category
|
Assignment
of
intermediate
or
overall
interpretation
results
to
a
general
category
|
|
|
111006
|
Breast
composition
|
Assessment
of
annotating
tissues
in
breast;
generally
including
fatty,
mixed
or
dense
|
|
|
111007
|
Breast
Outline
including
Pectoral
Muscle
Tissue
|
Purpose
of
reference
for
an
SCOORD
content
item
that
is
an
outline
of
the
breast
that
includes
the
pectoral
muscle
tissue
|
Purpose
of
Reference
for
content
item
of
value
type
COMPOSITE
or
SCOORD
|
|
111008
|
Calcification
Distribution
|
The
type
of
distribution
associated
with
detected
calcifications
|
|
|
111009
|
Calcification
Type
|
Identification
of
the
morphology
of
detected
calcifications
|
|
|
111010
|
Center
|
Purpose
of
reference
for
an
SCOORD
content
item
that
identifies
the
central
point
of
a
finding
or
feature
|
Purpose
of
Reference
for
content
item
of
value
type
COMPOSITE
or
SCOORD
|
|
111011
|
Certainty
of
Feature
|
The
likelihood
that
the
feature
analyzed
is
in
fact
the
type
of
feature
identified
|
|
|
111012
|
Certainty
of
Finding
|
The
likelihood
that
the
finding
detected
is
in
fact
the
type
of
finding
identified
|
|
|
111013
|
Certainty
of
Impression
|
The
certainty
that
a
device
places
on
an
impression,
where
0
equals
no
certainty
and
100
equals
certainty
|
|
|
111014
|
Clockface
or
region
|
A
location
identifier
based
on
clock-face
numbering
or
anatomic
sub-region
|
|
|
111015
|
Composite
Feature
|
An
item
that
is
an
inferred
correlation
relating
two
or
more
individual
findings
or
features
|
|
|
111016
|
Composite
type
|
The
inferred
relationship
between
the
findings
or
features
making
up
a
composite
feature
|
|
|
111017
|
CAD
Processing
and
Findings
Summary
|
General
assessment
of
whether
or
not
CAD
processing
was
successful,
and
whether
any
findings
resulted
|
|
|
111018
|
Content
Date
|
The
date
the
data
creation
started
|
|
|
111019
|
Content
Time
|
The
time
the
data
creation
started
|
|
|
111020
|
Depth
|
A
location
identifier
based
on
a
feature's
inferred
distance
from
the
surface
of
the
associated
anatomy
|
|
|
111021
|
Description
of
Change
|
A
textual
description
of
the
change
that
occurred
over
time
in
a
qualitative
characteristic
of
a
feature
|
|
|
111022
|
Detection
Performed
|
The
type
of
finding
sought
after
by
a
specific
algorithm
applied
to
one
image
|
|
|
111023
|
Differential
Diagnosis/Impression
|
A
general
change
that
occurred
within
an
imaged
area
between
a
prior
imaging
procedure
and
the
current
imaging
procedure
|
|
|
111024
|
Failed
Analyses
|
A
group
of
analysis
algorithms
that
were
attempted,
but
failed
|
|
|
111025
|
Failed
Detections
|
A
group
of
detection
algorithms
that
were
attempted,
but
failed
|
|
|
111026
|
Horizontal
Pixel
Spacing
|
For
projection
radiography,
the
horizontal
physical
distance
measured
at
the
front
plane
of
an
Image
Receptor
housing
between
the
center
of
each
pixel.
For
tomographic
images,
the
horizontal
physical
distance
in
the
patient
between
the
center
of
each
pixel
|
|
|
111027
|
Image
Laterality
|
Laterality
of
(possibly
paired)
body
part
contained
in
an
image
|
|
|
111028
|
Image
Library
|
A
container
that
references
all
image
data
used
as
evidence
to
produce
a
report
|
|
|
111029
|
Image
Quality
Rating
|
A
numeric
value
in
the
range
0
to
100,
inclusive,
where
0
is
worst
quality
and
100
is
best
quality
|
|
|
111030
|
Image
Region
|
Purpose
of
reference
for
an
SCOORD
content
item
that
identifies
a
specific
region
of
interest
within
an
image
|
Purpose
of
Reference
for
content
item
of
value
type
COMPOSITE
or
SCOORD
|
|
111031
|
Image
View
|
The
projection
of
the
anatomic
region
of
interest
on
an
image
receptor
|
|
|
111032
|
Image
View
Modifier
|
Modifier
for
Image
View
|
|
|
111033
|
Impression
Description
|
Free-form
text
describing
the
overall
or
an
individual
impression
|
|
|
111034
|
Individual
Impression/Recommendation
|
A
container
for
a
group
of
related
results
from
interpretation
of
one
or
more
images
and
associated
clinical
information
|
|
|
111035
|
Lesion
Density
|
The
X-Ray
attenuation
of
a
lesion
relative
to
the
expected
attenuation
of
an
equal
volume
of
fibroglandular
breast
tissue
|
|
|
111036
|
Mammography
CAD
Report
|
A
structured
report
containing
the
results
of
computer-aided
detection
or
diagnosis
applied
to
breast
imaging
and
associated
clinical
information
|
|
|
111037
|
Margins
|
The
characteristic
of
the
boundary,
edges
or
border
of
a
detected
lesion
|
|
|
111038
|
Number
of
calcifications
|
The
quantity
of
calcifications
detected
within
an
identified
group
or
cluster
|
|
|
111039
|
Object
type
|
A
non-lesion
object
identified
within
one
or
more
images
|
|
|
111040
|
Original
Source
|
Purpose
of
reference
for
a
COMPOSITE
content
item
that
identifies
it
as
the
original
source
of
evidence
for
another
content
item
in
the
report
|
Purpose
of
Reference
for
content
item
of
value
type
COMPOSITE
or
SCOORD
|
|
111041
|
Outline
|
Purpose
of
reference
for
an
SCOORD
content
item
that
identifies
the
outline
or
bounding
region
of
a
finding
or
feature
|
Purpose
of
Reference
for
content
item
of
value
type
COMPOSITE
or
SCOORD
|
|
111042
|
Pathology
|
The
inferred
type
of
disease
associated
with
an
identified
feature
|
|
|
111043
|
Patient
Orientation
Column
|
The
patient
orientation
relative
to
the
image
plane,
specified
by
a
value
that
designates
the
anatomical
direction
of
the
positive
column
axis
(top
to
bottom)
|
|
|
111044
|
Patient
Orientation
Row
|
The
patient
orientation
relative
to
the
image
plane,
specified
by
a
value
that
designates
the
anatomical
direction
of
the
positive
row
axis
(left
to
right)
|
|
|
111045
|
Pectoral
Muscle
Outline
|
Purpose
of
reference
for
an
SCOORD
content
item
that
is
an
outline
of
the
pectoral
muscle
tissue
only
|
Purpose
of
Reference
for
content
item
of
value
type
COMPOSITE
or
SCOORD
|
|
111046
|
Percent
Fibroglandular
Tissue
|
Percent
of
breast
area
that
is
mammographically
dense,
excluding
pectoralis
muscle
|
|
|
111047
|
Probability
of
cancer
|
The
likelihood
that
an
identified
finding
or
feature
is
cancerous
|
|
|
111048
|
Quadrant
location
|
A
location
identifier
based
on
the
division
of
an
area
into
four
regions
|
|
|
111049
|
Qualitative
Difference
|
A
qualitative
characteristic
of
a
feature
that
has
changed
over
time
|
|
|
111050
|
Quality
Assessment
|
The
effect
of
the
quality
of
an
image
on
its
usability
|
|
|
111051
|
Quality
Control
Standard
|
The
quality
control
standard
used
to
make
a
quality
assessment
|
|
|
111052
|
Quality
Finding
|
A
specific
quality
related
deficiency
detected
within
an
image
|
|
|
111053
|
Recommended
Follow-up
|
Recommended
type
of
follow-up
to
an
imaging
procedure,
based
on
interpreted
results
|
|
|
111054
|
Recommended
Follow-up
Date
|
Recommended
follow-up
date
to
an
imaging
procedure,
based
on
interpreted
results
|
|
|
111055
|
Recommended
Follow-up
Interval
|
Recommended
follow-up
interval
to
an
imaging
procedure,
based
on
interpreted
results
|
|
|
111056
|
Rendering
Intent
|
The
recommendation
of
the
producer
of
a
content
item
regarding
presentation
of
the
content
item
by
recipients
of
the
report
|
|
|
111057
|
Scope
of
Feature
|
An
indication
of
how
widespread
the
detection
of
a
feature
is
within
the
analyzed
image
data
set
|
|
|
111058
|
Selected
Region
Description
|
A
textual
description
of
the
contents
of
a
selected
region
identified
within
an
image
|
|
|
111059
|
Single
Image
Finding
|
An
item
that
was
detected
on
one
image
|
|
|
111060
|
Study
Date
|
Date
on
which
the
acquisition
of
the
study
information
was
started
|
|
|
111061
|
Study
Time
|
Time
at
which
the
acquisition
of
the
study
information
was
started
|
|
|
111062
|
Successful
Analyses
|
A
group
of
analysis
algorithms
that
were
attempted
and
completed
successfully
|
|
|
111063
|
Successful
Detections
|
A
group
of
detection
algorithms
that
were
attempted
and
completed
successfully
|
|
|
111064
|
Summary
of
Detections
|
An
overall
indication
of
whether
the
CAD
detection
algorithms
applied
were
completed
successfully
|
|
|
111065
|
Summary
of
Analyses
|
An
overall
indication
of
whether
the
CAD
analysis
algorithms
applied
were
completed
successfully
|
|
|
111066
|
Vertical
Pixel
Spacing
|
For
projection
radiography,
the
vertical
physical
distance
measured
at
the
front
plane
of
an
Image
Receptor
housing
between
the
center
of
each
pixel.
For
tomographic
images,
the
vertical
physical
distance
in
the
patient
between
the
center
of
each
pixel
|
|
|
111069
|
Crosstable
|
A
radiographic
projection
that
has
been
with
the
patient
lying
on
a
table
with
the
X-Ray
source
on
one
side
of
the
table
and
the
detector
on
the
other;
e.g.
may
describe
a
cross-table
cervical
spine,
chest
or
pelvis
X-Ray
image
|
|
|
111071
|
CAD
Operating
Point
|
One
of
a
number
of
discrete
points
on
the
Receiver-Operator
Characteristics
(ROC)
curve
that
reflects
the
expected
sensitivity
and
specificity
of
a
CAD
algorithm,
where
zero
indicates
the
highest
specificity,
lowest
sensitivity
operating
point.
The
value
should
not
exceed
the
Maximum
CAD
Operating
Point
|
|
|
111072
|
Maximum
CAD
Operating
Point
|
The
maximum
value
of
CAD
Operating
Point
for
the
specific
CAD
algorithm
used
|
|
|
111081
|
CAD
Operating
Point
Description
|
The
intended
interpretation
of
a
CAD
Operating
Point
|
|
|
111086
|
False
Markers
per
Image
|
The
number
of
false
CAD
markers
per
image.
Correlates
to
inverse
of
Image
Specificity
|
|
|
111087
|
False
Markers
per
Case
|
The
number
of
false
markers
per
collection
of
images
that
are
CAD
processed
as
a
group.
Correlates
to
inverse
of
Case
Specificity
|
|
|
111088
|
Case
Sensitivity
|
The
percentage
of
cancers
that
should
be
detected
by
a
CAD
algorithm
where
CAD
marks
the
cancers
in
at
least
one
view
|
|
|
111089
|
Lesion
Sensitivity
|
The
percentage
of
cancers
that
should
be
detected
by
a
CAD
algorithm
where
CAD
marks
the
cancers
in
each
view
|
|
|
111090
|
Case
Specificity
|
The
percentage
of
cases
(collections
of
images
CAD
processed
as
a
group)
without
cancer
that
have
no
CAD
findings
whatsoever.
Correlates
to
inverse
of
False
Markers
per
Case
|
|
|
111091
|
Image
Specificity
|
The
percentage
of
images
without
cancer
that
have
no
CAD
findings
whatsoever.
Correlates
to
inverse
of
False
Markers
per
Image
|
|
|
111092
|
Recommended
CAD
Operating
Point
|
The
CAD
operating
point
that
is
recommended
for
initial
display
by
the
creator
of
the
structured
report
|
|
|
111093
|
CAD
Operating
Point
Table
|
A
list
of
CAD
operating
points
including
their
corresponding
characteristics
|
|
|
111099
|
Selected
region
|
A
specific
area
of
interest
noted
within
an
image
|
|
|
111100
|
Breast
geometry
|
The
surface
shape
of
all
or
a
portion
of
breast
related
anatomy
|
|
|
111101
|
Image
Quality
|
Image
quality
incorporates
the
following
clinical
image
evaluation
parameters:
assessment
of
positioning,
compression,
artifacts,
exposure,
contrast,
sharpness,
and
labeling
|
|
|
111102
|
Non-lesion
|
A
finding
or
feature
that
is
identified
as
a
non-anatomic
foreign
object
|
|
|
111103
|
Density
|
A
space-occupying
lesion
identified
in
a
single
image
or
projection
|
|
|
111104
|
Individual
Calcification
|
A
single
identified
calcification
|
|
|
111105
|
Calcification
Cluster
|
Multiple
calcifications
identified
as
occupying
a
small
area
of
tissue
(less
than
2
cc)
|
|
|
111111
|
Cooper's
ligament
changes
|
Straightening
or
thickening
of
Cooper's
ligaments
|
|
|
111112
|
Mass
in
the
skin
|
An
abnormality
noted
at
imaging
within
the
dermis
of
the
breast
|
|
|
111113
|
Mass
on
the
skin
|
An
abnormality
noted
at
imaging
on
the
epidermis
of
the
breast
|
|
|
111120
|
Post
Procedure
Mammograms
for
Marker
Placement
|
An
assessment
category
to
indicate
that
images
have
been
acquired
to
assess
marker
placement
following
a
breast
interventional
procedure
|
|
|
111121
|
Follow-up
post
biopsy
as
directed
by
clinician
|
An
indication
that
the
patient
should
seek
post
procedural
follow-up
directives
from
a
clinical
health
care
provider
|
|
|
111122
|
Known
biopsy
proven
malignancy
-
take
appropriate
action
|
A
recommendation
on
a
patient
with
known
cancer
to
take
steps
appropriate
to
the
diagnosis
|
|
|
111123
|
Marker
placement
|
Positioning
of
a
radiopaque
marker
|
|
|
111124
|
Personal
history
of
breast
cancer
with
mastectomy
|
Patient
has
previous
diagnosis
of
breast
cancer
resulting
in
mastectomy
|
|
|
111125
|
Known
biopsy
proven
malignancy
|
Patient
has
had
biopsy
containing
proven
malignancy
|
|
|
111126
|
Image
detected
mass
|
Patient
has
a
finding
of
mass
reported
on
a
prior
imaging
exam
|
|
|
111127
|
Targeted
|
A
breast
imaging
procedure
performed
on
a
specific
area
of
the
breast
|
|
|
111128
|
Survey
|
A
breast
imaging
procedure
performed
on
the
entire
breast
|
|
|
111129
|
Clustered
microcysts
|
A
cluster
of
tiny
anechoic
foci
each
smaller
than
2-3
mm
in
diameter
with
thin
(less
than
0.5
mm)
intervening
septations
and
no
discrete
solid
components
|
|
|
111130
|
Complicated
cyst
|
A
fluid
filled
mass
most
commonly
characterized
by
homogeneous
low-level
internal
echoes
on
ultrasound
|
|
|
111135
|
Additional
projections
|
Views
not
inclusive
of
MLO
and
CC
(BI-RADS®)
|
|
|
111136
|
Spot
magnification
view(s)
|
A
spot
or
coned
down
compression
of
the
breast
providing
a
reduction
in
the
thickness
and
a
magnification
of
the
localized
area
of
interest
and
improved
separation
of
breast
tissue
|
|
|
111137
|
Ultrasound
|
Use
of
sound
waves
to
visualize
muscles,
tendons,
and
many
internal
organs,
to
capture
their
size,
structure
and
any
pathological
lesions
with
real
time
tomographic
images.
|
|
|
111138
|
Old
films
for
comparison
|
Obtain
previous
mammography
studies
to
compare
to
present
study
|
|
|
111139
|
Ductography
|
A
medical
procedure
used
for
the
sampling
of
mammary
duct
tissue
|
|
|
111140
|
Normal
interval
follow-up
|
Follow
up
study
at
12
months
for
women
40
years
of
age
having
a
prior
negative
study
and
no
mitigating
risk
factors
for
breast
cancer
|
|
|
111141
|
Any
decision
to
biopsy
should
be
based
on
clinical
assessment
|
Any
decision
to
perform
tissue
acquisition
should
be
based
on
clinical
assessment
|
|
|
111142
|
Follow-up
at
short
interval
(1-11
months)
|
Follow-up
at
short
interval
(1-11
months)
|
|
|
111143
|
Biopsy
should
be
considered
|
Tissue
acquisition
should
be
considered
|
|
|
111144
|
Needle
localization
and
biopsy
|
Breast
tissue
acquisition
following
the
identification
of
an
area
of
concern
with
the
placement
of
a
needle
or
needle-wire
assembly
|
|
|
111145
|
Histology
using
core
biopsy
|
Pathologic
analysis
of
breast
tissue
and
lesions
using
core
tissue
samples
|
|
|
111146
|
Suggestive
of
malignancy
-
take
appropriate
action
|
Lesions
that
do
not
have
the
characteristic
morphologies
of
breast
cancer
but
have
a
definite
probability
of
being
malignant.
There
is
a
sufficient
concern
to
urge
a
biopsy
|
|
|
111147
|
Cytologic
analysis
|
Cellular
analysis
of
specimen
|
|
|
111148
|
Biopsy
should
be
strongly
considered
|
Tissue
acquisition
should
be
strongly
considered
|
|
|
111149
|
Highly
suggestive
of
malignancy
-
take
appropriate
action
|
Lesions
have
a
high
probability
of
being
cancer,
which
require
additional
action
|
|
|
111150
|
Presentation
Required:
Rendering
device
is
expected
to
present
|
The
producer
of
a
report
intends
for
a
recipient
of
the
report
to
present
or
display
the
associated
content
item
|
|
|
111151
|
Presentation
Optional:
Rendering
device
may
present
|
The
producer
of
a
report
considers
the
presentation
or
display
of
the
associated
content
item
by
a
recipient
to
be
optional
|
|
|
111152
|
Not
for
Presentation:
Rendering
device
expected
not
to
present
|
The
producer
of
a
report
intends
for
a
recipient
of
the
report
NOT
to
present
or
display
the
associated
content
item
|
|
|
111153
|
Target
content
items
are
related
temporally
|
The
associated
content
items
are
identified
as
being
the
same
finding
or
feature
at
different
points
in
time
|
|
|
111154
|
Target
content
items
are
related
spatially
|
The
associated
content
items
are
identified
as
being
the
same
finding
or
feature
on
different
projections
taken
at
the
same
point
in
time
|
|
|
111155
|
Target
content
items
are
related
contra-laterally
|
The
associated
content
items
are
identified
as
being
related
side-to-side
|
|
|
111156
|
Feature
detected
on
the
only
image
|
There
is
one
image
in
the
interpreted
data
set
|
|
|
111157
|
Feature
detected
on
only
one
of
the
images
|
There
is
more
than
one
image
of
the
same
modality
in
the
interpreted
data
set
|
|
|
111158
|
Feature
detected
on
multiple
images
|
There
is
more
than
one
image
of
the
same
modality
in
the
interpreted
data
set
|
|
|
111159
|
Feature
detected
on
images
from
multiple
modalities
|
The
interpreted
data
set
contains
images
from
multiple
modalities
|
|
|
111168
|
Scar
tissue
|
The
fibrous
tissue
replacing
normal
tissues
destroyed
by
disease
or
injury
|
|
|
111170
|
J
Wire
|
A
medical
appliance
used
for
localization
of
non
palpable
breast
lesions
to
insure
that
the
proper
area
is
removed
in
a
surgical
biopsy
|
|
|
111171
|
Pacemaker
|
A
medical
appliance
used
for
regulating
cardiac
rhythms
|
|
|
111172
|
Paddle
|
A
compression
device
used
for
obtaining
mammographic
images
|
|
|
111173
|
Collimator
|
A
device
used
for
restricting
an
X-Ray
beam
|
|
|
111174
|
ID
Plate
|
An
area
designated
on
a
radiographic
film
for
facility
and
patient
ID
information
|
|
|
111175
|
Other
Marker
|
Site
specific
markers
|
|
|
111176
|
Unspecified
|
The
value
of
the
concept
is
not
specified
|
This
term
may
not
be
used
in
Context
Group
Extensions;
see
Section
7.2.3
|
|
111177
|
View
and
Laterality
Marker
is
missing
|
Image
quality
deficiency
according
to
MQSA
|
|
|
111178
|
View
and
Laterality
Marker
does
not
have
both
view
and
laterality
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111179
|
View
and
Laterality
Marker
does
not
have
approved
codes
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111180
|
View
and
Laterality
Marker
is
not
near
the
axilla
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111181
|
View
and
Laterality
Marker
overlaps
breast
tissue
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111182
|
View
and
Laterality
Marker
is
partially
obscured
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111183
|
View
and
Laterality
Marker
is
incorrect
|
Image
quality
deficiency
|
|
|
111184
|
View
and
Laterality
Marker
is
off
image
|
Image
quality
deficiency
|
|
|
111185
|
Flash
is
not
near
edge
of
film
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111186
|
Flash
is
illigible,
does
not
fit,
or
is
lopsided
|
Image
quality
deficiency
according
to
MQSA
|
|
|
111187
|
Flash
doesn't
include
patient
name
and
additional
patient
id
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111188
|
Flash
doesn't
include
date
of
examination
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111189
|
Flash
doesn't
include
facility
name
and
location
|
Image
quality
deficiency
according
to
MQSA
|
|
|
111190
|
Flash
doesn't
include
technologist
identification
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111191
|
Flash
doesn't
include
cassette/screen/detector
identification
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111192
|
Flash
doesn't
include
mammography
unit
identification
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111193
|
Date
sticker
is
missing
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111194
|
Technical
factors
missing
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111195
|
Collimation
too
close
to
breast
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111196
|
Inadequate
compression
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111197
|
MLO
Insufficient
pectoral
muscle
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111198
|
MLO
No
fat
is
visualized
posterior
to
fibroglandular
tissues
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111199
|
MLO
Poor
separation
of
deep
and
superficial
breast
tissues
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111200
|
MLO
Evidence
of
motion
blur
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111201
|
MLO
Inframammary
fold
is
not
open
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111202
|
CC
Not
all
medial
tissue
visualized
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111203
|
CC
Nipple
not
centered
on
image
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111204
|
CC
Posterior
nipple
line
does
not
measure
within
1
cm
of
MLO
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111205
|
Nipple
not
in
profile
|
Image
quality
deficiency
|
|
|
111206
|
Insufficient
implant
displacement
incorrect
|
Image
quality
deficiency
according
to
MQCM
|
|
|
111207
|
Image
artifact(s)
|
Signals
that
do
not
faithfully
reproduce
actual
anatomic
structures
because
of
distortion
or
of
addition
or
deletion
of
information
|
|
|
111208
|
Grid
artifact(s)
|
Feature(s)
arising
from
the
acquisition
unit's
anti-scatter
grid
mechanism.
For
two-dimensional
systems,
such
features
include
those
of
mechanically
damaged
or
incorrectly
positioned
grids.
For
moving
or
Bucky
grids,
artifacts
may
result
from
intentional
grid
motion
that
is
inadequate
in
duration
or
velocity
uniformity
|
|
|
111209
|
Positioning
|
Inadequate
arrangement
of
the
anatomy
of
interest
with
respect
to
the
X-Ray
field
and
image
detector
sensitive
area.
Examples:
1)
positioning
is
"cutoff"
when
the
projection
of
anatomy
of
interest
falls
outside
the
sensitive
area
of
the
detector;
2)
"cone
cut",
in
which
the
X-Ray
field
does
not
adequately
cover
the
anatomy
of
interest;
3)
detector's
sensitive
surface
is
too
small
to
cover
the
projection
of
the
anatomy
of
interest;
4)
improper
angular
orientation
or
"rotation"
of
anatomy
of
interest
with
respect
to
the
X-Ray
source,
or
detector;
5)
projection
of
other
anatomy
or
clothing
over
the
anatomy
of
interest
in
the
image
|
|
|
111210
|
Motion
blur
|
Unacceptable
image
blur
resulting
from
motion
of
the
anatomy
of
interest
during
exposure
or
the
inadequately
compensated
motion
of
X-Ray
source
with
respect
to
the
image
detector
during
exposure
|
|
|
111211
|
Under
exposed
|
Inadequate
number
of
quanta
reached
the
detector
during
exposure.
Reasons
for
under
exposed
images
include
low
kVp,
low
mAs
product,
excess
Source
Image
Distance.
Under
exposed
images
have
inadequate
signal
and
higher
noise
in
the
areas
of
interest
|
|
|
111212
|
Over
exposed
|
An
excess
number
of
quanta
reached
the
detector
during
exposure.
Reasons
for
over
exposed
images
include
high
kVp,
high
mAs
product,
short
Source
Image
Distance.
Over
exposed
images
have
high
signal
and
lower
noise
in
the
areas
of
interest.
Over
exposed
area
may
demonstrate
lack
of
contrast
from
over
saturation
of
the
detector
|
|
|
111213
|
No
image
|
No
evidence
of
a
patient
exposure
|
|
|
111214
|
Detector
artifact(s)
|
Superposed
features
or
flaws
of
the
detector
|
|
|
111215
|
Artifact(s)
other
than
grid
or
detector
artifact
|
Features
or
discontinuities
arising
from
causes
other
than
the
anti-scatter
grid
and
image
detector
|
|
|
111216
|
Mechanical
failure
|
Failure
of
the
device
to
operate
according
to
mechanical
design
specifications
|
|
|
111217
|
Electrical
failure
|
Failure
of
a
device
to
operate
according
to
electrical
design
specifications
|
|
|
111218
|
Software
failure
|
Attributable
to
software
used
in
generation
or
handling
of
image
|
|
|
111219
|
Inappropriate
image
processing
|
Images
processed
inappropriately,
not
following
appropriate
protocol
|
|
|
111220
|
Other
failure
|
Failure
that
is
not
mechanical
or
electrical
or
otherwise
described
|
|
|
111221
|
Unknown
failure
|
Unidentified
or
unknown
cause
of
failure
|
|
|
111222
|
Succeeded
|
The
attempted
process
was
completely
successful
|
|
|
111223
|
Partially
Succeeded
|
The
attempted
process
succeeded
in
some
ways,
but
failed
in
others
|
|
|
111224
|
Failed
|
The
attempted
process
completely
failed
|
|
|
111225
|
Not
Attempted
|
No
process
was
performed
|
|
|
111233
|
Individual
Impression
/
Recommendation
Analysis
|
Analysis
of
a
related
group
of
findings
or
features
detected
during
image
data
inspection,
to
produce
a
summary
impression
and/or
recommendation
|
|
|
111234
|
Overall
Impression
/
Recommendation
Analysis
|
Analysis
of
all
groups
of
findings
or
features,
to
produce
a
single
impression
and/or
recommendation
|
|
|
111235
|
Unusable
-
Quality
renders
image
unusable
|
The
usability
of
an
image
for
diagnostic
interpretation
or
CAD,
based
on
a
quality
control
standard
|
|
|
111236
|
Usable
-
Does
not
meet
the
quality
control
standard
|
The
usability
of
an
image
for
diagnostic
interpretation
or
CAD,
based
on
a
quality
control
standard
|
|
|
111237
|
Usable
-
Meets
the
quality
control
standard
|
The
usability
of
an
image
for
diagnostic
interpretation
or
CAD,
based
on
a
quality
control
standard
|
|
|
111238
|
Mammography
Quality
Control
Manual
1999,
ACR
|
An
image
quality
control
standard
specified
by
the
American
College
of
Radiology
|
|
|
111239
|
Title
21
CFR
Section
900,
Subpart
B
|
An
image
quality
control
standard
in
the
US
Code
of
Federal
Regulations
|
|
|
111240
|
Institutionally
defined
quality
control
standard
|
An
image
quality
control
standard
specified
or
adopted
by
the
institution
responsible
for
the
document
|
|
|
111241
|
All
algorithms
succeeded;
without
findings
|
No
findings
resulted
upon
successful
completion
of
all
attempted
computer-aided
detection
and/or
analysis
|
|
|
111242
|
All
algorithms
succeeded;
with
findings
|
One
or
more
findings
resulted
upon
successful
completion
of
all
attempted
computer-aided
detection
and/or
analysis
|
|
|
111243
|
Not
all
algorithms
succeeded;
without
findings
|
No
findings
resulted
from
the
attempted
computer-aided
detection
and/or
analysis,
but
one
or
more
failures
occurred
in
the
process
|
|
|
111244
|
Not
all
algorithms
succeeded;
with
findings
|
One
or
more
findings
resulted
from
the
attempted
computer-aided
detection
and/or
analysis,
but
one
or
more
failures
occurred
in
the
process
|
|
|
111245
|
No
algorithms
succeeded;
without
findings
|
All
of
the
attempted
computer-aided
detection
and/or
analysis
failed,
so
there
could
be
no
findings
|
|
|
111248
|
Adenolipoma
|
A
benign
tumor
having
glandular
characteristics
but
composed
of
fat,
with
the
presence
of
normal
mammary
ducts
|
|
|
111249
|
Ductal
hyperplasia
|
Hyperplasia
is
also
known
as
epithelial
hyperplasia
or
proliferative
breast
disease.
It's
an
overgrowth
of
the
cells
that
line
the
ducts
or
the
lobules.
Based
on
how
the
cells
look
under
a
microscope,
the
hyperplasia
is
called
either
ductal
hyperplasia
(also
called
duct
epithelial
hyperplasia)
or
lobular
hyperplasia.
Based
on
the
pattern
of
the
cells,
hyperplasia
may
be
called
usual
or
atypical.
In
usual
hyperplasia,
the
pattern
of
cells
is
very
close
to
normal.
Atypical
hyperplasia
(or
hyperplasia
with
atypia)
is
a
term
used
when
the
cells
are
more
distorted.
FROM:
http://www.cancer.org/healthy/findcancerearly/womenshealth/non-cancerousbreastconditions/non-cancerous-breast-conditions-hyperplasia
|
|
|
111250
|
Adenomyoepithelioma
|
Neoplasms
composed
of
myoepithelial
cells
|
|
|
111251
|
Normal
axillary
node
|
Axillary
node
that
is
normal
in
appearance
with
no
associated
pathology
|
|
|
111252
|
Axillary
node
with
calcifications
|
Axillary
node
containing
calcifications
|
|
|
111253
|
Axillary
node
hyperplasia
|
Excessive
proliferation
of
normal
tissue
arrangement
of
the
axillary
node
|
|
|
111254
|
Asynchronous
involution
|
|
|
|
111255
|
Benign
cyst
with
blood
|
Cyst
with
benign
morphology
containing
blood
|
|
|
111256
|
Benign
Calcifications
|
Calcifications
having
typically
benign
morphology.
They
are
not
of
intermediate
or
high
probability
of
concern
for
malignancy
|
|
|
111257
|
Intracystic
papilloma
|
Growing
within
a
cystic
adenoma,
filling
the
cavity
with
a
mass
of
branching
epithelial
processes
|
|
|
111258
|
Ductal
adenoma
|
Adenoma
located
in
mammary
duct,
present
as
discrete
sclerotic
nodules,
solitary
or
multiple
|
|
|
111259
|
Diabetic
fibrous
mastopathy
|
The
occurrence
of
fibrous
tumor-forming
stromal
proliferation
in
patients
with
diabetes
mellitus
|
|
|
111260
|
Extra
abdominal
desmoid
|
A
deep
seated
firm
tumor
frequently
occurring
on
the
chest
consisting
of
collagenous
tissue
that
infiltrates
surround
muscle;
frequently
recurs
but
does
not
metastasize
|
|
|
111262
|
Epidermal
inclusion
cyst
|
A
cyst
formed
of
a
mass
of
epithelial
cells,
as
a
result
of
trauma
has
been
pushed
beneath
the
epidermis.
The
cyst
is
lined
with
squamous
epithelium
and
contains
concentric
layers
or
keratin
|
|
|
111263
|
Fibroadenomatoid
hyperplasia
|
Excessive
proliferation
of
fibroadenoma
tissue
|
|
|
111264
|
Fibroadenolipoma
|
A
lipoma
with
an
abundant
stroma
of
fibrous
tissue
|
|
|
111265
|
Foreign
body
(reaction)
|
|
|
|
111269
|
Galactocele
|
Retention
cyst
caused
by
occlusion
of
a
lactiferous
duct
|
|
|
111271
|
Hemangioma
-
nonparenchymal,
subcutaneous
|
A
congenital
anomaly
that
leads
to
a
proliferation
of
blood
vessels
leading
to
a
mass
that
resembles
a
neoplasm,
not
located
in
parenchymal
areas
but
subcutaneous
|
|
|
111273
|
Hyperplasia,
usual
|
Hyperplasia
is
also
known
as
epithelial
hyperplasia
or
proliferative
breast
disease.
It's
an
overgrowth
of
the
cells
that
line
the
ducts
or
the
lobules.
Based
on
how
the
cells
look
under
a
microscope,
the
hyperplasia
is
called
either
ductal
hyperplasia
(also
called
duct
epithelial
hyperplasia)
or
lobular
hyperplasia.
FROM:
http://www.cancer.org/healthy/findcancerearly/womenshealth/non-cancerousbreastconditions/non-cancerous-breast-conditions-hyperplasia
|
|
|
111277
|
Juvenile
papillomatosis
|
A
form
of
fibrocystic
disease
in
young
woman
with
florid
and
sclerosing
adenosis
that
microscopically
may
suggest
carcinoma
|
|
|
111278
|
Lactating
adenoma
|
Enlarging
masses
during
lactation.
A
circumscribed
benign
tumor
composed
primarily
of
glandular
structures
with
scanty
stroma,
with
prominent
secretory
changes
in
the
duct
|
|
|
111279
|
Lactational
change
|
Changes
related
to
the
process
of
lactation
|
|
|
111281
|
Large
duct
papilloma
|
A
papilloma
pertaining
to
large
mammary
duct
|
|
|
111283
|
Myofibroblastoma
|
Solitary
or
multiple
tumors
of
muscles
and
fibrous
tissues,
or
tumors
composed
of
myofibroblasts
|
|
|
111284
|
Microglandular
adenosis
|
Irregular
clusters
of
small
tubules
are
present
in
adipose
or
fibrous
tissue,
resembling
tubular
carcinoma
but
lacking
stromal
fibroblastic
proliferation
|
|
|
111285
|
Multiple
Intraductal
Papillomas
|
Papilloma
typically
involving
an
aggregate
of
adjacent
ducts
in
the
periphery
of
the
breast,
likely
representing
involvement
of
several
foci
of
one
or
two
duct
systems
|
|
|
111286
|
No
abnormality
|
No
abnormality
|
|
|
111287
|
Normal
breast
tissue
|
Normal
breast
tissue
|
|
|
111288
|
Neurofibromatosis
|
Condition
in
which
there
are
tumors
of
various
sizes
on
peripheral
nerves.
They
may
be
neuromas
or
fibromas
|
|
|
111290
|
Oil
cyst
(fat
necrosis
cyst)
|
A
cyst
resulting
from
the
loss
of
the
epithelial
lining
of
a
sebaceous
dermoid
or
lacteal
cyst
|
|
|
111291
|
Post
reduction
mammoplasty
|
Breast
tissue
with
characteristics
of
a
benign
nature,
following
breast
reduction
surgery
|
|
|
111292
|
Pseudoangiomatous
stromal
hyperplasia
|
A
benign
stromal
lesion
composed
of
intermixed
stromal
and
epithelial
elements.
The
lobular
and
duct
structures
of
the
breast
parenchyma
are
separated
by
an
increased
amount
of
stroma,
non
specific
proliferative
epithelial
changes
include
hyperplasia
of
duct
and
lobular
epithelium
often
with
accentuation
of
myoepithelial
cells
and
aprocine
metaplasia
with
or
without
cyst
formation
|
|
|
111293
|
Radial
scar
|
An
nonencapsulated
stellate
lesion
consisting
of
a
fibroelastic
core
and
radiating
bands
of
fibrous
connective
tissue
containing
lobules
manifesting
adenosis
and
ducts
with
papillary
or
diffuse
intraductal
hyperplasia
|
|
|
111294
|
Sclerosing
adenosis
|
Prominent
interductal
fibrosis
of
the
terminal
ductules
|
|
|
111296
|
Silicone
granuloma
|
Nodular
inflammatory
lesions
due
to
the
presence
of
silicone
in
the
breast
tissue
|
|
|
111297
|
Nipple
Characteristic
|
The
morphologic
status
of
the
nipple
|
|
|
111298
|
Virginal
hyperplasia
|
Spontaneous
excessive
proliferation
of
breast
tissue,
usually
found
in
younger
women
|
|
|
111299
|
Peripheral
duct
papillomas
|
Papilloma(s)
pertaining
the
peripheral
ducts
|
|
|
111300
|
Axillary
node
with
lymphoma
|
Axillary
node
with
lymphoid
tissue
neoplasm
|
|
|
111301
|
Axillary
nodal
metastases
|
Metastatic
disease
to
the
axillary
node
|
|
|
111302
|
Angiosarcoma
|
A
malignant
neoplasm
occurring
most
often
in
breast
and
skin,
believed
to
originate
from
endothelial
cells
of
blood
vessels,
microscopically
composed
of
closely
packed
round
or
spindle
shaped
cells,
some
of
which
line
small
spaces
resembling
vascular
clefts
|
|
|
111303
|
Blood
vessel
(vascular)
invasion
|
Histological
changes
to
the
vascular
system
related
to
an
invasive
process
|
|
|
111304
|
Carcinoma
in
children
|
Carcinoma
of
the
breast
found
in
patients
less
than
20
years
of
age
|
|
|
111305
|
Carcinoma
in
ectopic
breast
|
A
carcinoma
found
in
supernumerary
breasts
and
aberrant
breast
tissue
|
|
|
111306
|
Carcinoma
with
endocrine
differentiation
|
A
carcinoma
that
synthesizes
substances,
including
hormones,
not
considered
to
be
normal
products
of
the
breast
|
|
|
111307
|
Basal
cell
carcinoma
of
nipple
|
A
basal
cell
carcinoma
that
arises
in
the
nipple
of
the
breast
|
|
|
111308
|
Carcinoma
with
metaplasia
|
Metaplastic
carcinoma
is
cancer
that
begins
in
cells
that
have
changed
into
another
cell
type
(for
example,
a
squamous
cell
of
the
esophagus
changing
to
resemble
a
cell
of
the
stomach).
In
some
cases,
metaplastic
changes
alone
may
mean
there
is
an
increased
chance
of
cancer
developing
at
the
site.
Metaplastic
carcinoma
is
a
relatively
uncommon
type
of
cancer
with
treatment
generally
similar
to
that
of
invasive
ductal
carcinoma
of
no
special
type.[1]
FROM:
https://en.wikipedia.org/wiki/Metaplastic_carcinoma
|
|
|
111309
|
Cartilaginous
and
osseous
change
|
Tissue
changes
to
bones
and
cartilage
|
|
|
111310
|
Carcinoma
in
pregnancy
and
lactation
|
Carcinoma
of
the
breast
presenting
during
pregnancy
or
lactation
|
|
|
111311
|
Carcinosarcoma
|
A
malignant
neoplasm
that
contains
elements
of
carcinoma
and
sarcoma,
so
extensively
intermixed
as
to
indicate
neoplasia
of
epithelial
and
mesenchymal
tissue
|
|
|
111312
|
Intraductal
comedocarcinoma
with
necrosis
|
Comedocarcinoma
of
a
duct
with
areas
of
necrotic
tissue
|
|
|
111313
|
Intraductal
carcinoma,
low
grade
|
A
non-invasive
carcinoma
restricted
to
the
glandular
lumen
characterized
by
less
aggressive
malignant
cytologic
features
and
behavior
|
|
|
111314
|
Intraductal
carcinoma
micro-papillary
|
Papillary
and
micropapillary
Ductal
Carcinoma
In
Situ
(DCIS):
the
cancer
cells
arrange
themselves
in
a
fern-like
pattern
within
the
affected
breast
ducts;
micropapillary
DCIS
cells
are
smaller
than
papillary
DCIS
cells.
FROM:
http://www.imaginis.com/breast-cancer-diagnosis/ductal-carcinoma-in-situ-dcis-3
|
|
|
111315
|
Intracystic
papillary
carcinoma
|
A
malignant
neoplasm
characterized
by
the
formation
of
numerous,
irregular,
finger-like
projections
of
fibrous
stroma
that
is
covered
with
a
surface
layer
of
neoplastic
epithelial
cells
found
in
a
cyst
|
|
|
111316
|
Invasive
and
in-situ
carcinoma
|
Carcinoma
with
both
characteristics
of
localized
and
spreading
disease
|
|
|
111317
|
Invasive
lobular
carcinoma
|
Invasive
lobular
carcinoma
is
a
type
of
breast
cancer
that
begins
in
the
milk-producing
glands
(lobules)
of
the
breast.
Invasive
cancer
means
the
cancer
cells
have
broken
out
of
the
lobule
where
they
began
and
have
the
potential
to
spread
to
the
lymph
nodes
and
other
areas
of
the
body.
Invasive
lobular
carcinoma
typically
doesn't
form
a
lump,
which
is
common
in
breast
cancer.
Instead,
there
is
a
change
in
the
breast
that
feels
like
a
thickening
or
fullness
in
one
part
of
the
breast
and
is
different
from
the
surrounding
breast
tissue.
FROM:
http://www.mayoclinic.org/diseases-conditions/invasive-lobular-carcinoma/basics/definition/con-20033968
|
|
|
111318
|
Leukemic
infiltration
|
Mammary
infiltrates
as
a
secondary
manifestation
in
patients
with
established
leukemia
|
|
|
111320
|
Lympathic
vessel
invasion
|
Histological
changes
to
the
lymphatic
system
related
to
an
invasive
process
|
|
|
111321
|
Lymphoma
|
A
heterogeneous
group
of
neoplasms
arising
in
the
reticuloendoethelial
and
lymphatic
systems
|
|
|
111322
|
Occult
carcinoma
presenting
with
axillary
lymph
node
metastases
|
A
small
carcinoma,
either
asymptomatic
or
giving
rise
to
metastases
without
symptoms
due
to
the
primary
carcinoma
presenting
with
metastatic
disease
in
the
axillary
lymph
nodes
|
|
|
111323
|
Metastatic
cancer
to
the
breast
|
A
malignant
lesion
in
the
breast
with
morphologic
patterns
not
typical
of
breast
carcinoma
arising
from
a
non-mammary
malignant
neoplasm
|
|
|
111324
|
Metastatic
cancer
to
the
breast
from
the
colon
|
A
malignant
lesion
in
the
breast
with
morphologic
patterns
not
typical
of
breast
carcinoma
arising
from
a
neoplasm
in
the
colon
|
|
|
111325
|
Metastatic
cancer
to
the
breast
from
the
lung
|
A
malignant
lesion
in
the
breast
with
morphologic
patterns
not
typical
of
breast
carcinoma
arising
from
a
neoplasm
in
the
lung
|
|
|
111326
|
Metastatic
melanoma
to
the
breast
|
A
malignant
lesion
in
the
breast
with
morphologic
patterns
not
typical
of
breast
carcinoma
arising
from
a
melanoma
|
|
|
111327
|
Metastatic
cancer
to
the
breast
from
the
ovary
|
A
malignant
lesion
in
the
breast
with
morphologic
patterns
not
typical
of
breast
carcinoma
arising
from
a
neoplasm
in
the
ovary
|
|
|
111328
|
Metastatic
sarcoma
to
the
breast
|
A
malignant
lesion
in
the
breast
with
morphologic
patterns
not
typical
of
breast
carcinoma
arising
from
a
sarcoma
|
|
|
111329
|
Multifocal
intraductal
carcinoma
|
Multiple
foci
of
non-invasive
carcinoma
restricted
to
the
glandular
lumen
|
|
|
111330
|
Metastatic
disease
to
axillary
node
|
A
malignant
lesion
in
an
axillary
node
arising
from
a
non-axillary
neoplasm
|
|
|
111331
|
Malignant
fibrous
histiocytoma
|
Pleomorphic
undifferentiated
sarcoma
(abbreviated
PUS),
also
undifferentiated
pleomorphic
sarcoma
and
previously
malignant
fibrous
histiocytoma
(abbreviated
MFH),
is
a
type
of
soft
tissue
sarcoma.
FROM:
https://en.wikipedia.org/wiki/Pleomorphic_undifferentiated_sarcoma
|
|
|
111332
|
Multifocal
invasive
ductal
carcinoma
|
Multiple
sites
of
ductal
carcinoma
|
|
|
111333
|
Metastasis
to
an
intramammary
lymph
node
|
A
malignant
lesion
in
a
intramammary
lymph
node
arising
from
a
non-intramammary
lymph
node
neoplasm
|
|
|
111334
|
Malignant
melanoma
of
nipple
|
A
malignant
melanoma
of
the
skin
that
arises
in
the
nipple
of
the
breast
|
|
|
111335
|
Neoplasm
of
the
mammary
skin
|
|
|
|
111336
|
Papillary
carcinoma
in-situ
|
Papillary
and
micropapillary
Ductal
Carcinoma
In
Situ
(DCIS):
the
cancer
cells
arrange
themselves
in
a
fern-like
pattern
within
the
affected
breast
ducts;
micropapillary
DCIS
cells
are
smaller
than
papillary
DCIS
cells.
FROM:
http://www.imaginis.com/breast-cancer-diagnosis/ductal-carcinoma-in-situ-dcis-3
|
|
|
111338
|
Recurrent
malignancy
|
Recurrent
malignancy
|
|
|
111340
|
Squamous
cell
carcinoma
of
the
nipple
|
Squamous
cell
carcinoma
to
the
terminal
portion
of
the
alveolar
|
|
|
111341
|
Intraductal
carcinoma,
high
grade
|
A
non-invasive
carcinoma
restricted
to
the
glandular
lumen
characterized
by
more
aggressive
malignant
cytologic
features
and
behavior
|
|
|
111342
|
Invasive
cribriform
carcinoma
|
Invasive
tumor
with
cribriform
pattern
similar
to
cribriform
DCIS.
Low
grade,
cribriform
appearance
(well
defined
spaces
formed
by
arches
of
cells)
similar
to
cribriform
DCIS
but
with
larger
cells,
more
cytoplasm
and
more
vesicular
nuclei:
Tumor
cells
are
small,
often
have
apical
snouts,
mild/moderate
nuclear
pleomorphism;
Also
stromal
invasion
by
islands
of
cells,
often
angulated;
May
have
predominantly
solid
appearance;
Associated
with
cribriform
DCIS;
Often
mixed
with
tubular
carcinoma.
FROM:
http://www.pathologyoutlines.com/topic/breastmalignantcribriform.html
|
|
|
111343
|
Angular
margins
|
An
indication
that
some
or
all
of
the
margin
of
a
lesion
has
sharp
corners,
often
forming
acute
angles
|
|
|
111344
|
Fine
pleomorphic
calcification
|
Calcifications
that
vary
in
sizes
and
shapes
and
are
usually
smaller
than0.5
mm
in
diameter
|
|
|
111345
|
Macrocalcifications
|
Coarse
calcifications
that
are
0.5
mm
or
greater
in
size
|
|
|
111346
|
Calcifications
within
a
mass
|
An
indicator
that
calcifications
are
imbedded
within
a
mass
|
|
|
111347
|
Calcifications
outside
of
a
mass
|
An
indicator
that
calcifications
are
imaged
outside
of
a
mass
finding
|
|
|
111350
|
Breast
background
echotexture
|
Tissue
composition
of
the
breast
noted
on
sonography
|
|
|
111351
|
Homogeneous
fat
echotexture
|
Fat
lobules
and
uniformly
echogenic
bands
of
supporting
structures
comprise
the
bulk
of
breast
tissue
|
|
|
111352
|
Homogeneous
fibroglandular
echotexture
|
A
uniformly
echogenic
layer
of
fibroglandular
tissue
is
seen
beneath
a
thin
layer
of
subcutaneous
fat
|
|
|
111353
|
Heterogeneous
echotexture
|
The
breast
texture
is
characterized
by
multiple
small
areas
of
increased
and
decreased
echogenicity
|
|
|
111354
|
Orientation
|
Referential
relationship
of
the
finding
to
the
imaging
device
as
noted
on
sonography
|
|
|
111355
|
Parallel
|
The
long
axis
of
a
lesion
parallels
the
skin
line
("wider-than-tall"
or
in
a
horizontal
orientation)
|
|
|
111356
|
Not
parallel
|
The
anterior-posterior
or
vertical
dimension
is
greater
than
the
transverse
or
horizontal
dimension
|
|
|
111357
|
Lesion
boundary
|
The
lesion
boundary
describes
the
transition
zone
between
themas
and
the
surrounding
tissue
|
|
|
111358
|
Abrupt
interface
|
The
sharp
demarcation
between
the
lesion
and
surrounding
tissue
can
be
imperceptible
or
a
distinct
well-defined
echogenic
rim
of
any
thickness
|
|
|
111359
|
Echogenic
halo
|
There
is
no
sharp
demarcation
between
the
mass
and
the
surrounding
tissue,
which
is
bridged
by
an
echogenic
transition
zone
|
|
|
111360
|
Echo
pattern
|
An
imaging
characteristic
of
resonance
noted
during
sonography
|
|
|
111361
|
Anechoic
|
Without
internal
echoes
|
|
|
111362
|
Hyperechoic
|
Having
increased
echogenicity
relative
to
fat
or
equal
to
fibroglandular
tissue
|
|
|
111363
|
Complex
|
Mass
contains
both
anechoic
and
echogenic
components
|
|
|
111364
|
Hypoechoic
|
Defined
relative
to
fat;
masses
are
characterized
by
low-level
echoes
throughout;
e.g.
appearance
of
a
complicated
cyst
or
fibroadenoma
|
|
|
111365
|
Isoechoic
|
Having
the
same
echogenicity
as
fat
(a
complicated
cyst
or
fibroadenoma
may
be
isoechoic
or
hypoechoic)
|
|
|
111366
|
Posterior
acoustic
features
|
The
attenuation
characteristics
of
a
mass
with
respect
to
its
acoustic
transmission
|
|
|
111367
|
No
posterior
acoustic
features
|
No
posterior
shadowing
or
enhancement
|
|
|
111368
|
Posterior
enhancement
|
Increased
posterior
echoes
|
|
|
111369
|
Posterior
shadowing
|
Decreased
posterior
echoes;
edge
shadows
are
excluded
|
|
|
111370
|
Combined
posterior
enhancement
and
shadowing
|
More
than
one
pattern
of
posterior
attenuation,
both
shadowing
and
enhancement
|
|
|
111371
|
Identifiable
effect
on
surrounding
tissues
|
Sonographic
appearance
of
adjacent
structures
relative
to
a
mass
finding
|
|
|
111372
|
Vascularity
|
Characterization
of
vascularization
in
region
of
interest
|
|
|
111373
|
Vascularity
not
present
|
Vascularity
not
evident,
such
as
on
ultrasound
|
|
|
111374
|
Vascularity
not
assessed
|
Vascularity
not
evaluated
|
|
|
111375
|
Vascularity
present
in
lesion
|
Vascularity
on
imaging
is
seen
within
a
lesion
|
|
|
111376
|
Vascularity
present
immediately
adjacent
to
lesion
|
Vascularity
on
imaging
is
seen
immediately
adjacent
to
a
lesion
|
|
|
111377
|
Diffusely
increased
vascularity
in
surrounding
tissue
|
Vascularity
on
imaging
is
considered
diffusely
elevated
within
the
surrounding
breast
tissue
|
|
|
111380
|
Correlation
to
other
Findings
|
Relationship
of
the
new
anomaly
to
other
clinical
or
imaging
anomalies
|
|
|
111381
|
Correlates
to
physical
exam
findings
|
An
indication
that
the
current
imaging
finding
relates
to
a
finding
from
a
clinical
breast
exam
|
|
|
111382
|
Correlates
to
mammography
findings
|
An
indication
that
the
current
imaging
finding
relates
to
a
finding
from
a
mammography
exam
|
|
|
111383
|
Correlates
to
MRI
findings
|
An
indication
that
the
current
imaging
finding
relates
to
a
finding
from
a
breast
MRI
exam
|
|
|
111384
|
Correlates
to
ultrasound
findings
|
An
indication
that
the
current
imaging
finding
relates
to
a
finding
from
a
breast
ultrasound
exam
|
|
|
111385
|
Correlates
to
other
imaging
findings
|
An
indication
that
the
current
imaging
finding
relates
to
a
finding
from
an
imaging
exam
|
|
|
111386
|
No
correlation
to
other
imaging
findings
|
An
indication
that
the
current
imaging
finding
has
no
relation
to
findings
from
any
other
imaging
exam
|
|
|
111387
|
No
correlation
to
clinical
findings
|
An
indication
that
the
current
imaging
finding
has
no
relation
to
any
other
clinical
findings
|
|
|
111388
|
Malignancy
Type
|
Classification
of
the
cancer
as
invasive,
DCIS,
or
other
|
|
|
111389
|
Invasive
breast
carcinoma
|
A
malignancy
that
has
spread
beyond
an
area
of
focus
|
|
|
111390
|
Other
malignancy
type
|
A
breast
cancer
with
malignant
pathology
findings
that
are
not
classified
as
invasive
or
in
situ
|
|
|
111391
|
Menstrual
Cycle
Phase
|
A
specific
timeframe
during
menses
|
|
|
111392
|
1st
week
|
In
the
first
week
of
the
menstrual
cycle
phase,
that
is,
one
week
following
menses
|
|
|
111393
|
2nd
week
|
In
the
second
week
of
the
menstrual
cycle
phase,
that
is,
two
weeks
following
menses
|
|
|
111394
|
3rd
week
|
In
the
third
week
of
the
menstrual
cycle
phase,
that
is,
three
weeks
following
menses
|
|
|
111395
|
Estimated
Timeframe
|
An
estimated
period
of
time
|
|
|
111396
|
<
3
months
ago
|
An
event
occurred
less
than
3
months
ago
|
|
|
111397
|
4
months
to
1
year
ago
|
An
event
occurred
between
4
months
and
1
year
ago
|
|
|
111398
|
>
1
year
ago
|
An
event
occurred
longer
than
1
year
ago
|
|
|
111399
|
Timeframe
uncertain
|
The
timing
of
an
event
is
not
recalled
|
|
|
111400
|
Breast
Imaging
Report
|
Report
title
for
the
diagnostic
report
for
one
or
more
breast
imaging
or
intervention
procedures
|
|
|
111401
|
Reason
for
procedure
|
Concept
name
for
the
description
of
why
a
procedure
has
been
performed
|
|
|
111402
|
Clinical
Finding
|
A
finding
during
clinical
examination
(i.e.,
history
and
physical
examination)
such
as
pain,
palpable
mass
or
discharge
|
|
|
111403
|
Baseline
screening
mammogram
|
First
screening
mammogram
taken
for
patient
that
is
used
as
a
comparison
baseline
for
further
examinations
|
|
|
111404
|
First
mammogram
ever
|
First
mammogram
taken
for
a
patient
without
regard
to
whether
it
was
for
screening
or
a
diagnostic
procedure
|
|
|
111405
|
Implant
type
|
Concept
name
for
the
material
of
which
a
breast
prosthetic
device
is
constructed
|
|
|
111406
|
Number
of
similar
findings
|
A
numeric
count
of
findings
classified
as
similar
in
nature
|
|
|
111407
|
Implant
finding
|
Concept
name
for
the
status
of
a
breast
prosthetic
device
as
noted
by
imaging
|
|
|
111408
|
Film
Screen
Mammography
|
Mammogram
using
traditional
X-Ray
film
|
|
|
111409
|
Digital
Mammography
|
Mammogram
using
a
digital
image
acquisition
system
|
|
|
111410
|
Surgical
consult
|
Referred
for
evaluation
by
a
surgeon
|
|
|
111411
|
Mammography
CAD
|
Computer
aided
detection
and/or
computer
aided
diagnosis
for
mammography
|
|
|
111412
|
Narrative
Summary
|
Concept
name
for
a
text-based
section
of
a
report
|
|
|
111413
|
Overall
Assessment
|
A
title
for
a
report
section
that
summarizes
all
interpretation
results
for
a
report
with
one
overriding
assessment;
e.g.
benign
or
negative
|
|
|
111414
|
Supplementary
Data
|
Concept
name
for
a
collection
of
supporting
evidence
for
a
report
|
|
|
111415
|
Additional
evaluation
requested
from
prior
study
|
Prior
study
indicates
that
additional
imaging
be
performed
to
further
evaluate
a
suspicious
or
questionable
anatomic
region
|
|
|
111416
|
Follow-up
at
short
interval
from
prior
study
|
The
prior
study
recommended
a
follow-up
breast
imaging
exam
in
1
to
11
months
(generally
in
6
months)
|
|
|
111417
|
History
of
breast
augmentation,
asymptomatic
|
Prior
breast
augmentation
(breast
enlargement)
and
is
not
presenting
with
any
symptoms
|
|
|
111418
|
Review
of
an
outside
study
|
Review
or
second
opinion
made
on
an
image
performed
outside
of
the
facility
|
|
|
111419
|
Additional
evaluation
requested
from
abnormal
screening
exam
|
Additional
breast
imaging
performed
at
the
time
of
the
patient's
screening
mammogram
|
|
|
111420
|
History
of
benign
breast
biopsy
|
Patient
has
had
previous
benign
breast
biopsies
|
|
|
111421
|
Personal
history
of
breast
cancer
with
breast
conservation
therapy
|
Patient
has
had
a
prior
surgery
such
as
a
lumpectomy
or
quadrantectomy
to
remove
malignant
breast
tissue,
but
breast
tissue
remains
|
|
|
111423
|
Physical
Examination
Results
|
The
results
of
a
physical
examination
performed
on
the
patient,
possibly
including
the
results
of
inspection,
palpation,
auscultation,
or
percussion
|
|
|
111424
|
Comparison
to
previous
findings
|
The
result
of
assessing
the
current
imaging
exam
in
comparison
to
previous
imaging
exams
|
|
|
111425
|
Intraluminal
filling
defect
|
An
abnormality
observed
during
ductography
where
the
ductal
system
within
the
breast
fills
in
an
abnormal
pattern.
Ductography
is
an
imaging
exam
in
which
a
radio
opaque
contrast
media
is
introduced
into
the
ductal
system
of
the
breast
through
the
nipple
and
images
of
the
ductal
system
are
obtained
|
|
|
111426
|
Multiple
filling
defect
|
During
ductography
an
observation
of
more
than
one
filling
abnormality
within
the
breast
ductal
system
|
|
|
111427
|
Abrupt
duct
termination
|
An
abnormality
observed
during
ductography
where
the
ductal
system
within
the
breast
terminates
in
an
unusual
fashion
|
|
|
111428
|
Extravasation
|
Abnormal
flowage
of
contrast
media
within
the
breast
noted
on
ductography
|
|
|
111429
|
Duct
narrowing
|
An
abnormality
observed
during
ductography
where
the
ductal
system
within
the
breast
appears
narrow
|
|
|
111430
|
Cyst
fill
|
During
ductography
an
observation
of
the
contrast
media
filling
a
cyst
within
the
breast
|
|
|
111431
|
Instrument
Approach
|
The
area
and
line
within
the
anatomy
through
which
a
needle
or
instrument
passes
during
an
interventional
procedure
|
|
|
111432
|
Inferolateral
to
superomedial
|
The
line
within
the
anatomy
from
the
lower
outer
to
the
upper
inner
aspect;
e.g.
through
which
a
needle
or
instrument
passes
in
an
interventional
procedure
|
|
|
111433
|
Inferomedial
to
superolateral
|
The
line
within
the
anatomy
from
the
lower
inner
to
the
upper
outer
aspect;
e.g.
through
which
a
needle
or
instrument
passes
in
an
interventional
procedure
|
|
|
111434
|
Superolateral
to
inferomedial
|
The
line
within
the
anatomy
from
the
upper
outer
to
the
lower
inner
aspect;
e.g.
through
which
a
needle
or
instrument
passes
in
an
interventional
procedure
|
|
|
111435
|
Superomedial
to
inferolateral
|
The
line
within
the
anatomy
from
the
upper
inner
to
the
lower
outer
aspect;
e.g.
through
which
a
needle
or
instrument
passes
in
an
interventional
procedure
|
|
|
111436
|
Number
of
passes
|
The
number
of
times
a
biopsy
instrument
is
passed
through
an
area
of
interest
|
|
|
111437
|
Number
of
specimens
|
The
number
of
biopsy
specimens
obtained
from
an
interventional
procedure
|
|
|
111438
|
Needle
in
target
|
An
indicator
of
whether
or
not
a
biopsy
or
localizing
needle
in
an
interventional
procedure
is
seen
to
be
in
the
area
of
interest
|
|
|
111439
|
Number
of
needles
around
target
|
The
number
of
localizing
needles
placed
around
the
area
of
interest
in
an
interventional
procedure
|
|
|
111440
|
Incision
made
|
An
indicator
of
whether
or
not
an
incision
was
made
in
the
anatomy
during
an
interventional
procedure
|
|
|
111441
|
Microclip
placed
|
An
indicator
of
whether
or
not
a
radio
opaque
microclip
was
placed
in
the
anatomy
during
an
interventional
procedure
|
|
|
111442
|
Confirmation
of
target
|
An
indicator
of
the
degree
of
success
of
an
interventional
procedure
|
|
|
111443
|
Target
completely
contained
in
the
specimen
|
An
indicator
that
during
an
interventional
procedure
the
area
of
interest
was
fully
excised
and
is
noted
in
the
resultant
biopsy
specimen
|
|
|
111444
|
Target
partially
obtained
in
the
specimen
|
An
indicator
that
during
an
interventional
procedure
the
area
of
interest
was
partially
excised
and
is
noted
in
the
resultant
biopsy
specimen
|
|
|
111445
|
Target
not
in
the
specimen
|
An
indicator
that
following
an
interventional
procedure
the
area
of
interest
is
not
seen
in
the
resultant
biopsy
specimen
|
|
|
111446
|
Calcifications
seen
in
the
core
|
An
indicator
that
following
an
interventional
procedure
the
targeted
calcifications
are
noted
in
the
resultant
biopsy
specimen
|
|
|
111447
|
Lesion
completely
removed
|
An
indicator
that
during
an
interventional
procedure
the
area
of
interest
was
fully
excised
and
is
noted
in
the
resultant
biopsy
specimen
|
|
|
111448
|
Lesion
partially
removed
|
An
indicator
that
during
an
interventional
procedure
the
area
of
interest
was
partially
excised
and
is
noted
in
the
resultant
biopsy
specimen
|
|
|
111449
|
Fluid
obtained
|
An
indicator
that
during
an
interventional
procedure
fluid
was
successfully
aspirated
|
|
|
111450
|
Light
brown
color
|
Color
that
is
a
light
shade
of
brown
|
|
|
111451
|
Dark
red
color
|
Color
that
is
a
dark
shade
of
red
|
|
|
111452
|
Dark
brown
color
|
Color
that
is
a
dark
shade
of
brown
|
|
|
111453
|
Bright
red
color
|
Color
that
is
a
bright
shade
of
red
|
|
|
111454
|
Blood
tinged
color
|
Color
that
is
tinged
with
the
color
of
blood
|
|
|
111455
|
Occult
blood
test
result
|
An
indicator
of
whether
or
not
the
fluid
obtained
during
an
interventional
procedure
contains
red
blood
cells
|
|
|
111456
|
Action
on
fluid
|
An
indicator
of
whether
or
not
fluid
during
an
interventional
procedure
was
sent
for
cytological
analysis
or
simply
discarded
|
|
|
111457
|
Sent
for
analysis
|
An
indicator
that
fluid
obtained
during
an
interventional
procedure
was
sent
to
a
laboratory
for
analysis
|
|
|
111458
|
Discarded
|
An
indicator
that
fluid
obtained
during
an
interventional
procedure
was
discarded
|
|
|
111459
|
Mass
with
calcifications
|
A
radiopaque
density
noted
during
diagnostic
imaging
that
has
associated
calcific
densities
|
|
|
111460
|
Complex
cyst
|
A
fluid-filled
sac
with
greater
than
normal
characteristics
|
|
|
111461
|
Intracystic
lesion
|
A
tumor
within
a
cyst
|
|
|
111462
|
Solid
mass
|
A
tumor
or
lesion
|
|
|
111463
|
Supplementary
Data
for
Intervention
|
Supporting
evidence
for
interpretation
results
of
an
interventional
procedure
|
|
|
111464
|
Procedure
Modifier
|
A
descriptor
that
further
qualifies
or
characterizes
a
type
of
procedure
|
|
|
111465
|
Needle
Gauge
|
Needle
size
(diameter)
characterization;
e.g.
of
a
biopsy
needle
|
|
|
111466
|
Severity
of
Complication
|
An
indicator
of
the
gravity
of
a
problem
experienced
by
a
patient,
related
to
a
procedure
that
was
performed
|
|
|
111467
|
Needle
Length
|
Distance
from
the
hub
or
bushing
to
the
tip
of
the
needle
|
|
|
111468
|
Pathology
Results
|
The
collection
of
observations
and
findings
from
pathologic
analysis
|
|
|
111469
|
Sampling
DateTime
|
The
date
and
time
that
the
sample
was
collected
from
the
patient
|
|
|
111470
|
Uninvolved
|
Indicates
that
the
margin
of
the
biopsy
specimen
was
not
involved
with
the
tumor
|
|
|
111471
|
Involved
|
Indicates
that
the
margin
of
the
biopsy
specimen
was
involved
with
the
tumor
|
|
|
111472
|
Nipple
involved
|
Indicates
whether
the
nipple
was
involved
in
an
interventional
procedure
or
pathologic
analysis
|
|
|
111473
|
Number
of
nodes
removed
|
Indicates
the
number
of
lymph
nodes
removed
|
|
|
111474
|
Number
of
nodes
positive
|
Indicates
the
number
of
lymph
nodes
removed
that
contain
cancer
cells
|
|
|
111475
|
Estrogen
receptor
|
The
result
of
a
test
for
the
presence
of
a
protein
that
binds
with
estrogen
|
|
|
111476
|
Progesterone
receptor
|
The
result
of
a
test
for
the
presence
of
a
protein
that
binds
with
progesterone
|
|
|
111477
|
S
Phase
|
Indicates
the
percentage
of
cells
in
S
phase.
Cell
division
is
defined
by
phases;
the
S
phase
is
the
stage
during
which
DNA
replicates
|
|
|
111478
|
Non-bloody
discharge
(from
nipple)
|
The
visible
emission
of
non-bloody
fluid
from
the
nipple
|
|
|
111479
|
Difficult
physical/clinical
examination
|
The
inability
to
discern
normal
versus
abnormal
breast
tissue
during
palpation
|
|
|
111480
|
Cancer
elsewhere
|
An
indication
that
a
patient
has
or
had
a
malignant
occurrence
in
an
area
of
the
body
other
than
the
breast
|
|
|
111481
|
Saline
implant
|
A
salt
water
filled
prosthetic
device
implanted
in
the
breast
|
|
|
111482
|
Polyurethane
implant
|
A
polymer
based
(plastic)
prosthetic
device
implanted
in
the
breast
|
|
|
111483
|
Percutaneous
silicone
injection
|
The
introduction
of
polymeric
organic
silicon
based
material
through
the
skin,
as
for
breast
augmentation
or
reconstruction
|
|
|
111484
|
Combination
implant
|
A
prosthetic
device
that
contains
more
than
one
material
implanted
in
the
breast
|
|
|
111485
|
Pre-pectoral
implant
|
A
breast
implant
placed
in
front
of
the
pectoralis
major
muscle
|
|
|
111486
|
Retro-pectoral
implant
|
A
breast
implant
placed
behind
the
pectoralis
major
muscle
|
|
|
111487
|
Mammographic
(crosshair)
|
Using
X-Ray
technique
and
a
superimposed
set
of
crossed
lines
for
detection
or
placement
|
|
|
111488
|
Mammographic
(grid)
|
Using
X-Ray
technique
and
a
superimposed
aperture
for
detection
or
placement
|
|
|
111489
|
Palpation
guided
|
Using
physical
touch
for
detection
or
placement
|
|
|
111490
|
Vacuum
assisted
|
The
performance
of
a
biopsy
procedure
using
a
vacuum
device
attached
to
the
biopsy
needle
|
|
|
111491
|
Abnormal
discharge
|
Unusual
or
unexpected
emission
of
fluid
|
|
|
111492
|
No
complications
|
Having
experienced
no
adverse
medical
conditions
related
to
or
resulting
from
an
interventional
procedure
|
|
|
111494
|
Stage
0
|
TNM
grouping
of
tumor
stage,
from
AJCC,
where
primary
tumor
is
Tis,
regional
lymph
node
is
N0,
and
distant
metastasis
is
M0
|
|
|
111495
|
Stage
I
|
TNM
grouping
of
tumor
stage,
from
AJCC,
where
primary
tumor
is
T1,
regional
lymph
node
is
N0,
and
distant
metastasis
is
M0
|
|
|
111496
|
Stage
IIA
|
TNM
grouping
of
tumor
stage,
from
AJCC,
where
primary
tumor
is
T0
or
T1,
with
regional
lymph
node
N1
and
distant
metastasis
is
M0,
or
T2
with
N0
and
M0
|
|
|
111497
|
Stage
IIB
|
TNM
grouping
of
tumor
stage,
from
AJCC,
where
primary
tumor
is
T2,
with
regional
lymph
node
N1
and
distant
metastasis
is
M0,
or
T3
with
N0
and
M0
|
|
|
111498
|
Stage
IIIA
|
TNM
grouping
of
tumor
stage,
from
AJCC,
where
primary
tumor
is
T0,
T1
or
T2,
with
regional
lymph
node
N2
and
distant
metastasis
is
M0,
or
T3
with
N1
or
N2
and
M0
|
|
|
111499
|
Stage
IIIB
|
TNM
grouping
of
tumor
stage,
from
AJCC,
where
primary
tumor
is
T4,
regional
lymph
node
is
N0,
N1
or
N2,
and
distant
metastasis
is
M0
|
|
|
111500
|
Stage
IIIC
|
TNM
grouping
of
tumor
stage,
from
AJCC,
where
primary
tumor
is
any
T
value,
regional
lymph
node
is
N3,
and
distant
metastasis
is
M0
|
|
|
111501
|
Stage
IV
|
TNM
grouping
of
tumor
stage,
from
AJCC,
where
primary
tumor
is
any
T
value,
regional
lymph
node
is
any
N
value,
and
distant
metastasis
is
M1
|
|
|
111502
|
Bloom-Richardson
Grade
|
Histologic
tumor
grade
(sometimes
called
Scarff-Bloom-Richardson
grade)
is
based
on
the
arrangement
of
the
cells
in
relation
to
each
other
--
whether
they
form
tubules,
how
closely
they
resemble
normal
breast
cells
(nuclear
grade)
and
how
many
of
the
cancer
cells
are
in
the
process
of
dividing
(mitotic
count)
|
|
|
111503
|
Normal
implants
|
Breast
prosthetic
devices
are
intact,
not
leaking,
and
are
in
a
normal
shape
and
form
|
|
|
111504
|
Asymmetric
implants
|
Breast
prosthetic
devices
are
not
symmetric,
equal,
corresponding
in
form,
or
are
in
one
breast
(unilateral)
|
|
|
111505
|
Calcified
implant
|
Fibrous
or
calcific
contracture
of
the
tissue
capsule
that
forms
around
a
breast
prosthetic
device
|
|
|
111506
|
Distorted
implant
|
Breast
prosthetic
device
is
twisted
out
of
normal
shape
or
form
|
|
|
111507
|
Silicone-laden
lymph
nodes
|
Silicone
from
breast
prosthetic
device
found
in
lymphatic
tissue
|
|
|
111508
|
Free
silicone
|
Silicone
found
in
breast
tissue
outside
of
the
prosthetic
capsule
or
implant
membrane
|
|
|
111509
|
Herniated
implant
|
Protrusion
of
part
of
the
structure
normally
encapsulating
the
content
of
the
breast
prosthetic
device
|
|
|
111510
|
Explantation
|
Evidence
of
removal
of
a
breast
prosthetic
device
|
|
|
111511
|
Relevant
Patient
Information
for
Breast
Imaging
|
Historical
patient
health
information
of
interest
to
the
breast
health
clinician
|
|
|
111512
|
Medication
History
|
Information
regarding
usage
by
the
patient
of
certain
medications,
such
as
hormones
|
|
|
111513
|
Relevant
Previous
Procedures
|
Interventional
or
non-interventional
procedures
previously
performed
on
the
patient,
such
as
breast
biopsies
|
|
|
111514
|
Relevant
Indicated
Problems
|
Abnormal
conditions
experienced
by
the
patient
that
serve
as
the
reason
for
performing
a
procedure,
such
as
a
breast
exam
|
|
|
111515
|
Relevant
Risk
Factors
|
Personal,
familial,
and
other
health
factors
that
may
indicate
an
increase
in
the
patient's
chances
of
developing
a
health
condition
or
disease,
such
as
breast
cancer
|
|
|
111516
|
Medication
Type
|
A
classification
of
a
medicinal
substance,
such
as
hormonal
contraceptive
or
antibiotic
|
|
|
111517
|
Relevant
Patient
Information
|
Historical
patient
health
information
for
general
purpose
use
|
|
|
111518
|
Age
when
first
menstrual
period
occurred
|
The
age
of
the
patient
at
the
first
occurrence
of
menses
|
|
|
111519
|
Age
at
First
Full
Term
Pregnancy
|
The
age
of
the
patient
at
the
time
of
her
first
full
term
pregnancy
|
|
|
111520
|
Age
at
Menopause
|
The
age
of
the
patient
at
the
cessation
of
menses
|
|
|
111521
|
Age
when
hysterectomy
performed
|
The
age
of
the
patient
at
the
time
her
uterus
was
removed
|
|
|
111522
|
Age
when
left
ovary
removed
|
The
age
of
the
patient
at
the
time
she
had
her
left
ovary
removed
|
|
|
111523
|
Age
when
right
ovary
removed
|
The
age
of
the
patient
at
the
time
she
had
her
right
ovary
removed
|
|
|
111524
|
Age
Started
|
The
age
of
a
patient
on
the
first
occurrence
of
an
event,
such
as
the
first
use
of
a
medication
|
|
|
111525
|
Age
Ended
|
The
age
of
a
patient
on
the
last
occurrence
of
an
event,
such
as
the
last
use
of
a
medication
|
|
|
111526
|
DateTime
Started
|
The
date
and
time
of
the
first
occurrence
of
an
event,
such
as
the
first
use
of
a
medication
|
|
|
111527
|
DateTime
Ended
|
The
date
and
time
of
the
last
occurrence
of
an
event,
such
as
the
last
use
of
a
medication
|
|
|
111528
|
Ongoing
|
An
indicator
of
whether
an
event
is
still
in
progress,
such
as
the
use
of
a
medication
or
substance,
or
environmental
exposure
|
|
|
111529
|
Brand
Name
|
Product
name
of
a
device
or
substance,
such
as
medication,
to
identify
it
as
the
product
of
a
single
firm
or
manufacturer
|
|
|
111530
|
Risk
Factor
modifier
|
A
descriptor
that
further
qualifies
or
characterizes
a
risk
factor
|
|
|
111531
|
Previous
Procedure
|
A
prior
non-interventional
exam
or
interventional
procedure
performed
on
a
patient
|
|
|
111532
|
Pregnancy
Status
|
Describes
the
pregnancy
state
of
a
referenced
subject
|
|
|
111533
|
Indicated
Problem
|
A
symptom
experienced
by
a
patient
that
is
used
as
the
reason
for
performing
an
exam
or
procedure
|
|
|
111534
|
Role
of
person
reporting
|
The
function
of
the
individual
who
is
reporting
information
on
a
patient,
which
could
be
a
specific
health
care
related
profession,
the
patient
him/herself,
or
a
relative
or
friend
|
|
|
111535
|
DateTime
problem
observed
|
The
date
and
time
that
a
symptom
was
noted
|
|
|
111536
|
DateTime
of
last
evaluation
|
The
date
and
time
of
the
most
recent
evaluation
of
an
indicated
problem
|
|
|
111537
|
Family
Member
with
Risk
Factor
|
A
patient's
biological
relative
who
exhibits
a
health
factor
that
may
indicate
an
increase
in
the
patient's
chances
of
developing
a
particular
disease
or
medical
problem
|
|
|
111538
|
Age
at
Occurrence
|
The
age
at
which
an
individual
experienced
a
specific
event,
such
as
breast
cancer
|
|
|
111539
|
Menopausal
phase
|
The
current
stage
of
an
individual
in
her
gynecological
development
|
|
|
111540
|
Side
of
Family
|
An
indicator
of
paternal
or
maternal
relationship
|
|
|
111541
|
Maternal
|
Relating
to
biological
female
parentage
|
|
|
111542
|
Unspecified
gynecological
hormone
|
A
gynecological
hormone
for
which
the
specific
type
is
not
specified;
e.g.
contraceptive,
estrogen,
Tamoxifen
|
|
|
111543
|
Breast
feeding
history
|
An
indicator
of
whether
or
not
a
patient
ever
provided
breast
milk
to
her
offspring
|
|
|
111544
|
Average
breast
feeding
period
|
The
average
length
of
time
that
a
patient
provided
breast
milk
to
her
offspring
|
|
|
111545
|
Substance
Use
History
|
Information
regarding
usage
by
the
patient
of
certain
legal
or
illicit
substances
|
|
|
111546
|
Used
Substance
Type
|
A
classification
of
a
substance,
such
as
alcohol
or
a
legal
or
illicit
drug
|
|
|
111547
|
Environmental
Exposure
History
|
Information
regarding
exposure
of
the
patient
to
potentially
harmful
environmental
factors
|
|
|
111548
|
Environmental
Factor
|
A
classification
of
a
potentially
harmful
substance
or
gas
in
a
subject's
environment,
such
as
asbestos,
lead,
or
carcinogens
|
|
|
111549
|
Previous
Reports
|
Previous
Structured
Reports
that
could
have
relevant
information
for
a
current
imaging
service
request
|
|
|
111550
|
Personal
breast
cancer
history
|
An
indication
that
a
patient
has
had
a
previous
malignancy
of
the
breast
|
|
|
111551
|
History
of
endometrial
cancer
|
Indicates
a
previous
occurrence
of
cancer
of
the
lining
of
the
uterus
|
|
|
111552
|
History
of
ovarian
cancer
|
Indicates
a
previous
occurrence
of
cancer
of
the
lining
of
the
ovary
|
|
|
111553
|
History
of
high
risk
lesion
on
previous
biopsy
|
Indicates
a
prior
diagnosis
of
pre-cancerous
cells
or
tissue
removed
for
pathologic
evaluation
|
|
|
111554
|
Post
menopausal
patient
|
A
female
patient
whose
menstrual
periods
have
ceased
|
|
|
111555
|
Late
child
bearing
(after
30)
|
A
female
patient
whose
first
child
was
born
after
the
patient
was
30
years
old
|
|
|
111556
|
BRCA1
breast
cancer
gene
|
The
first
level
genetic
marker
indicating
risk
for
breast
cancer
|
|
|
111557
|
BRCA2
breast
cancer
gene
|
The
second
level
genetic
marker
indicating
risk
for
breast
cancer
|
|
|
111558
|
BRCA3
breast
cancer
gene
|
The
third
level
genetic
marker
indicating
risk
for
breast
cancer
|
|
|
111559
|
Weak
family
history
of
breast
cancer
|
A
patient's
biological
aunt,
grandmother,
or
female
cousin
was
diagnosed
with
breast
cancer.
Definition
from
BI-RADS®
|
|
|
111560
|
Intermediate
family
history
of
breast
cancer
|
A
patient's
biological
mother
or
sister
was
diagnosed
with
breast
cancer
after
they
had
gone
through
menopause.
Definition
from
BI-RADS®
|
|
|
111561
|
Very
strong
family
history
of
breast
cancer
|
A
patient's
biological
mother
or
sister
was
diagnosed
with
breast
cancer
before
they
had
gone
through
menopause,
or
more
than
one
of
the
patient's
first-degree
relatives
(biological
mother
or
sister)
were
diagnosed
with
breast
cancer
after
they
had
gone
through
menopause.
Definition
from
BI-RADS®
|
|
|
111562
|
Family
history
of
prostate
cancer
|
Previous
diagnosis
of
a
malignancy
of
the
prostate
gland
in
a
biological
relative
|
|
|
111563
|
Family
history
unknown
|
The
health
record
of
a
patient's
biological
relatives
is
not
known
|
|
|
111564
|
Nipple
discharge
cytology
|
The
study
of
cells
obtained
from
fluid
emitted
from
the
breast
|
|
|
111565
|
Uterine
malformations
|
A
developmental
abnormality
resulting
in
an
abnormal
shape
of
the
uterus
|
|
|
111566
|
Spontaneous
Abortion
|
A
naturally
occurring
premature
expulsion
from
the
uterus
of
the
products
of
conception
-
the
embryo
or
a
nonviable
fetus
|
|
|
111567
|
Gynecologic
condition
|
An
ailment/abnormality
or
state
of
the
female
reproductive
tract
|
|
|
111568
|
Gynecologic
surgery
|
A
surgical
operation
performed
on
any
portion
of
the
female
reproductive
tract
|
|
|
111569
|
Previous
LBW
or
IUGR
birth
|
Prior
pregnancy
with
a
low
birth
weight
baby
or
a
fetus
with
Intrauterine
Growth
Restriction
or
Retardation
|
|
|
111570
|
Previous
fetal
malformation/syndrome
|
History
of
at
least
one
prior
pregnancy
with
fetal
anatomic
abnormality(s)
|
|
|
111571
|
Previous
RH
negative
or
blood
dyscrasia
at
birth
|
History
of
delivering
a
Rhesis
Isoimmunization
affected
child(ren)
or
a
child(ren)
with
another
blood
disorder
|
|
|
111572
|
History
of
multiple
fetuses
|
History
of
at
least
one
pregnancy
that
contained
more
than
one
fetus;
e.g.
twins,
triplets,
etc.
|
|
|
111573
|
Current
pregnancy,
known
or
suspected
malformations/syndromes
|
At
least
one
fetus
of
this
pregnancy
has
an
anatomic
abnormality(s)
that
is
known
to
exist,
or
a
"marker"
is
present
that
suggests
the
abnormality(s)
may
be
present
|
|
|
111574
|
Family
history,
fetal
malformation/syndrome
|
Biological
relatives
have
previously
conceived
a
fetus
with
an
anatomic
abnormality(s)
|
|
|
111575
|
High
|
A
subjective
descriptor
for
an
elevated
amount
of
exposure,
use,
or
dosage,
incurring
high
risk
of
adverse
effects
|
|
|
111576
|
Medium
|
A
subjective
descriptor
for
a
moderate
amount
of
exposure,
use,
or
dosage,
incurring
medium
risk
of
adverse
effects
|
|
|
111577
|
Low
|
A
subjective
descriptor
for
a
limited
amount
of
exposure,
use,
or
dosage,
incurring
low
risk
of
adverse
effects
|
|
|
111578
|
Dose
frequency
|
A
measurement
of
the
rate
of
occurrence
of
which
a
patient
takes
a
certain
medication
|
|
|
111579
|
Rate
of
exposure
|
The
quantity
per
unit
of
time
that
a
patient
was
or
is
being
exposed
to
an
environmental
irritant
|
|
|
111580
|
Volume
of
use
|
The
quantity
per
unit
of
time
that
a
medication
or
substance
was
or
is
being
used
|
|
|
111581
|
Relative
dose
amount
|
A
qualitative
descriptor
for
the
amount
of
a
medication
that
was
or
is
being
taken
|
|
|
111582
|
Relative
amount
of
exposure
|
A
qualitative
descriptor
for
the
amount
of
present
or
past
exposure
to
an
environmental
irritant
|
|
|
111583
|
Relative
amount
of
use
|
A
qualitative
descriptor
for
the
amount
of
a
medication
or
substance
that
was
or
is
being
used
|
|
|
111584
|
Relative
dose
frequency
|
A
qualitative
descriptor
for
the
frequency
with
which
a
medication
was
or
is
being
taken
|
|
|
111585
|
Relative
frequency
of
exposure
|
A
qualitative
descriptor
for
the
frequency
of
present
or
past
exposure
to
an
environmental
irritant
|
|
|
111586
|
Relative
frequency
of
use
|
A
qualitative
descriptor
for
the
frequency
with
which
a
medication
or
substance
was
or
is
being
used
|
|
|
111587
|
No
known
exposure
|
Patient
is
not
known
to
have
been
exposed
to
or
used
the
substance
or
medication
|
|
|
111590
|
Recall
for
technical
reasons
|
Patient
returns
for
additional
images
to
improve
the
quality
of
the
most
recent
exam
|
|
|
111591
|
Recall
for
imaging
findings
|
Patient
returns
for
additional
images
to
clarify
findings
from
the
most
recent
exam
|
|
|
111592
|
Recall
for
patient
symptoms/
clinical
findings
|
Patient
returns
for
additional
images
to
clarify
symptoms
or
signs
reported
by
the
patient
or
a
healthcare
professional
at
the
time
of
the
most
recent
exam
|
|
|
111593
|
LBW
or
IUGR
|
Number
of
births
with
low
birth
weight
or
intrauterine
growth
restriction
|
|
|
111601
|
Green
filter
|
Filter
that
transmits
green
light
while
blocking
the
other
colors,
typically
centered
at
510-540
nm
|
|
|
111602
|
Red
filter
|
Filter
that
transmits
red
light
while
blocking
the
other
colors,
typically
centered
at
630-680
nm
|
|
|
111603
|
Blue
filter
|
Filter
that
transmits
blue
while
blocking
the
other
colors,
typically
centered
at
460-480
nm
|
|
|
111604
|
Yellow-green
filter
|
A
filter
of
560nm
that
is
used
for
retinal
imaging
and
can
provide
good
contrast
and
good
visibility
of
the
retinal
vasculature
|
|
|
111605
|
Blue-green
filter
|
A
filter
of
490nm
that
is
used
for
retinal
imaging
because
of
excessive
scattering
of
some
retinal
structures
at
very
short
wavelengths
|
|
|
111606
|
Infrared
filter
|
Filter
that
transmits
the
infrared
spectrum,
which
is
light
that
lies
outside
of
the
visible
spectrum,
with
wavelengths
longer
than
those
of
red
light,
while
blocking
visible
light
|
|
|
111607
|
Polarizing
filter
|
A
filter
that
reduces
reflections
from
non-metallic
surfaces
such
as
glass
or
water
by
blocking
light
waves
that
are
vibrating
at
selected
angles
to
the
filter
|
|
|
111609
|
No
filter
|
No
filter
used
|
|
|
111621
|
Field
1
for
Joslin
3
field
|
Joslin
NM-1
is
a
45
degree
field
focused
centrally
between
the
temporal
margin
of
optic
disc
and
the
center
of
the
macula:
Center
the
camera
on
the
papillomacular
bundle
midway
between
the
temporal
margin
of
the
optic
disc
and
the
center
of
the
macula.
The
horizontal
centerline
of
the
image
should
pass
directly
through
the
center
of
the
disc
|
|
|
111622
|
Field
2
for
Joslin
3
field
|
Joslin
NM-2
is
a
45
degree
field
focused
superior
temporal
to
the
optic
disc:
Center
the
camera
laterally
approximately
one-half
disc
diameter
temporal
to
the
center
of
the
macula.
The
lower
edge
of
the
field
is
tangent
to
a
horizontal
line
passing
through
the
upper
edge
of
the
optic
disc.
The
image
is
taken
temporal
to
the
macula
but
includes
more
retinal
nasal
and
superior
to
the
macula
than
standard
field
2
|
|
|
111623
|
Field
3
for
Joslin
3
field
|
Joslin
NM-3
is
a
45
degree
field
focused
nasal
to
the
optic
disc:
This
field
is
nasal
to
the
optic
disc
and
may
include
part
of
the
optic
disc.
The
horizontal
centerline
of
the
image
should
pass
tangent
to
the
lower
edge
of
the
optic
disc
|
|
|
111625
|
Diffuse
direct
illumination
|
A
broad
or
"soft"
light
supplied
from
a
single
source
|
|
|
111626
|
Scheimpflug
Camera
|
A
slit
reflected
light
microscope,
which
has
the
ability
to
form
an
image
of
the
back
scattered
light
from
the
eye
in
a
sagittal
plane.
Scheimpflug
cameras
are
able
to
achieve
a
wide
depth
of
focus
by
employing
the
"Sheimpflug
principle"
where
the
lens
and
image
planes
are
not
parallel
with
each
other.
Rotating
Sheimplug
cameras
are
able
to
generate
three-dimensional
images
and
calculate
measurements
of
the
anterior
chamber
of
the
eye
|
|
|
111627
|
Scotopic
light
|
Lighting
condition
approximately
0.04
lux
|
|
|
111628
|
Mesopic
light
|
Lighting
condition
approximately
4
lux
|
|
|
111629
|
Photopic
light
|
Lighting
condition
approximately
40
lux
|
|
|
111630
|
Dynamic
light
|
Acquisition
preceded
by
intense
light
|
|
|
111631
|
Average
Glandular
Dose
|
Calculated
from
values
of
entrance
exposure
in
air,
the
X-Ray
beam
quality
(half-value
layer),
and
compressed
breast
thickness,
is
the
energy
deposited
per
unit
mass
of
glandular
tissue
averaged
over
all
the
glandular
tissue
in
the
breast
|
|
|
111632
|
Anode
Target
Material
|
The
primary
material
in
the
anode
of
an
X-Ray
source
|
|
|
111633
|
Compression
Thickness
|
The
average
thickness
of
the
body
part
examined
when
compressed,
if
compression
has
been
applied
during
X-Ray
exposure
|
|
|
111634
|
Half
Value
Layer
|
Thickness
of
Aluminum
required
to
reduce
the
X-Ray
output
at
the
patient
entrance
surface
by
a
factor
of
two
|
|
|
111635
|
X-Ray
Grid
|
An
anti-scatter
device
based
on
radiation
absorbing
strips
above
the
detector;
e.g.
in
the
patient
support
|
|
|
111636
|
Entrance
Exposure
at
RP
|
Exposure
measurement
in
air
at
the
reference
point
that
does
not
include
back
scatter,
according
to
MQCM
1999
|
|
|
111637
|
Accumulated
Average
Glandular
Dose
|
Average
Glandular
Dose
to
a
single
breast
accumulated
over
multiple
images
|
|
|
111638
|
Patient
Equivalent
Thickness
|
Value
of
the
control
variable
used
to
parametrize
the
Automatic
Exposure
Control
(AEC)
closed
loop;
e.g.
"Water
Value"
|
|
|
111641
|
Fixed
grid
|
An
X-Ray
Grid
that
does
not
move
during
exposure
|
|
|
111642
|
Focused
grid
|
An
X-Ray
Grid
with
radiation
absorbing
strips
that
are
focused
toward
the
focal
spot,
to
eliminate
grid
cutoff
|
|
|
111643
|
Reciprocating
grid
|
An
X-Ray
Grid
that
is
designed
to
move
during
exposure,
to
eliminate
the
appearance
of
grid
lines
on
the
image
|
|
|
111644
|
Parallel
grid
|
An
X-Ray
Grid
with
radiation
absorbing
strips
that
are
parallel
to
each
other
and
that
is
used
only
with
long
source
to
image
distances
|
|
|
111645
|
Crossed
grid
|
An
X-Ray
Grid
with
crossed
radiation
absorbing
strips
used
for
more
complete
cleanup
of
scatter
radiation
|
|
|
111646
|
No
grid
|
No
X-Ray
Grid
was
used
due
to
low
scatter
conditions
|
|
|
111671
|
Spectacle
Prescription
Report
|
The
spectacle
prescription
for
a
patient
|
|
|
111672
|
Add
Near
|
Refractive
measurements
of
the
eye
to
correct
for
inability
to
focus
at
near
while
wearing
the
distance
prescription
|
|
|
111673
|
Add
Intermediate
|
Refractive
measurements
of
the
eye
to
correct
for
inability
to
focus
at
intermediate
distance
while
wearing
the
distance
prescription
|
|
|
111674
|
Add
Other
|
Refractive
measurements
of
the
eye
to
correct
for
inability
to
focus
at
the
specified
distance
while
wearing
the
distance
prescription
|
|
|
111675
|
Horizontal
Prism
Power
|
The
power
of
a
prism
to
bend
light
in
the
horizontal
direction,
in
prism
diopters
|
|
|
111676
|
Horizontal
Prism
Base
|
Direction
of
the
base
of
a
horizontal
prism
--
either
in
(toward
the
nose),
or
out
(away
from
the
nose)
|
|
|
111677
|
Vertical
Prism
Power
|
The
power
of
a
prism
to
bend
light
in
the
vertical
direction,
in
prism
diopters
|
|
|
111678
|
Vertical
Prism
Base
|
Direction
of
the
base
of
a
vertical
prism
--
either
up,
or
down
|
|
|
111679
|
Distance
Pupillary
Distance
|
Distance
in
mm
between
the
pupils
when
the
patient's
object
of
regard
is
in
the
distance
|
|
|
111680
|
Near
Pupillary
Distance
|
Distance
in
mm
between
the
pupils
when
the
patient's
object
of
regard
is
at
near
|
|
|
111685
|
Autorefraction
Visual
Acuity
|
A
patient's
vision
with
the
correction
measured
by
an
autorefractor
in
place
|
|
|
111686
|
Habitual
Visual
Acuity
|
A
patient's
vision
with
whichever
vision
correction
the
patient
customarily
wears
|
|
|
111687
|
Prescription
Visual
Acuity
|
A
patient's
vision
with
the
final
spectacle
prescription
in
place
|
|
|
111688
|
Right
Eye
Rx
|
The
spectacle
prescription
for
the
right
eye
|
|
|
111689
|
Left
Eye
Rx
|
The
spectacle
prescription
for
the
left
eye
|
|
|
111690
|
Macular
Grid
Thickness
and
Volume
Report
|
A
macular
grid
thickness
and
volume
report
for
a
patient.
The
macular
grid
is
an
analytic
tool
described
in
PS3.1
|
|
|
111691
|
Number
of
Images
Used
for
Macular
Measurements
|
Number
of
images
used
for
the
macular
grid
measurement
|
|
|
111692
|
Number
of
Samples
Used
per
Image
|
Number
of
samples
used
per
Image
for
analysis
|
|
|
111693
|
Analysis
Quality
Rating
|
A
numeric
rating
of
the
quality
of
the
entire
analysis
with
respect
to
grading
and
diagnostic
purposes.
Higher
numbers
indicate
greater
quality
|
|
|
111694
|
Image
Set
Quality
Rating
|
A
numeric
rating
of
the
quality
of
an
entire
image
set
with
respect
to
grading
and
diagnostic
purposes.
Higher
numbers
indicate
greater
quality
|
|
|
111695
|
Interfering
Tears
or
Drops
|
Tear
film
or
drops
affecting
test
quality
|
|
|
111696
|
Visual
Fixation
Quality
During
Acquisition
|
The
assessment
of
the
centricity
and
persistence
of
the
visual
fixation
(direction
of
gaze)
during
the
acquisition
|
|
|
111697
|
Visual
Fixation
Quality
Problem
|
The
reason
why
the
patient's
visual
fixation
was
not
steady
or
was
indeterminate
|
|
|
111698
|
Ophthalmic
Macular
Grid
Problem
|
The
reason
why
the
macular
grid
measurements
may
be
questionable
|
|
|
111700
|
Specimen
Container
Identifier
|
Identifier
of
container
(box,
block,
microscope
slide,
etc.)
for
the
specimen
under
observation
|
|
|
111701
|
Processing
type
|
Type
of
processing
that
tissue
specimen
underwent
|
|
|
111702
|
DateTime
of
processing
|
Date
and
time
of
processing
step
|
|
|
111703
|
Processing
step
description
|
Description
of
the
individual
step
in
the
tissue
processing
sequence
|
|
|
111704
|
Sampling
Method
|
Method
of
sampling
used
to
derive
specimen
from
its
parent
|
|
|
111705
|
Parent
Specimen
Identifier
|
Identifier
of
the
parent
specimen
that
gave
rise
to
the
current
specimen
|
|
|
111706
|
Issuer
of
Parent
Specimen
Identifier
|
Assigning
authority
for
parent
specimen's
identifier
|
|
|
111707
|
Parent
specimen
type
|
Parent
specimen
type
that
gave
rise
to
current
specimen
|
|
|
111708
|
Position
Frame
of
Reference
|
Description
of
coordinate
system
and
origin
reference
point
on
parent
specimen,
or
parent
specimen
container,
or
image
used
for
localizing
the
sampling
site
or
location
within
container
or
image
|
|
|
111709
|
Location
of
sampling
site
|
Reference
to
image
of
parent
specimen
localizing
the
sampling
site;
may
include
referenced
Presentation
State
object
|
|
|
111710
|
Location
of
sampling
site
X
offset
|
Location
of
sampling
site
of
specimen
(nominal
center)
relative
to
the
Position
Frame
of
Reference
in
the
X
dimension
|
|
|
111711
|
Location
of
sampling
site
Y
offset
|
Location
of
sampling
site
of
specimen
(nominal
center)
relative
to
the
Position
Frame
of
Reference
in
the
Y
dimension
|
|
|
111712
|
Location
of
sampling
site
Z
offset
|
Location
of
sampling
site
of
specimen
(nominal
center)
relative
to
the
Position
Frame
of
Reference
in
the
Z
dimension
|
|
|
111718
|
Location
of
Specimen
|
Description
of
specimen
location,
either
in
absolute
terms
or
relative
to
the
Position
Frame
of
Reference
|
|
|
111719
|
Location
of
Specimen
X
offset
|
Location
of
specimen
(nominal
center)
relative
to
the
Position
Frame
of
Reference
in
the
X
dimension
|
|
|
111720
|
Location
of
Specimen
Y
offset
|
Location
of
specimen
(nominal
center)
relative
to
the
Position
Frame
of
Reference
in
the
Y
dimension
|
|
|
111721
|
Location
of
Specimen
Z
offset
|
Location
of
specimen
(nominal
center)
relative
to
the
Position
Frame
of
Reference
in
the
Z
dimension
|
|
|
111723
|
Visual
Marking
of
Specimen
|
Description
of
visual
distinguishing
identifiers;
e.g.
ink,
or
a
particular
shape
of
the
specimen
|
|
|
111724
|
Issuer
of
Specimen
Identifier
|
Assigning
authority
for
specimen
identifier
|
|
|
111726
|
Dissection
with
entire
specimen
submission
|
Dissection
of
specimen
with
submission
of
all
its
sections
for
further
processing
or
examination
|
|
|
111727
|
Dissection
with
representative
sections
submission
|
Dissection
of
specimen
with
submission
of
representative
sections
for
further
processing
or
examination
|
|
|
111729
|
Specimen
storage
|
A
workflow
step,
during
which
tissue
specimens
are
stored
in
a
climate-controlled
environment
|
|
|
111741
|
Transmission
illumination
|
Transmission
illumination
method
for
specimen
microscopy
|
|
|
111742
|
Reflection
illumination
|
Reflection
illumination
method
for
specimen
microscopy
|
|
|
111743
|
Epifluorescence
illumination
|
Epifluorescence
illumination
method
for
specimen
microscopy
|
|
|
111744
|
Brightfield
illumination
|
Brightfield
illumination
method
for
specimen
microscopy
|
|
|
111745
|
Darkfield
illumination
|
Darkfield
illumination
method
for
specimen
microscopy
|
|
|
111746
|
Oblique
illumination
|
Oblique
illumination
method
for
specimen
microscopy
|
|
|
111747
|
Phase
contrast
illumination
|
Phase
contrast
illumination
method
for
specimen
microscopy
|
|
|
111748
|
Differential
interference
contrast
|
Differential
interference
contrast
method
for
specimen
microscopy
|
|
|
111749
|
Total
internal
reflection
fluorescence
|
Total
internal
reflection
fluorescence
method
for
specimen
microscopy
|
|
|
111750
|
Ultrasound
Contact
|
A
method
of
obtaining
ophthalmic
axial
measurements
that
uses
ultrasound,
and
that
requires
applanation
of
the
cornea
|
|
|
111751
|
Ultrasound
Immersion
|
A
method
of
obtaining
ophthalmic
axial
measurements
that
uses
ultrasound,
and
that
requires
immersion
of
the
patient's
eye
in
fluid
as
he
lies
in
a
supine
position
|
|
|
111752
|
Optical
|
A
method
of
obtaining
ophthalmic
axial
measurements
that
uses
light
|
|
|
111753
|
Manual
Keratometry
|
Measurements
taken
of
the
corneal
curvature
using
a
manual
keratometer
|
|
|
111754
|
Auto
Keratometry
|
Measurements
taken
of
the
corneal
curvature
using
an
automated
keratometer
|
|
|
111755
|
Simulated
Keratometry
|
Simulated
Keratometry
measurements
derived
from
corneal
topography
|
|
|
111756
|
Equivalent
K-reading
|
Corneal
power
measurements
using
Scheimpflug
camera
|
|
|
111760
|
Haigis
|
The
Haigis
IOL
calculation
formula.
Haigis
W,
Lege
B,
Miller
N,
Schneider
B.
Comparison
of
immersion
ultrasound
biometry
and
partial
coherence
interferometry
for
intraocular
lens
calculation
according
to
Haigis.
Graefes
Arch
Clin
Exp
Ophthalmol
2000;238:765-73
|
|
|
111761
|
Haigis-L
|
The
Haigis-L
IOL
calculation
formula.
Haigis
W.
Intraocular
lens
calculation
after
refractive
surgery
for
myopia:
Haigis-L
formula.
J
Cataract
Refract
Surg.
2008
Oct;34(10):1658-63
|
|
|
111762
|
Holladay
1
|
The
Holladay
1
IOL
calculation
formula.
Holladay
JT,
Prager
TC,
Chandler
TY,
Musgrove
KH,
Lewis
JW,
Ruiz
RS.
A
three-part
system
for
refining
intraocular
lens
power
calculations.
J
Cataract
Refract
Surg.
1988;
14:17-24
|
|
|
111763
|
Holladay
2
|
The
Holladay
2
IOL
calculation
formula
|
|
|
111764
|
Hoffer
Q
|
The
Hoffer
Q
IOL
calculation
formula.
Hoffer
KJ.
The
Hoffer
Q
formula:
a
comparison
of
theoretic
and
regression
formulas.
J
Cataract
Refract
Surg
1993;19:700-12.
Errata.
J
Cataract
Refract
Surg
1994;20:677
and
2007;33:2-3
|
|
|
111765
|
Olsen
|
The
Olsen
IOL
calculation
formula.
Olsen
T.
Calculation
of
intraocular
lens
power:
a
review.
Acta
Ophthalmol.
Scand.
2007:
85:
472-485
|
|
|
111766
|
SRKII
|
The
SRKII
IOL
calculation
formula.
Sanders
DR,
Retzlaff
J,
Kraff
MC.
Comparison
of
the
SRK
II
formula
and
other
second
generation
formulas.
J
Cataract
Refract
Surg.
1988
Mar;14(2):136-41
|
|
|
111767
|
SRK-T
|
The
SRK-T
IOL
calculation
formula.
Retzlaff
JA,
Sanders
DR,
Kraff
MC.
Development
of
the
SRK/T
intraocular
lens
implant
power
calculation
formula.
J
Cataract
Refract
Surg
1990;16:333-40.
Erratum
1990;16:528
|
|
|
111768
|
ACD
Constant
|
The
"ACD
Constant"
used
in
IOL
calculation
|
|
|
111769
|
Haigis
a0
|
The
"Haigis
a0"
constant
used
in
IOL
calculation
|
|
|
111770
|
Haigis
a1
|
The
"Haigis
a1"
constant
used
in
IOL
calculation
|
|
|
111771
|
Haigis
a2
|
The
"Haigis
a2"
constant
used
in
IOL
calculation
|
|
|
111772
|
Hoffer
pACD
Constant
|
The
"Hoffer
pACD
Constant"
used
in
IOL
calculation
|
|
|
111773
|
Surgeon
Factor
|
The
"Surgeon
Factor"
constant
used
in
IOL
calculation
|
|
|
111776
|
Front
Of
Cornea
To
Front
Of
Lens
|
Anterior
chamber
depth
defined
as
the
front
of
the
cornea
to
the
front
of
the
lens
|
|
|
111777
|
Back
Of
Cornea
To
Front
Of
Lens
|
Anterior
chamber
depth
defined
as
the
back
of
the
cornea
to
the
front
of
the
lens
|
|
|
111778
|
Single
or
Anterior
Lens
|
Refers
to
the
anterior
lens
when
there
are
two
lenses
in
the
eye.
The
distance,
in
mm,
from
the
anterior
surface
of
the
lens
to
the
posterior
surface
of
the
lens
|
|
|
111779
|
Posterior
Lens
|
Refers
to
the
posterior
lens
when
there
are
two
lenses
in
the
eye.
The
distance,
in
mm,
from
the
anterior
surface
of
the
lens
to
the
posterior
surface
of
the
lens
|
|
|
111780
|
Measurement
From
This
Device
|
Value
obtained
from
measurements
taken
by
the
device
creating
this
SOP
Instance
|
|
|
111781
|
External
Data
Source
|
Value
obtained
by
data
transfer
from
an
external
source
-
not
from
measurements
taken
by
the
device
providing
the
value
|
|
|
111782
|
Axial
Measurements
SOP
Instance
|
Axial
Measurements
DICOM
SOP
Instance
|
|
|
111783
|
Refractive
Measurements
SOP
Instance
|
Refractive
Measurements
DICOM
SOP
Instance
|
|
|
111786
|
Standard
Deviation
of
measurements
used
|
Standard
Deviation
is
a
simple
measure
of
the
variability
of
a
data
set
|
|
|
111787
|
Signal
to
Noise
Ratio
|
Signal
to
Noise
Ratio
of
the
data
samples
taken
to
create
a
measurement
|
|
|
111791
|
Spherical
projection
|
Projection
from
2D
image
pixels
to
3D
Cartesian
coordinates
based
on
a
spherical
mathematical
model
|
|
|
111792
|
Surface
contour
mapping
|
Mapping
from
2D
image
pixels
to
3D
Cartesian
coordinates
based
on
measurements
of
the
retinal
surface;
e.g.
of
the
retina,
derived
via
a
measurement
technology
such
as
Optical
Coherence
Tomography,
Ultrasound
etc
|
|
|
111800
|
Visual
Field
24-2
Test
Pattern
|
Test
pattern,
nominally
covering
an
area
within
24°
of
fixation.
Consists
of
54
test
points
a
minimum
of
3°
from
each
meridian
and
placed
6°
apart.
The
"-2"
distinguishes
this
from
another
24°
pattern
(no
longer
supported)
|
|
|
111801
|
Visual
Field
10-2
Test
Pattern
|
Test
pattern,
nominally
covering
an
area
within
10°
of
fixation.
Consists
of
68
test
points
a
minimum
of
1°
from
each
meridian
and
placed
2°
apart.
The
"-2"
in
this
case
indicates
its
point
layout
to
be
similar
to
the
30-2
and
24-2
|
|
|
111802
|
Visual
Field
30-2
Test
Pattern
|
Test
pattern
consisting
of
test
point
locations
within
30°
of
fixation.
Consists
of
76
test
points
a
minimum
of
3°
from
each
meridian
and
placed
6°
apart.
The
"-2"
distinguishes
this
from
another
30°
pattern
(no
longer
supported)
|
|
|
111803
|
Visual
Field
60-4
Test
Pattern
|
Test
pattern
consisting
of
60
test
point
locations
between
30°
and
60°
of
fixation
a
minimum
of
6°
from
each
meridian
and
placed
12°
apart.
The
"-4"
distinguishes
this
from
a
similar
60°
pattern
having
4
additional
points
|
|
|
111804
|
Visual
Field
Macula
Test
Pattern
|
Test
pattern
consisting
of
16
test
point
locations
within
10°
of
fixation
a
minimum
of
1°
from
each
meridian
and
placed
2°
apart
|
|
|
111805
|
Visual
Field
Central
40
Point
Test
Pattern
|
Test
pattern
consisting
of
40
test
point
locations
within
30°
of
fixation
that
spread
out
radially
from
fixation
|
|
|
111806
|
Visual
Field
Central
76
Point
Test
Pattern
|
Test
pattern
consisting
of
76
test
point
locations
within
30°
of
fixation
a
minimum
of
3°
from
each
meridian
and
placed
6°
apart
|
|
|
111807
|
Visual
Field
Peripheral
60
Point
Test
Pattern
|
Test
pattern
consisting
of
60
test
point
locations
between
30°
and
60°
of
fixation
a
minimum
of
6°
from
each
meridian
and
placed
12°
apart
|
|
|
111808
|
Visual
Field
Full
Field
81
Point
Test
Pattern
|
Test
pattern
consisting
of
81
test
point
locations
within
60°
of
fixation
that
spread
out
radially
from
fixation
|
|
|
111809
|
Visual
Field
Full
Field
120
Point
Test
Pattern
|
Test
pattern
consisting
of
120
test
point
locations
within
60°
of
fixation
that
spread
out
radially
from
fixation,
concentrated
in
the
nasal
hemisphere
|
|
|
111810
|
Visual
Field
G
Test
Pattern
|
Test
pattern
for
Glaucoma
and
general
visual
field
assessment
with
59
test
locations
of
which
16
test
locations
are
in
the
macular
area
(up
to
10°
eccentricity)
and
where
the
density
of
test
location
is
reduced
with
eccentricity.
The
test
can
be
extended
with
the
inclusion
of
14
test
locations
between
30°
and
60°
eccentricity,
6
of
which
are
located
at
the
nasal
step
|
|
|
111811
|
Visual
Field
M
Test
Pattern
|
Test
pattern
for
the
macular
area.
Orthogonal
test
pattern
with
0.7°
spacing
within
the
central
4°
of
eccentricity
and
reduced
density
of
test
locations
between
4
and
10,
5°
of
eccentricity.
81
test
locations
over
all.
The
test
can
be
extended
to
include
the
test
locations
of
the
Visual
Field
G
Test
Pattern
between
10,
5°
and
60°
|
|
|
111812
|
Visual
Field
07
Test
Pattern
|
Full
field
test
pattern
with
48
test
locations
from
0-30°
and
82
test
locations
from
30-70°.
Reduced
test
point
density
with
increased
eccentricity.
Can
be
combined
with
screening
and
threshold
strategies
|
|
|
111813
|
Visual
Field
LVC
Test
Pattern
|
Low
Vision
Central.
Orthogonal
off-center
test
pattern
with
6°
spacing.
75
test
locations
within
the
central
30°.
Corresponds
with
the
32/30-2
excluding
the
2
locations
at
the
blind
spot,
including
a
macular
test
location.
The
LVC
is
linked
with
a
staircase
threshold
strategy
starting
at
0
dB
intensity
and
applies
stimulus
area
V
|
|
|
111814
|
Visual
Field
Central
Test
Pattern
|
General
test
corresponding
to
the
30-2
but
excluding
the
2
test
locations
in
the
blind
spot
area,
hence
with
74
instead
of
76
test
locations
|
|
|
111815
|
Visual
Field
SITA-Standard
Test
Strategy
|
Swedish
Interactive
Thresholding
Algorithm
(SITA).
Strategy
gains
testing
efficiency
through
use
of
visual
field
and
information
theory
models.
In:
Bengtsson
B,
Olsson
J,
Heijl
A,
Rootzen
H.
A
new
generation
of
algorithms
for
computerized
threshold
perimetry,
SITA.
Acta
Ophthalmologica
Scandinavica,
1997,
75:
368-375
|
|
|
111816
|
Visual
Field
SITA-SWAP
Test
Strategy
|
Adaptation
of
SITA
testing
methods
to
Blue-Yellow
testing
|
|
|
111817
|
Visual
Field
SITA-Fast
Test
Strategy
|
Similar
to
SITA-Standard
but
with
less
strict
criteria
for
closing
test
points.
Intended
for
patients
who
must
be
tested
in
the
shortest
possible
time.
In:
Bengtsson
B,
Hejl
A.
SITA
Fast,
a
new
rapid
perimetric
threshold
test.
Description
of
methods
and
evaluation
in
patients
with
manifest
and
suspect
glaucoma.
Acta
Ophthalmologica
Scandinavica,
1998,
76:
431-437
|
|
|
111818
|
Visual
Field
Full
Threshold
Test
Strategy
|
Threshold
test
algorithm
that
determines
a
patient's
sensitivity
at
each
test
point
in
the
threshold
test
pattern
by
adjusting
intensity
by
4
dB
steps
until
the
patient
changes
their
response,
and
then
adjusts
the
intensity
in
the
opposite
direction
by
2
dB
steps
until
the
patient
changes
their
response
again.
The
last
stimulus
seen
by
the
patient
is
recognized
as
the
threshold
for
that
point.
The
starting
values
are
determined
by
first
thresholding
a
"primary"
point
in
each
quadrant
then
using
the
results
of
each
primary
point
to
determine
the
starting
values
for
neighboring
points
|
|
|
111819
|
Visual
Field
FastPac
Test
Strategy
|
Similar
to
the
Full
Threshold
algorithm
except
that
it
steps
by
3
dB
and
only
crosses
the
threshold
only
once.
In:
Flanagan
JG,
Wild
JM,
Trope
GE.
Evaluation
of
FASTPAC,
a
new
strategy
for
threshold
estimation
with
the
Humphrey
Field
Analyzer,
in
a
glaucomatous
population.
Ophthalmology,
1993,
100:
949-954
|
|
|
111820
|
Visual
Field
Full
From
Prior
Test
Strategy
|
Identical
to
Full
Threshold
except
that
starting
values
are
determined
by
the
results
of
a
previous
test
performed
using
the
same
test
pattern
and
the
Full
Threshold
test
strategy
|
|
|
111821
|
Visual
Field
Optima
Test
Strategy
|
Similar
to
FastPac
except
that
the
steps
are
pseudo-dynamic
(differ
based
on
the
intensity
of
the
last
presentation)
|
|
|
111822
|
Visual
Field
Two-Zone
Test
Strategy
|
Suprathreshold
testing
strategy,
in
which
each
point
is
initially
tested
using
stimulus
that
is
6
dB
brighter
than
the
expected
hill
of
vision.
If
the
patient
does
not
respond,
the
stimulus
is
presented
a
second
time
at
the
same
brightness.
If
the
patient
sees
either
presentation,
the
point
is
marked
as
"seen";
otherwise
it
is
marked
as
"not
seen"
|
|
|
111823
|
Visual
Field
Three-Zone
Test
Strategy
|
An
extension
of
the
two-zone
strategy
in
which
test
points
where
the
second
stimulus
is
not
seen
are
presented
with
a
third
stimulus
at
maximum
brightness
|
|
|
111824
|
Visual
Field
Quantify-Defects
Test
Strategy
|
An
extension
of
the
two-zone
strategy,
in
which
test
points
where
the
second
stimulus
is
not
seen
receive
threshold
testing
to
quantify
the
depth
of
any
detected
scotomas
|
|
|
111825
|
Visual
Field
TOP
Test
Strategy
|
Tendency
Oriented
Perimetry.
Fast
thresholding
algorithm.
Test
strategy
makes
use
of
the
interaction
between
neighboring
test
locations
to
reduce
the
test
time
compared
to
normal
full
threshold
strategy
by
60-80%.
In:
Morales
J,
Weitzman
ML,
Gonzalez
de
la
Rosa
M.
Comparison
between
Tendency-Oriented
Perimetry
(TOP)
and
octopus
threshold
perimetry.
Ophthalmology,
2000,
107:
134-142
|
|
|
111826
|
Visual
Field
Dynamic
Test
Strategy
|
Dynamic
strategy
is
a
fast
thresholding
strategy
reducing
test
duration
by
adapting
the
dB
step
sizes
according
to
the
frequency-of-seeing
curve
of
the
threshold.
Reduction
of
test
time
compared
to
normal
full
threshold
strategy
30-50%
|
|
|
111827
|
Visual
Field
Normal
Test
Strategy
|
Traditional
full
threshold
staircase
strategy.
Initial
intensities
are
presented,
based
on
anchor
point
sensitivities
in
each
quadrant
and
based
on
already
known
neighboring
sensitivities.
In
a
first
run,
thresholds
are
changed
in
4dB
steps
until
the
first
response
reversal.
Then
the
threshold
is
changed
in
2
dB
steps
until
the
second
response
reversal.
The
threshold
is
calculated
as
the
average
between
the
last
seen
and
last
not-seen
stimulus,
supposed
to
correspond
with
the
50%
point
in
the
frequency-of-seeing
curve
|
|
|
111828
|
Visual
Field
1-LT
Test
Strategy
|
One
level
screening
test:
Each
test
location
is
tested
with
a
single
intensity.
The
result
is
shown
as
seen
or
not-seen.
The
intensity
can
either
be
a
0
dB
stimulus
or
a
predefined
intensity
|
|
|
111829
|
Visual
Field
2-LT
Test
Strategy
|
Two
level
screening
test:
Each
test
location
is
initially
tested
6
dB
brighter
than
the
age
corrected
normal
value
|
|
|
111830
|
Visual
Field
LVS
Test
Strategy
|
Low
Vision
Strategy
is
a
full
threshold
normal
strategy
with
the
exception
that
it
starts
at
0
dB
intensity
and
applies
stimulus
area
V
|
|
|
111831
|
Visual
Field
GATE
Test
Strategy
|
German
Adaptive
Threshold
Estimation
is
a
fast
strategy
based
on
a
modified
4-2
staircase
algorithm,
using
prior
visual
fields
to
calculate
the
starting
intensity.
In:
Chiefer
U,
Pascual
JP,
Edmunds
B,
Feudner
E,
Hoffmann
EM,
Johnson
CA,
Lagreze
WA,
Pfeiffer
N,
Sample
PA,
Staubach
F,
Weleber
RG,
Vonthein
R,
Krapp
E,
Paetzold
J.
Comparison
of
the
new
perimetric
GATE
strategy
with
conventional
full-threshold
and
SITA
standard
strategies.
Investigative
Ophthalmology
and
Visual
Science,
2009,
51:
488-494
|
|
|
111832
|
Visual
Field
GATEi
Test
Strategy
|
Similar
to
GATE.
The
i
stands
for
initial.
If
there
was
no
prior
visual
field
test
to
calculate
the
starting
values,
an
anchor
point
method
is
used
to
define
the
local
start
values
|
|
|
111833
|
Visual
Field
2LT-Dynamic
Test
Strategy
|
A
test
started
as
two
level
screening
test.
In
the
course
of
the
test,
the
threshold
of
relative
defects
and/or
normal
test
locations
has
been
quantified
using
the
dynamic
threshold
strategy
|
|
|
111834
|
Visual
Field
2LT-Normal
Test
Strategy
|
A
test
started
as
two
level
screening
test.
In
the
course
of
the
test,
the
threshold
of
relative
defects
and/or
normal
test
locations
has
been
quantified
using
the
normal
full
threshold
strategy
|
|
|
111835
|
Visual
Field
Fast
Threshold
Test
Strategy
|
Takes
neighborhood
test
point
results
into
account
and
offers
stimuli
with
an
adapted
value
to
save
time
|
|
|
111836
|
Visual
Field
CLIP
Test
Strategy
|
Continuous
Luminance
Incremental
Perimetry,
which
measures
at
first
the
individual
reaction
time
of
the
patient
and
threshold
values
in
every
quadrant.
The
starting
value
for
the
main
test
is
slightly
below
in
individual
threshold
|
|
|
111837
|
Visual
Field
CLASS
Strategy
|
A
supra
threshold
screening
strategy.
The
starting
stimuli
intensities
depend
on
the
classification
of
the
patient's
visual
hill
by
measuring
the
central
(fovea)
or
peripheral
(15°
meridian)
threshold.
The
result
of
each
dot
slightly
underestimates
the
sensitivity
value
(within
5
dB)
|
|
|
111838
|
Age
corrected
|
Mode
for
determining
the
starting
luminance
for
screening
test
points
-
the
starting
luminance
s
is
chosen
based
on
the
age
of
the
patient
|
|
|
111839
|
Threshold
related
|
Mode
for
determining
the
starting
luminance
for
screening
test
points
-
the
starting
luminance
is
chosen
based
on
the
results
of
thresholding
a
set
of
"primary"
test
points
(one
in
each
quadrant)
|
|
|
111840
|
Single
luminance
|
Mode
for
determining
the
starting
luminance
for
screening
test
points
-
in
this
case,
all
starting
luminance
is
set
to
the
same
value
|
|
|
111841
|
Foveal
sensitivity
related
|
Mode
for
determining
the
starting
luminance
for
screening
test
points
-
the
starting
luminance
is
chosen
based
on
the
result
of
the
foveal
threshold
value
|
|
|
111842
|
Related
to
non
macular
sensitivity
|
Mode
for
determining
the
starting
luminance
for
screening
test
points
-
the
starting
luminance
is
chosen
based
on
the
result
of
four
threshold
values
measured
near
the
15°
meridian
(one
in
each
quadrant)
|
|
|
111843
|
Automated
Optical
|
Real
time
evaluation
of
the
camera
image
to
recognize
blinks
and
fixation
losses
with
influence
on
the
test
procedure.
Blinks
that
interfere
with
stimuli
presentation
cause
the
automated
repetition
of
such
stimulus
presentations.
Fixation
losses
can
be
used
to
delay
the
stimulus
presentation
until
correct
fixation
is
regained
|
|
|
111844
|
Blind
Spot
Monitoring
|
A
method
of
monitoring
the
patient's
fixation
by
periodically
presenting
stimulus
in
a
location
on
the
background
surface
that
corresponds
to
the
patient's
blind
spot
|
|
|
111845
|
Macular
Fixation
Testing
|
A
method
of
monitoring
the
patient's
fixation
by
presenting
the
stimulus
to
the
patient's
macula
|
|
|
111846
|
Observation
by
Examiner
|
A
method
of
monitoring
the
patient's
fixation
by
observation
from
the
examiner
of
the
patient
|
|
|
111847
|
Outside
normal
limits
|
Analysis
Results
are
outside
normal
limits
|
|
|
111848
|
Borderline
|
Analysis
Results
are
borderline
|
|
|
111849
|
Abnormally
high
sensitivity
|
Analysis
Results
identify
abnormally
high
sensitivity
|
|
|
111850
|
General
reduction
in
sensitivity
|
Analysis
Results
identify
general
reduction
in
sensitivity
|
|
|
111851
|
Borderline
and
general
reduction
in
sensitivity
|
Analysis
Results
identify
Borderline
and
general
reduction
in
sensitivity
|
|
|
111852
|
Visual
Field
Index
|
Index
of
a
patient's
remaining
visual
field
normalized
for
both
age
and
generalized
defect
|
|
|
111853
|
Visual
Field
Loss
Due
to
Diffuse
Defect
|
Estimate
of
the
portion
of
a
patient's
visual
field
loss
that
is
diffuse
(i.e.,
spread
evenly
across
all
portions
of
the
visual
field)
|
|
|
111854
|
Visual
Field
Loss
Due
to
Local
Defect
|
Estimate
of
the
portion
of
a
patient's
visual
field
loss
that
is
local
(i.e.,
not
spread
evenly
across
all
portions
of
the
visual
field)
|
|
|
111855
|
Glaucoma
Hemifield
Test
Analysis
|
An
analysis
of
asymmetry
between
zones
of
the
superior
and
inferior
visual
field.
It
is
designed
to
be
specific
for
defects
due
to
glaucoma
|
|
|
111856
|
Optical
Fixation
Measurements
|
The
data
output
of
an
optical
fixation
monitoring
process,
consisting
of
a
list
of
positive
and
negative
numbers
indicating
the
quality
of
patient
fixation
over
the
course
of
a
visual
field
test.
The
value
0
represents
the
initial
fixation.
Negative
numbers
indicate
a
measuring
error
(i.e.,
the
patient
blinked).
Positive
numbers
quantify
the
degree
of
eccentricity
from
initial
fixation
|
|
|
111900
|
Macula
centered
|
An
image
of
at
least
15°
angular
subtend
that
is
centered
on
the
macula;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111901
|
Disc
centered
|
An
image
of
at
least
15°
angular
subtend
that
is
centered
on
the
optic
disc;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111902
|
Lesion
centered
|
An
image
of
any
angular
subtend
that
is
centered
on
a
lesion
located
in
any
region
of
the
fundus;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111903
|
Disc-macula
centered
|
An
image
of
at
least
15°
angular
subtend
centered
midway
between
the
disc
and
macula
and
containing
at
least
a
portion
of
the
disc
and
both
the
disc
and
the
macula;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111904
|
Mid-peripheral-superior
|
An
image
of
at
least
15°
angular
subtend
positioned
between
the
central
zone
and
the
equator,
and
spanning
both
the
superior-temporal
and
superior-nasal
quadrants
of
the
fundus;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111905
|
Mid-peripheral-superior
temporal
|
An
image
of
at
least
15°
angular
subtend
positioned
between
the
central
zone
and
the
equator
in
the
superior-temporal
quadrant
of
the
fundus;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111906
|
Mid-peripheral-temporal
|
An
image
of
at
least
15°
angular
subtend
positioned
between
the
central
zone
and
the
equator,
and
spanning
both
the
superior-temporal
and
inferior-temporal
quadrants
of
the
fundus;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111907
|
Mid-peripheral-inferior
temporal
|
An
image
of
at
least
15°
angular
subtend
positioned
between
the
central
zone
and
the
equator
in
the
inferior-temporal
quadrant
of
the
fundus;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111908
|
Mid-peripheral-inferior
|
An
image
of
at
least
15°
angular
subtend
positioned
between
the
central
zone
and
the
equator,
and
spanning
both
the
inferior-temporal
and
inferior-nasal
quadrants
of
the
fundus;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111909
|
Mid-peripheral-inferior
nasal
|
An
image
of
at
least
15°
angular
subtend
positioned
between
the
central
zone
and
the
equator
in
the
inferior-nasal
quadrant
of
the
fundus;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111910
|
Mid-peripheral-nasal
|
An
image
of
at
least
15°
angular
subtend
positioned
between
the
central
zone
and
the
equator,
and
spanning
both
the
superior-nasal
and
inferior-nasal
quadrants
of
the
fundus;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111911
|
Mid-peripheral-superior
nasal
|
An
image
of
at
least
15°
angular
subtend
positioned
between
the
central
zone
and
the
equator
in
the
superior-nasal
quadrant
of
the
fundus;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111912
|
Peripheral-superior
|
An
image
of
at
least
15°
angular
subtend
positioned
between
the
equator
and
the
ora
serrata,
and
spanning
both
the
superior
temporal
and
superior
nasal
quadrants
of
the
fundus;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111913
|
Peripheral-superior
temporal
|
An
image
of
at
least
15°
angular
subtend
positioned
between
the
equator
and
ora
serrata
in
the
superior-temporal
quadrant
of
the
fundus;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111914
|
Peripheral-temporal
|
An
image
of
at
least
15°
angular
subtend
positioned
between
the
equator
and
ora
serrata,
and
spanning
both
the
superior-temporal
and
inferior-temporal
quadrants
of
the
fundus;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111915
|
Peripheral-inferior
temporal
|
An
image
of
at
least
15°
angular
subtend
positioned
between
the
equator
and
ora
serrata
in
the
inferior-temporal
quadrant
of
the
fundus;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111916
|
Peripheral-inferior
|
An
image
of
at
least
15°
angular
subtend
positioned
between
the
equator
and
ora
serrata,
and
spanning
both
the
inferior-temporal
and
inferior-nasal
quadrants
of
the
fundus;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111917
|
Peripheral-inferior
nasal
|
An
image
of
at
least
15°
angular
subtend
positioned
between
the
equator
and
ora
serrata
in
the
inferior-nasal
quadrant
of
the
fundus;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111918
|
Peripheral-nasal
|
An
image
of
at
least
15°
angular
subtend
positioned
between
the
equator
and
ora
serrata,
and
spanning
both
the
superior-nasal
and
inferior-nasal
quadrants
of
the
fundus;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111919
|
Peripheral-superior
nasal
|
An
image
of
at
least
15°
angular
subtend
positioned
between
the
equator
and
ora
serrata
in
the
superior-nasal
quadrant
of
the
fundus;
see
Section
U.1.8
"Relative
Image
Position
Definitions"
in
PS3.17
|
|
|
111920
|
Time
domain
|
Identifies
the
use
of
physical
signals
with
respect
to
time
to
capture
information
|
|
|
111921
|
Spectral
domain
|
Identifies
the
use
of
physical
signals
with
respect
to
multiple
frequencies
to
capture
information
|
|
|
111922
|
No
corneal
compensation
|
No
compensation
algorithm
for
corneal
birefringence
|
|
|
111923
|
Corneal
birefringence
compensation
|
Algorithm
to
compensate
for
variability
in
corneal
birefringence
|
|
|
111924
|
Retinal
topography
|
Measurement
of
the
retinal
surface
contour
relative
to
an
assigned
datum
plane
|
|
|
111925
|
Retinal
nerve
fiber
layer
thickness
|
Measurement
approximating
the
distance
related
to
the
structure
between
the
internal
limiting
membrane
(ILM)
and
the
outer
boarder
of
the
retinal
nerve
fiber
layer
(RNFL);
see
Section
III.6
"Retinal
Thickness
Definition"
in
PS3.17
|
|
|
111926
|
Ganglion
cell
complex
thickness
|
Measurement
approximating
the
distance
related
to
the
structure
between
the
ILM
and
the
outer
border
of
the
inner
plexiform
layer
(IPL),
called
the
ganglion
cell
complex
(GCC);
see
Section
III.6
"Retinal
Thickness
Definition"
in
PS3.17
|
|
|
111927
|
Total
retinal
thickness
(ILM
to
IS-OS)
|
Measurement
approximating
the
distance
related
to
the
structure
between
the
ILM
and
the
inner-outer
segment
junction
(IS-OS);
see
Section
III.6
"Retinal
Thickness
Definition"
in
PS3.17
|
|
|
111928
|
Total
retinal
thickness
(ILM
to
RPE)
|
Measurement
approximating
the
distance
related
to
the
structure
between
the
ILM
and
the
retinal
pigment
epithelium
(RPE);
see
Section
III.6
"Retinal
Thickness
Definition"
in
PS3.17
|
|
|
111929
|
Total
retinal
thickness
(ILM
to
BM)
|
Measurement
approximating
the
distance
related
to
the
structure
between
the
ILM
and
the
Bruch's
membrane
(BM);
see
Section
III.6
"Retinal
Thickness
Definition"
in
PS3.17
|
|
|
111930
|
Absolute
ophthalmic
thickness
|
Thickness
of
a
component
of
the
posterior
segment
of
the
eye;
e.g.
thickness
of
retina,
choroid,
etc
|
|
|
111931
|
Thickness
deviation
category
from
normative
data
|
Ophthalmic
Thickness
map
based
upon
statistical
significance
category
(such
as
percentile)
from
a
normative
data
set
|
|
|
111932
|
Thickness
deviation
from
normative
data
|
Ophthalmic
Thickness
map
based
upon
deviation
(such
as
microns)
from
a
normative
data
set
|
|
|
111933
|
Related
ophthalmic
thickness
map
|
Ophthalmic
Thickness
Map
related
to
another
Ophthalmic
Thickness
Map
or
another
SOP
Instance
|
|
|
111934
|
Disc-Fovea
|
An
anatomic
point
centered
midway
between
the
disc
and
fovea
centralis
|
|
|
111935
|
p>5%
|
Assuming
the
null
hypothesis
is
true,
the
conditional
percent
probability
of
observing
this
result
is
not
statistically
significant
|
|
|
111936
|
p<5%
|
Assuming
the
null
hypothesis
is
true,
the
conditional
percent
probability
of
observing
this
result
is
statistically
significant,
95%
unlikely
to
happen
by
chance
|
|
|
111937
|
p<2%
|
Assuming
the
null
hypothesis
is
true,
the
conditional
percent
probability
of
observing
this
result
is
statistically
significant,
98%
unlikely
to
happen
by
chance
|
|
|
111938
|
p<1%
|
Assuming
the
null
hypothesis
is
true,
the
conditional
percent
probability
of
observing
this
result
is
statistically
significant,
99%
unlikely
to
happen
by
chance
|
|
|
111939
|
p<0.5%
|
Assuming
the
null
hypothesis
is
true,
the
conditional
percent
probability
of
observing
this
result
is
statistically
significant,
99.5%
unlikely
to
happen
by
chance
|
|
|
111940
|
Corneal
axial
power
map
|
A
two
dimensional
representation
of
the
axial
curvature
of
the
cornea.
Axial
curvature
is
calculated
from
the
reciprocal
of
the
distance
from
a
point
on
a
meridian
normal
at
the
point
to
the
corneal
topographer
axis.
Also
known
as
sagittal
curvature
|
|
|
111941
|
Corneal
instantaneous
power
map
|
A
two
dimensional
representation
of
the
instantaneous
curvature
of
the
cornea.
Instantaneous
curvature
is
calculated
from
the
reciprocal
of
the
distance
from
a
point
on
a
meridian
normal
at
the
point
to
the
center
of
curvature
of
that
point.
Also
called
tangential
curvature
|
|
|
111942
|
Corneal
refractive
power
map
|
A
two
dimensional
representation
of
the
refractive
power
of
the
cornea.
Corneal
refractive
power
is
calculated
using
Snell's
Law
|
|
|
111943
|
Corneal
elevation
map
|
A
two
dimensional
representation
of
the
elevation
of
the
cornea.
Elevation
is
calculated
as
the
distance
from
a
point
on
the
corneal
surface
to
a
point
on
a
reference
surface
along
a
line
parallel
to
the
corneal
topographer
axis.
For
the
purpose
of
visualization
the
reference
surface
is
usually
a
sphere
or
an
ellipse
|
|
|
111944
|
Corneal
wavefront
map
|
A
two
dimensional
representation
of
a
wavefront
aberration
surface
of
the
cornea.
Wavefront
aberration
surface
is
calculated
from
the
corneal
elevation
data
fit
with
either
the
Zernike
polynomial
series
or
the
Fourier
Series.
Maps
generally
display
total
aberrations
and
selectable
higher
order
aberrations
|
|
|
111945
|
Elevation-based
corneal
tomographer
|
A
device
that
measures
corneal
anterior
surface
shape
using
elevation-based
methods
(stereographic
and
light
slit-based).
Rasterstereography
images
a
grid
pattern
illuminating
the
fluorescein
dyed
tear
film
with
2
cameras
to
produce
3D.
Slit-based
devices
scan
the
cornea,
usually
by
rotation
about
the
instrument
axis
centered
on
the
cornea
vertex
|
|
|
111946
|
Reflection-based
corneal
topographer
|
A
reflection-based
device
that
projects
a
pattern
of
light
onto
the
cornea
and
an
image
of
the
reflection
of
that
pattern
from
the
tear
film
is
recorded
in
one
video
frame.
Light
patterns
include
the
circular
mire
pattern
(Placido
disc)
and
spot
matrix
patterns.
Sequential
scanning
of
light
spots
reflected
from
the
corneal
surface
is
also
used
requiring
multiple
video
frames
for
recording
|
|
|
111947
|
Interferometry-based
corneal
tomographer
|
An
Interference-based
device
that
projects
a
beam
of
light
onto
and
through
the
cornea.
Light
reflected
from
within
the
cornea
is
combined
with
a
reference
beam
giving
rise
to
an
interference
pattern.
Appropriately
scanned,
this
imaging
is
used
to
construct
3-dimensional
images
of
the
cornea
from
anterior
to
posterior
surfaces;
e.g.
swept
source
OCT
|
|
|
112000
|
Chest
CAD
Report
|
A
structured
report
containing
the
results
of
computer-aided
detection
or
diagnosis
applied
to
chest
imaging
and
associated
clinical
information
|
|
|
112001
|
Opacity
|
The
shadow
of
an
absorber
that
attenuates
the
X-Ray
beam
more
effectively
than
do
surrounding
absorbers.
In
a
radiograph,
any
circumscribed
area
that
appears
more
nearly
white
(of
lesser
photometric
density)
than
its
surround
[Fraser
and
Pare]
|
|
|
112002
|
Series
Instance
UID
|
A
unique
identifier
for
a
series
of
DICOM
SOP
instances
|
|
|
112003
|
Associated
Chest
Component
|
A
named
anatomic
region
within
the
chest
cavity
|
|
|
112004
|
Abnormal
interstitial
pattern
|
A
collection
of
opacities
detected
within
the
continuum
of
loose
connective
tissue
throughout
the
lung,
that
is
not
expected
in
a
diagnostically
normal
radiograph
|
|
|
112005
|
Radiographic
anatomy
|
A
type
of
anatomy
that
is
expected
to
be
detectable
on
a
radiographic
(X-Ray
based)
image
|
|
|
112006
|
Distribution
Descriptor
|
Characteristic
of
the
extent
of
spreading
of
a
finding
or
feature
|
|
|
112007
|
Border
definition
|
Characteristic
of
the
clarity
of
the
boundary
or
edges
of
a
finding
or
feature
|
|
|
112008
|
Site
involvement
|
The
part(s)
of
the
anatomy
affected
or
encompassed
by
a
finding
or
feature
|
|
|
112009
|
Type
of
Content
|
Characteristic
of
the
matter
or
substance
within
a
finding
or
feature
|
|
|
112010
|
Texture
Descriptor
|
Characteristic
of
the
surface
or
consistency
of
a
finding
or
feature
|
|
|
112011
|
Positioner
Primary
Angle
|
Position
of
the
X-Ray
beam
about
the
patient
from
the
RAO
to
LAO
direction
where
movement
from
RAO
to
vertical
is
positive
|
|
|
112012
|
Positioner
Secondary
Angle
|
Position
of
the
X-Ray
beam
about
the
patient
from
the
caudal
to
cranial
direction
where
movement
from
caudal
to
vertical
is
positive
|
|
|
112013
|
Location
in
Chest
|
The
zone,
lobe
or
segment
within
the
chest
cavity
in
which
a
finding
or
feature
is
situated
|
|
|
112014
|
Orientation
Descriptor
|
Vertical
refers
to
orientation
parallel
to
the
superior-inferior
(cephalad-caudad)
axis
of
the
body,
with
horizontal
being
perpendicular
to
this,
and
an
oblique
orientation
having
projections
in
both
the
horizontal
and
vertical
|
|
|
112015
|
Border
shape
|
Characteristic
of
the
shape
formed
by
the
boundary
or
edges
of
a
finding
or
feature
|
|
|
112016
|
Baseline
Category
|
Indicates
whether
a
finding
was
considered
a
target
lesion,
non-target
lesion,
or
non-lesion
during
evaluation
of
a
baseline
series,
according
to
a
method
such
as
RECIST
|
|
|
112017
|
Cavity
extent
as
percent
of
volume
|
The
extent
of
a
detected
cavity,
represented
as
the
percent
of
the
surrounding
volume
that
it
occupies
|
|
|
112018
|
Calcification
extent
as
percent
of
surface
|
The
extent
of
a
detected
calcification,
represented
as
the
percent
of
the
surrounding
surface
that
it
occupies
|
|
|
112019
|
Calcification
extent
as
percent
of
volume
|
The
extent
of
a
detected
calcification,
represented
as
the
percent
of
the
surrounding
volume
that
it
occupies
|
|
|
112020
|
Response
Evaluation
|
A
heading
for
the
reporting
of
response
evaluation
for
treatment
of
solid
tumors
|
|
|
112021
|
Response
Evaluation
Method
|
The
system
applied
in
the
reporting
of
response
evaluation
for
treatment
of
solid
tumors
|
|
|
112022
|
RECIST
|
Response
Evaluation
Criteria
In
Solid
Tumors;
see
Normative
References
|
|
|
112023
|
Composite
Feature
Modifier
|
A
term
that
further
specifies
the
name
of
an
item
that
is
an
inferred
correlation
relating
two
or
more
individual
findings
or
features
|
|
|
112024
|
Single
Image
Finding
Modifier
|
A
term
that
further
specifies
the
name
of
an
item
that
was
detected
on
one
image
|
|
|
112025
|
Size
Descriptor
|
A
qualitative
descriptor
for
the
extent
of
a
finding
or
feature
|
|
|
112026
|
Width
Descriptor
|
A
qualitative
descriptor
for
the
thickness
of
tubular
structures,
such
as
blood
vessels
|
|
|
112027
|
Opacity
Descriptor
|
A
characteristic
that
further
describes
the
nature
of
an
opacity
|
|
|
112028
|
Abnormal
Distribution
of
Anatomic
Structure
|
The
type
of
adverse
affect
that
a
finding
or
feature
is
having
on
the
surrounding
anatomy
|
|
|
112029
|
WHO
|
Response
evaluation
method
as
defined
in
chapter
5,
"Reporting
of
Response"
of
the
WHO
Handbook
for
Reporting
Results
for
Cancer
Treatment;
see
Normative
References
|
|
|
112030
|
Calcification
Descriptor
|
Identification
of
the
morphology
of
detected
calcifications
|
|
|
112031
|
Attenuation
Coefficient
|
A
quantitative
numerical
statement
of
the
relative
attenuation
of
the
X-Ray
beam
at
a
specified
point.
Coefficient
that
describes
the
fraction
of
a
beam
of
X-Rays
or
gamma
rays
that
is
absorbed
or
scattered
per
unit
thickness
of
the
absorber.
This
value
basically
accounts
for
the
number
of
atoms
in
a
cubic
cm
volume
of
material
and
the
probability
of
a
photon
being
scattered
or
absorbed
from
the
nucleus
or
an
electron
of
one
of
these
atoms.
Usually
expressed
in
Hounsfield
units
[referred
to
as
CT
Number
in
Fraser
and
Pare]
|
|
|
112032
|
Threshold
Attenuation
Coefficient
|
An
X-Ray
attenuation
coefficient
that
is
used
as
a
threshold;
e.g.
in
calcium
scoring
|
|
|
112033
|
Abnormal
opacity
|
An
opacity
that
is
not
expected
in
a
diagnostically
normal
radiograph
|
|
|
112034
|
Calculation
Description
|
A
textual
description
of
the
mathematical
method
of
calculation
that
resulted
in
a
calculated
value
|
|
|
112035
|
Performance
of
Pediatric
and
Adult
Chest
Radiography,
ACR
|
American
College
of
Radiology.
ACR
Standard
for
the
Performance
of
Pediatric
and
Adult
Chest
Radiography.
In:
Standards.
Reston,
Va:
2001:95-98
|
|
|
112036
|
ACR
Position
Statement
|
American
College
of
Radiology.
ACR
Position
Statement
for
Quality
Control
and
Improvement,
Safety,
Infection
Control,
and
Patient
Concerns.
In:
Practice
Guidelines
and
Technical
Standards.
Reston,
Va:
2001:iv
|
|
|
112037
|
Non-lesion
Modifier
|
A
descriptor
for
a
non-lesion
object
finding
or
feature,
used
to
indicate
whether
the
object
was
detected
as
being
internal
or
external
to
the
patient's
body
|
|
|
112038
|
Osseous
Modifier
|
A
concept
modifier
for
an
Osseous
Anatomy,
or
bone
related,
finding
|
|
|
112039
|
Tracking
Identifier
|
A
text
label
used
for
tracking
a
finding
or
feature,
potentially
across
multiple
reporting
objects,
over
time.
This
label
shall
be
unique
within
the
domain
in
which
it
is
used
|
|
|
112040
|
Tracking
Unique
Identifier
|
A
unique
identifier
used
for
tracking
a
finding
or
feature,
potentially
across
multiple
reporting
objects,
over
time
|
|
|
112041
|
Target
Lesion
Complete
Response
|
Disappearance
of
all
target
lesions
|
|
|
112042
|
Target
Lesion
Partial
Response
|
At
least
a
30%
decrease
in
the
sum
of
the
Longest
Diameter
of
target
lesions,
taking
as
reference
the
baseline
sum
Longest
Diameter
|
|
|
112043
|
Target
Lesion
Progressive
Disease
|
At
least
a
20%
increase
in
the
sum
of
the
Longest
Diameter
of
target
lesions,
taking
as
reference
the
smallest
sum
Longest
Diameter
recorded
since
the
treatment
started,
or
the
appearance
of
one
or
more
new
lesions
|
|
|
112044
|
Target
Lesion
Stable
Disease
|
Neither
sufficient
shrinkage
to
qualify
for
Partial
Response
nor
sufficient
increase
to
qualify
for
Progressive
Disease,
taking
as
reference
the
smallest
sum
Longest
Diameter
since
the
treatment
started
|
|
|
112045
|
Non-Target
Lesion
Complete
Response
|
Disappearance
of
all
non-target
lesions
and
normalization
of
tumor
marker
level
|
|
|
112046
|
Non-Target
Lesion
Incomplete
Response
or
Stable
Disease
|
Persistence
of
one
or
more
non-target
lesions
and/or
maintenance
of
tumor
marker
level
above
the
normal
limits
|
|
|
112047
|
Non-Target
Lesion
Progressive
Disease
|
Appearance
of
one
or
more
new
lesions
and/or
unequivocal
progression
of
existing
non-target
lesions
|
|
|
112048
|
Current
Response
|
The
current
response
evaluation
for
treatment
of
solid
tumors,
according
to
a
method
such
as
RECIST
|
|
|
112049
|
Best
Overall
Response
|
Best
response
recorded
from
the
start
of
the
treatment
until
disease
progression/recurrence,
taking
as
reference
for
Progressive
Disease
the
smallest
measurements
recorded
since
the
treatment
started,
according
to
a
method
such
as
RECIST
|
|
|
112050
|
Anatomic
Identifier
|
A
text
identifier
of
an
anatomic
feature
when
a
multiplicity
of
features
of
that
type
may
be
present,
such
as
"Rib
1",
"Rib
2"
or
thoracic
vertebrae
"T1"
or
"T2"
|
|
|
112051
|
Measurement
of
Response
|
A
measured
or
calculated
evaluation
of
response;
e.g.
according
to
a
method
such
as
RECIST,
the
value
would
be
the
calculated
sum
of
the
lengths
of
the
longest
axes
of
a
set
of
target
lesions
|
|
|
112052
|
Bronchovascular
|
Of
or
relating
to
a
bronchial
(lung)
specific
channel
for
the
conveyance
of
a
body
fluid
|
|
|
112053
|
Osseous
|
Of,
relating
to,
or
composed
of
bone
|
|
|
112054
|
Secondary
pulmonary
lobule
|
The
smallest
unit
of
lung
surrounded
by
connective
tissue
septa;
the
unit
of
lung
subtended
by
any
bronchiole
that
gives
off
three
to
five
terminal
bronchioles
[Fraser
and
Pare]
|
|
|
112055
|
Agatston
scoring
method
|
A
method
of
calculating
an
overall
calcium
score,
reflecting
the
calcification
of
coronary
arteries,
based
on
the
maximum
X-Ray
attenuation
coefficient
and
the
area
of
calcium
deposits
|
|
|
112056
|
Volume
scoring
method
|
A
method
of
calculating
an
overall
calcium
score,
reflecting
the
calcification
of
coronary
arteries,
based
on
the
volume
of
each
calcification,
typically
expressed
in
mm3
|
|
|
112057
|
Mass
scoring
method
|
A
method
of
calculating
an
overall
calcium
score,
reflecting
the
calcification
of
coronary
arteries,
based
on
the
total
mass
of
calcification,
typically
expressed
in
mg
|
|
|
112058
|
Calcium
score
|
A
measure
often
arrived
at
through
calculation
of
findings
from
CT
examination,
which
is
a
common
predictor
of
significant
stenosis
of
the
coronary
arteries
|
|
|
112059
|
Primary
complex
|
The
combination
of
a
focus
of
pneumonia
due
to
a
primary
infection
with
granulomas
in
the
draining
hilar
or
mediastinal
lymph
nodes
[Fraser
and
Pare]
|
|
|
112060
|
Oligemia
|
General
or
local
decrease
in
the
apparent
width
of
visible
pulmonary
vessels,
suggesting
less
than
normal
blood
flow
(reduced
blood
flow)
[Fraser
and
Pare]
|
|
|
112061
|
Abnormal
lines
(1D)
|
Linear
opacity
of
very
fine
width,
i.e.,
a
nearly
one
dimensional
opacity
|
|
|
112062
|
Abnormal
lucency
|
Area
of
abnormal
very
low
X-Ray
attenuation,
typically
lower
than
aerated
lung
when
occurring
in
or
projecting
over
lung,
or
lower
than
soft
tissue
when
occurring
in
or
projecting
over
soft
tissue
|
|
|
112063
|
Abnormal
calcifications
|
A
calcific
opacity
within
the
lung
that
may
be
organized,
but
does
not
display
the
trabecular
organization
of
true
bone
[Fraser
and
Pare]
|
|
|
112064
|
Abnormal
texture
|
Relatively
homogeneous,
extended,
pattern
of
abnormal
opacity
in
the
lung,
typically
low
in
contrast
|
|
|
112065
|
Reticulonodular
pattern
|
A
collection
of
innumerable
small,
linear,
and
nodular
opacities
that
together
produce
a
composite
appearance
resembling
a
net
with
small
superimposed
nodules.
The
reticular
and
nodular
elements
are
dimensionally
of
similar
magnitude
[Fraser
and
Pare]
|
|
|
112066
|
Beaded
septum
sign
|
Irregular
septal
thickening
that
suggests
the
appearance
of
a
row
of
beads;
usually
a
sign
of
lymphangitic
carcinomatosis,
but
may
also
occur
rarely
in
sarcoidosis
[Fraser
and
Pare]
|
|
|
112067
|
Nodular
pattern
|
A
collection
of
innumerable,
small
discrete
opacities
ranging
in
diameter
from
2-10
mm,
generally
uniform
in
size
and
widespread
in
distribution,
and
without
marginal
spiculation
[Fraser
and
Pare]
|
|
|
112068
|
Pseudoplaque
|
An
irregular
band
of
peripheral
pulmonary
opacity
adjacent
to
visceral
pleura
that
simulates
the
appearance
of
a
pleural
plaque
and
is
formed
by
coalescence
of
small
nodules
[Fraser
and
Pare]
|
|
|
112069
|
Signet-ring
sign
|
A
ring
of
opacities
(usually
representing
a
dilated,
thick-walled
bronchus)
in
association
with
a
smaller,
round,
soft
tissue
opacity
(the
adjacent
pulmonary
artery)
suggesting
a
"signet
ring"
[Fraser
and
Pare]
|
|
|
112070
|
Air
bronchiologram
|
Equivalent
of
air
bronchogram,
but
in
airways
assumed
to
be
bronchioles
because
of
peripheral
location
and
diameter
[Fraser
and
Pare]
|
|
|
112071
|
Air
bronchogram
|
Radiographic
shadow
of
an
air-containing
bronchus;
presumed
to
represent
an
air-containing
segment
of
the
bronchial
tree
(identity
often
inferred)
[Fraser
and
Pare]
|
|
|
112072
|
Air
crescent
|
Air
in
a
crescentic
shape
in
a
nodule
or
mass,
in
which
the
air
separates
the
outer
wall
of
the
lesion
from
an
inner
sequestrum,
which
most
commonly
is
a
fungus
ball
of
Aspergillusspecies
[Fraser
and
Pare]
|
|
|
112073
|
Halo
sign
|
Ground-glass
opacity
surrounding
the
circumference
of
a
nodule
or
mass.
May
be
a
sign
of
invasive
aspergillosis
or
hemorrhage
of
various
causes
[Fraser
and
Pare]
|
|
|
112074
|
Target
Lesion
at
Baseline
|
Flag
denoting
that
this
lesion
was
identified,
at
baseline,
as
a
target
lesion
intended
for
tracking
over
time
[RECIST]
|
|
|
112075
|
Non-Target
Lesion
at
Baseline
|
Flag
denoting
that
this
lesion
was
not
identified,
at
baseline,
as
a
target
lesion,
and
was
not
intended
for
tracking
over
time
[RECIST]
|
|
|
112076
|
Non-Lesion
at
Baseline
|
Flag
denoting
that
this
finding
was
identified,
at
baseline,
as
a
category
other
than
a
lesion,
and
was
not
intended
for
tracking
over
time
[RECIST]
|
|
|
112077
|
Vasoconstriction
|
Local
or
general
reduction
in
the
caliber
of
visible
pulmonary
vessels,
presumed
to
result
from
decreased
flow
occasioned
by
contraction
of
muscular
pulmonary
arteries
[Fraser
and
Pare]
|
|
|
112078
|
Vasodilation
|
Local
or
general
increase
in
the
width
of
visible
pulmonary
vessels
resulting
from
increased
pulmonary
blood
flow
[Fraser
and
Pare]
|
|
|
112079
|
Architectural
distortion
|
A
manifestation
of
lung
disease
in
which
bronchi,
pulmonary
vessels,
a
fissure
or
fissures,
or
septa
of
secondary
pulmonary
lobules
are
abnormally
displaced
[Fraser
and
Pare]
|
|
|
112080
|
Mosaic
perfusion
|
A
patchwork
of
regions
of
varied
attenuation,
interpreted
as
secondary
to
regional
differences
in
perfusion
[Fraser
and
Pare]
|
|
|
112081
|
Pleonemia
|
Increased
blood
flow
to
the
lungs
or
a
portion
thereof,
manifested
by
a
general
or
local
increase
in
the
width
of
visible
pulmonary
vessels
[Fraser
and
Pare]
|
|
|
112082
|
Interface
|
The
common
boundary
between
the
shadows
of
two
juxtaposed
structures
or
tissues
of
different
texture
or
opacity
(edge,
border)
[Fraser
and
Pare]
|
|
|
112083
|
Line
|
A
longitudinal
opacity
no
greater
than
2
mm
in
width
[Fraser
and
Pare]
|
|
|
112084
|
Lucency
|
The
shadow
of
an
absorber
that
attenuates
the
primary
X-Ray
beam
less
effectively
than
do
surrounding
absorbers.
In
a
radiograph,
any
circumscribed
area
that
appears
more
nearly
black
(of
greater
photometric
density)
than
its
surround
[Fraser
and
Pare]
|
|
|
112085
|
Midlung
window
|
A
midlung
region,
characterized
by
the
absence
of
large
blood
vessels
and
by
a
paucity
of
small
blood
vessels,
that
corresponds
to
the
minor
fissure
and
adjacent
peripheral
lung
[Fraser
and
Pare]
|
|
|
112086
|
Carina
angle
|
The
angle
formed
by
the
right
and
left
main
bronchi
at
the
tracheal
bifurcation
[Fraser
and
Pare]
|
|
|
112087
|
Centrilobular
structures
|
The
pulmonary
artery
and
its
immediate
branches
in
a
secondary
lobule;
HRCT
depicts
these
vessels
in
certain
cases;
a.k.a.
core
structures
or
lobular
core
structures
[Fraser
and
Pare]
|
|
|
112088
|
Anterior
junction
line
|
A
vertically
oriented
linear
or
curvilinear
opacity
approximately
1-2
mm
wide,
commonly
projected
on
the
tracheal
air
shadow
[Fraser
and
Pare]
|
|
|
112089
|
Posterior
junction
line
|
A
vertically
oriented,
linear
or
curvilinear
opacity
approximately
2
mm
wide,
commonly
projected
on
the
tracheal
air
shadow,
and
usually
slightly
concave
to
the
right
[Fraser
and
Pare]
|
|
|
112090
|
Azygoesophageal
recess
interface
|
A
space
in
the
right
side
of
the
mediastinum
into
which
the
medial
edge
of
the
right
lower
lobe
extends
[Fraser
and
Pare]
|
|
|
112091
|
Paraspinal
line
|
A
vertically
oriented
interface
usually
seen
in
a
frontal
chest
radiograph
to
the
left
of
the
thoracic
vertebral
column
[Fraser
and
Pare]
|
|
|
112092
|
Posterior
tracheal
stripe
|
A
vertically
oriented
linear
opacity
ranging
in
width
from
2-5
mm,
extending
from
the
thoracic
inlet
to
the
bifurcation
of
the
trachea,
and
visible
only
on
lateral
radiographs
of
the
chest
[Fraser
and
Pare]
|
|
|
112093
|
Right
tracheal
stripe
|
A
vertically
oriented
linear
opacity
approximately
2-3
mm
wide
extending
from
the
thoracic
inlet
to
the
right
tracheobronchial
angle
[Fraser
and
Pare]
|
|
|
112094
|
Stripe
|
A
longitudinal
composite
opacity
measuring
2-5
mm
in
width;
acceptable
when
limited
to
anatomic
structures
within
the
mediastinum
[Fraser
and
Pare]
|
|
|
112095
|
Hiatus
|
A
gap
or
passage
through
an
anatomical
part
or
organ;
especially
:
a
gap
through
which
another
part
or
organ
passes
|
|
|
112096
|
Rib
Scalene
Tubercle
|
A
small
rounded
elevation
or
eminence
on
the
first
rib
for
the
attachment
of
the
scalenus
anterior
|
|
|
112097
|
Vertebral
Intervertebral
Notch
|
A
groove
that
serves
for
the
transmission
of
the
vertebral
artery
|
|
|
112098
|
Subscapular
Fossa
|
The
concave
depression
of
the
anterior
surface
of
the
scapula
|
|
|
112099
|
Scapular
Spine
|
A
sloping
ridge
dividing
the
dorsal
surface
of
the
scapula
into
the
supraspinatous
fossa
(above),
and
the
infraspinatous
fossa
(below)
|
|
|
112100
|
Scapular
Supraspinatus
Fossa
|
The
portion
of
the
dorsal
surface
of
the
scapula
above
the
scapular
spine
|
|
|
112101
|
Scapular
Infraspinatus
Fossa
|
The
portion
of
the
dorsal
surface
of
the
scapula
below
the
scapular
spine
|
|
|
112102
|
Aortic
knob
|
The
portion
of
the
aortic
arch
that
defines
the
transition
between
its
ascending
and
descending
limbs
|
|
|
112103
|
Arch
of
the
Azygos
vein
|
Section
of
Azygos
vein
near
the
fourth
thoracic
vertebra,
where
it
arches
forward
over
the
root
of
the
right
lung,
and
ends
in
the
superior
vena
cava,
just
before
that
vessel
pierces
the
pericardium
|
|
|
112104
|
Air-fluid
level
|
A
local
collection
of
gas
and
liquid
that,
when
traversed
by
a
horizontal
X-Ray
beam,
creates
a
shadow
characterized
by
a
sharp
horizontal
interface
between
gas
density
above
and
liquid
density
below
[Fraser
and
Pare]
|
|
|
112105
|
Corona
radiata
|
A
circumferential
pattern
of
fine
linear
spicules,
approximately
5
mm
long,
extending
outward
from
the
margin
of
a
solitary
pulmonary
nodule
through
a
zone
of
relative
lucency
[Fraser
and
Pare]
|
|
|
112106
|
Honeycomb
pattern
|
A
number
of
closely
approximated
ring
shadows
representing
air
spaces
5-10
mm
in
diameter
with
walls
2-3
mm
thick
that
resemble
a
true
honeycomb;
implies
"end-stage"
lung
[Fraser
and
Pare]
|
|
|
112107
|
Fleischner's
line(s)
|
A
straight,
curved,
or
irregular
linear
opacity
that
is
visible
in
multiple
projections;
usually
situated
in
the
lower
half
of
the
lung;
vary
markedly
in
length
and
width
[Fraser
and
Pare]
|
|
|
112108
|
Intralobular
lines
|
Fine
linear
opacities
present
in
a
lobule
when
the
intralobular
interstitium
is
thickened.
When
numerous,
they
may
appear
as
a
fine
reticular
pattern
[Fraser
and
Pare]
|
|
|
112109
|
Kerley
A
line
|
Essentially
straight
linear
opacity
2-6
cm
in
length
and
1-3
mm
in
width,
usually
in
an
upper
lung
zone
[Fraser
and
Pare]
|
|
|
112110
|
Kerley
B
line
|
A
straight
linear
opacity
1.5-2
cm
in
length
and
1-2
mm
in
width,
usually
at
the
lung
base
[Fraser
and
Pare]
|
|
|
112111
|
Kerley
C
lines
|
A
group
of
branching,
linear
opacities
producing
the
appearing
of
a
fine
net,
at
the
lung
base
[Fraser
and
Pare]
|
|
|
112112
|
Parenchymal
band
|
Elongated
opacity,
usually
several
millimeters
wide
and
up
to
about
5
cm
long,
often
extending
to
the
pleura,
which
may
be
thickened
and
retracted
at
the
site
of
contact
[Fraser
and
Pare]
|
|
|
112113
|
Reticular
pattern
|
A
collection
of
innumerable
small
linear
opacities
that
together
produce
an
appearance
resembling
a
net
[Fraser
and
Pare]
|
|
|
112114
|
Septal
line(s)
|
Usually
used
in
the
plural,
a
generic
term
for
linear
opacities
of
varied
distribution
produced
when
the
interstitium
between
pulmonary
lobules
is
thickened
[Fraser
and
Pare]
|
|
|
112115
|
Subpleural
line
|
A
thin
curvilinear
opacity,
a
few
millimeters
or
less
in
thickness,
usually
less
than
1
cm
from
the
pleural
surface
and
paralleling
the
pleura
[Fraser
and
Pare]
|
|
|
112116
|
Tramline
shadow
|
Parallel
or
slightly
convergent
linear
opacities
that
suggest
the
planar
projection
of
tubular
structures
and
that
correspond
in
location
and
orientation
to
elements
of
the
bronchial
tree
[Fraser
and
Pare]
|
|
|
112117
|
Tubular
shadow
|
Paired,
parallel,
or
slightly
convergent
linear
opacities
presumed
to
represent
the
walls
of
a
tubular
structure
seen
en
face;
used
if
the
anatomic
nature
of
a
shadow
is
obscure
[Fraser
and
Pare]
|
|
|
112118
|
Density
|
The
opacity
of
a
radiographic
shadow
to
visible
light;
film
blackening;
the
term
should
never
be
used
to
mean
an
"opacity"
or
"radiopacity"
[Fraser
and
Pare]
|
|
|
112119
|
Dependent
opacity
|
Subpleural
increased
attenuation
in
dependent
lung.
The
increased
attenuation
disappears
when
the
region
of
lung
is
nondependent;
a.k.a.
dependent
increased
attenuation
[Fraser
and
Pare]
|
|
|
112120
|
Ground
glass
opacity
|
Hazy
increased
attenuation
of
lung,
but
with
preservation
of
bronchial
and
vascular
margins;
caused
by
partial
filling
of
air
spaces,
interstitial
thickening,
partial
collapse
of
alveoli,
normal
expiration,
or
increased
capillary
blood
volume
[Fraser
and
Pare]
|
|
|
112121
|
Infiltrate
|
Any
ill-defined
opacity
in
the
lung
[Fraser
and
Pare]
|
|
|
112122
|
Micronodule
|
Discrete,
small,
round,
focal
opacity
of
at
least
soft
tissue
attenuation
and
with
a
diameter
no
greater
than
7
mm
[Fraser
and
Pare]
|
|
|
112123
|
Phantom
tumor
(pseudotumor)
|
A
shadow
produced
by
a
local
collection
of
fluid
in
one
of
the
interlobar
fissures,
usually
elliptic
in
one
radiographic
projection
and
rounded
in
the
other,
resembling
a
tumor
[Fraser
and
Pare]
|
|
|
112124
|
Shadow
|
Any
perceptible
discontinuity
in
film
blackening
attributed
to
the
attenuation
of
the
X-Ray
beam
by
a
specific
anatomic
absorber
or
lesion
on
or
within
the
body
of
the
patient;
to
be
employed
only
when
more
specific
identification
is
not
possible
[Fraser
and
Pare]
|
|
|
112125
|
Small
irregular
opacities
|
Term
used
to
define
a
reticular
pattern
specific
to
pneumoconioses
[Fraser
and
Pare]
|
|
|
112126
|
Small
rounded
opacities
|
Term
used
to
define
a
nodular
pattern
specific
to
pneumoconioses
[Fraser
and
Pare]
|
|
|
112127
|
Tree-in-bud
sign
|
Nodular
dilation
of
centrilobular
branching
structures
that
resembles
a
budding
tree
and
represents
exudative
bronchiolar
dilation
[Fraser
and
Pare]
|
|
|
112128
|
Granular
pattern
|
Any
extended,
finely
granular
pattern
of
pulmonary
opacity
within
which
normal
anatomic
details
are
partly
obscured
[Fraser
and
Pare]
|
|
|
112129
|
Miliary
pattern
|
A
collection
of
tiny
discrete
opacities
in
the
lungs,
each
measuring
2
mm
or
less
in
diameter,
generally
uniform
in
size
and
widespread
in
distribution
[Fraser
and
Pare]
|
|
|
112130
|
Mosaic
pattern
|
Generalized
pattern
of
relatively
well
defined
areas
in
the
lung
having
different
X-Ray
attenuations
due
to
a
longstanding
underlying
pulmonary
disease
|
|
|
112131
|
Extremely
small
|
A
qualitative
descriptor
of
a
size
that
is
dramatically
less
than
typical
|
|
|
112132
|
Very
small
|
A
qualitative
descriptor
of
a
size
that
is
considerably
less
than
typical
|
|
|
112133
|
Too
small
|
A
qualitative
descriptor
of
a
size
that
is
so
small
as
to
be
abnormal
versus
expected
size
|
|
|
112134
|
Elliptic
|
Shaped
like
an
ellipse
(oval)
|
|
|
112135
|
Lobulated
|
A
border
shape
that
is
made
up
of,
provided
with,
or
divided
into
lobules
(small
lobes,
curved
or
rounded
projections
or
divisions)
|
|
|
112136
|
Spiculated
|
Radially
orientated
border
shape
|
|
|
112137
|
Sharply
defined
|
The
border
of
a
shadow
(opacity)
is
sharply
defined
[Fraser
and
Pare]
|
|
|
112138
|
Distinctly
defined
|
The
border
of
a
shadow
(opacity)
is
distinctly
defined
[Fraser
and
Pare]
|
|
|
112139
|
Well
demarcated
|
The
border
of
a
shadow
(opacity)
is
well
distinct
from
adjacent
structures
[Fraser
and
Pare]
|
|
|
112140
|
Sharply
demarcated
|
The
border
of
a
shadow
(opacity)
is
sharply
distinct
from
adjacent
structures
[Fraser
and
Pare]
|
|
|
112141
|
Poorly
demarcated
|
The
border
of
a
shadow
(opacity)
is
poorly
distinct
from
adjacent
structures
[Fraser
and
Pare]
|
|
|
112142
|
Circumscribed
|
A
shadow
(opacity)
possessing
a
complete
or
nearly
complete
visible
border
[Fraser
and
Pare]
|
|
|
112143
|
Air
|
Inspired
atmospheric
gas.
The
word
is
sometimes
used
to
describe
gas
within
the
body
regardless
of
its
composition
or
site
[Fraser
and
Pare]
|
|
|
112144
|
Soft
tissue
|
Material
having
X-Ray
attenuation
properties
similar
to
muscle
|
|
|
112145
|
Calcium
|
Material
having
X-Ray
attenuation
properties
similar
to
calcium,
a
silver-white
bivalent
metallic
element
occurring
in
plants
and
animals
|
|
|
112146
|
Acinar
|
A
pulmonary
opacity
4-8
mm
in
diameter,
presumed
to
represent
anatomic
acinus,
or
a
collection
of
opacities
in
the
lung,
each
measuring
4-8
mm
in
diameter,
and
together
producing
an
extended,
homogeneous
shadow
[Fraser
and
Pare]
|
|
|
112147
|
Air
space
|
The
gas-containing
portion
of
the
lung
parenchyma,
including
the
acini
and
excluding
the
interstitium
[Fraser
and
Pare]
|
|
|
112148
|
Fibronodular
|
Sharply
defined,
approximately
circular
opacities
occurring
singly
or
in
clusters,
usually
in
the
upper
lobes
[Fraser
and
Pare]
|
|
|
112149
|
Fluffy
|
A
shadow
(opacity)
that
is
ill-defined,
lacking
clear-cut
margins
[Fraser
and
Pare]
|
|
|
112150
|
Linear
|
A
shadow
resembling
a
line;
any
elongated
opacity
of
approximately
uniform
width
[Fraser
and
Pare]
|
|
|
112151
|
Profusion
|
The
number
of
small
opacities
per
unit
area
or
zone
of
lung.
In
the
International
Labor
Organization
(ILO)
classification
of
radiographs
of
the
pneumoconioses,
the
qualifiers
0
through
3
subdivide
the
profusion
into
4
categories.
The
profusion
categories
may
be
further
subdivided
by
employing
a
12-point
scale
[Fraser
and
Pare]
|
|
|
112152
|
Silhouette
sign
|
The
effacement
of
an
anatomic
soft
tissue
border
by
either
a
normal
anatomic
structure
or
a
pathologic
state
such
as
airlessness
of
adjacent
lung
or
accumulation
of
fluid
in
the
contiguous
pleural
space;
useful
in
detecting
and
localizing
an
opacity
along
the
axis
of
the
X-Ray
beam
[Fraser
and
Pare]
|
|
|
112153
|
Subpleural
|
Situated
or
occurring
between
the
pleura
and
the
body
wall
|
|
|
112154
|
Bat's
wing
distribution
|
Spatial
arrangement
of
opacities
that
bears
vague
resemblance
to
the
shape
of
a
bat
in
flight;
bilaterally
symmetric
[Fraser
and
Pare]
|
|
|
112155
|
Butterfly
distribution
|
Spatial
arrangement
of
opacities
that
bears
vague
resemblance
to
the
shape
of
a
butterfly
in
flight;
bilaterally
symmetric
[Fraser
and
Pare]
|
|
|
112156
|
Centrilobular
|
Referring
to
the
region
of
the
bronchioloarteriolar
core
of
a
secondary
pulmonary
lobule
[Fraser
and
Pare]
|
|
|
112157
|
Coalescent
|
The
joining
together
of
a
number
of
opacities
into
a
single
opacity
[Fraser
and
Pare]
|
|
|
112158
|
Lobar
|
Of
or
relating
to
a
lobe
(a
curved
or
rounded
projection
or
division);
e.g.
involving
an
entire
lobe
of
the
lung
|
|
|
112159
|
Hyper-acute
|
Extremely
or
excessively
acute,
as
a
qualitative
measure
of
severity
|
|
|
112160
|
Homogeneous
(uniform
opacity)
|
Of
uniform
opacity
or
texture
throughout
[Fraser
and
Pare]
|
|
|
112161
|
Inhomogeneous
|
Lack
of
homogeneity
in
opacity
or
texture
|
|
|
112162
|
Target
|
Discrete
opacity
centrally
within
a
larger
opacity,
as
a
calcification
descriptor
|
|
|
112163
|
Fibrocalcific
|
Pertaining
to
sharply
defined,
linear,
and/or
nodular
opacities
containing
calcification(s)
[Fraser
and
Pare]
|
|
|
112164
|
Flocculent
|
Calcifications
made
up
of
loosely
aggregated
particles,
resembling
wool
|
|
|
112165
|
Difference
in
border
shape
|
A
change
in
the
shape
formed
by
the
boundary
or
edges
of
a
finding
or
feature
|
|
|
112166
|
Difference
in
border
definition
|
A
change
in
the
clarity
of
the
boundary
or
edges
of
a
finding
or
feature
|
|
|
112167
|
Difference
in
distribution
|
A
change
in
the
extent
of
spreading
of
a
finding
or
feature
|
|
|
112168
|
Difference
in
site
involvement
|
A
change
in
the
part(s)
of
the
anatomy
affected
or
encompassed
by
a
finding
or
feature
|
|
|
112169
|
Difference
in
Type
of
Content
|
A
change
in
the
matter
or
substance
within
a
finding
or
feature
|
|
|
112170
|
Difference
in
Texture
|
A
change
in
the
surface
or
consistency
of
a
finding
or
feature
|
|
|
112171
|
Fiducial
mark
|
A
location
in
image
space,
which
may
or
may
not
correspond
to
an
anatomical
reference,
which
is
often
used
for
registering
data
sets
|
|
|
112172
|
Portacath
|
Connected
to
an
injection
chamber
placed
under
the
skin
in
the
upper
part
of
the
chest.
When
it
is
necessary
to
inject
some
drug,
a
specific
needle
is
put
in
the
chamber
through
the
skin
and
a
silicon
membrane.
The
advantage
of
a
portacath
is
that
it
may
be
left
in
place
several
months
contrarily
of
"classical"
catheters
|
|
|
112173
|
Chest
tube
|
A
tube
inserted
into
the
chest
wall
from
outside
the
body,
for
drainage.
Sometimes
used
for
collapsed
lung.
Usually
connected
to
a
receptor
placed
lower
than
the
insertion
site
|
|
|
112174
|
Central
line
|
A
tube
placed
into
the
subclavian
vein
to
deliver
medication
directly
into
the
venous
system
|
|
|
112175
|
Kidney
stent
|
A
stent
is
a
tube
inserted
into
another
tube.
Kidney
stent
is
a
tube
that
is
inserted
into
the
kidney,
ureter,
and
bladder,
to
help
drain
urine.
Usually
inserted
through
a
scoping
device
presented
through
the
urethra
|
|
|
112176
|
Pancreatic
stent
|
A
stent
is
a
tube
inserted
into
another
tube.
Pancreatic
stent
is
inserted
through
the
common
bile
duct
to
the
pancreatic
duct,
to
drain
bile
|
|
|
112177
|
Nipple
ring
|
A
non-lesion
object
that
appears
to
be
a
circular
band,
attached
to
the
body
via
pierced
nipple
|
|
|
112178
|
Coin
|
A
non-lesion
object
that
appears
to
be
a
flat
round
piece
of
metal
|
|
|
112179
|
Minimum
Attenuation
Coefficient
|
The
least
quantity
assignable,
admissible,
or
possible;
the
least
of
a
set
of
X-Ray
attenuation
coefficients
|
|
|
112180
|
Maximum
Attenuation
Coefficient
|
The
greatest
quantity
or
value
attainable
or
attained;
the
largest
of
a
set
of
X-Ray
attenuation
coefficients
|
|
|
112181
|
Mean
Attenuation
Coefficient
|
The
value
that
is
computed
by
dividing
the
sum
of
a
set
of
X-Ray
attenuation
coefficients
by
the
number
of
values
|
|
|
112182
|
Median
Attenuation
Coefficient
|
The
value
in
an
ordered
set
of
X-Ray
attenuation
coefficients,
below
and
above
which
there
is
an
equal
number
of
values
|
|
|
112183
|
Standard
Deviation
of
Attenuation
Coefficient
|
For
a
set
of
X-Ray
attenuation
coefficients:
1)
a
measure
of
the
dispersion
of
a
frequency
distribution
that
is
the
square
root
of
the
arithmetic
mean
of
the
squares
of
the
deviation
of
each
of
the
class
frequencies
from
the
arithmetic
mean
of
the
frequency
distribution;
2)
a
parameter
that
indicates
the
way
in
which
a
probability
function
or
a
probability
density
function
is
centered
around
its
mean
and
that
is
equal
to
the
square
root
of
the
moment
in
which
the
deviation
from
the
mean
is
squared
|
|
|
112184
|
Performance
of
Pediatric
and
Adult
Thoracic
CT
|
American
College
of
Radiology.
ACR
Standard
for
the
Performance
of
Pediatric
and
Adult
Thoracic
Computed
Tomography
(CT).
In:
Standards.
Reston,
Va:
2001:103-107
|
|
|
112185
|
Performance
of
CT
for
Detection
of
Pulmonary
Embolism
in
Adults
|
American
College
of
Radiology.
ACR
Standard
for
the
Performance
of
Computed
Tomography
for
the
Detection
of
Pulmonary
Embolism
in
Adults.
In:
Standards.
Reston,
Va:
2001:109-113
|
|
|
112186
|
Performance
of
High-Resolution
CT
of
the
Lungs
in
Adults
|
American
College
of
Radiology.
ACR
Standard
for
the
Performance
of
High-Resolution
Computed
Tomography
(HRCT)
of
the
Lungs
in
Adults.
In:
Standards.
Reston,
Va:
2001:115-118
|
|
|
112187
|
Unspecified
method
of
calculation
|
The
method
of
calculation
of
a
measurement
or
other
type
of
numeric
value
is
not
specified
|
|
|
112188
|
Two-dimensional
method
|
The
calculation
method
was
performed
in
two-dimensional
space
|
|
|
112189
|
Three-dimensional
method
|
The
calculation
method
was
performed
in
three-dimensional
space
|
|
|
112191
|
Breast
tissue
density
|
The
relative
density
of
parenchymal
tissue
as
a
proportion
of
breast
volume
|
|
|
112192
|
Volume
of
parenchymal
tissue
|
The
volume
of
parenchymal
tissue
|
|
|
112193
|
Volume
of
breast
|
The
volume
of
the
breast
|
|
|
112194
|
Mass
of
parenchymal
tissue
|
The
mass
of
parenchymal
tissue
|
|
|
112195
|
Mass
of
breast
|
The
mass
of
the
breast
|
|
|
112196
|
Area
of
Vascular
Calcification
|
A
measured
or
calculated
area
of
vascular
calcification
|
|
|
112197
|
Volume
of
Vascular
Calcification
|
A
measured
or
calculated
volume
of
vascular
calcification
|
|
|
112198
|
Percentage
of
Vascular
Calcification
|
A
measured
or
calculated
percentage
of
vascular
calcification
|
|
|
112199
|
Mass
of
Vascular
Calcification
|
A
measured
or
calculated
mass
of
vascular
calcification
|
|
|
112200
|
Average
calcification
distance
in
a
calcification
cluster
|
The
average
nearest
neighbor
distance
of
all
individual
microcalcifications
in
a
cluster
|
|
|
112201
|
Standard
deviation
distance
of
calcifications
in
a
cluster
|
The
standard
deviation
of
nearest
neighbor
distance
of
all
individual
microcalcifications
in
a
cluster
|
|
|
112220
|
Colon
CAD
Report
|
A
structured
report
containing
the
results
of
computer-aided
detection
or
diagnosis
applied
to
colon
imaging
and
associated
clinical
information
|
|
|
112222
|
Colon
Overall
Assessment
|
Overall
interpretation
of
the
colon
using
C-RADS
categorization
system
|
|
|
112224
|
Image
Set
Properties
|
Characteristics
of
a
set
of
images
|
|
|
112225
|
Slice
Thickness
|
Nominal
slice
thickness,
in
mm
|
|
|
112226
|
Spacing
between
slices
|
Distance
between
contiguous
images,
measured
from
the
center-to-center
of
each
image
|
|
|
112227
|
Frame
of
Reference
UID
|
Uniquely
identifies
groups
of
composite
instances
that
have
the
same
coordinate
system
that
conveys
spatial
and/or
temporal
information
|
|
|
112228
|
Recumbent
Patient
Position
with
respect
to
gravity
|
Patient
orientation
with
respect
to
downward
direction
(gravity)
|
|
|
112229
|
Identifying
Segment
|
Distinguishes
a
part
of
a
segmentation
|
|
|
112232
|
Polyp
stalk
width
|
The
diameter
of
a
polyp
stalk
measured
perpendicular
to
the
axis
of
the
stalk
|
|
|
112233
|
Distance
from
anus
|
The
length
of
the
path
following
the
centerline
of
the
colon
from
the
anus
to
the
area
of
interest
|
|
|
112238
|
Anatomic
non-colon
|
A
location
in
the
body
that
is
outside
the
colon
|
|
|
112240
|
C0
-
Inadequate
Study/Awaiting
Prior
Comparisons
|
An
inadequate
study
or
a
study
that
is
awaiting
prior
comparisons.
The
study
may
have
inadequate
preparation
and
cannot
exclude
lesions
greater
than
or
equal
to
ten
millimeters
owing
to
presence
of
fluid
or
feces.
The
study
may
have
inadequate
insufflation
where
one
or
more
colonic
segments
collapsed
on
both
views.
Based
on
"CT
Colonography
Reporting
and
Data
System:
A
Consensus
Proposal",
Radiology,
July
2005;
236:3-9
|
|
|
112241
|
C1
-
Normal
Colon
or
Benign
Lesion
|
The
study
has
a
normal
colon
or
benign
lesion,
with
the
recommendation
to
continue
routine
screening.
The
study
has
no
visible
abnormalities
of
the
colon.
The
study
has
no
polyps
greater
than
six
millimeters.
The
study
may
have
lipoma,
inverted
diverticulum,
or
nonneoplastic
findings,
such
as
colonic
diverticula.
Based
on
"CT
Colonography
Reporting
and
Data
System:
A
Consensus
Proposal",
Radiology,
July
2005;
236:3-9
|
|
|
112242
|
C2
-
Intermediate
Polyp
or
Indeterminate
Finding
|
The
study
has
an
intermediate
polyp
or
indeterminate
finding
and
surveillance
or
colonoscopy
is
recommended.
There
may
be
intermediate
polyps
between
six
and
nine
millimeters
and
there
are
less
than
three
in
number.
The
study
may
have
an
intermediate
finding
and
cannot
exclude
a
polyp
that
is
greater
than
or
equal
to
six
millimeters
in
a
technically
adequate
exam.
Based
on
"CT
Colonography
Reporting
and
Data
System:
A
Consensus
Proposal",
Radiology,
July
2005;
236:3-9
|
|
|
112243
|
C3
-
Polyp,
Possibly
Advanced
Adenoma
|
The
study
has
a
polyp,
possibly
advanced
adenoma,
and
a
follow-up
colonoscopy
is
recommended.
The
study
has
a
polyp
greater
than
or
equal
to
ten
millimeters
or
the
study
has
three
or
more
polyps
that
are
each
between
six
to
nine
millimeters.
Based
on
"CT
Colonography
Reporting
and
Data
System:
A
Consensus
Proposal",
Radiology,
July
2005;
236:3-9
|
|
|
112244
|
C4
-
Colonic
Mass,
Likely
Malignant
|
The
study
has
a
colonic
mass,
likely
malignant,
and
surgical
consultation
is
recommended.
The
lesion
compromises
bowel
lumen
and
demonstrates
extracolonic
invasion.
Based
on
"CT
Colonography
Reporting
and
Data
System:
A
Consensus
Proposal",
Radiology,
July
2005;
236:3-9
|
|
|
112248
|
ACR
Guideline,
Performance
of
Adult
CT
Colonography
|
American
College
of
Radiology
Practice
Guideline
for
the
Performance
of
Computed
Tomography
(CT)
Colonography
in
Adults.
In:
Practice
Guidelines
and
Technical
Standards.Reston,
Va:
American
College
of
Radiology;2006:371-376
|
|
|
112249
|
ACR
Standard,
CT
medical
physics
performance
monitoring
|
American
College
of
Radiology
Technical
Standard
for
Diagnostic
Medical
Physics
Performance
Monitoring
of
Computed
Tomography
(CT)
Equipment.
In:
Practice
Guidelines
and
Technical
Standards.Reston,
Va:
American
College
of
Radiology;2006:945-948
|
|
|
112300
|
AP+45
|
View
Orientation
Modifier
indicates
that
the
view
orientation
of
the
imaging
plane
is
rotated
+45°
along
the
cranial-caudal
axis
|
|
|
112301
|
AP-45
|
View
Orientation
Modifier
indicates
that
the
view
orientation
of
the
imaging
plane
is
rotated
-45°
along
the
cranial-caudal
axis
|
|
|
112302
|
Anatomical
axis
of
femur
|
The
axis
following
the
shaft
of
the
femur
|
|
|
112303
|
Acetabular
Center
of
Rotation
|
Center
of
Rotation
of
the
natural
Acetabulum
|
|
|
112304
|
Femur
Head
Center
of
Rotation
|
Center
of
Rotation
of
the
natural
femur
head
|
|
|
112305
|
Acetabular
Cup
Shell
|
Prosthetic
component
implanted
into
the
acetabulum.
Provides
hold
for
the
insert
that
is
mounted
inside
the
cup
|
|
|
112306
|
Acetabular
Cup
Insert
|
Prosthetic
pelvic
joint
component.
Inserted
into
the
cup,
takes
in
the
femoral
head
replacement
|
|
|
112307
|
Acetabular
Cup
Monoblock
|
Prosthetic
pelvic
joint
cup
including
insert
|
|
|
112308
|
Femoral
Head
Ball
Component
|
Component
for
Femoral
Head
Prosthesis
where
the
conic
intake
for
the
stem
neck
can
be
exchanged.
Combined
with
a
Femoral
Head
Cone
Taper
Component
|
|
|
112309
|
Femoral
Head
Cone
Taper
Component
|
Exchangeable
neck
intake
for
composite
femoral
head
prosthesis.
Combined
with
a
Femoral
Head
Ball
Component
|
|
|
112310
|
Femoral
Stem
|
Prosthesis
Implanted
into
the
femoral
bone
to
provide
force
transmission
between
joint
replacement
and
bone.
On
the
proximal
end
a
conic
neck
holds
the
femoral
head
replacement
|
|
|
112311
|
Femoral
Stem
Distal
Component
|
Distal
half
of
a
modular
stem
prosthesis
system.
Combined
with
a
Stem
Proximal
Component
|
|
|
112312
|
Femoral
Stem
Proximal
Component
|
Proximal
half
of
a
modular
stem
prosthesis
system.
Combined
with
a
Stem
Distal
Component
|
|
|
112313
|
Femoral
Stem
Component
|
Stem
prosthetic
component
with
a
modular
insert
for
an
exchangeable
neck
component.
Combined
with
a
Neck
Component
|
|
|
112314
|
Neck
Component
|
Prosthetic
Neck
to
be
combined
with
a
Stem
Component
|
|
|
112315
|
Monoblock
Stem
|
Prosthetic
Stem
and
Femoral
Head
in
one
piece
|
|
|
112316
|
Prosthetic
Shaft
Augment
|
A
proximal
attachment
to
the
shaft
used
to
compensate
for
bone
deficiencies
or
bone
loss
|
|
|
112317
|
Femoral
Head
Resurfacing
Component
|
Artificial
femur
head
surface
needed
for
the
partial
replacement
of
the
femoral
head
where
only
the
surface
is
replaced
|
|
|
112318
|
Pinning
|
Fixation
using
a
pin
|
|
|
112319
|
Sewing
|
Fixation
sewing
several
objects
together
|
|
|
112320
|
Bolting
|
Fixation
using
a
bolt
|
|
|
112321
|
Wedging
|
Fixation
due
to
forcing
an
object
into
a
narrow
space
|
|
|
112325
|
Distal
Centralizer
|
Attachment
to
the
distal
end
of
a
cemented
stem
assuring
that
the
stem
is
in
a
central
position
inside
the
drilled
femoral
canal
before
cementation
|
|
|
112340
|
Generic
2D
Planning
|
Planning
by
an
unspecified
2D
method
|
|
|
112341
|
Generic
3D
Planning
|
Planning
by
an
unspecified
3D
method
|
|
|
112342
|
Generic
Planning
for
Hip
Replacement
|
Planning
of
a
Hip
Replacement,
by
an
unspecified
method
|
|
|
112343
|
Generic
Planning
for
Knee
Replacement
|
Planning
of
Knee
Replacement,
by
an
unspecified
method
|
|
|
112344
|
Müller
Method
Planning
for
Hip
Replacement
|
Planning
of
Hip
Replacement
according
to
the
procedure
of
M.
E.
Müller
[Eggli
et.
al.1998]
|
|
|
112345
|
Implantation
Plan
|
A
Report
containing
the
results
of
an
Implantation
Planning
Activity
|
|
|
112346
|
Selected
Implant
Component
|
A
selection
of
one
Implant
Component
|
|
|
112347
|
Component
ID
|
Identification
ID
of
an
Implant
Component
|
|
|
112348
|
Implant
Template
|
An
implant
template
describing
the
properties
(2D/3D
geometry
and
other
data)
of
one
Implant
Component
|
|
|
112350
|
Component
Connection
|
A
connection
of
two
Connected
Implantation
Plan
Components
|
|
|
112351
|
Mating
Feature
Set
ID
|
ID
of
a
Mating
Feature
Set
in
an
Implant
Component
|
|
|
112352
|
Mating
Feature
ID
|
ID
of
the
Mating
Feature
in
a
Mating
Feature
Set
in
an
Implant
Component
|
|
|
112353
|
Spatial
Registration
|
The
Spatial
Registration
of
one
or
more
Implant
Components
|
|
|
112354
|
Patient
Image
|
Patient
Images
used
for
an
implantation
planning
activity
|
|
|
112355
|
Assembly
|
A
collection
of
Component
Connections
of
Implant
Components
|
|
|
112356
|
User
Selected
Fiducial
|
Fiducials
that
are
selected
by
the
user
and
may
or
may
not
belong
to
anatomical
landmarks
|
|
|
112357
|
Derived
Fiducial
|
Fiducials
that
represent
geometric
characteristics,
such
as
center
of
rotation,
and
are
derived
from
other
fiducials
|
|
|
112358
|
Information
used
for
planning
|
All
parameters
and
data
that
were
used
for
the
planning
activity
|
|
|
112359
|
Supporting
Information
|
A
description
of
the
plan
as
encapsulated
PDF
SOP
Instance
|
|
|
112360
|
Implant
Component
List
|
A
list
of
all
Implant
Components
selected
for
an
implantation
|
|
|
112361
|
Patient
Data
Used
During
Planning
|
Reference
to
objects
containing
patient
data
that
is
used
for
planning
|
|
|
112362
|
Degrees
of
Freedom
Specification
|
A
specification
of
the
values
from
one
or
more
Degrees
of
Freedom
|
|
|
112363
|
Degree
of
Freedom
ID
|
ID
of
one
Degree
of
Freedom
|
|
|
112364
|
Related
Patient
Data
Not
Used
During
Planning
|
Reference
to
objects
containing
patient
data
that
were
not
used
for
planning
but
are
somehow
related
|
|
|
112365
|
Related
Implantation
Reports
|
Implantation
Reports
that
are
somehow
related;
e.g.
contemporaneous
implantations
that
are
independent
|
|
|
112366
|
Implant
Assembly
Template
|
Implant
Assembly
Template
|
|
|
112367
|
Planning
Information
for
Intraoperative
Usage
|
Information
that
is
intended
to
be
used
intra-operatively
|
|
|
112368
|
Implantation
Patient
Positioning
|
Position
of
the
patient
on
the
operating
room
table
|
|
|
112369
|
Fiducial
Intent
|
Intended
use
of
the
fiducial
|
|
|
112370
|
Component
Type
|
Type
of
an
Implant
Component
|
|
|
112371
|
Manufacturer
Implant
Template
|
Implant
Template
released
by
the
Manufacturer
|
|
|
112372
|
Derived
Planning
Images
|
Images
that
are
created
by
a
planning
application
|
|
|
112373
|
Other
Derived
Planning
Data
|
Data
that
is
created
by
a
planning
application
|
|
|
112374
|
Connected
Implantation
Plan
Component
|
One
Implant
Component
that
is
connected
to
another
Implant
Component
|
|
|
112375
|
Planning
Method
|
The
method
used
for
planning
|
|
|
112376
|
Degree
of
Freedom
Exact
Translational
Value
|
Defines
the
exact
value
that
was
planned
for
translation
|
|
|
112377
|
Degree
of
Freedom
Minimum
Translational
Value
|
Defines
the
minimum
value
that
was
planned
for
translation
|
|
|
112378
|
Degree
of
Freedom
Maximum
Translational
Value
|
Defines
the
maximum
value
that
was
planned
for
translation
|
|
|
112379
|
Degree
of
Freedom
Exact
Rotational
Translation
Value
|
Defines
the
exact
value
that
was
planned
for
rotation
|
|
|
112380
|
Degree
of
Freedom
Minimum
Rotational
Value
|
Defines
the
minimum
value
that
was
planned
for
rotation
|
|
|
112381
|
Degree
of
Freedom
Maximum
Rotational
Value
|
Defines
the
maximum
value
that
was
planned
for
rotation
|
|
|
112700
|
Peri-operative
Photographic
Imaging
|
Procedure
step
protocol
for
photographic
imaging
of
surgical
procedures,
including
photography
of
specimens
collected
|
|
|
112701
|
Gross
Specimen
Imaging
|
Procedure
step
protocol
for
imaging
gross
specimens,
typically
with
a
photographic
camera
(modality
XC),
and
planning
further
dissection
|
|
|
112702
|
Slide
Microscopy
|
Procedure
step
protocol
for
imaging
slide
specimens
|
|
|
112703
|
Whole
Slide
Imaging
|
Procedure
step
protocol
for
imaging
slide
specimens
using
a
whole
slide
scanner
|
|
|
112704
|
WSI
20X
RGB
|
Procedure
step
protocol
for
imaging
slide
specimens
using
a
whole
slide
scanner
with
a
20X
nominal
objective
lens,
in
full
color,
with
a
single
imaging
focal
plane
across
the
image
|
|
|
112705
|
WSI
40X
RGB
|
Procedure
step
protocol
for
imaging
slide
specimens
using
a
whole
slide
scanner
with
a
40X
nominal
objective
lens,
in
full
color,
with
a
single
imaging
focal
plane
across
the
image
|
|
|
112706
|
Illumination
Method
|
Technique
of
illuminating
specimen
|
|
|
112707
|
Number
of
focal
planes
|
Number
of
focal
planes
for
a
microscopy
image
acquisition
|
|
|
112708
|
Focal
plane
Z
offset
|
Nominal
distance
above
a
reference
plane
(typically
a
slide
glass
substrate
top
surface)
of
the
focal
plane
|
|
|
112709
|
Magnification
selection
|
Microscope
magnification
based
on
nominal
objective
lens
power
|
|
|
112710
|
Illumination
wavelength
|
Nominal
center
wavelength
for
an
imaging
spectral
band
|
|
|
112711
|
Illumination
spectral
band
|
Name
(coded)
for
an
imaging
spectral
band
|
|
|
112712
|
Optical
filter
type
|
Type
of
filter
inserted
into
the
optical
imaging
path
|
|
|
112713
|
Tissue
selection
method
|
Technique
for
identifying
tissue
to
be
imaged
versus
area
of
slide
not
to
be
imaged
|
|
|
112714
|
Multiple
planes
|
Imaging
performed
at
multiple
imaging
(focal)
planes
|
|
|
112715
|
5X
|
Nominal
5
power
objective
lens,
resulting
in
a
digital
image
at
approximately
2
um/pixel
spacing
|
|
|
112716
|
10X
|
Nominal
10
power
objective
lens,
resulting
in
a
digital
image
at
approximately
1
um/pixel
spacing
|
|
|
112717
|
20X
|
Nominal
20
power
microscope
objective
lens,
resulting
in
a
digital
image
at
approximately
0.5
um/pixel
spacing
|
|
|
112718
|
40X
|
Nominal
40
power
microscope
objective
lens,
with
a
combined
condenser
and
objective
lens
numerical
aperture
of
approximately
1.3,
resulting
in
a
digital
image
at
approximately
0.25
um/pixel
spacing
|
|
|
112719
|
Nominal
empty
tile
suppression
|
Equipment-specific
nominal
or
default
method
for
identifying
tiles
without
tissue
imaged
for
suppression
from
inclusion
in
image
object
|
|
|
112720
|
High
threshold
empty
tile
suppression
|
Equipment-specific
high
threshold
method
for
identifying
tiles
without
tissue
imaged
for
suppression
from
inclusion
in
image
object
|
|
|
112721
|
No
empty
tile
suppression
|
Tiles
without
tissue
imaged
are
not
suppressed
from
inclusion
in
image
object
|
|
|
113000
|
Of
Interest
|
Of
Interest
|
|
|
113001
|
Rejected
for
Quality
Reasons
|
Rejected
for
Quality
Reasons
|
|
|
113002
|
For
Referring
Provider
|
For
Referring
Provider
|
|
|
113003
|
For
Surgery
|
For
Surgery
|
|
|
113004
|
For
Teaching
|
For
Teaching
|
|
|
113005
|
For
Conference
|
For
Conference
|
|
|
113006
|
For
Therapy
|
For
Therapy
|
|
|
113007
|
For
Patient
|
For
Patient
|
|
|
113008
|
For
Peer
Review
|
For
Peer
Review
|
|
|
113009
|
For
Research
|
For
Research
|
|
|
113010
|
Quality
Issue
|
Quality
Issue
|
|
|
113011
|
Document
Title
Modifier
|
Document
Title
Modifier
|
|
|
113012
|
Key
Object
Description
|
Key
Object
Description
|
|
|
113013
|
Best
In
Set
|
A
selection
that
represents
the
"best"
chosen
from
a
larger
set
of
items;
e.g.
the
best
images
within
a
Study
or
Series.
The
criteria
against
which
"best"
is
measured
is
not
defined.
Contrast
this
with
the
more
specific
term
"Best
illustration
of
finding"
|
|
|
113014
|
Study
|
A
study
is
a
collection
of
one
or
more
series
of
medical
images,
presentation
states,
and/or
SR
documents
that
are
logically
related
for
the
purpose
of
diagnosing
a
patient.
A
study
may
include
composite
instances
that
are
created
by
a
single
modality,
multiple
modalities
or
by
multiple
devices
of
the
same
modality.
[From
Section
A.1.2.2
"Study
IE"
in
PS3.3
]
|
|
|
113015
|
Series
|
A
distinct
logical
set
used
to
group
composite
instances.
All
instances
within
a
Series
are
of
the
same
modality,
in
the
same
Frame
of
Reference
(if
any),
and
created
by
the
same
equipment.
[See
Section
A.1.2.3
"Series
IE"
in
PS3.3
]
|
|
|
113016
|
Performed
Procedure
Step
|
An
arbitrarily
defined
unit
of
service
that
has
actually
been
performed
(not
just
scheduled).
[From
Section
7.3.1.9
"Modality
Performed
Procedure
Step"
in
PS3.3
]
|
|
|
113017
|
Stage-View
|
An
image
or
set
of
images
illustrating
a
specific
stage
(phase
in
a
stress
echo
exam
protocol)
and
view
(combination
of
the
transducer
position
and
orientation
at
the
time
of
image
acquisition)
|
|
|
113018
|
For
Printing
|
For
Printing
|
|
|
113020
|
For
Report
Attachment
|
Selection
of
information
objects
for
attachment
to
the
clinical
report
of
the
Current
Requested
Procedure
|
|
|
113021
|
For
Litigation
|
List
of
objects
that
are
related
to
litigation
and
should
be
specially
handled;
e.g.
may
apply
if
a
complaint
has
been
received
regarding
a
patient,
or
a
specific
set
of
images
has
been
the
subject
of
a
subpoena,
and
needs
to
be
sequestered
or
excluded
from
automatic
purging
according
to
retention
policy
|
|
|
113026
|
Double
exposure
|
Double
exposure
|
|
|
113030
|
Manifest
|
A
list
of
objects
that
have
been
exported
out
of
one
organizational
domain
into
another
domain.
Typically,
the
first
domain
has
no
direct
control
over
what
the
second
domain
will
do
with
the
objects
|
|
|
113031
|
Signed
Manifest
|
A
signed
list
of
objects
that
have
been
exported
out
of
one
organizational
domain
into
another
domain,
referenced
securely
with
either
Digital
Signatures
or
MACs.
Typically,
the
first
domain
has
no
direct
control
over
what
the
second
domain
will
do
with
the
objects
|
|
|
113032
|
Complete
Study
Content
|
The
list
of
objects
that
constitute
a
study
at
the
time
that
the
list
was
created
|
|
|
113033
|
Signed
Complete
Study
Content
|
The
signed
list
of
objects
that
constitute
a
study
at
the
time
that
the
list
was
created,
referenced
securely
with
either
Digital
Signatures
or
MACs
|
|
|
113034
|
Complete
Acquisition
Content
|
The
list
of
objects
that
were
generated
in
a
single
procedure
step
|
|
|
113035
|
Signed
Complete
Acquisition
Content
|
The
signed
list
of
objects
that
were
generated
in
a
single
procedure
step,
referenced
securely
with
either
Digital
Signatures
or
MACs
|
|
|
113036
|
Group
of
Frames
for
Display
|
A
list
of
frames
or
single-frame
or
entire
multi-frame
instances
that
together
constitute
a
set
for
some
purpose,
such
as
might
be
displayed
together
in
the
same
viewport,
as
distinct
from
another
set
that
might
be
displayed
in
a
separate
viewport
|
|
|
113037
|
Rejected
for
Patient
Safety
Reasons
|
List
of
objects
whose
use
is
potentially
harmful
to
the
patient;
e.g.
an
improperly
labeled
image
could
lead
to
dangerous
surgical
decisions
|
|
|
113038
|
Incorrect
Modality
Worklist
Entry
|
List
of
objects
that
were
acquired
using
an
incorrect
modality
worklist
entry,
and
that
should
not
be
used,
since
they
may
be
incorrectly
identified
|
|
|
113039
|
Data
Retention
Policy
Expired
|
List
of
objects
that
have
expired
according
to
a
defined
data
retention
policy
|
|
|
113040
|
Lossy
Compression
|
Lossy
compression
has
been
applied
to
an
image
|
|
|
113041
|
Apparent
Diffusion
Coefficient
|
Values
are
derived
by
calculation
of
the
apparent
diffusion
coefficient
|
|
|
113042
|
Pixel
by
pixel
addition
|
Values
are
derived
by
the
pixel
by
pixel
addition
of
two
images
|
|
|
113043
|
Diffusion
weighted
|
Values
are
derived
by
calculation
of
the
diffusion
weighting
|
|
|
113044
|
Diffusion
Anisotropy
|
Values
are
derived
by
calculation
of
the
diffusion
anisotropy
|
|
|
113045
|
Diffusion
Attenuated
|
Values
are
derived
by
calculation
of
the
diffusion
attenuation
|
|
|
113046
|
Pixel
by
pixel
division
|
Values
are
derived
by
the
pixel
by
pixel
division
of
two
images
|
|
|
113047
|
Pixel
by
pixel
mask
|
Values
are
derived
by
the
pixel
by
pixel
masking
of
one
image
by
another
|
|
|
113048
|
Pixel
by
pixel
Maximum
|
Values
are
derived
by
calculating
the
pixel
by
pixel
maximum
of
two
or
more
images
|
|
|
113049
|
Pixel
by
pixel
mean
|
Values
are
derived
by
calculating
the
pixel
by
pixel
mean
of
two
or
more
images
|
|
|
113050
|
Metabolite
Maps
from
spectroscopy
data
|
Values
are
derived
by
calculating
from
spectroscopy
data
pixel
values
localized
in
two
dimensional
space
based
on
the
concentration
of
specific
metabolites
(i.e,
at
specific
frequencies)
|
|
|
113051
|
Pixel
by
pixel
Minimum
|
Values
are
derived
by
calculating
the
pixel
by
pixel
minimum
of
two
or
more
images
|
|
|
113052
|
Mean
Transit
Time
|
The
time
required
for
blood
to
pass
through
a
region
of
tissue
|
|
|
113053
|
Pixel
by
pixel
multiplication
|
Values
are
derived
by
the
pixel
by
pixel
multiplication
of
two
images
|
|
|
113054
|
Negative
Enhancement
Integral
|
Values
are
derived
by
calculating
negative
enhancement
integral
values
|
|
|
113055
|
Regional
Cerebral
Blood
Flow
|
The
flow
rate
of
blood
perfusing
a
region
of
the
brain
as
volume
per
mass
per
unit
of
time
|
|
|
113056
|
Regional
Cerebral
Blood
Volume
|
The
volume
of
blood
perfusing
a
region
of
brain
as
volume
per
mass
|
|
|
113057
|
R-Coefficient
|
Correlation
Coefficient,
r
|
|
|
113058
|
Proton
Density
|
Values
are
derived
by
calculating
proton
density
values
|
|
|
113059
|
Signal
Change
|
Values
are
derived
by
calculating
signal
change
values
|
|
|
113060
|
Signal
to
Noise
|
Values
are
derived
by
calculating
the
signal
to
noise
ratio
|
|
|
113061
|
Standard
Deviation
|
Values
are
derived
by
calculating
the
standard
deviation
of
two
or
more
images
|
|
|
113062
|
Pixel
by
pixel
subtraction
|
Values
are
derived
by
the
pixel
by
pixel
subtraction
of
two
images
|
|
|
113063
|
T1
|
Values
are
derived
by
calculating
T1
values
|
|
|
113064
|
T2*
|
Values
are
derived
by
calculating
T2*
values
|
|
|
113065
|
T2
|
Values
are
derived
by
calculating
T2
values
|
|
|
113066
|
Time
Course
of
Signal
|
Values
are
derived
by
calculating
values
based
on
the
time
course
of
signal
|
|
|
113067
|
Temperature
encoded
|
Values
are
derived
by
calculating
values
based
on
temperature
encoding
|
|
|
113068
|
Student's
T-Test
|
Values
are
derived
by
calculating
the
value
of
the
Student's
T-Test
statistic
from
multiple
image
samples
|
|
|
113069
|
Time
To
Peak
|
The
time
from
the
start
of
the
contrast
agent
injection
to
the
maximum
enhancement
value
|
|
|
113070
|
Velocity
encoded
|
Values
are
derived
by
calculating
values
based
on
velocity
encoded;
e.g.
phase
contrast
|
|
|
113071
|
Z-Score
|
Values
are
derived
by
calculating
the
value
of
the
Z-Score
statistic
from
multiple
image
samples
|
|
|
113072
|
Multiplanar
reformatting
|
Values
are
derived
by
reformatting
in
a
flat
plane
other
than
that
originally
acquired
|
|
|
113073
|
Curved
multiplanar
reformatting
|
Values
are
derived
by
reformatting
in
a
curve
plane
other
than
that
originally
acquired
|
|
|
113074
|
Volume
rendering
|
Values
are
derived
by
volume
rendering
of
acquired
data
|
|
|
113075
|
Surface
rendering
|
Values
are
derived
by
surface
rendering
of
acquired
data
|
|
|
113076
|
Segmentation
|
Values
are
derived
by
segmentation
(classification
into
tissue
types)
of
acquired
data
|
|
|
113077
|
Volume
editing
|
Values
are
derived
by
selectively
editing
acquired
data
(removing
values
from
the
volume),
such
as
in
order
to
remove
obscuring
structures
or
noise
|
|
|
113078
|
Maximum
intensity
projection
|
Values
are
derived
by
maximum
intensity
projection
of
acquired
data
|
|
|
113079
|
Minimum
intensity
projection
|
Values
are
derived
by
minimum
intensity
projection
of
acquired
data
|
|
|
113080
|
Glutamate
and
glutamine
|
For
single-proton
MR
spectroscopy,
the
resonance
peak
corresponding
to
glutamate
and
glutamine
|
|
|
113081
|
Choline/Creatine
Ratio
|
For
single-proton
MR
spectroscopy,
the
ratio
between
the
Choline
and
Creatine
resonance
peaks
|
|
|
113082
|
N-acetylaspartate
/Creatine
Ratio
|
For
single-proton
MR
spectroscopy,
the
ratio
between
the
N-acetylaspartate
and
Creatine
resonance
peaks
|
|
|
113083
|
N-acetylaspartate
/Choline
Ratio
|
For
single-proton
MR
spectroscopy,
the
ratio
between
the
N-acetylaspartate
and
Choline
resonance
peaks
|
|
|
113085
|
Spatial
resampling
|
Values
are
derived
by
spatial
resampling
of
acquired
data
|
|
|
113086
|
Edge
enhancement
|
Values
are
derived
by
edge
enhancement
|
|
|
113087
|
Smoothing
|
Values
are
derived
by
smoothing
|
|
|
113088
|
Gaussian
blur
|
Values
are
derived
by
Gaussian
blurring
|
|
|
113089
|
Unsharp
mask
|
Values
are
derived
by
unsharp
masking
|
|
|
113090
|
Image
stitching
|
Values
are
derived
by
stitching
two
or
more
images
together
|
|
|
113091
|
Spatially-related
frames
extracted
from
the
volume
|
Spatially-related
frames
in
this
image
are
representative
frames
from
the
referenced
3D
volume
data
set
|
|
|
113092
|
Temporally-related
frames
extracted
from
the
set
of
volumes
|
Temporally-related
frames
in
this
image
are
representative
frames
from
the
referenced
3D
volume
data
set
|
|
|
113093
|
Polar
to
Rectangular
Scan
Conversion
|
Conversion
of
a
polar
coordinate
image
to
rectangular
(Cartesian)
coordinate
image
|
|
|
113094
|
Creatine
and
Choline
|
For
single-proton
MR
spectroscopy,
the
resonance
peak
corresponding
to
creatine
and
choline
|
|
|
113095
|
Lipid
and
Lactate
|
For
single-proton
MR
spectroscopy,
the
resonance
peak
corresponding
to
lipid
and
lactate
|
|
|
113096
|
Creatine+Choline/
Citrate
Ratio
|
For
single-proton
MR
spectroscopy,
the
ratio
between
the
Choline
and
Creatine
resonance
peak
and
the
Citrate
resonance
peak
|
|
|
113097
|
Multi-energy
proportional
weighting
|
Image
pixels
created
through
proportional
weighting
of
multiple
acquisitions
at
distinct
X-Ray
energies
|
|
|
113100
|
Basic
Application
Confidentiality
Profile
|
De-identification
using
a
profile
defined
in
PS3.15
that
requires
removing
all
information
related
to
the
identity
and
demographic
characteristics
of
the
patient,
any
responsible
parties
or
family
members,
any
personnel
involved
in
the
procedure,
the
organizations
involved
in
ordering
or
performing
the
procedure,
additional
information
that
could
be
used
to
match
instances
if
given
access
to
the
originals,
such
as
UIDs,
dates
and
times,
and
private
attributes,
when
that
information
is
present
in
the
non-Pixel
Data
Attributes,
including
graphics
or
overlays
|
|
|
113101
|
Clean
Pixel
Data
Option
|
Additional
de-identification
according
to
an
option
defined
in
PS3.15
that
requires
any
information
burned
in
to
the
Pixel
Data
corresponding
to
the
Attribute
information
specified
to
be
removed
by
the
Profile
and
any
other
Options
specified
also
be
removed
|
|
|
113102
|
Clean
Recognizable
Visual
Features
Option
|
Additional
de-identification
according
to
an
option
defined
in
PS3.15
that
requires
that
sufficient
removal
or
distortion
of
the
Pixel
Data
shall
be
applied
to
prevent
recognition
of
an
individual
from
the
instances
themselves
or
a
reconstruction
of
a
set
of
instances
|
|
|
113103
|
Clean
Graphics
Option
|
Additional
de-identification
according
to
an
option
defined
in
PS3.15
that
requires
that
any
information
encoded
in
graphics,
text
annotations
or
overlays
corresponding
to
the
Attribute
information
specified
to
be
removed
by
the
Profile
and
any
other
Options
specified
also
be
removed
|
|
|
113104
|
Clean
Structured
Content
Option
|
Additional
de-identification
according
to
an
option
defined
in
PS3.15
that
requires
that
any
information
encoded
in
SR
Content
Items
or
Acquisition
Context
Sequence
Items
corresponding
to
the
Attribute
information
specified
to
be
removed
by
the
Profile
and
any
other
Options
specified
also
be
removed
|
|
|
113105
|
Clean
Descriptors
Option
|
Additional
de-identification
according
to
an
option
defined
in
PS3.15
that
requires
that
any
information
that
is
embedded
in
text
or
string
Attributes
corresponding
to
the
Attribute
information
specified
to
be
removed
by
the
Profile
and
any
other
Options
specified
also
be
removed
|
|
|
113106
|
Retain
Longitudinal
Temporal
Information
Full
Dates
Option
|
Retention
of
information
that
would
otherwise
be
removed
during
de-identification
according
to
an
option
defined
in
PS3.15
that
requires
that
any
dates
and
times
be
retained,
|
|
|
113107
|
Retain
Longitudinal
Temporal
Information
Modified
Dates
Option
|
Retention
of
information
that
would
otherwise
be
removed
during
de-identification
according
to
an
option
defined
in
PS3.15
that
requires
that
any
dates
and
times
be
modified
in
a
manner
that
preserves
temporal
relationships;
e.g.
Study
Date
and
Time
|
|
|
113108
|
Retain
Patient
Characteristics
Option
|
Retention
of
information
that
would
otherwise
be
removed
during
de-identification
according
to
an
option
defined
in
PS3.15
that
requires
that
any
physical
characteristics
of
the
patient,
which
are
descriptive
rather
than
identifying
information
per
se,
be
retained;
e.g.
Patient's
Age,
Sex,
Size
(height)
and
Weight
|
|
|
113109
|
Retain
Device
Identity
Option
|
Retention
of
information
that
would
otherwise
be
removed
during
de-identification
according
to
an
option
defined
in
PS3.15
that
requires
that
any
information
that
identifies
a
device
be
retained;
e.g.
Device
Serial
Number
|
|
|
113110
|
Retain
UIDs
Option
|
Retention
of
information
that
would
otherwise
be
removed
during
de-identification
according
to
an
option
defined
in
PS3.15
that
requires
that
UIDs
be
retained;
e.g.
SOP
Instance
UID
|
|
|
113111
|
Retain
Safe
Private
Option
|
Retention
of
information
that
would
otherwise
be
removed
during
de-identification
according
to
an
option
defined
in
PS3.15
that
requires
that
private
attributes
that
are
known
not
to
contain
identity
information
be
retained;
e.g.
private
SUV
scale
factor
|
|
|
113500
|
Radiopharmaceutical
Radiation
Dose
Report
|
The
procedure
report
is
a
Radiopharmaceutical
Radiation
Dose
report
|
|
|
113502
|
Radiopharmaceutical
Administration
|
Information
pertaining
to
the
administration
of
a
radiopharmaceutical
|
|
|
113503
|
Radiopharmaceutical
Administration
Event
UID
|
Unique
identification
of
a
single
radiopharmaceutical
administration
event
|
|
|
113505
|
Intravenous
Extravasation
Symptoms
|
Initial
signs
or
symptoms
of
extravasation
|
|
|
113506
|
Estimated
Extravasation
Activity
|
The
estimated
percentage
of
administered
activity
lost
at
the
injection
site.
The
estimation
includes
extravasation,
paravenous
administration
and
leakage
at
the
injection
site
|
|
|
113507
|
Administered
activity
|
The
calculated
activity
at
the
Radiopharmaceutical
Start
Time
when
the
radiopharmaceutical
is
administered
to
the
patient.
The
residual
activity
(i.e.
radiopharmaceutical
not
administered)
,
if
measured,
is
reflected
in
the
calculated
value.
The
estimated
extravasation
is
not
reflected
in
the
calculated
value
|
|
|
113508
|
Pre-Administration
Measured
Activity
|
Radioactivity
measurement
of
radiopharmaceutical
before
or
during
the
administration
|
|
|
113509
|
Post-Administration
Measured
Activity
|
Radioactivity
measurement
of
radiopharmaceutical
after
the
administration
|
|
|
113510
|
Drug
Product
Identifier
|
Registered
drug
establishment
code
for
product,
coding
scheme
example
is
NDC
or
RxNorm
|
|
|
113511
|
Radiopharmaceutical
Dispense
Unit
Identifier
|
The
human
readable
identification
of
the
specific
radiopharmaceutical
dispensed
quantity
or
dose
("dose"
as
unit
of
medication
delivery,
not
radiation
dose
measure)
to
be
administered
to
the
patient
|
|
|
113512
|
Radiopharmaceutical
Lot
Identifier
|
Identifies
the
vial,
batch
or
lot
number
from
which
the
individual
dispense
radiopharmaceutical
quantity
(dose)
is
produced.
The
Radiopharmaceutical
Dispense
Unit
Identifier
records
the
identification
for
each
individual
dose
|
|
|
113513
|
Reagent
Vial
Identifier
|
Identifies
the
lot
or
unit
serial
number
for
the
reagent
component
for
the
radiopharmaceutical
|
|
|
113514
|
Radionuclide
Vial
Identifier
|
Identifies
the
lot
or
unit
serial
number
for
the
radionuclide
component
for
the
radiopharmaceutical
|
|
|
113516
|
Prescription
Identifier
|
Administered
Product's
Prescription
Number
|
|
|
113517
|
Organ
Dose
Information
|
Information
pertaining
to
the
estimated
absorbed
radiation
dose
to
an
organ
|
|
|
113518
|
Organ
Dose
|
The
absorbed
radiation
dose
to
organ
|
|
|
113520
|
MIRD
Pamphlet
1
|
Reference
authority
MIRD
Pamphlet
No.1
(rev)
,Society
of
Nuclear
Medicine,
1976
|
|
|
113521
|
ICRP
Publication
53
|
Reference
authority
ICRP,
1988.
Radiation
Dose
to
Patients
from
Radiopharmaceuticals.
ICRP
Publication
53.
Ann.
ICRP
18
(1-4)
|
|
|
113522
|
ICRP
Publication
80
|
Reference
authority
ICRP,
1998.
Radiation
Dose
to
Patients
from
Radiopharmaceuticals
(Addendum
to
ICRP
Publication
53).
ICRP
Publication
80.
Ann.
ICRP
28
(3)
|
|
|
113523
|
ICRP
Publication
106
|
Reference
authority
ICRP,
2008.
Radiation
Dose
to
Patients
from
Radiopharmaceuticals
-
Addendum
3
to
ICRP
Publication
53.
ICRP
Publication
106.
Ann.
ICRP
38
(1-2)
|
|
|
113526
|
MIRDOSE
|
Reference
authority
Stabin
MG,
Sparks
RB,
Crowe
E
(1994)
MIRDOSE:
personal
computer
software
for
internal
dose
assessment
in
nuclear
medicine
[Computer
program]
|
|
|
113527
|
OLINDA-EXM
|
Reference
authority
Stabin
MG,
Sparks
RB,
Crowe
E
(2005)
OLINDA/EXM:
The
Second-Generation
Personal
Computer
Software
for
Internal
Dose
Assessment
in
Nuclear
Medicine
[Computer
program]
|
|
|
113528
|
Package
Insert
|
Reference
authority
The
reported
organ
dose
is
based
on
radiopharmaceutical's
package
insert
|
|
|
113529
|
Institutionally
Approved
Estimates
|
Reference
authority
The
reported
organ
dose
is
based
on
Institutionally
approved
estimates
from
the
Radioactive
Drug
Research
Committee
(RDRC)
of
the
institution
itself
|
|
|
113530
|
Investigational
New
Drug
|
Reference
authority
The
reported
organ
dose
is
based
on
an
Investigation
new
drug
|
|
|
113540
|
Activity
Measurement
Device
|
The
type
of
device
that
performed
the
activity
measurement
|
|
|
113541
|
Dose
Calibrator
|
The
device
that
measures
the
radiation
activity
of
the
radiopharmaceutical
|
|
|
113542
|
Infusion
System
|
Radiopharmaceutical
Infusion
System
|
|
|
113543
|
Generator
|
Radioisotope
Generator
|
|
|
113550
|
Fasting
Duration
|
The
number
hours
the
patient
has
gone
without
food
|
|
|
113551
|
Hydration
Volume
|
The
amount
of
fluids
the
patient
has
consumed
before
the
procedure
|
|
|
113552
|
Recent
Physical
Activity
|
A
description
of
physical
activity
the
patient
performed
before
the
start
of
the
procedure,
such
as
that
which
may
affect
imaging
agent
biodistribution
|
|
|
113560
|
Acute
unilateral
renal
blockage
|
Blockage
in
one
of
the
tubes
(ureters)
that
drain
urine
from
the
kidneys
|
|
|
113561
|
Low
Thyroid
Uptake
|
5%
or
less
Thyroid
Uptake
of
Iodine
|
|
|
113562
|
High
Thyroid
Uptake
|
25%
or
higher
Thyroid
Uptake
of
Iodine
|
|
|
113563
|
Severely
Jaundiced
|
The
patient
exhibits
symptoms
severe
of
jaundice
and/or
has
a
Bilirubin
>10
mg/dL
|
|
|
113568
|
Extravasation
visible
in
image
|
Extravasation
or
paravenous
administration
of
the
product
is
visible
in
the
images
|
|
|
113570
|
Cockroft-Gault
Formula
estimation
of
GFR
|
The
measurement
method
of
the
Glomerular
Filtration
Rate
is
Cockroft-Gault
Formula
|
|
|
113571
|
CKD-EPI
Formula
estimation
of
GFR
|
The
measurement
method
of
the
Glomerular
Filtration
Rate
is
CKD-EPI
Formula
|
|
|
113572
|
Glomerular
Filtration
Rate
(MDRD)
|
The
measurement
method
of
the
Glomerular
Filtration
Rate
is
MDRD
|
|
|
113573
|
Glomerular
Filtration
Rate
non-black
(MDRD)
|
The
measurement
method
of
the
Glomerular
Filtration
Rate
is
non-black
MDRD
|
|
|
113574
|
Glomerular
Filtration
Rate
black
(MDRD)
|
The
measurement
method
of
the
Glomerular
Filtration
Rate
is
black
(MDRD)
|
|
|
113575
|
Glomerular
Filtration
Rate
female
(MDRD)
|
The
measurement
method
of
the
Glomerular
Filtration
Rate
is
female
(MDRD)
|
|
|
113576
|
Glomerular
Filtration
Rate
Cystatin-based
formula
|
The
measurement
method
of
the
Glomerular
Filtration
Rate
is
Cystatin-based
formula
|
|
|
113577
|
Glomerular
Filtration
Rate
Creatinine-based
formula
(Schwartz)
|
The
measurement
method
of
the
Glomerular
Filtration
Rate
is
Creatinine-based
formula
(Schwartz)
|
|
|
113601
|
Small:
<
32.0
cm
lateral
thickness
|
Small
body
thickness
for
calcium
scoring
adjustment.
Lateral
thickness
is
measured
from
skin-to-skin,
at
the
level
of
the
proximal
ascending
aorta,
from
an
A/P
localizer
image
|
|
|
113602
|
Medium:
32.0-38.0
cm
lateral
thickness
|
Medium
body
thickness
for
calcium
scoring
adjustment.
Lateral
thickness
is
measured
from
skin-to-skin,
at
the
level
of
the
proximal
ascending
aorta,
from
an
A/P
localizer
image
|
|
|
113603
|
Large:
>
38.0
cm
lateral
thickness
|
Large
body
thickness
for
calcium
scoring
adjustment.
Lateral
thickness
is
measured
from
skin-to-skin,
at
the
level
of
the
proximal
ascending
aorta,
from
an
A/P
localizer
image
|
|
|
113605
|
Irradiation
Event
Label
|
A
human-readable
label
identifying
an
irradiation
event
|
|
|
113606
|
Label
Type
|
The
type
of
a
human-readable
label
|
|
|
113607
|
Series
Number
|
A
number
that
identifies
a
Series.
Corresponds
to
(0020,0011)
in
PS3.3
|
|
|
113608
|
Acquisition
Number
|
A
number
that
identifies
an
Acquisition.
Corresponds
to
(0020,0012)
in
PS3.3
|
|
|
113609
|
Instance
Number
|
A
number
that
identifies
an
Instance.
Corresponds
to
(0020,0013)
in
PS3.3
|
|
|
113611
|
Stationary
Acquisition
|
Acquisition
where
the
X-Ray
source
does
not
move
in
relation
to
the
patient
|
|
|
113612
|
Stepping
Acquisition
|
Acquisition
where
the
X-Ray
source
moves
laterally
in
relation
to
the
patient
|
|
|
113613
|
Rotational
Acquisition
|
Acquisition
where
the
X-Ray
source
moves
angularly
in
relation
to
the
patient
|
|
|
113620
|
Plane
A
|
Primary
plane
of
a
Biplane
acquisition
equipment
|
|
|
113621
|
Plane
B
|
Secondary
plane
of
a
Biplane
acquisition
equipment
|
|
|
113622
|
Single
Plane
|
Single
plane
acquisition
equipment
|
|
|
113630
|
Continuous
|
Continuous
X-Ray
radiation
is
applied
during
an
irradiation
event
|
|
|
113631
|
Pulsed
|
Pulsed
X-Ray
radiation
is
applied
during
an
irradiation
event
|
|
|
113650
|
Strip
filter
|
Filter
with
uniform
thickness
|
|
|
113651
|
Wedge
filter
|
Filter
with
variation
in
thickness
from
one
edge
to
the
opposite
edge
|
|
|
113652
|
Butterfly
filter
|
Filter
with
two
triangular
sections
|
|
|
113653
|
Flat
filter
|
Filter
with
uniform
thickness
that
is
for
spectral
filtering
only;
e.g.
filter
out
low
energy
portion
of
the
X-Ray
that
would
only
contribute
to
skin
dose,
but
not
to
image
|
|
|
113661
|
Outline
of
lobulations
|
A
polyline
defining
the
outline
of
a
lobulated
finding
|
|
|
113662
|
Inner
limits
of
fuzzy
margin
|
A
polyline
defining
the
inner
limits
of
a
finding
with
fuzzy
margin
|
|
|
113663
|
Outer
limits
of
fuzzy
margin
|
A
polyline
defining
the
outer
limits
of
a
finding
with
fuzzy
margin
|
|
|
113664
|
Outline
of
spiculations
|
A
polyline
defining
the
outline
of
the
spiculations
of
a
finding
|
|
|
113665
|
Linear
spiculation
|
A
polyline
segment
graphically
indicating
the
location
and
direction
of
a
spiculation
of
a
finding
|
|
|
113666
|
Pixelated
spiculations
|
A
collection
of
points
indicating
the
pixel
locations
of
the
spiculations
of
a
finding
|
|
|
113669
|
Orthogonal
location
arc
|
Connected
line
segments
indicating
the
center
of
location
of
a
finding
on
an
orthogonal
view
|
|
|
113670
|
Orthogonal
location
arc
inner
margin
|
Connected
line
segments
indicating
the
inner
margin
of
the
location
of
a
finding
on
an
orthogonal
view
|
|
|
113671
|
Orthogonal
location
arc
outer
margin
|
Connected
line
segments
indicating
the
outer
location
of
a
finding
on
an
orthogonal
view
|
|
|
113680
|
Quality
Control
Intent
|
This
procedure
is
intended
to
gather
data
that
is
used
for
calibration
or
other
quality
control
purposes
|
|
|
113681
|
Phantom
|
An
artificial
subject
of
an
imaging
study
|
|
|
113682
|
ACR
Accreditation
Phantom
-
CT
|
A
phantom
acceptable
for
the
ACR
Computed
Tomography
Accreditation
program
|
|
|
113683
|
ACR
Accreditation
Phantom
-
MR
|
A
phantom
acceptable
for
the
ACR
Magnetic
Resonance
Imaging
Accreditation
program
|
|
|
113684
|
ACR
Accreditation
Phantom
-
Mammography
|
A
phantom
acceptable
for
the
ACR
Mammography
Accreditation
program
|
|
|
113685
|
ACR
Accreditation
Phantom
-
Stereotactic
Breast
Biopsy
|
A
phantom
acceptable
for
the
ACR
Stereotactic
Breast
Biopsy
Accreditation
program
|
|
|
113686
|
ACR
Accreditation
Phantom
-
ECT
|
A
phantom
acceptable
for
the
ACR
SPECT
Accreditation
program
(but
not
for
PET)
|
|
|
113687
|
ACR
Accreditation
Phantom
-
PET
|
A
phantom
acceptable
for
the
ACR
PET
Accreditation
program
(but
not
for
SPECT)
|
|
|
113688
|
ACR
Accreditation
Phantom
-
ECT/PET
|
A
SPECT
phantom
with
a
PET
faceplate
acceptable
for
both
the
ACR
SPECT
and
PET
Accreditation
programs
|
|
|
113689
|
ACR
Accreditation
Phantom
-
PET
Faceplate
|
A
PET
faceplate
(made
to
fit
an
existing
flangeless
or
flanged
ECT
phantom)
acceptable
for
the
ACR
PET
Accreditation
program
|
|
|
113690
|
IEC
Head
Dosimetry
Phantom
|
A
phantom
used
for
CTDI
measurement
in
head
modes
according
to
IEC
60601-2-44,
Ed.2.1
(Head
16
cm
diameter
Polymethyl
methacrylate
PMMA)
|
|
|
113691
|
IEC
Body
Dosimetry
Phantom
|
A
phantom
used
for
CTDI
measurement
in
body
modes
according
to
IEC
60601-2-44,
Ed.2.1
(Body
32cm
diameter
Polymethyl
methacrylate
PMMA)
|
|
|
113692
|
NEMA
XR21-2000
Phantom
|
A
phantom
in
accordance
with
NEMA
standard
XR-21-2000
|
|
|
113701
|
X-Ray
Radiation
Dose
Report
|
X-Ray
Radiation
Dose
Report
|
|
|
113702
|
Accumulated
X-Ray
Dose
Data
|
X-Ray
dose
data
accumulated
over
multiple
irradiation
events;
e.g.
for
a
study
or
a
performed
procedure
step
|
|
|
113704
|
Projection
X-Ray
|
Imaging
using
a
point
X-Ray
source
with
a
diverging
beam
projected
onto
a
2
dimensional
detector
|
|
|
113705
|
Scope
of
Accumulation
|
Entity
over
which
dose
accumulation
values
are
integrated
|
|
|
113706
|
Irradiation
Event
X-Ray
Data
|
X-Ray
dose
data
for
a
single
Irradiation
Event
|
|
|
113710
|
Niobium
or
Niobium
compound
|
Material
containing
Niobium
or
a
Niobium
compound
|
|
|
113711
|
Europium
or
Europium
compound
|
Material
containing
Europium
or
a
Europium
compound
|
|
|
113720
|
Calibration
Protocol
|
Describes
the
method
used
to
derive
the
calibration
factor
|
|
|
113721
|
Irradiation
Event
Type
|
Denotes
the
type
of
irradiation
event
recorded
|
|
|
113722
|
Dose
Area
Product
Total
|
Total
calculated
Dose
Area
Product
(in
the
scope
of
the
including
report)
|
|
|
113723
|
Calibration
Date
|
Last
calibration
Date
for
the
integrated
dose
meter
or
dose
calculation
|
|
|
113724
|
Calibration
Responsible
Party
|
Individual
or
organization
responsible
for
calibration
|
|
|
113725
|
Dose
(RP)
Total
|
Total
Dose
related
to
Reference
Point
(RP).
(in
the
scope
of
the
including
report)
|
|
|
113726
|
Fluoro
Dose
Area
Product
Total
|
Total
calculated
Dose
Area
Product
applied
in
Fluoroscopy
Modes
(in
the
scope
of
the
including
report)
|
|
|
113727
|
Acquisition
Dose
Area
Product
Total
|
Total
calculated
Dose
Area
Product
applied
in
Acquisition
Modes
(in
the
scope
of
the
including
report)
|
|
|
113728
|
Fluoro
Dose
(RP)
Total
|
Dose
applied
in
Fluoroscopy
Modes,
related
to
Reference
Point
(RP).
(in
the
scope
of
the
including
report)
|
|
|
113729
|
Acquisition
Dose
(RP)
Total
|
Dose
applied
in
Acquisition
Modes,
related
to
Reference
Point
(RP).
(in
the
scope
of
the
including
report)
|
|
|
113730
|
Total
Fluoro
Time
|
Total
accumulated
clock
time
of
Fluoroscopy
in
the
scope
of
the
including
report
(i.e.,
the
sum
of
the
Irradiation
Duration
values
for
accumulated
fluoroscopy
irradiation
events)
|
|
|
113731
|
Total
Number
of
Radiographic
Frames
|
Accumulated
Count
of
exposure
pulses
(single
or
multi-frame
encoded)
created
from
irradiation
events
performed
with
high
dose
(acquisition)
|
|
|
113732
|
Fluoro
Mode
|
Mode
of
application
of
X-Rays
during
Fluoroscopy
|
|
|
113733
|
KVP
|
Applied
X-Ray
Tube
voltage
at
peak
of
X-Ray
generation,
in
kilovolts;
Mean
value
if
measured
over
multiple
peaks
(pulses)
|
|
|
113734
|
X-Ray
Tube
Current
|
Mean
value
of
applied
Tube
Current
|
|
|
113735
|
Exposure
Time
|
Cumulative
time
the
patient
has
received
X-Ray
exposure
during
the
irradiation
event
|
|
|
113736
|
Exposure
|
Mean
value
of
X-Ray
Current
Time
product
|
|
|
113737
|
Distance
Source
to
Reference
Point
|
Distance
to
the
Reference
Point
(RP)
defined
according
to
IEC
60601-2-43
or
equipment
defined
|
|
|
113738
|
Dose
(RP)
|
Dose
applied
at
the
Reference
Point
(RP)
|
|
|
113739
|
Positioner
Primary
End
Angle
|
Positioner
Primary
Angle
at
the
end
of
an
irradiation
event.
For
further
definition
see
(112011,
DCM,
"Positioner
Primary
Angle")
|
|
|
113740
|
Positioner
Secondary
End
Angle
|
Positioner
Secondary
Angle
at
the
end
of
an
irradiation
event.
For
further
definition
see
(112012,
DCM,
"Positioner
Secondary
Angle")
|
|
|
113742
|
Irradiation
Duration
|
Clock
time
from
the
start
of
loading
time
of
the
first
pulse
until
the
loading
time
trailing
edge
of
the
final
pulse
in
the
same
irradiation
event.
Note
Loading
time
is
defined
in
IEC
60601-1-3:2008,
3.37,
and
described
in
IEC
60601-2-54:2009,
203.4.101.3
|
|
|
113743
|
Patient
Orientation
|
Orientation
of
the
Patient
with
respect
to
Gravity
|
|
|
113744
|
Patient
Orientation
Modifier
|
Enhances
or
modifies
the
Patient
orientation
specified
in
Patient
Orientation
|
|
|
113745
|
Patient
Table
Relationship
|
Orientation
of
the
Patient
with
respect
to
the
Head
of
the
Table
|
|
|
113748
|
Distance
Source
to
Isocenter
|
Distance
from
the
X-Ray
Source
to
the
Equipment
C-Arm
Isocenter.(Center
of
Rotation)
|
|
|
113750
|
Distance
Source
to
Detector
|
Measured
or
calculated
distance
from
the
X-Ray
source
to
the
detector
plane
in
the
center
of
the
beam
|
|
|
113751
|
Table
Longitudinal
Position
|
Table
Longitudinal
Position
with
respect
to
an
arbitrary
chosen
reference
by
the
equipment.
Table
motion
towards
LAO
is
positive
assuming
that
the
patient
is
positioned
supine
and
its
head
is
in
normal
position
|
|
|
113752
|
Table
Lateral
Position
|
Table
Lateral
Position
with
respect
to
an
arbitrary
chosen
reference
by
the
equipment.
Table
motion
towards
CRA
is
positive
assuming
that
the
patient
is
positioned
supine
and
its
head
is
in
normal
position
|
|
|
113753
|
Table
Height
Position
|
Table
Height
Position
with
respect
to
an
arbitrary
chosen
reference
by
the
equipment
in
(mm).
Table
motion
downwards
is
positive
|
|
|
113754
|
Table
Head
Tilt
Angle
|
Angle
of
the
head-feet
axis
of
the
table
in
degrees
relative
to
the
horizontal
plane.
Positive
values
indicate
that
the
head
of
the
table
is
upwards
|
|
|
113755
|
Table
Horizontal
Rotation
Angle
|
Rotation
of
the
table
in
the
horizontal
plane
(clockwise
when
looking
from
above
the
table)
|
|
|
113756
|
Table
Cradle
Tilt
Angle
|
Angle
of
the
left-right
axis
of
the
table
in
degrees
relative
to
the
horizontal
plane.
Positive
values
indicate
that
the
left
of
the
table
is
upwards
|
|
|
113757
|
X-Ray
Filter
Material
|
X-Ray
absorbing
material
used
in
the
filter
|
|
|
113758
|
X-Ray
Filter
Thickness
Minimum
|
The
minimum
thickness
of
the
X-Ray
absorbing
material
used
in
the
filters
|
|
|
113759
|
Table
Longitudinal
End
Position
|
Table
Longitudinal
Position
at
the
end
of
an
irradiation
event;
see
(113751,
DCM,
"Table
Longitudinal
Position")
|
|
|
113760
|
Table
Lateral
End
Position
|
Table
Lateral
Position
at
the
end
of
an
irradiation
event;
see
(113752,
DCM,
"Table
Lateral
Position")
|
|
|
113761
|
Table
Height
End
Position
|
Table
Height
Position
at
the
end
of
an
irradiation
event;
see
(113753,
DCM,
"Table
Height
Position")
|
|
|
113763
|
Calibration
Uncertainty
|
Uncertainty
of
the
'actual'
value
|
|
|
113764
|
Acquisition
Plane
|
Identification
of
Acquisition
Plane
with
Biplane
systems
|
|
|
113766
|
Focal
Spot
Size
|
Nominal
Size
of
Focal
Spot
of
X-Ray
Tube
|
|
|
113767
|
Average
X-Ray
Tube
Current
|
Average
X-Ray
Tube
Current
averaged
over
time
for
pulse
or
for
continuous
Fluoroscopy
|
|
|
113768
|
Number
of
Pulses
|
Number
of
pulses
applied
by
X-Ray
systems
during
an
irradiation
event
(acquisition
run
or
pulsed
fluoro)
|
|
|
113769
|
Irradiation
Event
UID
|
Unique
identification
of
a
single
irradiation
event
|
|
|
113770
|
Column
Angulation
|
Angle
of
the
X-Ray
beam
in
degree
relative
to
an
orthogonal
axis
to
the
detector
plane
|
|
|
113771
|
X-Ray
Filters
|
Devices
used
to
modify
the
energy
or
energy
distribution
of
X-Rays
|
|
|
113772
|
X-Ray
Filter
Type
|
Type
of
filter(s)
inserted
into
the
X-Ray
beam;
e.g.
wedges
|
|
|
113773
|
X-Ray
Filter
Thickness
Maximum
|
The
maximum
thickness
of
the
X-Ray
absorbing
material
used
in
the
filters
|
|
|
113780
|
Reference
Point
Definition
|
System
provided
definition
of
the
Reference
Point
used
for
Dose
calculations
|
|
|
113788
|
Collimated
Field
Height
|
Distance
between
the
collimator
blades
in
pixel
column
direction
as
projected
at
the
detector
plane
|
|
|
113789
|
Collimated
Field
Width
|
Distance
between
the
collimator
blades
in
pixel
row
direction
as
projected
at
the
detector
plane
|
|
|
113790
|
Collimated
Field
Area
|
Collimated
field
area
at
image
receptor.
Area
for
compatibility
with
IEC
60601-2-43
|
|
|
113791
|
Pulse
Rate
|
Pulse
rate
applied
by
equipment
during
Fluoroscopy
|
|
|
113792
|
Distance
Source
to
Table
Plane
|
Measured
or
calculated
distance
from
the
X-Ray
source
to
the
table
plane
in
the
center
of
the
beam
|
|
|
113793
|
Pulse
Width
|
(Average)
X-Ray
pulse
width
|
|
|
113794
|
Dose
Measurement
Device
|
Calibrated
device
to
perform
dose
measurements
|
|
|
113795
|
Acquired
Image
|
Image
acquired
during
a
specified
event
|
|
|
113800
|
DLP
to
E
conversion
via
MC
computation
|
Effective
Dose
evaluation
from
the
product
of
Dose
Length
Product
(DLP)
and
the
Effective
Dose
Conversion
Factor
(E/DLP
in
units
of
mSv/mGy-cm),
where
the
ratio
is
derived
by
means
of
Monte
Carlo
computations
|
|
|
113801
|
CTDIfreeair
to
E
conversion
via
MC
computation
|
Effective
Dose
evaluation
from
the
product
of
the
Mean
CTDIfreeair
and
the
ratio
E/CTDIfreeair
(mSv/mGy),
where
the
ratio
is
derived
by
means
of
Monte
Carlo
computations
|
|
|
113802
|
DLP
to
E
conversion
via
measurement
|
Effective
Dose
evaluation
from
the
product
of
Dose
Length
Product
(DLP)
and
the
Effective
Dose
Conversion
Factor
(E/DLP
in
units
of
mSv/mGy-cm),
where
the
ratio
is
derived
by
means
of
dosimetric
measurements
with
an
anthropomorphic
phantom
|
|
|
113803
|
CTDIfreeair
to
E
conversion
via
measurement
|
Effective
Dose
evaluation
from
the
product
of
the
Mean
CTDIfreeair
and
the
ratio
E/CTDIfreeair
(mSv/mGy),
where
the
ratio
is
derived
by
means
of
dosimetric
measurements
with
an
anthropomorphic
phantom
|
|
|
113804
|
Sequenced
Acquisition
|
The
CT
acquisition
was
performed
by
acquiring
single
or
multi
detector
data
while
rotating
the
source
about
the
gantry
while
the
table
is
not
moving.
Additional
slices
are
acquired
by
incrementing
the
table
position
and
again
rotating
the
source
about
the
gantry
while
the
table
is
not
moving
|
|
|
113805
|
Constant
Angle
Acquisition
|
The
CT
acquisition
was
performed
by
holding
the
source
at
a
constant
angle
and
moving
the
table
to
obtain
a
projection
image;
e.g.
localizer
|
|
|
113806
|
Stationary
Acquisition
|
The
CT
acquisition
was
performed
by
holding
the
table
at
a
constant
position
and
acquiring
multiple
slices
over
time
at
the
same
location
|
|
|
113807
|
Free
Acquisition
|
The
CT
acquisition
was
performed
while
rotating
the
source
about
the
gantry
while
the
table
movement
is
under
direct
control
of
a
human
operator
or
under
the
control
of
an
analysis
application;
e.g.
fluoro
|
|
|
113808
|
ICRP
Pub
60
|
Reference
authority
1990
Recommendations
of
the
International
Commission
on
Radiological
Protection
(ICRP
Publication
60,
published
as
the
Annals
of
the
ICRP
Vol.
21,
No.
1-3,
Pergamon
Press,1991)
|
|
|
113809
|
Start
of
X-Ray
Irradiation
|
Start,
DateTime
of
the
first
X-Ray
Irradiation
Event
of
the
accumulation
within
a
Study
|
|
|
113810
|
End
of
X-Ray
Irradiation
|
End,
DateTime
of
the
last
X-Ray
Irradiation
Event
of
the
accumulation
within
a
Study
|
|
|
113811
|
CT
Accumulated
Dose
Data
|
X-Ray
dose
accumulated
over
multiple
CT
irradiation
events;
e.g.
for
a
study
or
a
performed
procedure
step
|
|
|
113812
|
Total
Number
of
Irradiation
Events
|
Total
number
of
events
during
the
defined
scope
of
accumulation
|
|
|
113813
|
CT
Dose
Length
Product
Total
|
The
total
dose
length
product
defined
scope
of
accumulation
|
|
|
113814
|
CT
Effective
Dose
Total
|
The
total
Effective
Dose
at
the
defined
scope
of
accumulation
|
|
|
113815
|
Patient
Model
|
Identification
of
the
reference-patient
model
used
when
Effective
Dose
is
evaluated
via
Monte
Carlo
calculations
or
from
a
Dose
Length
Product
conversion
factor
based
on
Monte
Carlo
calculations
|
|
|
113816
|
Condition
Effective
Dose
measured
|
References
the
physical
phantom
and
the
type
of
dosimeter
used
when
measurements
are
done
to
establish
Effective
Dose
Conversion
Factors
(E/DLP)
or
ratios
E/CTDIfreeair
|
|
|
113817
|
Effective
Dose
Phantom
Type
|
Type
of
Effective
Dose
phantom
used
|
|
|
113818
|
Dosimeter
Type
|
Type
of
dosimeter
used
|
|
|
113819
|
CT
Acquisition
|
General
description
of
the
CT
Irradiation
event
|
|
|
113820
|
CT
Acquisition
Type
|
Method
of
the
CT
acquisition
|
|
|
113821
|
X-Ray
Filter
Aluminum
Equivalent
|
Thickness
of
an
equivalent
filter
in
mm
in
Aluminum
|
|
|
113822
|
CT
Acquisition
Parameters
|
General
description
of
the
acquisition
parameters
|
|
|
113823
|
Number
of
X-Ray
Sources
|
Number
of
X-Ray
sources
|
|
|
113824
|
Exposure
Time
|
Total
time
the
patient
has
received
X-Ray
exposure
during
the
irradiation
event
|
|
|
113825
|
Scanning
Length
|
Length
of
the
table
travel
during
the
entire
tube
loading,
according
to
IEC
60601-2-44
Note
Scanning
Length
might
be
longer
than
the
programmed
acquisition
length
(Length
of
Reconstructable
Volume)
|
|
|
113826
|
Nominal
Single
Collimation
Width
|
The
value
of
the
nominal
width
referenced
to
the
location
of
the
isocenter
along
the
z
axis
of
a
single
row
of
acquired
data
in
mm
|
|
|
113827
|
Nominal
Total
Collimation
Width
|
The
value
of
the
nominal
width
referenced
to
the
location
of
the
isocenter
along
the
z
axis
of
the
total
collimation
in
mm
over
the
area
of
active
X-Ray
detection
|
|
|
113828
|
Pitch
Factor
|
For
Spiral
scanning:
Pitch
Factor
=
(Table
Feed
per
Rotation
(mm))
/(Nominal
Total
Collimation
Width
(mm))
For
Sequenced
scanning:
Pitch
Factor
=
(Table
Feed
per
single
Sequenced
scan
(mm))
/(Nominal
Total
Collimation
Width
(mm))
|
|
|
113829
|
CT
Dose
|
General
description
of
CT
dose
values
|
|
|
113830
|
Mean
CTDIvol
|
"Mean
CTDIvol"
refers
to
the
average
value
of
the
CTDIvol
associated
with
this
acquisition
|
|
|
113831
|
CT
X-Ray
Source
Parameters
|
Identification,
tube-potential,
tube-current,
and
exposure-time
parameters
associated
with
an
X-Ray
source
during
an
acquisition
|
|
|
113832
|
Identification
of
the
X-Ray
Source
|
Identifies
the
particular
X-Ray
source
(in
a
multi-source
CT
system)
for
which
the
set
of
X-Ray
source
parameter
values
is
reported
|
|
|
113833
|
Maximum
X-Ray
Tube
Current
|
Maximum
X-Ray
tube
current
|
|
|
113834
|
Exposure
Time
per
Rotation
|
The
exposure
time
for
one
rotation
of
the
source
around
the
object
in
s
|
|
|
113835
|
CTDIw
Phantom
Type
|
A
label
describing
the
type
of
phantom
used
for
CTDIW
measurement
according
to
IEC
60601-2-44
(Head
16
cm
diameter
PMMA,
Body
32
cm
diameter
PMMA)
|
|
|
113836
|
CTDIfreeair
Calculation
Factor
|
The
CTDIfreeair
Calculation
Factor
is
the
CTDIfreeair
per
mAs,
expressed
in
units
of
mGy/mAs.
The
CTDIfreeair
Calculation
Factor
may
be
used
in
one
method
calculating
Dose
|
|
|
113837
|
Mean
CTDIfreeair
|
The
average
value
of
the
free-in-air
CTDI
associated
with
this
acquisition
|
|
|
113838
|
DLP
|
Dose
Length
Product
(DLP),
expressed
in
mGy-cm,
is
an
index
characterizing
the
product
of
the
CTDIvol
and
the
length
scanned.
For
Spiral
scanning,
DLP
=
CTDIvol
x
Scanning
Length.
For
Sequenced
scanning,
DLP
=
CTDIvol
x
Nominal
Total
Collimation
Width
x
Cumulative
Exposure
Time
/
Exposure
Time
per
Rotation.
For
Stationary
and
Free
scanning,
DLP
=
CTDIvol
x
Nominal
Total
Collimation
Width
|
|
|
113839
|
Effective
Dose
|
Effective
dose
in
mSv
|
|
|
113840
|
Effective
Dose
Conversion
Factor
|
Effective
Dose
per
DLP,
reference
value
for
Effective
Dose
calculation,
expressed
in
mSv/mGY.cm
|
|
|
113841
|
ICRP
Pub
103
|
Effective
Dose
Reference
authority
2007
Recommendations
of
the
International
Commission
on
Radiological
Protection
(ICRP
Publication
103,
published
as
the
Annals
of
the
ICRP
Vol.
37,
No.
2-4,
Elsevier,
2007)
|
|
|
113842
|
X-Ray
Modulation
Type
|
The
type
of
exposure
modulation
used
for
the
purpose
of
limiting
the
dose
|
|
|
113845
|
Exposure
Index
|
Measure
of
the
detector
response
to
radiation
in
the
relevant
image
region
of
an
image
acquired
with
a
digital
X-Ray
imaging
system
as
defined
in
IEC
62494-1;
see
PS3.3
definition
of
Exposure
Index
Macro
|
|
|
113846
|
Target
Exposure
Index
|
The
target
value
used
to
calculate
the
Deviation
Index
as
defined
in
IEC
62494-1;
see
PS3.3
definition
of
Exposure
Index
Macro
|
|
|
113847
|
Deviation
Index
|
A
scaled
representation
of
the
accuracy
of
the
Exposure
Index
compared
to
the
Target
Exposure
Index
as
defined
in
IEC
62494-1;
see
PS3.3
definition
of
Exposure
Index
Macro
|
|
|
113850
|
Irradiation
Authorizing
|
The
clinician
responsible
for
determining
that
the
irradiating
procedure
was
appropriate
for
the
indications
|
|
|
113851
|
Irradiation
Administering
|
The
person
responsible
for
the
administration
of
radiation
|
|
|
113852
|
Irradiation
Event
|
An
irradiation
event
is
the
loading
of
X-Ray
equipment
caused
by
a
single
continuous
actuation
of
the
equipment's
irradiation
switch,
from
the
start
of
the
loading
time
of
the
first
pulse
until
the
loading
time
trailing
edge
of
the
final
pulse.
Any
automatic
on-off
switching
of
the
irradiation
source
during
the
event
is
not
treated
as
separate
events,
rather
the
event
includes
the
time
between
start
and
stop
of
irradiation
as
triggered
by
the
user;
e.g.
a
pulsed
fluoro
X-Ray
acquisition
shall
be
treated
as
a
single
irradiation
event
|
|
|
113853
|
Irradiation
Event
UID
|
Unique
Identifier
of
an
Irradiation
Event
|
|
|
113854
|
Source
of
Dose
Information
|
Method
by
which
dose-related
details
of
an
Irradiation
Event
were
obtained
|
|
|
113855
|
Total
Acquisition
Time
|
Total
accumulated
acquisition
clock
time
in
the
scope
of
the
including
report
(i.e.,
the
sum
of
the
Irradiation
Duration
values
for
accumulated
acquisition
irradiation
events)
|
|
|
113856
|
Automated
Data
Collection
|
Direct
recording
of
data
by
a
relevant
system
|
|
|
113857
|
Manual
Entry
|
Recording
of
data
by
a
human
operator,
including
manual
transcription
of
electronic
data
|
|
|
113858
|
MPPS
Content
|
The
data
is
taken
from
an
MPPS
SOP
Instance
|
|
|
113859
|
Irradiating
Device
|
A
device
exposing
a
patient
to
ionizing
radiation
|
|
|
113860
|
15cm
from
Isocenter
toward
Source
|
15cm
from
the
isocenter
towards
the
X-Ray
source;
See
IEC
60601-2-43
|
|
|
113861
|
30cm
in
Front
of
Image
Input
Surface
|
30cm
in
front
(towards
the
tube)
of
the
input
surface
of
the
image
receptor;
See
FDA
Federal
Performance
Standard
for
Diagnostic
X-Ray
Systems
§1020.32(d)
(7)
|
|
|
113862
|
1cm
above
Tabletop
|
1cm
above
the
patient
tabletop
or
cradle;
See
FDA
Federal
Performance
Standard
for
Diagnostic
X-Ray
Systems
§1020.32(d)
(7)
|
|
|
113863
|
30cm
above
Tabletop
|
30cm
above
the
patient
tabletop
of
cradle;
See
FDA
Federal
Performance
Standard
for
Diagnostic
X-Ray
Systems
§1020.32(d)
(7)
|
|
|
113864
|
15cm
from
Table
Centerline
|
15cm
from
the
centerline
of
the
X-Ray
table
and
in
the
direction
of
the
X-Ray
source;
See
FDA
Federal
Performance
Standard
for
Diagnostic
X-Ray
Systems
§1020.32(d)
(7)
|
|
|
113865
|
Entrance
exposure
to
a
4.2
cm
breast
thickness
|
Standard
breast
means
a
4.2
centimeter
(cm)
thick
compressed
breast
consisting
of
50
percent
glandular
and
50
percent
adipose
tissue.
See
Department
of
Health
and
Human
Services,
Food
and
Drug
Administration.
Mammography
quality
standards;
final
rule.
Federal
Register.
Oct.
28,
1997;
68(208):55852-55994;
see
900.2(uu)
|
|
|
113866
|
Copied
From
Image
Attributes
|
The
data
is
copied
from
information
present
in
the
image
attributes;
e.g.
dose
attributes
such
as
CTDIvol
(0018,9345)
|
|
|
113867
|
Computed
From
Image
Attributes
|
The
data
is
computed
from
information
present
in
the
image
attributes;
e.g.
by
using
dosimetry
information
for
the
specific
irradiating
device
make
and
model,
applied
to
technique
information
such
as
KVP
and
mAs
|
|
|
113868
|
Derived
From
Human-Readable
Reports
|
The
data
is
derived
from
human-readable
reports;
e.g.
by
natural
language
parsing
of
text
reports,
or
optical
character
recognition
from
reports
saved
as
images
by
the
irradiating
device
|
|
|
113870
|
Person
Name
|
The
name
of
a
specific
person
|
|
|
113871
|
Person
ID
|
An
identification
number
or
code
for
a
specific
person
|
|
|
113872
|
Person
ID
Issuer
|
The
organization
that
issued
a
Person
ID
|
|
|
113873
|
Organization
Name
|
The
name
of
an
organization
|
|
|
113874
|
Person
Role
in
Organization
|
The
role
played
by
a
person
in
an
organization
|
|
|
113875
|
Person
Role
in
Procedure
|
The
role
played
by
a
person
in
a
procedure
|
|
|
113876
|
Device
Role
in
Procedure
|
The
role
played
by
a
device
in
a
procedure
|
|
|
113877
|
Device
Name
|
The
name
used
to
refer
to
a
device;
usually
locally
unique
|
|
|
113878
|
Device
Manufacturer
|
Manufacturer
of
a
device
|
|
|
113879
|
Device
Model
Name
|
Model
Name
of
a
device
|
|
|
113880
|
Device
Serial
Number
|
Serial
Number
of
a
device
|
|
|
113890
|
All
Planes
|
All
planes
of
a
multi-plane
acquisition
equipment
|
|
|
113893
|
Length
of
Reconstructable
Volume
|
The
length
from
which
images
may
be
reconstructed
(i.e.,
excluding
any
overranging
performed
in
a
spiral
acquisition
that
is
required
for
data
interpolation).
Value
is
distinct
from
(1113825,
DCM,
"Scanning
Length"),
which
is
the
actual
length
of
the
table
travel
during
the
entire
tube
loading,
according
to
IEC
60601-2-44,
and
includes
overranging.
Also
distinct
from
any
actual
Reconstructed
Volume,
which
may
depend
on
the
slice
thickness
chosen
for
a
particular
reconstruction
|
|
|
113895
|
Top
Z
Location
of
Reconstructable
Volume
|
The
Z
location
that
is
the
top
(highest
Z
value)
of
the
Reconstructable
Volume.
Specified
as
the
Z
component
within
the
Patient
Coordinate
System
defined
by
a
specified
Frame
of
Reference
|
|
|
113896
|
Bottom
Z
Location
of
Reconstructable
Volume
|
The
Z
location
that
is
the
bottom
(lowest
Z
value)
of
the
Reconstructable
Volume.
Specified
as
the
Z
component
within
the
Patient
Coordinate
System
defined
by
a
specified
Frame
of
Reference
|
|
|
113897
|
Top
Z
Location
of
Scanning
Length
|
The
Z
location
that
is
the
top
(highest
Z
value)
of
the
scanning
length.
Specified
as
the
Z
component
within
the
Patient
Coordinate
System
defined
by
a
specified
Frame
of
Reference
|
|
|
113898
|
Bottom
Z
Location
of
Scanning
Length
|
The
Z
location
that
is
the
bottom
(lowest
Z
value)
of
the
scanning
length.
Specified
as
the
Z
component
within
the
Patient
Coordinate
System
defined
by
a
specified
Frame
of
Reference
|
|
|
113899
|
Exposed
Range
|
The
range
along
the
z
axis
of
the
total
volume
irradiated,
per
IEC
60601-2-44,
Ed.
3,
203.115(b).
The
start
and
stop
of
loading
corresponding
to
the
outer
edge
of
the
full
width
half
maximum
of
the
free-in-air
dose
profile
for
the
beam
collimation
used
|
|
|
113900
|
Dose
Check
Alert
Details
|
Report
section
about
cumulative
dose
alerts
during
an
examination
|
|
|
113901
|
DLP
Alert
Value
Configured
|
Flag
denoting
whether
a
DLP
Alert
Value
was
configured
|
|
|
113902
|
CTDIvol
Alert
Value
Configured
|
Flag
denoting
whether
a
CTDIvol
Alert
Value
was
configured
|
|
|
113903
|
DLP
Alert
Value
|
Cumulative
Dose
Length
Product
value
configured
to
trigger
an
alert;
see
NEMA
XR
25-2010
Dose
Check
Standard
|
|
|
113904
|
CTDIvol
Alert
Value
|
Cumulative
CTDIvol
value
configured
to
trigger
an
alert;
see
NEMA
XR
25-2010
Dose
Check
Standard
|
|
|
113905
|
Accumulated
DLP
Forward
Estimate
|
A
forward
estimate
of
the
accumulated
DLP
plus
the
estimated
DLP
for
the
next
Protocol
Element
Group;
see
NEMA
XR
25-2010
Dose
Check
Standard
|
|
|
113906
|
Accumulated
CTDIvol
Forward
Estimate
|
A
forward
estimate
at
a
given
location
of
the
accumulated
CTDIvol
plus
the
estimated
CTDIvol
for
the
next
Protocol
Element
Group;
see
NEMA
XR
25-2010
Dose
Check
Standard
|
|
|
113907
|
Reason
for
Proceeding
|
Reason
provided
for
proceeding
with
a
procedure
that
is
projected
to
exceed
a
configured
dose
value
|
|
|
113908
|
Dose
Check
Notification
Details
|
Report
section
about
dose
notifications
during
a
protocol
element
|
|
|
113909
|
DLP
Notification
Value
Configured
|
Flag
denoting
whether
a
DLP
Notification
Value
was
configured
|
|
|
113910
|
CTDIvol
Notification
Value
Configured
|
Flag
denoting
whether
a
CTDIvol
Notification
Value
was
configured
|
|
|
113911
|
DLP
Notification
Value
|
Dose
Length
Product
value
configured
to
trigger
a
notification
for
a
given
protocol
element
|
|
|
113912
|
CTDIvol
Notification
Value
|
CTDIvol
value
configured
to
trigger
a
notification
for
a
given
protocol
element
|
|
|
113913
|
DLP
Forward
Estimate
|
A
forward
estimate
of
the
DLP
for
the
next
Protocol
Element
Group;
see
NEMA
XR
25-2010
Dose
Check
Standard
|
|
|
113914
|
CTDIvol
Forward
Estimate
|
A
forward
estimate
of
the
CTDIvol
for
the
next
Protocol
Element
Group;
see
NEMA
XR
25-2010
Dose
Check
Standard
|
|
|
113921
|
Radiation
Exposure
|
The
amount
of
ionizing
radiation
to
which
the
patient
was
exposed
|
|
|
113922
|
Radioactive
Substance
Administered
|
Type,
amount
and
route
of
radioactive
substance
administered
|
|
|
113923
|
Radiation
Exposure
and
Protection
Information
|
Exposure
to
ionizing
radiation
and
associated
preventive
measures
used
to
reduce
the
exposure
of
parts
of
the
body
like
lead
apron
or
eye,
thyroid
gland
or
gonad
protection
|
|
|
113930
|
Size
Specific
Dose
Estimation
|
The
Size-Specific
Dose
Estimate
is
a
patient
dose
estimate
that
takes
into
account
the
size
of
the
patient,
such
as
described
in
AAPM
Report
204
by
using
linear
dimensions
measured
on
the
patient
or
patient
images
or
estimated
from
patient
age
|
|
|
113931
|
Measured
Lateral
Dimension
|
The
side-to-side
(left
to
right)
dimension
of
the
body
part
being
scanned
(per
AAPM
Report
204)
|
|
|
113932
|
Measured
AP
Dimension
|
The
thickness
of
the
body
part
being
scanned,
in
the
antero-posterior
dimension
(per
AAPM
Report
204)
|
|
|
113933
|
Derived
Effective
Diameter
|
The
diameter
of
the
patient
at
a
given
location
along
the
Z-axis
of
the
patient,
assuming
that
the
patient
has
a
circular
cross-section
(per
AAPM
Report
204)
|
|
|
113934
|
AAPM
204
Lateral
Dimension
|
The
Size
Specific
Dose
Estimation
is
computed
using
Table
1B
(32cm
phantom)
or
Table
2B
(16cm
phantom)
of
AAPM
Report
204
|
|
|
113935
|
AAPM
204
AP
Dimension
|
The
Size
Specific
Dose
Estimation
is
computed
using
Table
1C
(32cm
phantom)
or
Table
2C
(16cm
phantom)
of
AAPM
Report
204
|
|
|
113936
|
AAPM
204
Sum
of
Lateral
and
AP
Dimension
|
The
Size
Specific
Dose
Estimation
is
computed
using
Table
1A
(32cm
phantom)
or
Table
2A
(16cm
phantom)
of
AAPM
Report
204
|
|
|
113937
|
AAPM
204
Effective
Diameter
Estimated
From
Patient
Age
|
The
Size
Specific
Dose
Estimation
is
computed
using
Table
1D
(32cm
phantom)
or
Table
2D
(16cm
phantom)
using
an
effective
diameter
estimated
from
the
patient's
age
using
Table
3
of
AAPM
Report
204
|
|
|
113940
|
System
Calculated
|
Values
calculated
from
other
existing
parameters
|
|
|
113941
|
In
Detector
Plane
|
A
segmented
region
of
the
detector
surface
within
the
irradiated
area
(but
might
not
be
near
the
center
of
the
detector)
|
|
|
113942
|
X-Ray
Reading
Device
|
A
device
that
creates
digital
images
from
X-Ray
detectors
(Direct,
Indirect
or
Storage)
|
|
|
113943
|
X-Ray
Source
Data
Available
|
Parameters
related
to
the
X-Ray
source
(generator,
tube,
etc.)
are
available
to
the
recording
application
|
|
|
113944
|
X-Ray
Mechanical
Data
Available
|
Parameters
related
to
the
X-Ray
Mechanical
System
(Stand,
Table)
are
available
to
the
recording
application
|
|
|
113945
|
X-Ray
Detector
Data
Available
|
Parameters
related
to
the
X-Ray
Detector
are
available
to
the
recording
application
|
|
|
113946
|
Projection
Eponymous
Name
|
Describes
the
radiographic
method
of
patient,
tube
and
detector
positioning
to
achieve
a
well
described
projection
or
view
|
|
|
113947
|
Detector
Type
|
Type
of
Detector
used
to
acquire
data;
e.g.
Images
|
|
|
113948
|
Direct
Detector
|
Detector
that
directly
transforms
the
input
signal
to
pixel
values
|
|
|
113949
|
Indirect
Detector
|
Detector
that
transforms
an
intermediate
signal
into
pixel
values;
e.g.
a
scintillator-based
detector
|
|
|
113950
|
Storage
Detector
|
Storage
detector
that
stores
a
signal
that
is
later
transformed
by
a
reader
into
pixel
values;
e.g.
a
phosphor-based
detector
|
|
|
113951
|
Film
|
Film
that
is
scanned
to
create
pixel
values
|
|
|
113952
|
Table
Mount
|
The
cassette/detector
is
mounted
in
the
patient
table
|
|
|
113953
|
Unmounted
Detector
|
The
cassette/detector
is
not
mounted.;
e.g.
a
cassette
placed
underneath
the
patient
|
|
|
113954
|
Upright
Stand
Mount
|
The
cassette/detector
is
mounted
in
an
upright
stand
|
|
|
113955
|
C-Arm
Mount
|
The
cassette/detector
is
mounted
on
a
c-arm
|
|
|
113956
|
CR/DR
Mechanical
Configuration
|
Method
of
mounting
or
positioning
a
CR/DR
cassette
or
detector
|
|
|
113957
|
Fluoroscopy-Guided
Projection
Radiography
System
|
An
integrated
projection
radiography
system
capable
of
fluoroscopy
|
|
|
113958
|
Integrated
Projection
Radiography
System
|
A
projection
radiography
system
where
the
X-Ray
detector,
X-Ray
Source
and
gantry
components
are
integrated
and
the
managing
system
is
able
to
access
details
of
each
component
|
|
|
113959
|
Cassette-based
Projection
Radiography
System
|
A
projection
radiography
system
where
the
X-Ray
detector,
X-Ray
Source
and
gantry
components
are
not
integrated;
e.g.
cassette-based
CR
and
DR
systems
|
|
|
113961
|
Reconstruction
Algorithm
|
Description
of
the
algorithm
used
when
reconstructing
the
image
from
the
data
acquired
during
the
acquisition
process
|
|
|
113962
|
Filtered
Back
Projection
|
An
algorithm
for
reconstructing
an
image
from
multiple
projections
by
back-projecting
the
measured
values
along
the
line
of
the
projection
and
filtering
the
result
to
reduce
blurring
|
|
|
113963
|
Iterative
Reconstruction
|
An
algorithm
for
reconstructing
an
image
from
multiple
projections
by
starting
with
an
assumed
reconstructed
image,
computing
projections
from
the
image,
comparing
the
original
projection
data
and
updating
the
reconstructed
image
based
upon
the
difference
between
the
calculated
and
the
actual
projections
|
|
|
113970
|
Procedure
Step
To
This
Point
|
The
period
of
time
from
the
start
of
a
Procedure
Step
until
the
time
point
established
by
the
context
of
the
reference
|
|
|
114000
|
Not
a
number
|
Measurement
not
available:
Not
a
number
(per
IEEE
754)
|
|
|
114001
|
Negative
Infinity
|
Measurement
not
available:
Negative
Infinity
(per
IEEE
754)
|
|
|
114002
|
Positive
Infinity
|
Measurement
not
available:
Positive
Infinity
(per
IEEE
754)
|
|
|
114003
|
Divide
by
zero
|
Measurement
not
available:
Divide
by
zero
(per
IEEE
754)
|
|
|
114004
|
Underflow
|
Measurement
not
available:
Underflow
(per
IEEE
754)
|
|
|
114005
|
Overflow
|
Measurement
not
available:
Overflow
(per
IEEE
754)
|
|
|
114006
|
Measurement
failure
|
Measurement
not
available:
Measurement
failure
|
|
|
114007
|
Measurement
not
attempted
|
Measurement
not
available:
Measurement
not
attempted
|
|
|
114008
|
Calculation
failure
|
Measurement
not
available:
Calculation
failure
|
|
|
114009
|
Value
out
of
range
|
Measurement
not
available:
Value
out
of
range
|
|
|
114010
|
Value
unknown
|
Measurement
not
available:
Value
unknown
|
|
|
114011
|
Value
indeterminate
|
Measurement
not
available:
Value
indeterminate
|
|
|
114201
|
Time
of
flight
|
Measures
the
time-of-flight
of
a
light
signal
between
the
camera
and
the
subject
for
each
point
of
the
image
|
|
|
114202
|
Interferometry
|
Interferometry
is
a
family
of
techniques
in
which
waves
are
superimposed
in
order
to
extract
depth
information
about
the
scanned
object
|
|
|
114203
|
Laser
scanning
|
Laser
scanning
describes
the
general
method
to
sample
or
scan
a
surface
using
laser
technology
|
|
|
114204
|
Pattern
projection
|
Projecting
a
narrow
band
of
light
onto
a
three-dimensionally
shaped
surface
produces
a
line
of
illumination
that
appears
distorted
from
other
perspectives
than
that
of
the
projector.
It
can
be
used
for
an
exact
geometric
reconstruction
of
the
surface
shape
|
|
|
114205
|
Shape
from
shading
|
A
technique
for
estimating
the
surface
normal
of
an
object
by
observing
that
object
under
different
lighting
conditions
|
|
|
114206
|
Shape
from
motion
|
A
technique
for
estimating
the
surface
normal
of
an
object
by
observing
that
object
under
different
motions
|
|
|
114207
|
Confocal
imaging
|
An
optical
imaging
technique
used
to
increase
optical
resolution
and
contrast
of
a
micrograph
by
using
point
illumination
and
a
spatial
pinhole
to
eliminate
out-of-focus
light
in
specimens
that
are
thicker
than
the
focal
plane.
It
enables
the
reconstruction
of
3D
structures
from
the
obtained
images
|
|
|
114208
|
Point
Cloud
Algorithmic
|
Point
cloud
that
was
calculated
by
an
algorithm
|
|
|
114209
|
Turntable
Scan
Method
|
Scanning
the
object
from
different
views
by
placing
it
on
a
rotating
table
|
|
|
114210
|
High
resolution
|
Higher
resolution
with
a
longer
acquisition
time
|
|
|
114211
|
Fast
mode
|
Lower
resolution
with
a
shorter
acquisition
time
|
|
|
114213
|
Iterative
Closest
Point
|
An
algorithm
employed
to
minimize
the
difference
between
two
clouds
of
points.
It
iteratively
revises
the
transformation
(translation,
rotation)
needed
to
minimize
the
distance
between
the
points
of
two
point
clouds
|
|
|
114215
|
Freehand
|
Human
controlled
minimization
of
the
distance
between
the
points
of
two
point
clouds
|
|
|
114216
|
Checkerboard
|
Scanning
the
object
from
different
views
by
placing
it
in
front
of
a
checkerboard
pattern
|
|
|
121001
|
Quotation
Mode
|
Type
of
source
for
observations
quoted
from
an
external
source
|
|
|
121002
|
Quoted
Source
|
Reference
to
external
source
of
quoted
observations
|
|
|
121003
|
Document
|
Documentary
source
of
quoted
observations
|
|
|
121004
|
Verbal
|
Verbal
source
of
quoted
observations
|
|
|
121005
|
Observer
Type
|
Type
of
observer
that
created
the
observations
|
|
|
121006
|
Person
|
Human
observer
created
the
observations
|
|
|
121007
|
Device
|
Automated
device
created
the
observations
|
|
|
121008
|
Person
Observer
Name
|
Name
of
human
observer
that
created
the
observations
|
|
|
121009
|
Person
Observer's
Organization
Name
|
Organization
or
institution
with
which
the
human
observer
is
affiliated
for
the
context
of
the
current
observation
|
|
|
121010
|
Person
Observer's
Role
in
the
Organization
|
Organizational
role
of
human
observer
for
the
context
of
the
current
observation
|
|
|
121011
|
Person
Observer's
Role
in
this
Procedure
|
Procedural
role
of
human
observer
for
the
context
of
the
current
observation
|
|
|
121012
|
Device
Observer
UID
|
Unique
identifier
of
automated
device
that
created
the
observations
|
|
|
121013
|
Device
Observer
Name
|
Institution-provided
identifier
of
automated
device
that
created
the
observations
|
|
|
121014
|
Device
Observer
Manufacturer
|
Manufacturer
of
automated
device
that
created
the
observations
|
|
|
121015
|
Device
Observer
Model
Name
|
Manufacturer-provided
model
name
of
automated
device
that
created
the
observations
|
|
|
121016
|
Device
Observer
Serial
Number
|
Manufacturer-provided
serial
number
of
automated
device
that
created
the
observations
|
|
|
121017
|
Device
Observer
Physical
Location
During
Observation
|
Location
of
automated
device
that
created
the
observations
whilst
the
observations
were
being
made
|
|
|
121018
|
Procedure
Study
Instance
UID
|
Unique
identifier
for
the
Study
or
Requested
Procedure
|
|
|
121019
|
Procedure
Study
Component
UID
|
Unique
identifier
for
the
Performed
Procedure
Step
|
|
|
121020
|
Placer
Number
|
Identifier
for
the
Order
(or
Service
Request)
assigned
by
the
order
placer
system
|
|
|
121021
|
Filler
Number
|
Identifier
for
the
Order
(or
Service
Request)
assigned
by
the
order
filler
system
|
|
|
121022
|
Accession
Number
|
Identifier
for
the
Order
(or
Service
Request)
assigned
by
the
department
information
system
|
|
|
121023
|
Procedure
Code
|
Type
of
procedure
scheduled
or
performed
|
|
|
121024
|
Subject
Class
|
Type
of
observation
subject
|
|
|
121025
|
Patient
|
A
patient
is
the
subject
of
observations
|
|
|
121026
|
Fetus
|
Fetus
of
patient
is
the
subject
of
observations
|
|
|
121027
|
Specimen
|
Specimen
is
the
subject
of
observations
|
|
|
121028
|
Subject
UID
|
Unique
Identifier
of
patient
or
fetus
who
is
the
subject
of
observations
|
|
|
121029
|
Subject
Name
|
Name
of
patient
who
is
the
subject
of
observations
|
|
|
121030
|
Subject
ID
|
Identifier
of
patient
or
fetus
who
is
the
subject
of
observations
|
|
|
121031
|
Subject
Birth
Date
|
Birth
Date
of
patient
who
is
the
subject
of
observations
|
|
|
121032
|
Subject
Sex
|
Sex
of
patient
who
is
the
subject
of
observations
|
|
|
121033
|
Subject
Age
|
Age
of
patient
who
is
the
subject
of
observations
|
|
|
121034
|
Subject
Species
|
Species
of
patient
who
is
the
subject
of
observations
|
|
|
121035
|
Subject
Breed
|
The
breed
of
the
subject
|
|
|
121036
|
Mother
of
fetus
|
Name
of
mother
of
fetus
that
is
the
subject
of
observations
|
|
|
121037
|
Fetus
number
|
|
|
|
121038
|
Number
of
Fetuses
|
|
|
|
121039
|
Specimen
UID
|
Unique
Identifier
of
specimen
that
is
the
subject
of
observations
|
|
|
121040
|
Specimen
Accession
Number
|
Accession
Number
of
specimen
that
is
the
subject
of
observations
|
|
|
121041
|
Specimen
Identifier
|
Identifier
of
specimen
that
is
the
subject
of
observations
|
|
|
121042
|
Specimen
Type
|
Coded
category
of
specimen
that
is
the
subject
of
observations
|
|
|
121043
|
Slide
Identifier
|
Identifier
of
specimen
microscope
slide
that
is
the
subject
of
observations
|
|
|
121044
|
Slide
UID
|
Unique
Identifier
of
specimen
microscope
slide
that
is
the
subject
of
observations
|
|
|
121045
|
Language
|
The
language
of
the
content,
being
a
language
that
is
primarily
used
for
human
communication;
e.g.
English,
French
|
|
|
121046
|
Country
of
Language
|
The
country-specific
variant
of
language;
e.g.
Canada
for
Candadian
French
|
|
|
121047
|
Language
of
Value
|
The
language
of
the
value
component
of
a
name-value
pair
|
|
|
121048
|
Language
of
Name
and
Value
|
The
language
of
both
the
name
component
and
the
value
component
of
a
name-value
pair
|
|
|
121049
|
Language
of
Content
Item
and
Descendants
|
The
language
of
the
current
content
item
(node
in
a
tree
of
content)
and
all
its
descendants
|
|
|
121050
|
Equivalent
Meaning
of
Concept
Name
|
The
human
readable
meaning
of
the
name
component
of
a
name-value
pair
that
is
equivalent
to
the
post-coordinated
meaning
conveyed
by
the
coded
name
and
its
concept
modifier
children
|
|
|
121051
|
Equivalent
Meaning
of
Value
|
The
human
readable
meaning
of
the
value
component
of
a
name-value
pair
that
is
equivalent
to
the
post-coordinated
meaning
conveyed
by
the
coded
value
and
its
concept
modifier
children
|
|
|
121052
|
Presence
of
property
|
Whether
or
not
the
property
concept
being
modified
is
present
or
absent
|
|
|
121053
|
Present
|
|
|
|
121054
|
Absent
|
|
|
|
121055
|
Path
|
A
set
of
points
on
an
image,
that
when
connected
by
line
segments,
provide
a
polyline
from
which
a
linear
measurement
was
inferred
|
|
|
121056
|
Area
outline
|
A
set
of
points
on
an
image,
that
when
connected
by
line
segments,
provide
a
closed
polyline
that
is
the
border
of
a
defined
region
from
which
an
area,
or
two-dimensional
measurement,
was
inferred
|
|
|
121057
|
Perimeter
outline
|
A
set
of
points
on
an
image,
that
when
connected
by
line
segments,
provide
a
closed
polyline
that
is
a
two-dimensional
border
of
a
three-dimensional
region's
intersection
with,
or
projection
into
the
image
|
|
|
121058
|
Procedure
reported
|
The
imaging
procedure
whose
results
are
reported
|
|
|
121059
|
Presence
Undetermined
|
Presence
or
absence
of
a
property
is
undetermined
|
|
|
121060
|
History
|
|
|
|
121062
|
Request
|
|
|
|
121064
|
Current
Procedure
Descriptions
|
|
|
|
121065
|
Procedure
Description
|
A
description
of
the
imaging
procedure
|
|
|
121066
|
Prior
Procedure
Descriptions
|
|
|
|
121068
|
Previous
Findings
|
|
|
|
121069
|
Previous
Finding
|
An
observation
found
on
a
prior
imaging
study
|
|
|
121070
|
Findings
|
|
|
|
121071
|
Finding
|
An
observation
found
on
an
imaging
study
|
|
|
121072
|
Impressions
|
|
|
|
121073
|
Impression
|
An
interpretation
in
the
clinical
context
of
the
finding(s)
on
an
imaging
study
|
|
|
121074
|
Recommendations
|
|
|
|
121075
|
Recommendation
|
A
recommendation
for
management
or
investigation
based
on
the
findings
and
impressions
of
an
imaging
study
|
|
|
121076
|
Conclusions
|
|
|
|
121077
|
Conclusion
|
An
interpretation
in
the
clinical
context
of
the
finding(s)
on
an
imaging
study
|
|
|
121078
|
Addendum
|
|
|
|
121079
|
Baseline
|
Initial
images
used
to
esyablish
a
beginning
condition
that
is
used
for
comparison
over
time
to
look
for
changes.
[Paraphrases
NCI-PT
(C1442488,
UMLS,
"Baseline"),
which
is
defined
as
"An
initial
measurement
that
is
taken
at
an
early
time
point
to
represent
a
beginning
condition,
and
is
used
for
comparison
over
time
to
look
for
changes.
For
example,
the
size
of
a
tumor
will
be
measured
before
treatment
(baseline)
and
then
afterwards
to
see
if
the
treatment
had
an
effect.
A
starting
point
to
which
things
may
be
compared."]
|
|
|
121080
|
Best
illustration
of
finding
|
A
selection
of
composite
instances
that
best
illustrates
a
particular
finding;
e.g.
an
image
slice
at
the
location
of
the
largest
extent
of
a
tumor
|
|
|
121081
|
Physician
|
|
|
|
121082
|
Nurse
|
|
|
|
121083
|
Technologist
|
|
|
|
121084
|
Radiographer
|
|
|
|
121085
|
Intern
|
|
|
|
121086
|
Resident
|
|
|
|
121087
|
Registrar
|
|
|
|
121088
|
Fellow
|
A
medical
practitioner
undergoing
sub-specialty
training;
e.g.
during
the
period
after
specialty
training
(residency)
|
|
|
121089
|
Attending
[Consultant]
|
|
|
|
121090
|
Scrub
nurse
|
|
|
|
121091
|
Surgeon
|
|
|
|
121092
|
Sonologist
|
A
medical
practitioner
with
sub-specialty
training
in
Ultrasound
|
|
|
121093
|
Sonographer
|
|
|
|
121094
|
Performing
|
The
person
responsible
for
performing
the
procedure
|
|
|
121095
|
Referring
|
The
person
responsible
for
referring
the
patient
for
the
procedure
|
|
|
121096
|
Requesting
|
The
person
responsible
for
requesting
the
procedure
|
|
|
121097
|
Recording
|
The
person
responsible
for
recording
the
procedure
or
observation
|
|
|
121098
|
Verifying
|
The
person
responsible
for
verifying
the
recorded
procedure
or
observation
|
|
|
121099
|
Assisting
|
The
person
responsible
for
assisting
with
the
procedure
|
|
|
121100
|
Circulating
|
The
person
responsible
for
making
preparations
for
and
monitoring
the
procedure
|
|
|
121101
|
Standby
|
The
person
responsible
for
standing
by
to
assist
with
the
precedure
if
required
|
|
|
121102
|
Other
sex
|
Other
sex
|
|
|
121103
|
Undetermined
sex
|
Sex
of
subject
undetermined
at
time
of
encoding
|
|
|
121104
|
Ambiguous
sex
|
Ambiguous
sex
|
|
|
121105
|
Radiation
Physicist
|
Radiation
Physicist
|
|
|
121106
|
Comment
|
Comment
|
|
|
121109
|
Indications
for
Procedure
|
Indications
for
Procedure
|
|
|
121110
|
Patient
Presentation
|
Patient
condition
at
the
beginning
of
a
healthcare
encounter
|
|
|
121111
|
Summary
|
Summary
of
a
procedure,
including
most
significant
findings
|
|
|
121112
|
Source
of
Measurement
|
Image
or
waveform
used
as
source
for
measurement
|
|
|
121113
|
Complications
|
Complications
from
a
procedure
|
|
|
121114
|
Performing
Physician
|
Physician
who
performed
a
procedure
|
|
|
121115
|
Discharge
Summary
|
Summary
of
patient
condition
upon
Discharge
from
a
healthcare
facility
|
|
|
121116
|
Proximal
Finding
Site
|
Proximal
Anatomic
Location
for
a
differential
measurement;
may
be
considered
subtype
of
term
(G-C0E3,
SRT,
"Finding
Site");
e.g.
distance
or
pressure
gradient
|
|
|
121117
|
Distal
Finding
Site
|
Distal
Anatomic
Location
for
a
differential
measurement;
may
be
considered
subtype
of
term
(G-C0E3,
SRT,
"Finding
Site");
e.g.
distance
or
pressure
gradient
|
|
|
121118
|
Patient
Characteristics
|
Patient
Characteristics
(findings)
|
|
|
121120
|
Cath
Lab
Procedure
Log
|
Time-stamped
record
of
events
that
occur
during
a
catheterization
procedure
|
|
|
121121
|
Room
identification
|
Room
identification
|
|
|
121122
|
Equipment
Identification
|
Equipment
identification
|
|
|
121123
|
Patient
Status
or
Event
|
A
recorded
Patient
Status
or
an
event
involving
a
patient
|
|
|
121124
|
Procedure
Action
Item
ID
|
Identification
of
a
step,
action,
or
phase
of
a
procedure
|
|
|
121125
|
DateTime
of
Recording
of
Log
Entry
|
DateTime
of
Recording
of
an
Entry
in
an
Event
Log
|
|
|
121126
|
Performed
Procedure
Step
SOP
Instance
UID
|
SOP
Instance
UID
of
a
Performed
Procedure
Step
|
|
|
121127
|
Performed
Procedure
Step
SOP
Class
UID
|
SOP
Class
UID
of
a
Performed
Procedure
Step
|
|
|
121128
|
Procedure
Action
Duration
|
Duration
of
a
step,
action,
or
phase
of
a
procedure
|
|
|
121130
|
Start
Procedure
Action
Item
|
Beginning
of
a
step,
action,
or
phase
of
a
procedure
|
|
|
121131
|
End
Procedure
Action
Item
|
End
of
a
step,
action,
or
phase
of
a
procedure
|
|
|
121132
|
Suspend
Procedure
Action
Item
|
Suspension
of
a
step,
action,
or
phase
of
a
procedure
|
|
|
121133
|
Resume
Procedure
Action
Item
|
Resumption
of
a
step,
action,
or
phase
of
a
procedure
|
|
|
121135
|
Observation
DateTime
Qualifier
|
Concept
modifier
for
the
DateTime
of
Recording
of
an
Entry
in
an
Event
Log
|
|
|
121136
|
DateTime
Unsynchronized
|
Recorded
DateTime
had
its
source
in
a
system
clock
not
synchronized
to
other
recorded
DateTimes
|
|
|
121137
|
DateTime
Estimated
|
Recorded
DateTime
is
estimated
|
|
|
121138
|
Image
Acquired
|
Event
of
the
acquisition
of
an
image
|
|
|
121139
|
Modality
|
Type
of
data
acquisition
device
|
|
|
121140
|
Number
of
Frames
|
Number
of
Frames
in
a
multi-frame
image
|
|
|
121141
|
Image
Type
|
Descriptor
of
an
Image
|
|
|
121142
|
Acquisition
Duration
|
Duration
of
the
acquisition
of
an
image
or
a
waveform
|
|
|
121143
|
Waveform
Acquired
|
Event
of
the
acquisition
of
an
image
|
|
|
121144
|
Document
Title
|
Document
Title
|
|
|
121145
|
Description
of
Material
|
Description
of
Material
used
in
a
procedure
|
|
|
121146
|
Quantity
of
Material
|
Quantity
of
Material
used
in
a
procedure
|
|
|
121147
|
Billing
Code
|
Billing
Code
for
materials
used
in
a
procedure
|
|
|
121148
|
Unit
Serial
Identifier
|
Unit
or
Device
Serial
Identifier
|
|
|
121149
|
Lot
Identifier
|
Lot
Identifier
|
|
|
121150
|
Device
Code
|
Vendor
or
local
coded
value
identifying
a
device
|
|
|
121151
|
Lesion
Identifier
|
Identification
of
a
Lesion
observed
during
an
imaging
procedure
|
|
|
121152
|
Person
administering
drug/contrast
|
Person
administering
drug/contrast
|
|
|
121153
|
Lesion
Risk
|
Assessment
of
the
risk
a
coronary
lesion
presents
to
the
health
of
a
patient
|
|
|
121154
|
Intervention
attempt
identifier
|
Identifier
for
an
attempted
Intervention
|
|
|
121155
|
Deployment
|
Use
of
a
device
to
deploy
another
device
|
|
|
121156
|
Percutaneous
Entry
Action
|
Action
of
a
clinical
professional
at
the
site
of
percutaneous
access
to
a
patient's
cardiovascular
system
|
|
|
121157
|
Begin
Circulatory
Support
|
The
action
or
event
of
beginning
circulatory
support
for
a
patient
|
|
|
121158
|
End
Circulatory
Support
|
The
action
or
event
of
ending
circulatory
support
for
a
patient
|
|
|
121160
|
Oxygen
Administration
Rate
|
Rate
of
Oxygen
Administration
|
|
|
121161
|
Begin
Oxygen
Administration
|
The
action
or
event
of
beginning
administration
of
oxygen
to
a
patient
|
|
|
121162
|
End
oxygen
administration
|
The
action
or
event
of
ending
administration
of
oxygen
to
a
patient
|
|
|
121163
|
By
ventilator
|
Method
of
administration
of
oxygen
to
a
patient
by
ventilator
|
|
|
121165
|
Patient
Assessment
Performed
|
The
action
or
event
of
assessing
the
clinical
status
of
a
patient
|
|
|
121166
|
Begin
Pacing
|
The
action
or
event
of
beginning
pacing
support
for
a
patient
|
|
|
121167
|
End
Pacing
|
The
action
or
event
of
ending
pacing
support
for
a
patient
|
|
|
121168
|
Begin
Ventilation
|
The
action
or
event
of
beginning
ventilation
support
for
a
patient
|
|
|
121169
|
End
Ventilation
|
The
action
or
event
of
ending
ventilation
support
for
a
patient
|
|
|
121171
|
Tech
Note
|
Procedural
note
originated
by
a
technologist
|
|
|
121172
|
Nursing
Note
|
Procedural
note
originated
by
a
nurse
|
|
|
121173
|
Physician
Note
|
Procedural
note
originated
by
a
Physician
|
|
|
121174
|
Procedure
Note
|
General
procedural
note
|
|
|
121180
|
Key
Images
|
List
of
references
to
images
considered
significant
|
|
|
121181
|
DICOM
Object
Catalog
|
List
of
references
to
DICOM
SOP
Instances
|
|
|
121190
|
Referenced
Frames
|
Individual
frames
selected
as
a
subset
of
a
multi-frame
image
|
|
|
121191
|
Referenced
Segment
|
Segment
selected
as
a
subset
of
a
segmentation
image,
specifically
the
pixels/voxels
identified
as
belonging
to
the
classification
of
the
identified
segment
|
|
|
121192
|
Device
Subject
|
A
device
is
the
subject
of
observations
|
|
|
121193
|
Device
Subject
Name
|
Name
or
other
identifier
of
a
device
that
is
the
subject
of
observations
|
|
|
121194
|
Device
Subject
Manufacturer
|
Manufacturer
of
a
device
that
is
the
subject
of
observations
|
|
|
121195
|
Device
Subject
Model
Name
|
Model
Name
of
a
device
that
is
the
subject
of
observations
|
|
|
121196
|
Device
Subject
Serial
Number
|
Serial
Number
of
a
device
that
is
the
subject
of
observations
|
|
|
121197
|
Device
Subject
Physical
Location
during
observation
|
Physical
Location
of
a
device
that
is
the
subject
of
observations
during
those
observations
|
|
|
121198
|
Device
Subject
UID
|
Unique
Identifier
of
a
device
that
is
the
subject
of
observations
|
|
|
121200
|
Illustration
of
ROI
|
Illustration
of
a
region
of
interest
|
|
|
121201
|
Area
Outline
|
|
|
|
121202
|
Area
of
Defined
Region
|
|
|
|
121206
|
Distance
|
A
one
dimensional,
or
linear,
numeric
measurement
|
|
|
121207
|
Height
|
Vertical
measurement
value
|
|
|
121208
|
Inter-Marker
Distance
|
Distance
between
marks
on
a
device
of
calibrated
size;
e.g.
a
ruler
|
|
|
121210
|
Path
|
|
|
|
121211
|
Path
length
|
A
one
dimensional,
or
linear,
numeric
measurement
along
a
polyline
|
|
|
121213
|
Perimeter
Outline
|
|
|
|
121214
|
Referenced
Segmentation
Frame
|
Frame
selected
from
a
segmentation
image,
specifically
the
pixels/voxels
identified
as
belonging
to
the
classification
of
the
segment
encompassing
the
identified
frame
|
|
|
121216
|
Volume
estimated
from
single
2D
region
|
A
three-dimensional
numeric
measurement
that
is
approximate,
based
on
a
two-dimensional
region
in
a
single
image
|
|
|
121217
|
Volume
estimated
from
three
or
more
non-coplanar
2D
regions
|
A
three-dimensional
numeric
measurement
that
is
approximate,
based
on
three
or
more
non-coplanar
two-dimensional
image
regions
|
|
|
121218
|
Volume
estimated
from
two
non-coplanar
2D
regions
|
A
three-dimensional
numeric
measurement
that
is
approximate,
based
on
two
non-coplanar
two-dimensional
image
regions
|
|
|
121219
|
Volume
of
bounding
three
dimensional
region
|
A
three-dimensional
numeric
measurement
of
the
bounding
region
of
a
three-dimensional
region
of
interest
in
an
image
set
|
|
|
121220
|
Volume
of
circumscribed
sphere
|
A
three-dimensional
numeric
measurement
of
the
bounding
sphere
of
a
three-dimensional
region
of
interest
in
an
image
set
|
|
|
121221
|
Volume
of
ellipsoid
|
A
three-dimensional
numeric
measurement
of
an
ellipsoid
shaped
three-dimensional
region
of
interest
in
an
image
set
|
|
|
121222
|
Volume
of
sphere
|
A
three-dimensional
numeric
measurement
of
a
sphere
shaped
three-dimensional
region
of
interest
in
an
image
set
|
|
|
121230
|
Path
Vertex
|
Coordinates
of
a
point
on
a
defined
path
|
|
|
121231
|
Volume
Surface
|
Surface
of
an
identified
or
measured
volume
|
|
|
121232
|
Source
series
for
segmentation
|
Series
of
image
instances
used
as
source
data
for
a
segmentation
|
|
|
121233
|
Source
image
for
segmentation
|
Image
instances
used
as
source
data
for
a
segmentation
|
|
|
121242
|
Distance
from
nipple
|
Indicates
the
location
of
the
area
of
interest
as
measured
from
the
nipple
of
the
breast
|
|
|
121243
|
Distance
from
skin
|
Indicates
the
location
of
the
area
of
interest
as
measured
from
the
most
direct
skin
point
of
the
breast
|
|
|
121244
|
Distance
from
chest
wall
|
Indicates
the
location
of
the
area
of
interest
as
measured
from
the
chest
wall
|
|
|
121290
|
Patient
exposure
to
ionizing
radiation
|
Patient
exposure
to
ionizing
radiation
(procedure)
|
|
|
121291
|
Results
communicated
|
The
act
of
communicating
actionable
findings
to
a
responsible
receiver
|
|
|
121301
|
Simultaneous
Doppler
|
Reference
is
to
a
Doppler
waveform
acquired
simultaneously
with
an
image
|
|
|
121302
|
Simultaneous
Hemodynamic
|
Reference
is
to
a
Hemodynamic
waveform
acquired
simultaneously
with
an
image
|
|
|
121303
|
Simultaneous
ECG
|
Reference
is
to
a
ECG
waveform
acquired
simultaneously
with
an
image
|
|
|
121304
|
Simultaneous
Voice
Narrative
|
Reference
is
to
a
voice
narrative
recording
acquired
simultaneously
with
an
image
|
|
|
121305
|
Simultaneous
Respiratory
Waveform
|
A
waveform
representing
chest
expansion
and
contraction
due
to
respiratory
activity,
measured
simultaneously
with
the
acquisition
of
this
Image
|
|
|
121306
|
Simultaneous
Arterial
Pulse
Waveform
|
Arterial
pulse
waveform
obtained
simultaneously
with
acquisition
of
a
referencing
image
|
|
|
121307
|
Simultaneous
Phonocardiographic
Waveform
|
Phonocardiographic
waveform
obtained
simultaneously
with
acquisition
of
a
referencing
image
|
|
|
121311
|
Localizer
|
Image
providing
an
anatomical
reference
on
the
patient
under
examination,
for
the
purpose
of
defining
the
location
of
the
ensuing
imaging
|
|
|
121312
|
Biopsy
localizer
|
Image
providing
an
anatomical
reference
on
the
patient
under
examination,
for
the
purpose
of
planning
or
documenting
a
biopsy
|
|
|
121313
|
Other
partial
views
|
Image
providing
a
partial
view
of
the
target
anatomy,
when
the
target
anatomy
is
too
large
for
a
single
image
|
|
|
121314
|
Other
image
of
biplane
pair
|
Image
providing
a
view
of
the
target
anatomy
in
a
different
imaging
plane,
typically
from
a
near
perpendicular
angle
|
|
|
121315
|
Other
image
of
stereoscopic
pair
|
Image
providing
a
view
of
the
target
anatomy
in
a
different
imaging
plane,
typically
with
a
small
angular
difference
|
|
|
121316
|
Images
related
to
standalone
object
|
Image
related
to
a
non-image
information
object
|
|
|
121317
|
Spectroscopy
|
Image
where
signals
are
identified
and
separated
according
to
their
frequencies;
e.g.
to
identify
individual
chemicals,
or
individual
nuclei
in
a
chemical
compound
|
|
|
121318
|
Spectroscopy
Data
for
Water
Phase
Correction
|
MR
spectroscopy
data
acquired
to
correct
the
phase
of
the
diagnostic
data
for
the
phase
signal
of
the
Water
|
|
|
121320
|
Uncompressed
predecessor
|
An
image
that
has
not
already
been
lossy
compressed
that
is
used
as
the
source
for
creation
of
a
lossy
compressed
image
|
|
|
121321
|
Mask
image
for
image
processing
operation
|
Image
used
as
the
mask
for
an
image
processing
operation,
such
as
subtraction
|
|
|
121322
|
Source
image
for
image
processing
operation
|
Image
used
as
the
source
for
an
image
processing
operation
|
|
|
121323
|
Source
series
for
image
processing
operation
|
Series
used
as
the
source
for
an
image
processing
operation
|
|
|
121324
|
Source
Image
|
Image
used
as
the
source
for
a
derived
or
compressed
image
|
|
|
121325
|
Lossy
compressed
image
|
Image
encoded
with
a
lossy
compression
transfer
syntax
|
|
|
121326
|
Alternate
SOP
Class
instance
|
SOP
Instance
encoded
with
a
different
SOP
Class
but
otherwise
equivalent
data
|
|
|
121327
|
Full
fidelity
image
|
Full
fidelity
image,
uncompressed
or
lossless
compressed
|
|
|
121328
|
Alternate
Photometric
Interpretation
image
|
Image
encoded
with
a
different
photometric
interpretation
|
|
|
121329
|
Source
image
for
montage
|
Image
used
as
a
source
for
a
montage
(stitched)
image
|
|
|
121330
|
Lossy
compressed
predecessor
|
An
image
that
has
previously
been
lossy
compressed
that
is
used
as
the
source
for
creation
of
another
lossy
compressed
image
|
|
|
121331
|
Equivalent
CDA
Document
|
HL7
Document
Architecture
(CDA)
Document
that
contains
clinical
content
equivalent
to
the
referencing
Instance
|
|
|
121332
|
Complete
Rendering
for
Presentation
|
Instance
that
contains
a
displayable
complete
rendering
of
the
referencing
Instance
|
|
|
121333
|
Partial
Rendering
for
Presentation
|
Instance
that
contains
a
displayable
partial
rendering
of
the
referencing
Instance
|
|
|
121334
|
Extended
Rendering
for
Presentation
|
Instance
that
contains
a
displayable
complete
rendering
of
the
referencing
Instance,
plus
additional
content
such
as
inline
rendering
of
referenced
images
|
|
|
121335
|
Source
Document
|
Document
whose
content
has
been
wholly
or
partially
transformed
to
create
the
referencing
document
|
|
|
121338
|
Anatomic
image
|
Image
showing
structural
anatomic
features
|
|
|
121339
|
Functional
image
|
Image
showing
physical
or
chemical
activity
|
|
|
121340
|
Spectral
filtered
image
|
Image
providing
the
same
view
of
the
target
anatomy
acquired
using
only
a
specific
imaging
wavelength,
frequency
or
energy
|
|
|
121341
|
Device
localizer
|
Image
providing
an
anatomical
reference
on
the
patient
under
examination,
for
the
purpose
of
documenting
the
location
of
device
such
as
a
diagnostic
or
therapeutic
catheter
|
|
|
121342
|
Dose
Image
|
Image
providing
a
graphic
view
of
the
distribution
of
radiation
dose
|
|
|
121346
|
Acquisition
frames
corresponding
to
volume
|
The
referenced
image
is
the
source
of
spatially-related
frames
from
which
the
referencing
3D
volume
data
set
was
derived
|
|
|
121347
|
Volume
corresponding
to
spatially-related
acquisition
frames
|
3D
Volume
containing
the
spatially-related
frames
in
the
referencing
instance
|
|
|
121348
|
Temporal
Predecessor
|
Instance
acquired
prior
to
the
referencing
instance
in
a
set
of
consecutively
acquired
instances
|
|
|
121349
|
Temporal
Successor
|
Instance
acquired
subsequent
to
the
referencing
instance
in
a
set
of
consecutively
acquired
instances
|
|
|
121350
|
Same
acquisition
at
lower
resolution
|
Image
of
the
same
target
area
at
lower
resolution
acquired
in
the
same
acquisition
process
|
|
|
121351
|
Same
acquisition
at
higher
resolution
|
Image
of
the
same
target
area
at
higher
resolution
acquired
in
the
same
acquisition
process
|
|
|
121352
|
Same
acquisition
at
different
focal
depth
|
Image
of
the
same
target
area
at
different
focal
depth
(Z-plane)
acquired
in
the
same
acquisition
process
|
|
|
121353
|
Same
acquisition
at
different
spectral
band
|
Image
of
the
same
target
area
at
different
spectral
band
acquired
in
the
same
acquisition
process
|
|
|
121354
|
Imaged
container
label
|
Image
specifically
targeting
the
container
label
|
|
|
121358
|
For
Processing
predecessor
|
Source
image
from
which
FOR
PRESENTATION
images
were
created
|
|
|
121360
|
Replaced
report
|
The
reference
is
to
a
predecessor
report
that
has
been
replaced
by
the
current
report
|
|
|
121361
|
Addended
report
|
The
reference
is
to
a
predecessor
report
to
which
the
current
report
provides
and
addendum
|
|
|
121362
|
Preliminary
report
|
A
report
that
precedes
the
final
report
and
may
contain
only
limited
information;
it
may
be
time
sensitive,
and
it
is
not
expected
to
contain
all
the
reportable
findings
|
|
|
121363
|
Partial
report
|
A
report
that
is
not
complete
|
|
|
121370
|
Composed
from
prior
doses
|
The
dose
object
created
was
calculated
by
summation
of
existing,
previously
calculated,
RT
Dose
instances
|
|
|
121371
|
Composed
from
prior
doses
and
current
plan
|
The
dose
object
created
was
calculated
by
summation
of
existing,
previously
calculated,
RT
Dose
instances
and
dose
newly
calculated
by
the
application.
The
newly
calculated
dose
may
or
may
not
exist
as
an
independent
object
|
|
|
121372
|
Source
dose
for
composing
current
dose
|
RT
Dose
Instances
used
as
source
for
calculated
dose
|
|
|
121380
|
Active
Ingredient
Undiluted
Concentration
|
Concentration
of
the
chemically
or
physically
interesting
(active)
ingredient
of
a
drug
or
contrast
agent
as
delivered
in
product
form
from
the
manufacturer,
typically
in
mg/ml
|
|
|
121381
|
Contrast/Bolus
Ingredient
Opaque
|
X-Ray
absorption
of
the
active
ingredient
of
a
contrast
agent
ingredient
is
greater
than
the
absorption
of
water
(tissue)
|
|
|
121382
|
Quantity
administered
|
Number
of
units
of
substance
administered
to
a
patient;
e.g.
tablets
|
|
|
121383
|
Mass
administered
|
Mass
of
substance
administered
to
a
patient
|
|
|
121401
|
Derivation
|
Method
of
deriving
or
calculating
a
measured
value;
e.g.
mean,
or
maximum
of
set
|
|
|
121402
|
Normality
|
Assessment
of
a
measurement
relative
to
a
normal
range
of
values;
may
be
considered
subtype
of
term
(G-C0F2,
SRT,
"has
interpretation")
|
|
|
121403
|
Level
of
Significance
|
Significance
of
a
measurement
|
|
|
121404
|
Selection
Status
|
Status
of
selection
of
a
measurement
for
further
processing
or
use
|
|
|
121405
|
Population
description
|
Description
of
a
population
of
measurements
|
|
|
121406
|
Reference
Authority
|
Bibliographic
or
clinical
reference
for
a
Description
of
a
population
of
measurements
|
|
|
121407
|
Normal
Range
description
|
Description
of
a
normal
range
of
values
for
a
measurement
concept
|
|
|
121408
|
Normal
Range
Authority
|
Bibliographic
or
clinical
reference
for
a
Description
of
a
normal
range
of
values
|
|
|
121410
|
User
chosen
value
|
Observation
value
selected
by
user
for
further
processing
or
use,
or
as
most
representative
|
|
|
121411
|
Most
recent
value
chosen
|
Observation
value
is
the
recently
obtained,
and
has
been
selected
for
further
processing
or
use
|
|
|
121412
|
Mean
value
chosen
|
Observation
value
is
the
mean
of
several
measurements,
and
has
been
selected
for
further
processing
or
use
|
|
|
121414
|
Standard
deviation
of
population
|
Standard
deviation
of
a
measurement
in
a
reference
population
|
|
|
121415
|
Percentile
Ranking
of
measurement
|
Percentile
Ranking
of
an
observation
value
with
respect
a
reference
population
|
|
|
121416
|
Z-Score
of
measurement
|
Z-score
of
an
observation
value
with
respect
a
reference
population,
expressed
as
the
dimensionless
quantity
(x-m)
/s,
where
(x-m)
is
the
deviation
of
the
observation
value
(x)
from
the
population
mean
(m),
and
s
is
the
standard
deviation
of
the
population
|
|
|
121417
|
2
Sigma
deviation
of
population
|
2
Sigma
deviation
of
a
measurement
in
a
reference
population
|
|
|
121420
|
Equation
|
Formula
used
to
compute
a
derived
measurement
|
|
|
121421
|
Equation
Citation
|
Bibliographic
reference
to
a
formula
used
to
compute
a
derived
measurement;
reference
may
be
to
a
specific
equation
in
a
journal
article
|
|
|
121422
|
Table
of
Values
Citation
|
Bibliographic
reference
to
a
Table
of
Values
used
to
look
up
a
derived
measurement
|
|
|
121423
|
Method
Citation
|
Bibliographic
reference
to
a
method
used
to
compute
a
derived
measurement
|
|
|
121424
|
Table
of
Values
|
A
Table
of
Values
used
to
look
up
a
derived
measurement
|
|
|
121425
|
Index
|
Factor
(divisor
or
multiplicand)
for
normalizing
a
measurement;
e.g.
body
surface
area
used
for
normalizing
hemodynamic
measurements
|
|
|
121427
|
Estimated
|
Measurement
obtained
by
observer
estimation,
rather
than
with
a
measurement
tool
or
by
calculation
|
|
|
121428
|
Calculated
|
Measurement
obtained
by
calculation
|
|
|
121430
|
Concern
|
Identified
issue
about
a
state
or
process
that
has
the
potential
to
require
intervention
or
management
|
|
|
121431
|
DateTime
Concern
Noted
|
DateTime
concern
noted
(noted
by
whom
is
determined
by
context
of
use)
|
|
|
121432
|
DateTime
Concern
Resolved
|
DateTime
the
concern
was
resolved
|
|
|
121433
|
DateTime
Problem
Resolved
|
DateTime
the
problem
was
resolved
|
|
|
121434
|
Service
Delivery
Location
|
Place
at
which
healthcare
services
may
be
provided
|
|
|
121435
|
Service
Performer
|
Identification
of
a
healthcare
provider
who
performed
a
healthcare
service;
may
be
either
a
person
or
an
organization
|
|
|
121436
|
Medical
Device
Used
|
Type
or
identifier
of
a
medical
device
used
on,
in,
or
by
a
patient
|
|
|
121437
|
Pharmacologic
and
exercise
stress
test
|
Cardiac
stress
test
using
pharmacologic
and
exercise
stressors
|
|
|
121438
|
Paced
stress
test
|
Cardiac
stress
test
using
an
implanted
or
external
cardiac
pacing
device
|
|
|
121439
|
Correction
of
congenital
cardiovascular
deformity
|
Procedure
for
correction
of
congenital
cardiovascular
deformity
|
|
|
121701
|
RT
Patient
Setup
|
Process
of
placing
patient
in
the
anticipated
treatment
position,
including
specification
and
location
of
positioning
aids,
and
other
treatment
delivery
accessories
|
|
|
121702
|
RT
Patient
Position
Acquisition,
single
plane
MV
|
Acquisition
of
patient
positioning
information
prior
to
treatment
delivery,
using
single-plane
megavoltage
imaging
|
|
|
121703
|
RT
Patient
Position
Acquisition,
dual
plane
MV
|
Acquisition
of
patient
positioning
information
prior
to
treatment
delivery,
using
dual-plane
megavoltage
imaging
|
|
|
121704
|
RT
Patient
Position
Acquisition,
single
plane
kV
|
Acquisition
of
patient
positioning
information
prior
to
treatment
delivery,
using
single-plane
kilovoltage
imaging
|
|
|
121705
|
RT
Patient
Position
Acquisition,
dual
plane
kV
|
Acquisition
of
patient
positioning
information
prior
to
treatment
delivery,
using
dual-plane
kilovoltage
imaging
|
|
|
121706
|
RT
Patient
Position
Acquisition,
dual
plane
kV/MV
|
Acquisition
of
patient
positioning
information
prior
to
treatment
delivery,
using
dual-plane
combination
kilovoltage
and
megavoltage
imaging
|
|
|
121707
|
RT
Patient
Position
Acquisition,
CT
kV
|
Acquisition
of
patient
positioning
information
prior
to
treatment
delivery,
using
kilovoltage
CT
imaging
|
|
|
121708
|
RT
Patient
Position
Acquisition,
CT
MV
|
Acquisition
of
patient
positioning
information
prior
to
treatment
delivery,
using
megavoltage
CT
imaging
|
|
|
121709
|
RT
Patient
Position
Acquisition,
Optical
|
Acquisition
of
patient
positioning
information
prior
to
treatment
delivery,
using
optical
imaging
|
|
|
121710
|
RT
Patient
Position
Acquisition,
Ultrasound
|
Acquisition
of
patient
positioning
information
prior
to
treatment
delivery,
using
ultrasound
imaging
|
|
|
121711
|
RT
Patient
Position
Acquisition,
Spatial
Fiducials
|
Acquisition
of
patient
positioning
information
prior
to
treatment
delivery,
using
spatial
fiducials
|
|
|
121712
|
RT
Patient
Position
Registration,
single
plane
|
Registration
of
intended
and
actual
patient
position
prior
to
treatment
delivery,
using
single-plane
images
|
|
|
121713
|
RT
Patient
Position
Registration,
dual
plane
|
Registration
of
intended
and
actual
patient
position
prior
to
treatment
delivery,
using
dual-plane
images
|
|
|
121714
|
RT
Patient
Position
Registration,
3D
CT
general
|
Registration
of
intended
and
actual
patient
position
prior
to
treatment
delivery,
using
3D
CT
images
and
an
unspecified
registration
approach
|
|
|
121715
|
RT
Patient
Position
Registration,
3D
CT
marker-based
|
Registration
of
intended
and
actual
patient
position
prior
to
treatment
delivery,
using
3D
CT
images
and
a
marker-based
registration
approach
|
|
|
121716
|
RT
Patient
Position
Registration,
3D
CT
volume-based
|
Registration
of
intended
and
actual
patient
position
prior
to
treatment
delivery,
using
3D
CT
images
and
a
volume-based
registration
approach
|
|
|
121717
|
RT
Patient
Position
Registration,
3D
on
2D
reference
|
Registration
of
intended
and
actual
patient
position
prior
to
treatment
delivery,
using
3D
verification
images
and
2D
reference
images
|
|
|
121718
|
RT
Patient
Position
Registration,
2D
on
3D
reference
|
Registration
of
intended
and
actual
patient
position
prior
to
treatment
delivery,
using
2D
verification
images
and
3D
reference
images
|
|
|
121719
|
RT
Patient
Position
Registration,
Optical
|
Registration
of
intended
and
actual
patient
position
prior
to
treatment
delivery,
using
optical
images
|
|
|
121720
|
RT
Patient
Position
Registration,
Ultrasound
|
Registration
of
intended
and
actual
patient
position
prior
to
treatment
delivery,
using
ultrasound
images
|
|
|
121721
|
RT
Patient
Position
Registration,
Spatial
Fiducials
|
Registration
of
intended
and
actual
patient
position
prior
to
treatment
delivery,
using
spatial
fiducials
|
|
|
121722
|
RT
Patient
Position
Adjustment
|
Adjustment
of
patient
position
such
that
the
patient
is
correctly
positioned
for
treatment
|
|
|
121723
|
RT
Patient
Position
In-treatment-session
Review
|
Review
of
patient
positioning
information
in
the
process
of
delivering
a
treatment
session
|
|
|
121724
|
RT
Treatment
Simulation
with
Internal
Verification
|
Simulated
radiotherapy
treatment
delivery
using
verification
integral
to
the
Treatment
Delivery
System
|
|
|
121725
|
RT
Treatment
Simulation
with
External
Verification
|
Simulated
radiotherapy
treatment
delivery
using
verification
by
a
external
Machine
Parameter
Verifier
|
|
|
121726
|
RT
Treatment
with
Internal
Verification
|
Radiotherapy
treatment
delivery
using
verification
integral
to
the
Treatment
Delivery
System
|
|
|
121727
|
RT
Treatment
with
External
Verification
|
Radiotherapy
treatment
delivery
using
verification
by
an
external
Machine
Parameter
Verifier
|
|
|
121728
|
RT
Treatment
QA
with
Internal
Verification
|
Quality
assurance
of
a
radiotherapy
treatment
delivery
using
verification
integral
to
the
Treatment
Delivery
System
|
|
|
121729
|
RT
Treatment
QA
with
External
Verification
|
Quality
assurance
of
a
radiotherapy
treatment
delivery
using
verification
by
an
external
Machine
Parameter
Verifier
|
|
|
121730
|
RT
Machine
QA
|
Quality
assurance
of
a
Treatment
Delivery
Device
|
|
|
121731
|
RT
Treatment
QA
by
RT
Plan
Dose
Check
|
Perform
Quality
Assurance
on
an
RT
Plan
by
evaluating
dosimetric
content
of
the
current
RT
Plan
|
|
|
121732
|
RT
Treatment
QA
by
RT
Plan
Difference
Check
|
Perform
Quality
Assurance
on
an
RT
Plan
by
comparing
the
content
of
previously
quality-assessed
RT
Plans
with
the
current
RT
Plan
|
|
|
121733
|
RT
Treatment
QA
by
RT
Ion
Plan
Dose
Check
|
Perform
Quality
Assurance
on
an
RT
Ion
Plan
by
evaluating
dosimetric
content
of
the
current
RT
Ion
Plan
|
|
|
121734
|
RT
Treatment
QA
with
RT
Ion
Plan
Difference
Check
|
Perform
Quality
Assurance
on
an
RT
Ion
Plan
by
comparing
the
content
of
previously
quality-assessed
RT
Ion
Plans
with
the
current
RT
Ion
Plan
|
|
|
121740
|
Treatment
Delivery
Type
|
Indicates
whether
the
treatment
to
be
delivered
is
a
complete
fraction
or
a
continuation
of
previous
incompletely
treated
fraction
|
|
|
122001
|
Patient
called
to
procedure
room
|
Patient
called
to
procedure
room
|
|
|
122002
|
Patient
admitted
to
procedure
room
|
Patient
admitted
to
procedure
room
|
|
|
122003
|
Patient
given
pre-procedure
instruction
|
Patient
given
pre-procedure
instruction
|
|
|
122004
|
Patient
informed
consent
given
|
Patient
informed
consent
given
|
|
|
122005
|
Patient
advance
directive
given
|
Patient
advance
directive
given
|
|
|
122006
|
Nil
Per
Os
(NPO)
status
confirmed
|
Nil
Per
Os
(NPO)
status
confirmed
|
|
|
122007
|
Patient
assisted
to
table
|
Patient
assisted
to
table
|
|
|
122008
|
Patient
prepped
and
draped
|
Patient
prepped
and
draped
|
|
|
122009
|
Patient
connected
to
continuous
monitoring
|
Patient
connected
to
continuous
monitoring
|
|
|
122010
|
Patient
transferred
to
holding
area
|
Patient
transferred
to
holding
area
|
|
|
122011
|
Patient
transferred
to
surgery
|
Patient
transferred
to
surgery
|
|
|
122012
|
Patient
transferred
to
CCU
|
Patient
transferred
to
CCU
|
|
|
122020
|
Patient
disoriented
|
Patient
disoriented
|
|
|
122021
|
Patient
reports
nausea
|
Patient
reports
nausea
|
|
|
122022
|
Patient
reports
discomfort
|
Patient
reports
discomfort
|
|
|
122023
|
Patient
reports
chest
pain
|
Patient
reports
chest
pain
|
|
|
122024
|
Patient
reports
no
pain
|
Patient
reports
no
pain
|
|
|
122025
|
Patient
alert
|
Patient
alert
|
|
|
122026
|
Patient
restless
|
Patient
restless
|
|
|
122027
|
Patient
sedated
|
Patient
sedated
|
|
|
122028
|
Patient
asleep
|
Patient
asleep
|
|
|
122029
|
Patient
unresponsive
|
Patient
unresponsive
|
|
|
122030
|
Patient
has
respiratory
difficulty
|
Patient
has
respiratory
difficulty
|
|
|
122031
|
Patient
coughed
|
Patient
coughed
|
|
|
122032
|
Patient
disconnected
from
continuous
monitoring
|
Patient
disconnected
from
continuous
monitoring
|
|
|
122033
|
Hemostasis
achieved
|
Hemostasis
achieved
|
|
|
122034
|
Hemostasis
not
achieved
-
oozing
|
Hemostasis
not
achieved
-
oozing
|
|
|
122035
|
Hemostasis
not
achieved
-
actively
bleeding
|
Hemostasis
not
achieved
-
actively
bleeding
|
|
|
122036
|
Patient
given
post-procedure
instruction
|
Patient
given
post-procedure
instruction
|
|
|
122037
|
Patient
discharged
from
department
|
Patient
discharged
from
department
or
laboratory
|
|
|
122038
|
Patient
pronounced
dead
|
Patient
pronounced
dead
|
|
|
122039
|
Patient
transferred
to
morgue
|
Patient
transferred
to
morgue
|
|
|
122041
|
Personnel
Arrived
|
Identified
personnel
or
staff
arrived
in
procedure
room
|
|
|
122042
|
Personnel
Departed
|
Identified
personnel
or
staff
departed
procedure
room
|
|
|
122043
|
Page
Sent
To
|
Page
sent
to
identified
personnel
or
staff
|
|
|
122044
|
Consultation
With
|
Consultation
with
identified
personnel
or
staff
|
|
|
122045
|
Office
called
|
Office
of
identified
personnel
or
staff
was
called
|
|
|
122046
|
Equipment
failure
|
Equipment
failure
|
|
|
122047
|
Equipment
brought
to
procedure
room
|
Equipment
brought
to
procedure
room
|
|
|
122048
|
Equipment
ready
|
Equipment
ready
for
procedure
|
|
|
122049
|
Equipment
removed
|
Equipment
removed
from
procedure
room
|
|
|
122052
|
Bioptome
|
Device
for
obtaining
biopsy
sample
|
|
|
122053
|
Valvular
Intervention
|
Valvular
Intervention
|
|
|
122054
|
Aortic
Intervention
|
Aortic
Intervention
|
|
|
122055
|
Septal
Defect
Intervention
|
Septal
Defect
Intervention
|
|
|
122056
|
Vascular
Intervention
|
Vascular
Intervention
|
|
|
122057
|
Myocardial
biopsy
|
Myocardial
biopsy
|
|
|
122058
|
Arterial
conduit
angiography
|
Arterial
conduit
angiography
|
|
|
122059
|
Single
plane
Angiography
|
Single
plane
Angiography
|
|
|
122060
|
Bi-plane
Angiography
|
Bi-plane
Angiography
|
|
|
122061
|
Percutaneous
Coronary
Intervention
|
Percutaneous
Coronary
Intervention
|
|
|
122062
|
15-Lead
ECG
|
15-Lead
electrocardiography
|
|
|
122072
|
Pre-procedure
log
|
Log
of
events
occurring
prior
to
the
current
procedure
|
|
|
122073
|
Current
procedure
evidence
|
Analysis
or
measurements
for
current
procedure
(purpose
of
reference
to
evidence
document)
|
|
|
122075
|
Prior
report
for
current
patient
|
Prior
report
for
current
patient
|
|
|
122076
|
Consumable
taken
from
inventory
|
Identifier
of
Consumable
taken
from
inventory
|
|
|
122077
|
Consumable
returned
to
inventory
|
Identifier
of
Consumable
returned
to
inventory
|
|
|
122078
|
Remaining
consumable
disposed
|
Identifier
of
consumable
whose
remaining
content
has
been
disposed
|
|
|
122079
|
Consumable
unusable
|
Identifier
of
Consumable
determined
to
be
unusable
|
|
|
122081
|
Drug
start
|
Identifier
of
Drug
whose
administration
has
started
|
|
|
122082
|
Drug
end
|
Identifier
of
Drug
whose
administration
has
ended
|
|
|
122083
|
Drug
administered
|
Identifier
of
Drug
administered
as
part
of
procedure
|
|
|
122084
|
Contrast
start
|
Identifier
of
Contrast
agent
whose
administration
has
started
|
|
|
122085
|
Contrast
end
|
Identifier
of
Contrast
agent
whose
administration
has
ended
|
|
|
122086
|
Contrast
administered
|
Identifier
of
Contrast
agent
administered
|
|
|
122087
|
Infusate
start
|
Identifier
of
Infusate
whose
administration
has
started
|
|
|
122088
|
Infusate
end
|
Identifier
of
Infusate
whose
administration
has
ended
|
|
|
122089
|
Device
crossed
lesion
|
Action
of
a
device
traversing
a
vascular
lesion
|
|
|
122090
|
Intervention
Action
|
Action
of
a
clinical
professional
performed
on
a
patient
for
therapeutic
purpose
|
|
|
122091
|
Volume
administered
|
Volume
of
Drug,
Contrast
agent,
or
Infusate
administered
|
|
|
122092
|
Undiluted
dose
administered
|
Undiluted
dose
of
Drug,
Contrast
agent,
or
Infusate
administered
|
|
|
122093
|
Concentration
|
Concentration
of
Drug,
Contrast
agent,
or
Infusate
administered
|
|
|
122094
|
Rate
of
administration
|
Rate
of
Drug,
Contrast
agent,
or
Infusate
administration
|
|
|
122095
|
Duration
of
administration
|
Duration
of
Drug,
Contrast
agent,
or
Infusate
administration
|
|
|
122096
|
Volume
unadministered
or
discarded
|
Volume
of
Drug,
Contrast
agent,
or
Infusate
unadministered
or
discarded
|
|
|
122097
|
Catheter
Curve
|
Numeric
parameter
of
Curvature
of
Catheter
|
|
|
122098
|
Transmit
Frequency
|
Transmit
Frequency
|
|
|
122099
|
ST
change
from
baseline
|
Measured
change
of
patient
electrocardiographic
ST
level
relative
to
baseline
measurement
|
|
|
122101
|
Aneurysm
on
cited
vessel
|
Anatomic
term
modifier
indicating
aneurysm
on
cited
vessel
is
the
subject
of
the
finding
|
|
|
122102
|
Graft
to
cited
segment,
proximal
section
|
Anatomic
term
modifier
indicating
proximal
section
of
graft
to
cited
vessel
is
the
subject
of
the
finding
|
|
|
122103
|
Graft
to
cited
segment,
mid
section
|
Anatomic
term
modifier
indicating
mid
section
of
graft
to
cited
vessel
is
the
subject
of
the
finding
|
|
|
122104
|
Graft
to
cited
segment,
distal
section
|
Anatomic
term
modifier
indicating
distal
section
of
graft
to
cited
vessel
is
the
subject
of
the
finding
|
|
|
122105
|
DateTime
of
Intervention
|
DateTime
of
Intervention
|
|
|
122106
|
Duration
of
Intervention
|
Duration
of
Intervention
|
|
|
122107
|
Baseline
Stenosis
Measurement
|
Lesion
stenosis
measured
prior
to
any
interventional
procedure
|
|
|
122108
|
Post-Intervention
Stenosis
Measurement
|
Lesion
stenosis
measured
after
an
interventional
procedure
|
|
|
122109
|
Baseline
TIMI
Flow
|
Assessment
of
perfusion
across
a
coronary
lesion
measured
prior
to
any
interventional
procedure
|
|
|
122110
|
Post-Intervention
TIMI
Flow
|
Assessment
of
perfusion
across
a
coronary
lesion
measured
after
an
interventional
procedure
|
|
|
122111
|
Primary
Intervention
Device
|
Indication
that
device
is
the
primary
(first
and/or
most
significant)
device
used
for
interventional
therapy
of
a
particular
pathology;
e.g.
lesion
|
|
|
122112
|
Normal
Myocardium
|
Normal
Myocardium
|
|
|
122113
|
Sacrred
Myocardial
|
Sacrred
Myocardial
|
|
|
122114
|
Thinning
Myocardium
|
Thinning
Myocardium
|
|
|
122120
|
Hemodynamics
Report
|
Hemodynamics
Report
|
|
|
122121
|
Atrial
pressure
measurements
|
Atrial
pressure
measurements,
report
section
|
|
|
122122
|
Ventricular
pressure
measurements
|
Ventricular
pressure
measurements,
report
section
|
|
|
122123
|
Gradient
assessment
|
Gradient
assessment,
report
section
|
|
|
122124
|
Blood
velocity
measurements
|
Blood
velocity
measurements,
report
section
|
|
|
122125
|
Blood
lab
measurements
|
Blood
lab
measurements,
report
section
|
|
|
122126
|
Derived
Hemodynamic
Measurements
|
Derived
Hemodynamic
Measurements,
report
section
|
|
|
122127
|
Clinical
Context
|
Clinical
Context,
report
section
|
|
|
122128
|
Patient
Transferred
From
|
Location
from
which
the
patient
was
transferred
|
|
|
122129
|
PCI
during
this
procedure
|
Indication
that
the
procedure
includes
a
percutaneous
coronary
intervention
|
|
|
122130
|
Dose
Area
Product
|
Radiation
dose
times
area
of
exposure
|
|
|
122131
|
Degree
of
Thrombus
|
Finding
of
probability
and/or
severity
of
thrombus
|
|
|
122132
|
Severity
of
Calcification
|
Severity
of
Calcification,
property
of
lesion
|
|
|
122133
|
Lesion
Morphology
|
Lesion
Morphology;
form
and/or
structural
properties
of
lesion
|
|
|
122134
|
Vessel
Morphology
|
Vessel
Morphology;
form
and/or
structural
properties
of
vessel
|
|
|
122138
|
Circulatory
Support
|
Technique
(device
or
procedure)
of
support
for
patient
circulatory
system;
hemodynamic
support
|
|
|
122139
|
Reason
for
Exam
|
Reason
for
Exam
|
|
|
122140
|
Comparison
with
Prior
Exam
Done
|
Indication
that
the
current
exam
data
has
been
compared
with
prior
exam
data
|
|
|
122141
|
Electrode
Placement
|
Electrocardiographic
electrode
placement
technique
|
|
|
122142
|
Acquisition
Device
Type
|
Acquisition
Device
Type
|
|
|
122143
|
Acquisition
Device
ID
|
Acquisition
Device
ID
|
|
|
122144
|
Quantitative
Analysis
|
Quantitative
Analysis,
report
section
|
|
|
122145
|
Qualitative
Analysis
|
Qualitative
Analysis,
report
section
|
|
|
122146
|
Procedure
DateTime
|
The
date
and
time
on
which
a
procedure
was
performed
on
a
patient
|
|
|
122147
|
Clinical
Interpretation
|
Clinical
Interpretation,
report
section
|
|
|
122148
|
Lead
ID
|
ECG
Lead
Identifier
|
|
|
122149
|
Beat
Number
|
Beat
Number;
ordinal
of
cardiac
cycle
within
an
acquisition
|
|
|
122150
|
Compound
Statement
|
Complex
coded
semantic
unit,
consisting
of
several
coded
components
|
|
|
122151
|
Trend
|
Trend
(temporal
progression)
of
a
clinical
condition,
finding,
or
disease
|
|
|
122152
|
Statement
|
Coded
semantic
unit
|
|
|
122153
|
Statement
Modifier
|
Coded
modifier
for
a
semantic
unit
|
|
|
122154
|
Conjunctive
Term
|
Conjunctive
term
between
semantic
units
|
|
|
122157
|
Probability
|
Probability
|
|
|
122158
|
ECG
Global
Measurements
|
ECG
Global
Measurements,
report
section
|
|
|
122159
|
ECG
Lead
Measurements
|
ECG
Lead
Measurements,
report
section
|
|
|
122160
|
Derived
Area,
Non-Valve
|
Derived
cross-sectional
area
of
a
vessel
or
anatomic
feature,
other
than
a
cardiac
valve
|
|
|
122161
|
Pulmonary
Flow
|
Rate
of
blood
flow
through
Pulmonary
artery
|
|
|
122162
|
Systemic
Flow
|
Rate
of
blood
flow
through
the
aorta
|
|
|
122163
|
Discharge
DateTime
|
DateTime
of
patient
discharge
from
hospital
admission
|
|
|
122164
|
Coronary
Artery
Bypass
During
This
Admission
|
Indication
that
a
Coronary
Artery
Bypass
operation
was
performed
during
the
current
hospital
admission
|
|
|
122165
|
Date
of
Death
|
Date
of
Death
|
|
|
122166
|
Death
During
This
Admission
|
Indication
that
the
patient
died
during
the
current
hospital
admission
|
|
|
122167
|
Death
During
Catheterization
|
Indication
that
the
patient
died
during
the
current
Catheterization
procedure
|
|
|
122170
|
Type
of
Myocardial
Infarction
|
Finding
of
type
of
Myocardial
Infarction
|
|
|
122171
|
Coronary
lesion
>
=
50%
stenosis
|
Finding
of
Coronary
lesion
with
greater
than
50%
stenosis
|
|
|
122172
|
Acute
MI
Present
|
Finding
of
Acute
Myocardial
Infarction
Presence
as
indication
for
interventional
procedure
|
|
|
122173
|
ST
Elevation
Onset
DateTime
|
DateTime
of
first
determination
of
elevated
ECG
ST
segment,
as
indication
of
Myocardial
Infarction
|
|
|
122175
|
Number
of
lesion
interventions
attempted
|
Number
of
lesion
interventions
attempted
during
current
procedure
|
|
|
122176
|
Number
of
lesion
interventions
successful
|
Number
of
lesion
interventions
successful
during
current
procedure,
where
the
residual
post
intervention
stenosis
is
less
than
or
equal
to
50%
of
the
arterial
luminal
diameter,
TIMI
Flow
is
3
and
the
minimal
decrease
in
stenosis
was
20%
|
|
|
122177
|
Procedure
Result
|
Overall
success
of
interventional
procedure
|
|
|
122178
|
Lesion
Intervention
Information
|
Lesion
Intervention
Information,
report
section
|
|
|
122179
|
Peri-procedural
MI
occurred
|
Indication
that
Myocardial
Infarction
occurred
during
current
procedure
|
|
|
122180
|
CK-MB
baseline
|
Creatine
Kinase-MB
value
at
baseline
(start
of
procedure)
|
|
|
122181
|
CK-MB
peak
|
Creatine
Kinase-MB
highest
value
measured
during
procedure
|
|
|
122182
|
R-R
interval
|
Time
interval
between
ECG
R-wave
peaks
in
subsequent
cardiac
cycles
|
|
|
122183
|
Blood
temperature
|
Blood
temperature
|
|
|
122185
|
Blood
Oxygen
content
|
Blood
Oxygen
content
|
|
|
122187
|
Blood
Carbon
dioxide
saturation
|
Blood
Carbon
dioxide
saturation
|
|
|
122188
|
Pulmonary
Arterial
Content
(FCpa)
|
Pulmonary
Arterial
Content
(FCpa)
|
|
|
122189
|
Pulmonary
Venous
Content
(FCpv)
|
Pulmonary
Venous
Content
(FCpv)
|
|
|
122190
|
Max
dp/dt/P
|
Max
dp/dt/P
|
|
|
122191
|
Ventricular
End
Diastolic
pressure
|
Ventricular
End
Diastolic
pressure
|
|
|
122192
|
Indicator
appearance
time
|
Elapsed
time
from
injection
of
an
indicator
bolus
until
it
is
observed
at
another
location
|
|
|
122193
|
Maximum
pressure
acceleration
|
Maximum
pressure
acceleration
|
|
|
122194
|
Ventricular
Systolic
blood
pressure
|
Ventricular
Systolic
blood
pressure
|
|
|
122195
|
Pulse
Strength
|
Pulse
Strength;
palpable
strength
of
systolic
flow
|
|
|
122196
|
C
wave
pressure
|
The
secondary
peak
pressure
in
the
atrium
during
atrial
contraction
|
|
|
122197
|
Gradient
pressure,
average
|
Gradient
pressure,
average
|
|
|
122198
|
Gradient
pressure,
peak
|
Gradient
pressure,
peak
|
|
|
122199
|
Pressure
at
dp/dt
max
|
Pressure
at
dp/dt
max
|
|
|
122201
|
Diastolic
blood
velocity,
mean
|
Diastolic
blood
velocity,
mean
|
|
|
122202
|
Diastolic
blood
velocity,
peak
|
Diastolic
blood
velocity,
peak
|
|
|
122203
|
Systolic
blood
velocity,
mean
|
Systolic
blood
velocity,
mean
|
|
|
122204
|
Systolic
blood
velocity,
peak
|
Systolic
blood
velocity,
peak
|
|
|
122205
|
Blood
velocity,
mean
|
Blood
velocity,
mean
|
|
|
122206
|
Blood
velocity,
minimum
|
Blood
velocity,
minimum
|
|
|
122207
|
Blood
velocity,
peak
|
Blood
velocity,
peak
|
|
|
122208
|
x-descent
pressure
|
Venous
or
atrial
pressure
minimum
during
ventricular
systole,
after
A-wave
|
|
|
122209
|
y-descent
pressure
|
Venous
or
atrial
pressure
minimum
when
tricuspid
valve
opens
during
diastole,
after
V-wave
|
|
|
122210
|
z-point
pressure
|
Atrial
pressure
upon
closure
of
tricuspid
and
mitral
valves
|
|
|
122211
|
Left
Ventricular
ejection
time
|
Left
Ventricular
ejection
time
|
|
|
122212
|
Left
Ventricular
filling
time
|
Left
Ventricular
filling
time
|
|
|
122213
|
Right
Ventricular
ejection
time
|
Right
Ventricular
ejection
time
|
|
|
122214
|
Right
Ventricular
filling
time
|
Right
Ventricular
filling
time
|
|
|
122215
|
Total
Pulmonary
Resistance
|
Total
Pulmonary
Resistance
|
|
|
122216
|
Total
Vascular
Resistance
|
Total
Vascular
Resistance
|
|
|
122217
|
Coronary
Flow
reserve
|
Coronary
Flow
reserve
|
|
|
122218
|
Diastolic/Systolic
velocity
ratio
|
Diastolic/Systolic
velocity
ratio
|
|
|
122219
|
Hyperemic
ratio
|
Hyperemic
ratio
|
|
|
122220
|
Hemodynamic
Resistance
Index
|
Hemodynamic
Resistance
Index
|
|
|
122221
|
Thorax
diameter,
sagittal
|
Thorax
diameter,
sagittal
|
|
|
122222
|
Procedure
Environmental
Characteristics
|
Environmental
characteristics
in
the
procedure
room
|
|
|
122223
|
Room
oxygen
concentration
|
Oxygen
concentration
in
the
procedure
room
|
|
|
122224
|
Room
temperature
|
Temperature
in
the
procedure
room
|
|
|
122225
|
Room
Barometric
pressure
|
Barometric
pressure
in
the
procedure
room
|
|
|
122227
|
Left
to
Right
Flow
|
Left
to
Right
Flow
|
|
|
122228
|
Right
to
Left
Flow
|
Right
to
Left
Flow
|
|
|
122229
|
Arteriovenous
difference
|
Arteriovenous
oxygen
content
difference
|
|
|
122230
|
10
Year
CHD
Risk
|
Framingham
Study
10
Year
CHD
Risk
|
|
|
122231
|
Comparative
Average10
Year
CHD
Risk
|
Framingham
Study
Comparative
Average10
Year
CHD
Risk
|
|
|
122232
|
Comparative
Low10
Year
CHD
Risk
|
Framingham
Study
Comparative
Low10
Year
CHD
Risk
|
|
|
122233
|
LDL
Cholesterol
Score
Sheet
for
Men
|
Framingham
Study
LDL
Cholesterol
Score
Sheet
for
Men
|
|
|
122234
|
LDL
Cholesterol
Score
Sheet
for
Women
|
Framingham
Study
LDL
Cholesterol
Score
Sheet
for
Women
|
|
|
122235
|
Total
Cholesterol
Score
Sheet
for
Men
|
Framingham
Study
Total
Cholesterol
Score
Sheet
for
Men
|
|
|
122236
|
Total
Cholesterol
Score
Sheet
for
Women
|
Framingham
Study
Total
Cholesterol
Score
Sheet
for
Women
|
|
|
122237
|
Corrected
Sinus
Node
Recovery
Time
|
Corrected
Sinus
Node
Recovery
Time
|
|
|
122238
|
Max
volume
normalized
to
50mmHg
pulse
pressure
|
Max
volume
normalized
to
50mmHg
pulse
pressure
|
|
|
122239
|
Oxygen
Consumption
|
Oxygen
Consumption
|
|
|
122240
|
BSA
=
3.207*WT^(0.7285-0.0188
log
(WT))
*HT^0.3
|
Body
Surface
Area
computed
from
patient
height
and
weight:
BSA
=
3.207*WT[g]^(0.7285-0.0188
log
(WT[g]))
*HT[cm]
^
0.3
[Boyd
E,
The
growth
of
the
surface
area
of
the
human
body.
Minneapolis:
University
of
Minnesota
Press,
1935,
eq.
(36)
]
|
|
|
122241
|
BSA
=
0.007184*WT^
0.425*HT^0.725
|
Body
Surface
Area
computed
from
patient
height
and
weight:
BSA
=
0.007184*
WT[kg]
^
0.425*HT[cm]
^
0.725
[Dubois
and
Dubois,
Arch
Int
Med
1916
17:863-71]
|
|
|
122242
|
BSA
=
0.0235*WT^0.51456*HT^
0.42246
|
Body
Surface
Area
computed
from
patient
height
and
weight:
BSA
=
0.0235*
WT[kg]
^0.51456*HT[cm]^
0.42246
[Gehan
EA,
George
SL,
'Estimation
of
human
body
surface
area
from
height
and
weight',
Cancer
Chemother
Rep
1970
54:225-35]
|
|
|
122243
|
BSA
=
0.024265*WT^0.5378*HT^0.3964
|
Body
Surface
Area
computed
from
patient
height
and
weight:
BSA
=
0.024265
*
WT[kg]
^
0.5378
*
HT[cm]
^
0.3964
[Haycock
G.B.,
Schwartz
G.J.,
Wisotsky
D.H.
'Geometric
method
for
measuring
body
surface
area:
A
height
weight
formula
validated
in
infants,
children
and
adults.'
The
Journal
of
Pediatrics
1978
93:1:62-66]
|
|
|
122244
|
BSA
=
(HT
*
WT/36)
^0.5
|
Body
Surface
Area
computed
from
patient
height
and
weight:
BSA
=
(HT[m]
*
WT[kg]
/
36)
^
0.5
[Mosteller,
R.D.
'Simplified
Calculation
of
Body
Surface
Area.'
N
Engl
J
Med
1987
Oct
22;317(17):1098]
|
|
|
122245
|
BSA
=
1321+0.3433*WT
|
Body
Surface
Area
computed
from
patient
weight:BSA
=
1321
+
0.3433
*
WT[kg]
(for
pediatrics
3-30
kg)
[Current,
J.D.
'A
Linear
Equation
For
Estimating
The
Body
Surface
Area
In
Infants
And
Children',
The
Internet
Journal
of
Anesthesiology.
1998.
2:2]
|
|
|
122246
|
BSA
=
0.0004688
*
WT
^
(0.8168
-
0.0154
*
log(WT))
|
BSA
=
0.0004688
*
(1000
*
WT)
^
(0.8168
-
0.0154
*
log(1000
*
WT))
Where
(WT
is
weight
in
kilogram)
Units
=
m2
Boyd,
Edith.
The
Growth
of
the
Surface
Area
of
the
Human
Body(originally
published
in
1935
by
the
University
of
Minnesota
Press),
Greenwood
Press,
Westport,
Connecticut,
1975,
p.
102.Equation
(35)
|
|
|
122247
|
VO2male
=
BSA
(138.1
-
11.49
*
loge(age)
+
0.378
*
HRf)
|
Equation
for
estimated
oxygen
consumption:
VO2male
=
BSA
(138.1
-
11.49
*
loge(age)
+
0.378
*
HRf)
|
|
|
122248
|
VO2female
=
BSA
(138.1
-
17.04
*
loge(age)
+
0.378
*
HRf)
|
Equation
for
estimated
oxygen
consumption:
VO2female
=
BSA
(138.1
-
17.04
*
loge(age)
+
0.378
*
HRf)
|
|
|
122249
|
VO2
=
VeSTPD
*
10
*
(FIO2
-
FE02)
|
Equation
for
estimated
oxygen
consumption:
VO2
=
VeSTPD
*
10
*
(FIO2
-
FE02)
|
|
|
122250
|
VO2
=
152
*
BSA
|
Equation
for
estimated
oxygen
consumption:
VO2
=
152
*
BSA
|
|
|
122251
|
VO2
=
175
*
BSA
|
Equation
for
estimated
oxygen
consumption:
VO2
=
175
*
BSA
|
|
|
122252
|
VO2
=
176
*
BSA
|
Equation
for
estimated
oxygen
consumption:
VO2
=
176
*
BSA
|
|
|
122253
|
Robertson
&
Reid
table
|
Robertson
&
Reid
Table
for
estimated
oxygen
consumption
|
|
|
122254
|
Fleisch
table
|
Fleisch
table
for
estimated
oxygen
consumption
|
|
|
122255
|
Boothby
table
|
Boothby
table
for
estimated
oxygen
consumption
|
|
|
122256
|
if
(prem
age<
3days)
P50
=
19.9
|
Estimate
of
Oxygen
partial
pressure
at
50%
saturation
for
premature
infants
less
than
3
days
old:
P50
=
19.9
|
|
|
122257
|
if
(age
<
1day)
P50
=
21.6
|
Estimate
of
Oxygen
partial
pressure
at
50%
saturation
for
infants
less
than
1
day
old:
P50
=
21.6
|
|
|
122258
|
if
(age
<
30day)
P50
=
24.6
|
Estimate
of
Oxygen
partial
pressure
at
50%
saturation
for
infants
less
than
30
days
old:
P50
=
24.6
|
|
|
122259
|
if
(age
<
18y)
P50
=
27.2
|
Estimate
of
Oxygen
partial
pressure
at
50%
saturation
for
patients
less
than
18
years
old:
P50
=
27.2
|
|
|
122260
|
if
(age
<
40y)
P50
=
27.4
|
Estimate
of
Oxygen
partial
pressure
at
50%
saturation
for
patients
less
than
40
years
old:
P50
=
27.4
|
|
|
122261
|
if
(age
>
60y)
P50
=
29.3
|
Estimate
of
Oxygen
partial
pressure
at
50%
saturation
for
patients
more
than
60
years
old:
P50
=
29.3
|
|
|
122262
|
Area
=
Flow
/
44.5
*
sqrt(Gradient[mmHg])
|
Cardiac
valve
area
computed
from
flow
and
pressure
gradient:
Area
=
Flow
/
44.5
*
sqrt(Gradient[mmHg])
[Gorlin
and
Gorlin,
Am
Heart
J,
1951]
|
|
|
122263
|
MVA
=
Flow
/
38.0
*
sqrt(Gradient[mmHg])
|
Mitral
valve
area
computed
from
flow
and
pressure
gradient:
Mitral
valve
Area
=
Flow
/
38.0
*
sqrt(Gradient[mmHg])
[Gorlin
and
Gorlin,
Am
Heart
J,
1951]
|
|
|
122265
|
BMI
=
Wt
/
Ht
^
2
|
Body
Mass
Index
computed
from
weight
and
height:
BMI
=
Wt/Ht^2
|
|
|
122266
|
BSA
=
0.007358
*
WT
^
0.425
*
HT
^
0.725
|
Body
Surface
Area
computed
from
patient
height
and
weight:
BSA
=
0.007358
*
WT[kg]
^
0.425
*
HT[cm]
^
0.725
(for
East
Asian
adult,
aged
15+
years)
[Kanai
Izumi,
Masamitsu
Kanai,
'Clinical
examination
method
summary']
|
|
|
122267
|
BSA
=
0.010265
*
WT
^
0.423
*
HT
^
0.651
|
Body
Surface
Area
computed
from
patient
height
and
weight:
BSA
=
0.010265
*
WT[kg]
^
0.423
*
HT[cm]
^
0.651
(For
East
Asian
child
aged
12-14
years)
|
|
|
122268
|
BSA
=
0.008883
*
WT
^
0.444
*
HT
^
0.663
|
Body
Surface
Area
computed
from
patient
height
and
weight:
BSA
=
0.008883*
WT[kg]
^
0.444
*
HT[cm]
^
0.663
(For
East
Asian
child
aged
6-11
years)
|
|
|
122269
|
BSA
=
0.038189
*
WT
^
0.423
*
HT
^
0.362
|
Body
Surface
Area
computed
from
patient
height
and
weight:
BSA
=
0.038189
*
WT[kg]
^
0.423
*
HT[cm]
^
0.362
(For
East
Asian
child
aged
1-5
years)
|
|
|
122270
|
BSA
=
0.009568
*
WT
^
0.473
*
HT
^
0.655
|
Body
Surface
Area
computed
from
patient
height
and
weight:
BSA
=
0.009568*
WT[kg]
^
0.473
*
HT[cm]
^
0.655
(For
East
Asian
child
aged
0-12
months)
|
|
|
122271
|
Skin
Condition
Warm
|
Skin
Condition
Warm
|
|
|
122272
|
Skin
Condition
Cool
|
Skin
Condition
Cool
|
|
|
122273
|
Skin
Condition
Cold
|
Skin
Condition
Cold
|
|
|
122274
|
Skin
Condition
Dry
|
Skin
Condition
Dry
|
|
|
122275
|
Skin
Condition
Clammy
|
Skin
Condition
Clammy
|
|
|
122276
|
Skin
Condition
Diaphoretic
|
Skin
Condition
Diaphoretic
|
|
|
122277
|
Skin
Condition
Flush
|
Skin
Condition
Flush
|
|
|
122278
|
Skin
Condition
Mottled
|
Skin
Condition
Mottled
|
|
|
122279
|
Skin
Condition
Pale
|
Skin
Condition
Pale
|
|
|
122281
|
Airway
unobstructed
|
Airway
unobstructed
|
|
|
122282
|
Airway
partially
obstructed
|
Airway
partially
obstructed
|
|
|
122283
|
Airway
severely
obstructed
|
Airway
severely
obstructed
|
|
|
122288
|
Not
Visualized
|
Anatomy
could
not
be
visualized
for
the
purpose
of
evaluation
|
|
|
122291
|
Quantitative
Arteriography
Report
|
Quantitative
Arteriography
Report
|
|
|
122292
|
Quantitative
Ventriculography
Report
|
Quantitative
Ventriculography
Report
|
|
|
122301
|
Guidewire
crossing
lesion
unsuccessful
|
Guidewire
crossing
lesion
unsuccessful
|
|
|
122302
|
Guidewire
crossing
lesion
successful
|
Guidewire
crossing
lesion
successful
|
|
|
122303
|
Angioplasty
balloon
inflated
|
Angioplasty
balloon
inflated
|
|
|
122304
|
Angioplasty
balloon
deflated
|
Angioplasty
balloon
deflated
|
|
|
122305
|
Device
deployed
|
Device
deployed
|
|
|
122306
|
Stent
re-expanded
|
Stent
re-expanded
|
|
|
122307
|
Object
removed
|
Object
removed
|
|
|
122308
|
Radiation
applied
|
Radiation
applied
|
|
|
122309
|
Radiation
removed
|
Radiation
removed
|
|
|
122310
|
Interventional
device
placement
unsuccessful
|
Interventional
device
placement
unsuccessful
|
|
|
122311
|
Interventional
device
placed
|
Interventional
device
placed
|
|
|
122312
|
Intervention
performed
|
Intervention
performed
|
|
|
122313
|
Interventional
device
withdrawn
|
Interventional
device
withdrawn
|
|
|
122319
|
Catheter
Size
|
Catheter
Size
|
|
|
122320
|
Injectate
Temperature
|
Injectate
Temperature
|
|
|
122321
|
Injectate
Volume
|
Injectate
Volume
|
|
|
122322
|
Calibration
Factor
|
Factor
by
which
a
measured
or
calculated
value
is
multiplied
to
obtain
the
estimated
real-world
value
|
|
|
122325
|
IVUS
Report
|
Intravascular
Ultrasound
Report
|
|
|
122330
|
EEM
Diameter
|
External
Elastic
Membrane
(EEM)
diameter
measured
through
the
center
point
of
the
vessel.
Center
point
of
the
vessel
is
defined
as
the
center
of
gravity
of
the
EEM
area.
The
EEM
is
a
discrete
interface
at
the
border
between
the
media
and
the
adventitia
|
|
|
122331
|
Plaque
Plus
Media
Thickness
|
The
distance
from
intimal
leading
edge
to
the
external
elastic
membrane
along
any
line
passing
through
the
luminal
center,
which
is
defined
as
the
center
of
gravity
of
the
lumen
area
|
|
|
122332
|
Lumen
Perimeter
|
Planimetered
perimeter
of
the
lumen
|
|
|
122333
|
EEM
Cross-Sectional
Area
|
Vessel
area
measured
at
the
External
Elastic
Membrane
(EEM),
a
discrete
interface
at
the
border
between
the
media
and
the
adventitia
|
|
|
122334
|
Plaque
plus
Media
Cross-Sectional
Area
|
Area
within
the
EEM
occupied
by
atheroma,
regardless
of
lumen
compromise.
Plaque
plus
Media
Area
=
EEM
cross-sectional
area
-
vessel
lumen
cross-sectional
area
|
|
|
122335
|
In-Stent
Neointimal
Cross-Sectional
Area
|
Measurement
of
in-stent
restenosis.
In-Stent
Intimal
Area
=
Stent
cross-sectional
area
-
vessel
lumen
cross-sectional
area
|
|
|
122336
|
Vascular
Volume
measurement
length
|
Longitudinal
extent
of
the
Vascular
Volume
Measurement.
This
is
the
distance
from
the
distal
edge
to
the
proximal
edge
of
the
Volume
measurement
|
|
|
122337
|
Relative
position
|
Longitudinal
distance
from
the
closest
edge
of
a
fiducial
feature
or
reference
location
to
the
start
of
the
vascular
measurement.
This
value
will
be
a
positive
if
the
measurement
is
distal
to
the
fiducial
feature
or
reference
location,
or
negative
if
the
measurement
is
proximal
to
the
fiducial
feature
or
reference
location
|
|
|
122339
|
Stent
Volume
Obstruction
|
In-Stent
Neointimal
Volume
/
Stent
Volume
|
|
|
122340
|
Fiducial
feature
|
Reference,
normally
anatomical,
which
is
used
for
locating
the
position
of
a
measurement
|
|
|
122341
|
Calcium
Length
|
Longitudinal
calcium
length
measurement
|
|
|
122343
|
Lumen
Eccentricity
Index
|
Measurement
of
vessel
lumen
eccentricity.
Lumen
Eccentricity
Index
=
(maximum
vessel
lumen
diameter
-
minimum
vessel
lumen
diameter)
/
maximum
vessel
lumen
diameter.
Lumen
diameters
are
measured
through
the
center
point
of
the
lumen,
which
is
defined
as
the
center
of
gravity
of
the
lumen
area
|
|
|
122344
|
Plaque
plus
Media
Eccentricity
Index
|
Plaque
plus
Media
Eccentricity
Index
=
(maximum
Plaque
plus
media
thickness
-
minimum
Plaque
plus
media
thickness)
/
maximum
Plaque
plus
media
thickness
|
|
|
122345
|
Remodeling
Index
|
Measurement
of
increase
or
decrease
in
EEM
area
that
occurs
during
the
development
of
atherosclerosis.
Remodeling
Index
=
Lesion
EEM
area
/
reference
EEM
area
|
|
|
122346
|
Stent
Symmetry
Index
|
Measurement
of
stent
circularity.
Stent
Symmetry
Index
=
(maximum
stent
diameter
-
minimum
stent
diameter)
/
maximum
stent
diameter
|
|
|
122347
|
Stent
Expansion
Index
|
Measurement
of
stent
area
relative
to
the
reference
lumen
area.
Stent
Expansion
Index
=
Minimum
stent
area
/
reference
vessel
lumen
cross-sectional
area
|
|
|
122348
|
Lumen
Shape
Index
|
Measurement
of
vessel
lumen
eccentricity.
Lumen
Shape
Index
=
(2p
*
sqrt(Vessel
lumen
cross-sectional
area
/
p)
/
Lumen
Perimeter)
2
Reference:
Tobis
&
Yock,
"Intravascular
Ultrasound
Imaging",
Chapter
7
|
|
|
122350
|
Lumen
Diameter
Ratio
|
Lumen
diameter
ratio
=
minimum
vessel
lumen
diameter
/
maximum
vessel
lumen
diameter,
measured
at
the
same
cross
section
in
the
vessel.
Lumen
diameters
are
measured
through
the
center
point
of
the
lumen,
which
is
defined
as
the
center
of
gravity
of
the
lumen
area
|
|
|
122351
|
Stent
Diameter
Ratio
|
Stent
diameter
ratio
=
Minimum
stent
diameter
/
Maximum
stent
diameter,
measured
at
the
same
cross
section
in
the
vessel.
Stent
diameters
are
measured
through
the
center
point
of
the
stent,
which
is
defined
as
the
center
of
gravity
of
the
stent
area
|
|
|
122352
|
EEM
Diameter
Ratio
|
EEM
diameter
ratio
=
minimum
EEM
diameter
/
maximum
EEM
diameter.
Measured
at
the
same
cross
section
in
the
vessel
|
|
|
122354
|
Plaque
Burden
|
Fractional
area
within
the
External
Elastic
Membrane
(EEM)
occupied
by
atheroma.
Plaque
Burden
=
(EEM
area
-
vessel
lumen
cross-sectional
area)
/
EEM
area
|
|
|
122355
|
Arc
of
Calcium
|
Angular
measurement
of
a
Calcium
deposit
with
the
apex
located
at
the
center
of
the
lumen,
which
is
defined
as
the
center
of
gravity
of
the
lumen
area
|
|
|
122356
|
Soft
plaque
|
Plaque
characterized
by
low
density
or
echogenicity
|
|
|
122357
|
In-Stent
Neointima
|
Abnormal
thickening
of
the
intima
within
the
stented
segment
|
|
|
122360
|
True
Lumen
|
Lumen
surrounded
by
all
three
layers
of
the
vessel-intima,
media,
and
adventitia
|
|
|
122361
|
False
Lumen
|
A
channel,
usually
parallel
to
the
true
lumen,
which
does
not
communicate
with
the
true
lumen
over
a
portion
of
its
length
|
|
|
122363
|
Plaque
Rupture
|
Plaque
ulceration
with
a
tear
detected
in
a
fibrous
cap
|
|
|
122364
|
Stent
Gap
|
Length
of
gap
between
two
consecutive
stents
|
|
|
122367
|
T-1
Worst
|
Worst
stenosis
-
the
stenosis
with
the
smallest
lumen
size
within
a
vessel
segment
|
|
|
122368
|
T-2
Secondary
|
2nd
most
severe
stenosis
within
a
vessel
segment
|
|
|
122369
|
T-3
Secondary
|
3rd
most
severe
stenosis
within
a
vessel
segment
|
|
|
122370
|
T-4
Secondary
|
4th
most
severe
stenosis
within
a
vessel
segment
|
|
|
122371
|
EEM
Volume
|
External
Elastic
Membrane
(EEM)
volume
measured
within
a
specified
region.
The
EEM
is
a
discrete
interface
at
the
border
between
the
media
and
the
Adventitia
|
|
|
122372
|
Lumen
Volume
|
Lumen
volume
measured
within
a
specified
region
|
|
|
122374
|
In-Stent
Neointimal
Volume
|
The
amount
of
plaque
between
the
lumen
and
stent,
within
the
stent
region;
In-stent
restenosis.
In-Stent
Neointimal
Volume
=
Stent
Volume
-
Lumen
Volume
|
|
|
122375
|
Native
Plaque
Volume
|
The
amount
of
plaque
between
the
stent
and
the
EEM,
within
the
stent
region.
Native
Plaque
Volume
=
EEM
Volume
-
Stent
Volume
|
|
|
122376
|
Total
Plaque
Volume
|
Total
amount
of
plaque
between
the
EEM
and
the
Lumen,
over
the
entire
region
that
is
measured.
Total
Plaque
Volume
=
EEM
Volume
-
Lumen
Volume
|
|
|
122380
|
Proximal
Reference
|
Proximal
reference
segment
measurement
site.
Typically
the
site
with
the
largest
lumen
proximal
to
a
stenosis
but
within
the
same
segment
(usually
within
10
mm
of
the
stenosis
with
no
major
intervening
branches)
|
|
|
122381
|
Distal
Reference
|
Distal
reference
segment
measurement
site.
Typically
the
site
with
the
largest
lumen
distal
to
a
stenosis
but
within
the
same
segment
(usually
within
10
mm
of
the
stenosis
with
no
major
intervening
branches)
|
|
|
122382
|
Site
of
Lumen
Minimum
|
Site
of
the
smallest
lumen
in
a
vessel;
e.g.
due
to
a
stenotic
lesion
|
|
|
122383
|
Entire
Pullback
|
Measurement
region
that
encompasses
the
entire
vessel
imaged
in
a
single
pullback
acquisition
|
|
|
122384
|
Stented
Region
|
Measurement
region
occupied
by
the
stent
|
|
|
122385
|
Proximal
Stent
Margin
|
Region
starting
at
the
proximal
edge
of
the
Stent
and
extending
several
millimeters
(usually
5
mm)
proximal
to
the
Stent
edge
|
|
|
122386
|
Distal
Stent
Margin
|
Region
starting
at
the
distal
edge
of
the
Stent
and
extending
several
millimeters
(usually
5
mm)
distal
to
the
Stent
edge
|
|
|
122387
|
Dissection
Classification
|
Classification
of
dissections
in
a
vessel
|
|
|
122388
|
Intra-stent
Dissection
|
Separation
of
neointimal
hyperplasia
from
stent
struts,
usually
seen
only
after
treatment
of
in-stent
restenosis
|
|
|
122389
|
Vulnerable
Plaque
|
Plaque
with
a
thin
cap
fibrous
atheroma
that
is
at
increased
risk
of
rupture
and
thrombosis
(or
re-thrombosis)
and
rapid
stenosis
progression
|
|
|
122390
|
Eroded
Plaque
|
Plaque
erosions
with
no
structural
defect
(beyond
endothelial
injury)
or
gap
in
the
plaque
|
|
|
122391
|
Relative
Stenosis
Severity
|
Stenosis
severity
classifications
of
multiple
lesions
in
a
vessel
|
|
|
122393
|
Restenotic
Lesion
|
A
finding
of
a
previously
treated
lesion
in
which
stenosis
has
reoccurred
|
|
|
122394
|
Fibro-Lipidic
Plaque
|
Loosely
packed
bundles
of
collagen
fibers
with
regions
of
lipid
deposition
present.
Region
is
cellular
and
no
cholesterol
clefts
or
necrosis
are
present.
Some
macrophage
infiltration.
Increase
in
extra
cellular
matrix
|
|
|
122395
|
Necrotic-Lipidic
Plaque
|
Area
within
the
plaque
with
very
low
echogenicity
separated
from
the
lumen
and
surrounded
by
more
echogenic
structures
(fibrous
cap).
Highly
lipidic
necrotic
region
with
remnants
of
foam
cells
and
dead
lymphocytes
present.
No
collagen
fibers
are
visible
and
mechanical
integrity
is
poor.
Cholesterol
clefts
and
micro
calcifications
are
visible
|
|
|
122398
|
Intimal
Dissection
|
Dissection
limited
to
the
intima
or
atheroma,
and
not
extending
to
the
media
|
|
|
122399
|
Medial
Dissection
|
Dissection
in
the
arterial
Media,
extending
into
the
media
|
|
|
122400
|
Simultaneously
Acquired
|
The
referenced
information
was
acquired
simultaneously
with
the
information
in
the
object
in
which
the
reference
occurs
|
|
|
122401
|
Same
Anatomy
|
Information
acquired
for
the
same
anatomic
region
|
|
|
122402
|
Same
Indication
|
Information
acquired
for
the
same
indication;
e.g.
to
elucidate
the
same
diagnostic
question
|
|
|
122403
|
For
Attenuation
Correction
|
The
referenced
information
was
used
to
correct
the
data
for
differential
attenuation
through
different
anatomic
tissue
|
|
|
122404
|
Reconstructed
|
Value
estimated
for
a
vessel
in
the
absence
of
a
stenosis
|
|
|
122405
|
Algorithm
Manufacturer
|
Manufacturer
of
application
used
|
|
|
122406
|
Left
Atrial
Ejection
Fraction
by
Angiography
|
Left
Atrial
Ejection
Fraction
by
Angiography
|
|
|
122407
|
Left
Atrial
ED
Volume
|
Left
Atrial
End
Diastolic
Volume
|
|
|
122408
|
Left
Atrial
ES
Volume
|
Left
Atrial
End
Systolic
Volume
|
|
|
122410
|
Contour
Realignment
|
Contour
repositioning
of
End
Diastolic
relative
to
End
Systolic
contour
|
|
|
122411
|
Threshold
Value
|
The
minimum
standard
deviation
to
define
the
hypokinesis
and
hyperkinesis
|
|
|
122417
|
Regional
Abnormal
Wall
Motion
|
Report
of
differentiation
of
wall
motion
compared
to
normal
|
|
|
122421
|
Calibration
Object
|
Object
used
for
Calibration
|
|
|
122422
|
Calibration
Method
|
Method
used
for
Calibration
|
|
|
122423
|
Calibration
Object
Size
|
Size
of
calibration
object
|
|
|
122428
|
Area
Length
Method
|
Method
how
long
axis
is
positioned
|
|
|
122429
|
Volume
Method
|
Model
for
cardiac
chamber
volume
calculation
|
|
|
122430
|
Reference
Method
|
Method
to
define
original
diameter
of
the
artery
|
|
|
122431
|
Regression
Slope
ED
|
Relation
between
calculated
End
Diastolic
volume
and
ventricular
End
Diastolic
volume.
The
specific
meaning
is
dependent
on
volume
method
used
|
|
|
122432
|
Regression
Offset
ED
|
Correction
factor
for
the
calculated
End
Diastolic
volume
and
ventricular
End
Diastolic
volume.
The
specific
meaning
is
dependent
on
volume
method
used
|
|
|
122433
|
Regression
Slope
ES
|
Relation
between
calculated
End
Systolic
volume
and
ventricular
End
Systolic
volume.
The
specific
meaning
is
dependent
on
volume
method
used
|
|
|
122434
|
Regression
Offset
ES
|
Correction
factor
for
the
calculated
End
Systolic
volume
and
ventricular
End
Systolic
volume.
The
specific
meaning
is
dependent
on
volume
method
used
|
|
|
122435
|
Regression
Volume
Exponent
|
Exponent
of
volume
in
regression
formula
|
|
|
122438
|
Reference
Points
|
Container
for
spatial
locations
or
coordinates
used
for
calculation
|
|
|
122445
|
Wall
Thickness
|
Average
thickness
of
the
chamber
wall
in
the
current
view
|
|
|
122446
|
Wall
Volume
|
Volume
of
the
chamber
wall
estimated
from
the
current
view
|
|
|
122447
|
Wall
Mass
|
Mass
of
the
chamber
wall
(myocardium)
|
|
|
122448
|
Wall
Stress
|
Peak
systolic
stress
of
chamber
wall
|
|
|
122449
|
Centerline
Wall
Motion
Analysis
|
Method
to
calculate
wall
motion
[example:
Sheehan,
1986]
|
|
|
122450
|
Normalized
Chord
Length
|
The
length
between
End
Diastolic
and
End
Systolic
contour
perpendicular
on
the
centerline
normalized
by
a
method
dependent
ventricular
perimeter
length.
The
centerline
is
the
line
equidistant
between
the
End
Diastolic
and
End
Systolic
contour
[example:
Sheehan,
1986]
|
|
|
122451
|
Abnormal
Region
|
The
report
of
the
boundaries
of
the
abnormal
(hyperkinetic,
hypokinetic,
a-kinetic)
regions
associated
with
the
territory
of
the
artery
[example:
Sheehan,
1986]
|
|
|
122452
|
First
Chord
of
Abnormal
Region
|
The
chord
number
specifying
the
begin
of
abnormal
region
[example:
Sheehan,
1986]
|
|
|
122453
|
Last
Chord
of
Abnormal
Region
|
The
chord
number
specifying
the
end
of
abnormal
region
[example:
Sheehan,
1986]
|
|
|
122459
|
Territory
Region
Severity
|
Severity
at
the
regional
abnormality
extent
[example:
Sheehan,
1986]
|
|
|
122461
|
Opposite
Region
Severity
|
Severity
at
the
opposite
regional
abnormality
extent
[example:
Sheehan,
1986]
|
|
|
122464
|
LAD
Region
in
RAO
Projection
|
Based
on
a
total
number
of
chords
of
100
and
RAO
project
the
range
of
chords
belonging
to
this
circumferential
extent
lies
between
5
-
85.
[Sheehan,
1986]
|
|
|
122465
|
RCA
Region
in
ROA
Projection
|
Based
on
a
total
number
of
chords
of
100
and
RAO
project
the
range
of
chords
belonging
to
this
circumferential
extent
lies
between
25
-
85.
[Sheehan,
1986]
|
|
|
122466
|
Single
LAD
Region
in
RAO
Projection
|
Based
on
a
total
number
of
chords
of
100
and
RAO
projection
the
range
of
chords
belonging
to
this
regional
extent
lies
between
10
-
66
(hypokinetic)
and
67
-
80
(hyperkinetic).
[Sheehan,
1986]
|
|
|
122467
|
Single
RCA
Region
in
RAO
Projection
|
Based
on
a
total
number
of
chords
of
100
and
RAO
projection
the
range
of
chords
belonging
to
this
regional
extent
lies
between
51
-
80
(hypokinetic)
and
10
-
50
(hyperkinetic).
[Sheehan,
1986]
|
|
|
122468
|
Multiple
LAD
Region
in
RAO
Projection
|
Based
on
a
total
number
of
chords
of
100
and
RAO
projection
the
range
of
chords
belonging
to
this
regional
extent
lies
between
10
-
58
(hypokinetic)
and
59
-80
(hyperkinetic).
[Sheehan,
1986]
|
|
|
122469
|
Multiple
RCA
Region
in
RAO
Projection
|
Based
on
a
total
number
of
chords
of
100
and
RAO
projection
the
range
of
chords
belonging
to
this
regional
extent
lies
between
59
-
80
(hypokinetic)
and
10
-
58
(hyperkinetic).
[Sheehan,
1986]
|
|
|
122470
|
LAD
Region
in
LAO
Projection
|
Based
on
a
total
number
of
chords
of
100
and
LAO
projection
the
range
of
chords
belonging
to
this
regional
extent
lies
between
50
-100
(hypokinetic)
and
20
-
49
(hyperkinetic).
[Sheehan,
1986]
|
|
|
122471
|
RCA
Region
in
LAO
Projection
|
Based
on
a
total
number
of
chords
of
100
and
LAO
projection
the
range
of
chords
belonging
to
this
regional
extent
lies
between
19
-
67
(hypokinetic)
and
68
-
100
(hyperkinetic).
[Sheehan,
1986]
|
|
|
122472
|
CFX
Region
in
LAO
Projection
|
Based
on
a
total
number
of
chords
of
100
and
LAO
projection
the
range
of
chords
belonging
to
this
regional
extent
lies
between
38
-74
(hypokinetic)
and
75
-
100
(hyperkinetic).
[Sheehan,
1986]
|
|
|
122473
|
Circular
Method
|
Method
based
on
assumption
that
the
image
object
is
circular
|
|
|
122474
|
Densitometric
Method
|
Method
based
on
the
gray
value
distribution
of
the
image
|
|
|
122475
|
Center
of
Gravity
|
End
Systolic
contour
realigned
to
End
Diastolic
contour
based
on
the
center
of
gravity
|
|
|
122476
|
Long
Axis
Based
|
End
Systolic
contour
realigned
to
End
Diastolic
contour
based
on
the
mid
point
of
the
long
axis.
The
long
axis
end-points
are
defined
as
the
posterior
and
apex
|
|
|
122477
|
No
Realignment
|
No
Contour
Realignment
applied
|
|
|
122480
|
Vessel
Lumen
Cross-Sectional
Area
|
Calculated
Vessel
Lumen
Cross-Sectional
Area
based
on
the
referenced
method
|
|
|
122481
|
Contour
Start
|
Location
of
the
beginning
of
a
contour
|
|
|
122482
|
Contour
End
|
Location
of
the
end
of
a
contour
|
|
|
122485
|
Sphere
|
Sphere
is
used
as
calibration
object
|
|
|
122486
|
Geometric
Isocenter
|
Object
of
interest
in
isocenter
of
image
and
pixel
separation
is
calculated
from
geometric
data
|
|
|
122487
|
Geometric
Non-Isocenter
|
Object
of
interest
not
in
isocenter
of
image
and
pixel
separation
is
calculated
from
geometric
data
and
out
of
isocenter
distances
|
|
|
122488
|
Calibration
Object
Used
|
Object
used
for
calibration;
e.g.
sphere
|
|
|
122489
|
Curve
Fitted
Reference
|
Application
dependent
method
to
calculate
the
reference
diameter
based
on
the
multiple
diameter
values
|
|
|
122490
|
Interpolated
Local
Reference
|
Application
dependent
method
to
calculate
reference
by
interpolation,
based
on
the
diameter
of
two
or
more
user
defined
reference
positions
|
|
|
122491
|
Mean
Local
Reference
|
Application
dependent
method
to
calculate
by
averaging
the
reference,
based
on
the
diameter
of
one
or
more
user
defined
reference
positions
|
|
|
122493
|
Radial
Based
Wall
Motion
Analysis
|
Method
to
calculate
wall
motion
based
on
the
lengths
of
the
radials
in
the
predefined
regions
[Ingels]
|
|
|
122495
|
Regional
Contribution
to
Ejection
Fraction
|
Contribution
of
Region
to
global
Ejection
factor
based
on
radial
or
landmark
based
wall
motion
method
|
|
|
122496
|
Radial
Shortening
|
The
reduction
of
area
between
End
Systolic
and
End
Diastolic
based
on
radial
wall
motion
analysis
|
|
|
122497
|
Landmark
Based
Wall
Motion
Analysis
|
Method
to
calculate
wall
motion
based
on
the
move
of
landmarks
on
the
wall
[Slager]
|
|
|
122498
|
Slice
Contribution
to
Ejection
Fraction
|
Contribution
to
the
ejection
fraction
of
a
specific
slice
region
[Slager]
|
|
|
122499
|
Frame
to
Frame
Analysis
|
Method
to
calculate
volumes
of
heart
chambers
for
every
image
in
a
range
|
|
|
122501
|
Area
of
closed
irregular
polygon
|
The
area
is
derived
by
considering
a
set
of
coordinates
as
a
closed
irregular
polygon,
accounting
for
inner
angles.
The
exact
method,
such
as
by
decomposition
into
triangles
or
quadrilaterals,
is
not
specified,
since
it
does
not
affect
the
numeric
result,
apart
from
the
effect
of
numeric
precision
during
computation
of
intermediate
results
|
|
|
122502
|
Area
of
a
closed
NURBS
|
The
area
is
derived
by
using
a
set
of
coordinates
as
control
points
for
a
Non
Uniform
Rational
B-Spline
(NURBS)
|
|
|
122503
|
Integration
of
sum
of
closed
areas
on
contiguous
slices
|
The
volume
derived
by
integrating
the
sum
of
the
areas
on
adjacent
slices
across
the
slice
interval;
each
area
is
defined
by
a
regular
planar
shape
or
by
considering
a
set
of
coordinates
as
a
closed
irregular
polygon,
accounting
for
inner
angles
|
|
|
122505
|
Calibration
|
Procedure
used
to
calibrate
measurements
or
measurement
devices
|
|
|
122507
|
Left
Contour
|
Left
contour
of
lumen
(direction
proximal
to
distal)
|
|
|
122508
|
Right
Contour
|
Right
contour
of
lumen
(direction
proximal
to
distal)
|
|
|
122509
|
Diameter
Graph
|
Ordered
set
of
diameters
values
derived
from
contours
(direction
proximal
to
distal)
|
|
|
122510
|
Length
Luminal
Segment
|
Length
Luminal
Segment
|
|
|
122511
|
Graph
Increment
|
Increment
value
along
X-axis
in
Diameter
Graph
|
|
|
122516
|
Site
of
Maximum
Luminal
|
Location
of
the
maximum
lumen
area
in
a
lesion
or
vessel
|
|
|
122517
|
Densitometric
Luminal
Cross-sectional
Area
Graph
|
Ordered
set
of
cross-sectional
Vessel
Lumen
Cross-Sectional
Area
values
derived
from
contours
(direction
proximal
to
distal)
based
on
densitometric
method
|
|
|
122528
|
Position
of
Proximal
Border
|
Position
of
proximal
border
of
segment
relative
to
the
contour
start
(proximal
end
of
analysis
area)
|
|
|
122529
|
Position
of
Distal
Border
|
Position
of
distal
border
of
segment
relative
to
the
contour
start
(proximal
end
of
analysis
area)
|
|
|
122542
|
Plaque
Area
|
Longitudinal
cross
sectional
area
of
plaque
|
|
|
122544
|
Diameter
Symmetry
|
Symmetry
of
stenosis
(0
=
complete
asymmetry,
1
=
complete
symmetry);
see
Section
T.2
"Definition
of
Diameter
Symmetry
with
Arterial
Plaques"
in
PS3.17
|
|
|
122545
|
Area
Symmetry
|
Symmetry
of
plaque
(0
=
complete
asymmetry,
1
=
complete
symmetry);
see
Section
T.2
"Definition
of
Diameter
Symmetry
with
Arterial
Plaques"
in
PS3.17
|
|
|
122546
|
Inflow
Angle
|
The
average
slope
of
the
diameter
function
between
the
position
of
the
minimum
luminal
diameter
and
the
position
of
the
proximal
border
of
the
segment
|
|
|
122547
|
Outflow
Angle
|
The
average
slope
of
the
diameter
function
between
the
position
of
the
minimum
luminal
diameter
and
the
position
of
the
distal
border
of
the
segment
|
|
|
122548
|
Stenotic
Flow
Reserve
|
The
relation
between
coronary
pressure
and
coronary
flow
|
|
|
122549
|
Poiseuille
Resistance
|
Poiseuille
Resistance
at
the
location
of
the
stenosis
|
|
|
122550
|
Turbulence
Resistance
|
Turbulence
Resistance
at
the
location
of
the
stenosis
|
|
|
122551
|
Pressure
Drop
at
SFR
|
Pressure
drop
over
the
stenosis
at
maximum
heart
output
|
|
|
122554
|
Segmentation
Method
|
Method
for
selection
of
vessel
sub-segments
|
|
|
122555
|
Estimated
Normal
Flow
|
Estimate
of
the
volume
of
blood
flow
in
the
absence
of
stenosis
|
|
|
122558
|
Area
Length
Kennedy
|
Area
Length
method
defined
by
Kennedy
[Kennedy,
1970]
|
|
|
122559
|
Area
Length
Dodge
|
Area
Length
method
defined
by
Dodge
[Dodge,
1960]
|
|
|
122560
|
Area
Length
Wynne
|
Area
Length
method
defined
by
Wynne
[Wynne]
|
|
|
122562
|
Multiple
Slices
|
Volume
method
based
on
multiple
slice
|
|
|
122563
|
Boak
|
Volume
method
defined
by
Boak
[Boak]
|
|
|
122564
|
TS
Pyramid
|
Volume
method
defined
by
Ferlinz
[Ferlinz]
|
|
|
122565
|
Two
Chamber
|
Volume
method
defined
by
Graham
[Graham]
|
|
|
122566
|
Parallelepiped
|
Volume
method
defined
by
Arcilla
[Arcilla]
|
|
|
122572
|
BSA^1.219
|
Corrected
Body
Surface
area
for
indexing
the
hemodynamic
measurements
for
a
pediatric
patient
|
|
|
122574
|
Equidistant
method
|
Method
for
selecting
sub-segments
that
are
all
of
the
same
length
|
|
|
122575
|
User
selected
method
|
Manually
selected
start
and
end
of
sub-segment
|
|
|
122582
|
Left
ventricular
posterobasal
segment
|
Left
ventricular
posterobasal
segment
|
|
|
122600
|
Cardiovascular
Analysis
Report
|
Report
of
a
Cardiovascular
Analysis,
typically
from
a
CT
or
MR
study
|
|
|
122601
|
Ventricular
Analysis
|
Ventricular
Analysis
|
|
|
122602
|
Myocardial
Perfusion
Analysis
|
Myocardial
Perfusion
Analysis
|
|
|
122603
|
Calcium
Scoring
Analysis
|
Calcium
Scoring
Analysis
|
|
|
122604
|
Flow
Quantification
|
Flow
Quantification
Analysis
|
|
|
122605
|
Vascular
Morphological
Analysis
|
Vascular
Morphological
Analysis
|
|
|
122606
|
Vascular
Functional
Analysis
|
Vascular
Functional
Analysis
|
|
|
122607
|
Thickening
Analysis
|
Analysis
of
myocardial
wall
thickening
|
|
|
122608
|
Absolute
Values
Of
Ventricular
Measurements
|
Section
Heading
for
absolute
values
of
ventricular
measurements
|
|
|
122609
|
Normalized
Values
Of
Ventricular
Measurements
|
Results
of
normalizing
ventricular
measurements
|
|
|
122611
|
Reference
Point
|
Reference
Point
of
a
measurement
|
|
|
122612
|
Central
breathing
position
|
Central
breathing
position
between
inspiration
and
expiration
|
|
|
122616
|
Peak
Ejection
Rate
|
Peak
of
the
ventricular
ejection
rate
|
|
|
122617
|
Peak
Ejection
Time
|
Time
of
the
peak
of
ventricular
ejection
|
|
|
122618
|
Peak
Filling
Rate
|
Peak
of
the
fluid
filling
rate
|
|
|
122619
|
Peak
Filling
Time
|
Time
interval
until
time
of
peak
filling
from
a
given
reference
point;
e.g.
end
systole
|
|
|
122620
|
Papillary
Muscle
Excluded
|
Papillary
muscle
was
excluded
from
the
measurement
|
|
|
122621
|
Papillary
Muscle
Included
|
Papillary
muscle
was
included
in
the
measurement
|
|
|
122624
|
Wall
Thickness
Ratio
end-systolic
to
end-diastolic
|
The
ratio
of
the
end-systolic
wall
thickness
compared
to
the
end-diastolic
wall
thickness
|
|
|
122627
|
Curve
Fit
Method
|
The
method
to
smooth
a
ventricular
volume
as
a
function
of
time
|
|
|
122628
|
Baseline
Result
Correction
|
Baseline
correction
used
in
the
calculation
of
the
results
|
|
|
122631
|
Signal
Earliest
Peak
Time
|
The
time
in
a
dynamic
set
of
images
at
which
the
first
peak
of
the
signal
is
observed
for
the
analyzed
myocardial
wall
segments
|
|
|
122633
|
Signal
Increase
Start
Time
|
This
is
the
time
at
which
the
signal
begins
to
increase
|
|
|
122634
|
Signal
Time
to
Peak
|
Time
interval
between
the
beginning
of
the
signal
increase
to
the
time
at
which
the
signal
intensity
reaches
its
first
maximum
in
a
dynamic
set
of
images
|
|
|
122635
|
MR
Perfusion
Peak
|
Peak
of
the
MR
perfusion
signal
|
|
|
122636
|
MR
Perfusion
Slope
|
Signal
intensity
as
a
function
of
time.
It
is
the
change
in
the
signal
intensity
divided
by
the
change
in
the
time
|
|
|
122637
|
MR
Perfusion
Time
Integral
|
MR
perfusion
time
integral
from
baseline
(foot
time)
to
earliest
peak
|
|
|
122638
|
Signal
Baseline
Start
|
First
time
point
in
a
dynamic
set
of
images
used
in
the
calculation
of
the
baseline
signal
intensity
for
each
myocardial
wall
segment
|
|
|
122639
|
Signal
Baseline
End
|
Last
time
point
in
a
dynamic
set
of
images
used
in
the
calculation
of
the
baseline
signal
intensity
for
each
myocardial
wall
segment
|
|
|
122640
|
Image
Interval
|
The
time
delta
between
images
in
a
dynamic
set
of
images
|
|
|
122642
|
Velocity
Encoding
Minimum
Value
|
The
minimum
velocity
encoded
by
the
phase
encoding
gradient
|
|
|
122643
|
Velocity
Encoding
Maximum
Value
|
The
maximum
velocity
encoded
by
the
phase
encoding
gradient
|
|
|
122645
|
Net
Forward
Volume
|
Forward
volume-reverse
volume
|
|
|
122650
|
Area
Based
Method
|
Area
Based
Method
for
estimating
volume
or
area
|
|
|
122651
|
Diameter
Based
Method
|
Diameter
Based
Method
for
estimating
volume,
area
or
diameter
|
|
|
122652
|
Volume
Based
Method
|
Volume
Based
Method
for
estimating
volume
|
|
|
122655
|
NASCET
|
A
method
of
diameter
measurements
according
to
NASCET
(North
American
Symptomatic
Carotid
Endarterectomy
Trial)
|
|
|
122656
|
ECST
|
A
method
of
diameter
measurements
according
to
ECST
(European
Carotid
Surgery
Trial)
|
|
|
122657
|
Agatston
Score
Threshold
|
Agatston
Score
Threshold
|
|
|
122658
|
Calcium
Mass
Threshold
|
Calcium
Mass
Threshold
|
|
|
122659
|
Calcium
Scoring
Calibration
|
Calcium
Scoring
Calibration
|
|
|
122660
|
Calcium
Volume
|
Calcium
Volume
|
|
|
122661
|
Calcium
Mass
|
Calcium
Mass
|
|
|
122664
|
Late
Contrast
Enhancement
|
Delayed
hyperenhancement
of
a
tissue
observed
in
an
image
acquired
after
injection
of
contrast
media
|
|
|
122665
|
Time
interval
since
injection
of
contrast
media
|
Time
interval
since
injection
of
contrast
media
|
|
|
122666
|
Time
relative
to
R-wave
peak
|
Time
relative
to
R-wave
peak
|
|
|
122667
|
Blood
velocity
vs.
time
of
cardiac
cycle
|
Relationship
between
blood
velocity
and
time
relative
to
R-wave
peak
|
|
|
122668
|
Time
interval
since
detection
of
contrast
bolus
|
Time
interval
since
detection
of
contrast
bolus
|
|
|
122670
|
Papillary
Muscle
Included/Excluded
|
Indicates
if
the
papillary
muscle
was
included
or
excluded
in
the
measurement
|
|
|
122675
|
Anterior-Posterior
|
Anterior
to
Posterior
direction
|
|
|
122680
|
endoleak
|
Persistent
flow
of
blood
into
the
stent-grafting
|
|
|
122683
|
Stent
Fracture
|
Fracture
of
a
stent
|
|
|
122684
|
Stent
Disintegration
|
Disintegration
of
a
stent
|
|
|
122685
|
Stent
Composition
|
Material
that
a
stent
consists
of
|
|
|
122686
|
Parent
Vessel
Finding
|
Finding
about
the
characteristics
of
the
parent
vessel
of
a
vessel
|
|
|
122687
|
Site
of
Lumen
Maximum
|
Site
of
Maximal
lumen
diameter
of
a
vessel
|
|
|
122698
|
X-Concept
|
The
physical
domain
(time,
space,
etc.)
to
the
horizontal
axis
of
the
graphical
presentation
|
|
|
122699
|
Y-Concept
|
The
physical
domain
(time,
space,
etc.)
to
the
vertical
axis
of
the
graphical
presentation
|
|
|
122700
|
Indications
for
Pharmacological
Stress
|
Indications
for
Pharmacological
Stress
|
|
|
122701
|
Procedure
time
base
|
Reference
time
for
measurement
of
elapsed
time
in
a
procedure
|
|
|
122702
|
Treadmill
speed
|
Treadmill
speed
|
|
|
122703
|
Treadmill
gradient
|
Treadmill
gradient
|
|
|
122704
|
Ergometer
power
|
Ergometer
power
|
|
|
122705
|
Pharmacological
Stress
Agent
Dose
Rate
|
Pharmacological
Stress
Agent
Dose
Rate
|
|
|
122706
|
Rating
of
Perceived
Exertion
|
Rating
of
Perceived
Exertion
|
|
|
122707
|
Number
of
Ectopic
Beats
|
Number
of
ectopic
beats
during
a
period
of
collection
|
|
|
122708
|
Double
Product
|
Heart
rate
times
systolic
blood
pressure
|
|
|
122709
|
Activity
workload
|
Physical
activity
workload
(intensity)
measurement
|
|
|
122710
|
Time
since
start
of
stage
|
Elapsed
time
at
stage
|
|
|
122711
|
Exercise
duration
after
stress
agent
injection
|
Exercise
duration
after
stress
agent
injection
|
|
|
122712
|
Imaging
Start
Time
|
Imaging
Start
Time
|
|
|
122713
|
Attenuation
correction
method
|
Attenuation
correction
method
|
|
|
122715
|
Pharmacological
Stress
Agent
Dose
|
Pharmacological
Stress
Agent
Dose
|
|
|
122716
|
Maximum
Power
Output
Achieved
|
Maximum
power
output
achieved
during
course
of
procedure
|
|
|
122717
|
Peak
activity
workload
|
Peak
physical
activity
intensity
measurement
during
course
of
procedure
|
|
|
122718
|
Peak
Double
Product
|
Peak
Double
Product
measurement
during
course
of
procedure
|
|
|
122720
|
OSEM
algorithm
|
Ordered
subsets
expectation
maximization
reconstruction
algorithm
|
|
|
122721
|
Chang
method
|
Chang
attenuation
correction
method
|
|
|
122726
|
Algorithmic
attenuation
correction
|
Attenuation
correction
not
based
on
image-based
attenuation
maps
|
|
|
122727
|
NM
transmission
attenuation
correction
|
NM
transmission
attenuation
correction
|
|
|
122728
|
CT-based
attenuation
correction
|
CT-based
attenuation
correction
|
|
|
122729
|
No
Attenuation
Correction
|
No
attenuation
correction
|
|
|
122730
|
Bazett
QTc
Algorithm
|
Bazett
QT
Correction
Algorithm;
QT/(RR
^
0.5);
Bazett
HC.
"An
analysis
of
the
time-relations
of
electrocardiograms"
Heart7:353-370
(1920)
|
|
|
122731
|
Hodges
QTc
Algorithm
|
Hodges
QT
Correction
Algorithm;
QT
+
1.75
(heart
rate-60);
Hodges
M,
Salerno
Q,
Erlien
D.
"Bazett's
QT
correction
reviewed.
Evidence
that
a
linear
QT
correction
for
heart
rate
is
better."
J
Am
Coll
Cardiol1:694
(1983)
|
|
|
122732
|
Fridericia
QTc
Algorithm
|
Fridericia
QT
Correction
Algorithm;
QT/(RR
^
0.333);
Fridericia
LS.
"The
duration
of
systole
in
the
electrocardiogram
of
normal
subjects
and
of
patients
with
heart
disease"
Acta
Med
Scand53:469-486
(1920)
|
|
|
122733
|
Framingham
QTc
Algorithm
|
Framingham
QT
Correction
Algorithm;
QT
+
0.154
(1-
RR);
Sagie
A,
Larson
MG,
Goldberg
RJ,
et
al.
"An
improved
method
for
adjusting
the
QT
interval
for
heart
rate
(the
Framingham
Heart
Study)."
Am
J
Cardiol70:797-801(1992)
|
|
|
122734
|
Borg
RPE
Scale
|
Borg
Rating
of
Perceived
Exertion
Scale,
range
6:20
|
|
|
122735
|
Borg
CR10
Scale
|
Borg
category
ratio
scale,
open
ended
range
with
nominal
range
0:10
|
|
|
122739
|
Overall
study
quality
|
Overall
study
quality
|
|
|
122740
|
Excellent
image
quality
|
Excellent
image
quality
|
|
|
122741
|
Good
image
quality
|
Good
image
quality
|
|
|
122742
|
Poor
image
quality
|
Poor
image
quality
|
|
|
122743
|
Body
habitus
attenuation
|
Image
attenuation
due
to
body
physique
(overweight)
|
|
|
122744
|
Breast
attenuation
|
Image
attenuation
due
to
breast
tissue
|
|
|
122745
|
Diaphragmatic
attenuation
|
Image
attenuation
due
to
diaphragm
|
|
|
122748
|
False
positive
defect
finding
|
Finding
of
a
defect
is
incorrect;
e.g.
from
automated
analysis
|
|
|
122750
|
Non-diagnostic
-
low
heart
rate
|
ECG
is
non-diagnostic
due
to
low
heart
rate
|
|
|
122751
|
Non-diagnostic
-
resting
ST
abnormalities
|
ECG
is
non-diagnostic
due
to
resting
ST
abnormalities
|
|
|
122752
|
Non-diagnostic
-
ventricular
pacing
or
LBBB
|
ECG
is
non-diagnostic
due
to
ventricular
pacing
or
Left
Bundle
Branch
Block
|
|
|
122753
|
Non-diagnostic
ECG
|
ECG
is
non-diagnostic
for
presence
of
acute
coronary
syndrome
|
|
|
122755
|
Strongly
positive
|
Strongly
positive
finding
|
|
|
122756
|
Strongly
positive
-
ST
elevation
|
Strongly
positive
finding
-
ST
elevation
|
|
|
122757
|
ST
Depression
-
Horizontal
|
Finding
of
ST
segment
depression
with
no
slope
|
|
|
122758
|
ST
Depression
-
Upsloping
|
Finding
of
ST
segment
depression
with
upslope
|
|
|
122759
|
ST
Depression
-
Downsloping
|
Finding
of
ST
segment
depression
with
downslope
|
|
|
122760
|
Stress
test
score
|
Stress
test
score
|
|
|
122762
|
Number
of
diseased
vessel
territories
|
Number
of
diseased
vessel
territories
|
|
|
122764
|
Weight
exceeds
equipment
limit
|
Patient
weight
exceeds
equipment
limit
|
|
|
122768
|
Difference
in
Ejection
Fraction
|
Difference
in
Ejection
Fraction
|
|
|
122769
|
Difference
in
ED
LV
Volume
|
Difference
in
End
Diastolic
Left
Ventricular
Volume
|
|
|
122770
|
Ratio
of
achieved
to
predicted
maximal
oxygen
consumption
|
Ratio
of
achieved
to
predicted
maximal
oxygen
consumption
|
|
|
122771
|
Ratio
of
achieved
to
predicted
functional
capacity
|
Ratio
of
achieved
to
predicted
functional
capacity
|
|
|
122772
|
Aerobic
index
|
Workload
(Watts)
at
target
heart
rate
divided
by
body
weight
|
|
|
122773
|
ST/HR
Index
|
ST
depression
at
peak
exercise
divided
by
the
exercise-induced
increase
in
heart
rate
[Kligfield
P,
Ameisen
O,
Okin
PM.
"Heart
rate
adjustment
of
ST
segment
depression
for
improved
detection
of
coronary
artery
disease."
Circulation
1989;79:245-55.]
|
|
|
122775
|
Agreement
with
prior
findings
|
Agreement
with
prior
findings
|
|
|
122776
|
Disagreement
with
prior
findings
|
Disagreement
with
prior
findings
|
|
|
122781
|
Rest
thallium/stress
technetium
procedure
|
Nuclear
Medicine
Rest
thallium/stress
technetium
procedure
|
|
|
122782
|
Rest
technetium/stress
technetium
1
day
procedure
|
Nuclear
Medicine
Rest
technetium/stress
technetium
1
day
procedure
|
|
|
122783
|
Rest
technetium/stress
technetium
2
day
procedure
|
Nuclear
Medicine
Rest
technetium/stress
technetium
2
day
procedure
|
|
|
122784
|
Stress
technetium/rest
technetium
1
day
procedure
|
Nuclear
Medicine
Stress
technetium/rest
technetium
1
day
procedure
|
|
|
122785
|
NM
Myocardial
Viability
procedure
|
Nuclear
Medicine
Myocardial
Viability
procedure
|
|
|
122791
|
PET
Myocardial
Perfusion,
Rest
only
|
Positron
Emission
Tomography
Perfusion
Imaging
procedure,
rest
only
|
|
|
122792
|
PET
Myocardial
Perfusion,
Stress
only
|
Positron
Emission
Tomography
Perfusion
Imaging
procedure,
stress
only
|
|
|
122793
|
PET
Myocardial
Perfusion,
Rest
and
Stress
|
Positron
Emission
Tomography
Perfusion
Imaging
procedure,
rest
and
stress
|
|
|
122795
|
PET
Myocardial
Viability,
Rest
only
|
Positron
Emission
Tomography
Myocardial
Viability
procedure,
rest
only
|
|
|
122796
|
PET
Myocardial
Viability,
Stress
only
|
Positron
Emission
Tomography
Myocardial
Viability
procedure,
stress
only
|
|
|
122797
|
PET
Myocardial
Viability,
Rest
and
Stress
|
Positron
Emission
Tomography
Myocardial
Viability
procedure,
rest
and
stress
|
|
|
122799
|
Anginal
Equivalent
|
Group
of
symptoms
heralding
angina
pectoris
that
does
not
include
chest
pain
(dyspnea,
diaphoresis,
profuse
vomiting
in
a
diabetic
patient,
or
arm
or
jaw
pain)
|
|
|
123001
|
Radiopharmaceutical
|
Active
ingredient
(molecular)
used
for
radioactive
tracing
|
|
|
123003
|
Radiopharmaceutical
Start
Time
|
Time
of
radiopharmaceutical
administration
to
the
patient
for
imaging
purposes
|
|
|
123004
|
Radiopharmaceutical
Stop
Time
|
Ending
time
of
radiopharmaceutical
administration
to
the
patient
for
imaging
purposes
|
|
|
123005
|
Radiopharmaceutical
Volume
|
Volume
of
radiopharmaceutical
administered
to
the
patient
|
|
|
123006
|
Radionuclide
Total
Dose
|
Total
amount
of
radionuclide
administered
to
the
patient
at
Radiopharmaceutical
Start
Time
|
|
|
123007
|
Radiopharmaceutical
Specific
Activity
|
Activity
per
unit
mass
of
the
radiopharmaceutical
at
Radiopharmaceutical
Start
Time
|
|
|
123009
|
Radionuclide
Syringe
Counts
|
Pre-injection
syringe
acquisition
count
rate
|
|
|
123010
|
Radionuclide
Residual
Syringe
Counts
|
Syringe
acquisition
count
rate
following
patient
injection
|
|
|
123011
|
Contrast/Bolus
Agent
|
Contrast
or
bolus
agent
|
|
|
123012
|
Pre-Medication
|
Medication
to
be
administered
at
the
beginning
of
the
Scheduled
Procedure
Step
|
|
|
123014
|
Target
Region
|
Anatomic
Region
to
be
imaged
|
|
|
123015
|
Imaging
Direction
|
Direction
of
imaging
(includes
view,
transducer
orientation,
patient
orientation,
and/or
projection)
|
|
|
123016
|
Imaging
Conditions
|
Imaging
condition
for
refinement
of
protocol
(includes
secondary
posture,
instruction,
X-Ray
/
electron
beam
energy
or
nuclide,
and
ultrasound
modes),
as
used
in
JJ1017
v3.0
|
|
|
123019
|
Caudal
10
degree
distal-cranioproximal
oblique
|
Caudal
10
degree
distal-cranioproximal
oblique
radiographic
projection,
defined
per
Smallwood
et
al
|
|
|
123101
|
Neighborhood
Analysis
|
Surface
processing
utilizing
predefined
weighting
factors
(i.e.,
kernels)
applied
to
different
data
values
depending
on
their
location
relative
to
other
data
values
within
the
data
domain.
Includes
Low
Pass,
High
Pass,
Gaussian,
Laplacian,
etc
|
|
|
123102
|
Adaptive
Filtering
|
Surface
processing
applied
non-uniformly
utilizing
a
priori
knowledge
of
the
system
and/or
relative
locations
of
the
data
values
within
the
data
domain.
Example:
Neighborhood
analysis
where
weighting
factors
are
modified
continuously
based
on
predefined
criteria
|
|
|
123103
|
Edge
Detection
|
Surface
processing
through
the
exploitation
of
discontinuities
in
the
data
values
within
their
domain.
Includes
Gradient
filters
|
|
|
123104
|
Morphological
Operations
|
Surface
processing
based
on
the
connectivity
of
values
based
on
the
shape
or
structure
of
the
data
values
within
their
domain.
Includes
erode,
dilate,
etc
|
|
|
123105
|
Histogram
Analysis
|
Surface
processing
applied
to
the
distribution
of
the
data
values.
Includes
thresholding,
Bayesian
Classification,
etc
|
|
|
123106
|
Multi-Scale/Resolution
Filtering
|
Surface
processing
accomplished
through
varying
the
data
domain
size.
Include
deformable
models
|
|
|
123107
|
Cluster
Analysis
|
Surface
processing
accomplished
by
combining
data
values
based
on
their
relative
location
within
their
domain
or
value
distribution.
Includes
K-
and
C-means,
Fuzzy
Analysis,
Watershed,
Seed
Growing,
etc
|
|
|
123108
|
Multispectral
Processing
|
Surface
processing
accomplished
through
the
weighted
combination
of
multiple
data
sets.
Includes
Principle
Component
Analysis,
linear
and
non-linear
weighed
combinations,
etc
|
|
|
123109
|
Manual
Processing
|
Surface
processing
accomplished
through
human
interaction.
Region
drawing
|
|
|
123110
|
Artificial
Intelligence
|
Surface
processing
using
Artificial
Intelligence
techniques,
such
as
Machine
Learning,
Neural
Networks,
etc
|
|
|
123111
|
Deformable
Models
|
Surface
processing
using
Deformable
Model
techniques,
such
as
Point
Distribution
Models,
Level
Sets,
Simplex
Meshes,
etc
|
|
|
125000
|
OB-GYN
Ultrasound
Procedure
Report
|
Document
Title
of
OB-GYN
procedure
report
|
|
|
125001
|
Fetal
Biometry
Ratios
|
Report
section
for
assessment
of
fetal
growth
using
ratios
and
indexes
|
|
|
125002
|
Fetal
Biometry
|
Report
section
for
assessment
of
fetal
growth
|
|
|
125003
|
Fetal
Long
Bones
|
Report
section
for
assessment
of
fetal
growth
by
long
bone
measurements
|
|
|
125004
|
Fetal
Cranium
|
Report
section
for
assessment
of
fetal
cranium
growth
|
|
|
125005
|
Biometry
Group
|
Biometric
assessment
of
|
|
|
125006
|
Biophysical
Profile
|
Report
section
for
assessment
of
biophysical
observations
that
evaluate
fetal
well-being
according
to
Manning,
Antepartum
Fetal
Evaluation:
Development
of
a
Fetal
Biophysical
Profile
Score,
Am.
J
Obstet
Gynecol,
1980;136:787
|
|
|
125007
|
Measurement
Group
|
A
grouping
of
related
measurements
and
calculations
that
share
a
common
context
|
|
|
125008
|
Fetus
Summary
|
Report
section
for
fetus
specific
procedure
summary
observations
|
|
|
125009
|
Early
Gestation
|
Report
section
for
assessment
of
early
gestation
fetus
|
|
|
125010
|
Identifier
|
A
name
to
differentiate
between
multiple
instances
of
some
item
|
|
|
125011
|
Pelvis
and
Uterus
|
Report
section
for
assessment
of
pelvis
and
uterus
|
|
|
125012
|
Growth
Percentile
rank
|
The
rank
of
a
measured
growth
indicator
relative
to
a
normal
distribution
expressed
as
a
percentage
|
|
|
125013
|
Growth
Z-score
|
The
rank
of
a
measured
growth
indicator
relative
to
a
normal
distribution
expressed
as
the
dimensionless
quantity
z
=
(x-m)
/s
where
(x-m)
is
the
deviation
of
the
value
x,
from
the
distribution
mean,
m,
and
s
is
the
standard
deviation
of
the
distribution
|
|
|
125015
|
Fetus
Characteristics
|
Fetus
characteristics
(findings
section
title)
|
|
|
125016
|
Fetal
Measurements
|
Fetal
Measurements
(findings
section
title)
|
|
|
125021
|
Frame
of
Reference
Identity
|
There
is
a
defined
equivalence
between
the
Frame
of
Reference
of
the
Registration
SOP
instance
and
the
Frame
of
Reference
of
the
referenced
images
|
|
|
125022
|
Fiducial
Alignment
|
The
registration
is
based
on
fiducials
that
represent
patient
or
specimen
features
identified
in
each
data
set
|
|
|
125023
|
Acquisition
Equipment
Alignment
|
Registration
based
on
a-priori
knowledge
of
the
acquisition
geometry.
This
is
not
an
object
registration
as
in
fiducial
registration.
Rather,
it
specifies
a
known
spatial
relationship
|
|
|
125024
|
Image
Content-based
Alignment
|
Computed
registration
based
on
global
image
information
|
|
|
125025
|
Visual
Alignment
|
Registration
by
visually
guided
manipulation
|
|
|
125030
|
Inter-Hemispheric
Plane
|
A
plane
fiducial
that
specifies
the
location
of
the
plane
separating
the
two
hemispheres
of
the
brain
|
|
|
125031
|
Right
Hemisphere
Most
Anterior
|
A
point
fiducial
that
specifies
the
location
in
the
plane
perpendicular
to
the
Anterior-
Posterior-Commissure
axis
and
tangential
to
the
anterior
limit
of
the
right
brain
hemisphere
|
|
|
125032
|
Right
Hemisphere
Most
Posterior
|
A
point
fiducial
that
specifies
the
location
in
the
plane
perpendicular
to
the
Anterior-
Posterior-Commissure
axis
and
tangential
to
the
posterior
limit
of
the
right
brain
hemisphere
|
|
|
125033
|
Right
Hemisphere
Most
Superior
|
A
point
fiducial
that
specifies
the
location
in
the
plane
perpendicular
to
the
Anterior-
Posterior-Commissure
axis
and
tangential
to
the
superior
limit
of
the
right
brain
hemisphere
|
|
|
125034
|
Right
Hemisphere
Most
Inferior
|
A
point
fiducial
that
specifies
the
location
in
the
plane
perpendicular
to
the
Anterior-
Posterior-Commissure
axis
and
tangential
to
the
inferior
limit
of
the
Right
brain
hemisphere
|
|
|
125035
|
Left
Hemisphere
Most
Anterior
|
A
point
fiducial
that
specifies
the
location
in
the
plane
perpendicular
to
the
Anterior-
Posterior-Commissure
axis
and
tangential
to
the
anterior
limit
of
the
left
brain
hemisphere
|
|
|
125036
|
Left
Hemisphere
Most
Posterior
|
A
point
fiducial
that
specifies
the
location
in
the
plane
perpendicular
to
the
Anterior-
Posterior-Commissure
axis
and
tangential
to
the
posterior
limit
of
the
left
brain
hemisphere
|
|
|
125037
|
Left
Hemisphere
Most
Superior
|
A
point
fiducial
that
specifies
the
location
in
the
plane
perpendicular
to
the
Anterior-
Posterior-Commissure
axis
and
tangential
to
the
superior
limit
of
the
left
brain
hemisphere
|
|
|
125038
|
Left
Hemisphere
Most
Inferior
|
A
point
fiducial
that
specifies
the
location
in
the
plane
perpendicular
to
the
Anterior-
Posterior-Commissure
axis
and
tangential
to
the
inferior
limit
of
the
left
brain
hemisphere
|
|
|
125040
|
Background
|
That
which
is
not
part
of
an
object
|
E.g.
background
of
an
image
(that
which
might
be
encoded
with
Pixel
Padding
Value,
or
a
Segmentation
Property
Type.
|
|
125041
|
Registration
Input
|
A
segment
for
use
as
an
input
to
an
image
registration
process;
e.g.
to
specify
the
bounding
region
for
determining
a
Frame
of
Reference
Transformation
Matrix
|
|
|
125100
|
Vascular
Ultrasound
Procedure
Report
|
Root
Document
Title
for
ultrasound
vascular
evidence
reports
(worksheets)
|
|
|
125101
|
Vessel
Branch
|
The
particular
vessel
branch,
such
as
the
inferior,
medial
or
lateral
|
|
|
125102
|
Graft
Type
|
A
descriptor
or
elaboration
of
the
type
of
graft
|
|
|
125105
|
Measurement
Orientation
|
A
modifier
to
a
2D
distance
measurement
to
describe
its
orientation;
e.g.
a
vascular
distance
measurement
for
a
vessel
plague
could
have
a
modifier
Transverse
or
Longitudinal
|
|
|
125106
|
Doppler
Angle
|
The
angle
formed
between
the
Doppler
beam
line
and
the
direction
of
blood
flow
within
a
region
of
interest
in
the
body
defined
by
the
sample
volume
|
|
|
125107
|
Sample
Volume
Depth
|
The
depth
of
the
center
of
the
Doppler
sample
volume
measured
from
skin
line
along
the
Doppler
line
|
|
|
125195
|
Pediatric
Cardiac
Ultrasound
Report
|
Pediatric
Cardiac
Ultrasound
Report
(document
title)
|
|
|
125196
|
Fetal
Cardiac
Ultrasound
Report
|
Fetal
Cardiac
Ultrasound
Report
(document
title)
|
|
|
125197
|
Adult
Congenital
Cardiac
Ultrasound
Report
|
Adult
Congenital
Cardiac
Ultrasound
Report
(document
title)
|
|
|
125200
|
Adult
Echocardiography
Procedure
Report
|
Document
title
of
adult
echocardiography
procedure
(evidence)
report
|
|
|
125201
|
Illustration
of
Finding
|
An
image
that
is
a
pictorial
representation
of
findings.
The
concept
is
typically
used
as
a
purpose
of
reference
to
an
image,
such
as
a
depiction
of
myocardium
segments
depicting
wall
motion
function
|
|
|
125202
|
LV
Wall
Motion
Score
Index
|
The
average
of
all
scored
(non-zero)
Left
Ventricle
segment
wall
motion
scores
|
|
|
125203
|
Acquisition
Protocol
|
A
type
of
clinical
acquisition
protocol
for
creating
images
or
image-derived
measurements.
Acquisition
protocols
may
be
specific
to
a
manufacturer's
product
|
|
|
125204
|
Area-length
biplane
|
Method
for
calculating
left
ventricular
volume
from
two
orthogonal
views
containing
the
true
long
axis
(usually
the
apical
4
and
2
chamber
views).
Volume
=
[pL1
/
6]
*
[(4A1)
÷
(pL1)
]
*
[(4A2)
÷
(pL2)
]
|
|
|
125205
|
Area-Length
Single
Plane
|
Method
for
calculating
left
ventricular
volume
from
a
view
containing
the
true
long
axis
(usually
the
apical
4-chamber
view).
Volume
=
[8(A)2]÷[3pL]
|
|
|
125206
|
Cube
|
Method
(formula)
for
calculating
left
ventricle
volumes
and
function
derivatives
(EF,
SV,
SI,
etc.)
that
estimates
the
volume
as
the
cube
of
diameter
|
|
|
125207
|
Method
of
Disks,
Biplane
|
Method
of
calculating
volume
based
on
the
summation
of
disk
volumes.
The
disk
axis
is
parallel
to
the
left
ventricular
long
axis
and
using
a
disk
diameter
averaged
from
the
two
chamber
and
four
chamber
views
|
|
|
125208
|
Method
of
Disks,
Single
Plane
|
Method
of
calculating
volume
based
on
the
summation
of
disk
volumes.
The
disk
axis
is
parallel
to
the
left
ventricular
long
axis
with
disk
diameter
taken
from
the
four-chamber
view
|
|
|
125209
|
Teichholz
|
Method
(formula)
for
calculating
left
ventricle
volumes
and
function
derivatives
(EF,
SV,
SI,
etc.)
Volume
=
[7.0/(2.4+D)
]*D3
|
|
|
125210
|
Area
by
Pressure
Half-Time
|
Mitral
valve
area
(cm2)
by
Pressure
Half-time
=
220
(cm2.ms)
/
PHT
(ms)
|
|
|
125211
|
Biplane
Ellipse
|
Area
=
P/4
X
d1
X
d2
d1
=
anterior/posterior
axis
d2
=
medial/lateral
axis
Hagen-Ansert,
Sandra
L.,
Textbook
of
Diagnostic
Ultrasound,
ed.
3,
The
C.V.Mosby
Co.,
1989,
p.
73.
|
|
|
125212
|
Continuity
Equation
|
For
conduits
in
series
("in
continuity"),
volume
flow
is
equal:
A1*V1
=
A2*V2.
where
V
is
the
velocity
|
|
|
125213
|
Continuity
Equation
by
Mean
Velocity
|
For
conduits
in
series
("in
continuity"),
volume
flow
is
equal:
A1*V1
=
A2*V2.
where
V
is
the
mean
velocity
|
|
|
125214
|
Continuity
Equation
by
Peak
Velocity
|
For
conduits
in
series
("in
continuity"),
volume
flow
is
equal:
A1*V1
=
A2*V2.
where
V
is
the
peak
velocity
|
|
|
125215
|
Continuity
Equation
by
Velocity
Time
Integral
|
For
conduits
in
series
("in
continuity"),
volume
flow
is
equal:
A1*V1
=
A2*V2.
where
V
is
the
velocity
time
integral
|
|
|
125216
|
Proximal
Isovelocity
Surface
Area
|
Utilizes
aliasing
velocity
(by
color
Doppler)
of
flow
into
an
orifice
(often
regurgitant
or
stenotic)
to
measure
instantaneous
flow
rate,
orifice
area,
and
flow
volume.
The
instantaneous
flow
rate
=
(2πr2vav
)
*
(α
/
π)
where
vav
is
the
constant
velocity
known
as
aliasing
velocity
at
radius
r,
vp
is
the
peak
velocity
at
the
orifice,
and
α
is
the
angle
in
radians
of
the
constant
velocity
surface.
Estimated
Orifice
area
=
Flow
rate
/
vp
,
where
vp
is
the
peak
velocity
at
the
orifice
and
the
flow
rate
is
the
PISA
peak
flow
rate.
The
volume
flow
is
then
the
product
of
the
orifice
area
and
Velocity
Time
Integral
|
|
|
125217
|
Full
Bernoulli
|
ΔP
=
4*(V12
-
V22)
|
|
|
125218
|
Simplified
Bernoulli
|
ΔP
=
4*V2
|
|
|
125219
|
Doppler
Volume
Flow
|
Volume
flow
=
Conduit
CSA
*
(Velocity
Time
Integral)
|
|
|
125220
|
Planimetry
|
Direct
measurement
of
an
area
by
tracing
an
irregular
perimeter
|
|
|
125221
|
Left
Ventricle
Mass
by
M-mode
|
Mass
=
1.04
*
[(ST+LVID+PWT)3
-
LVID3]
*
0.8+
0.6.
Mass
unit
is
grams
and
length
in
cm
|
|
|
125222
|
Left
Ventricle
Mass
by
Truncated
Ellipse
|
Mass
=
1.05P
((b
+
t)2
X
(2/3
(a
+
t)
+
d
-
d3
/3(a
+
t)2)
-
b2
(2/3a
+
d
-
d3
/3a2))
a
=
Semi-major
axis
from
widest
minor
axis
radius
to
apex.
b
=
Short
axis
radius
calculated
from
short
axis
cavity
area
t
=
Myocardial
thickness
calculated
from
short
axis
epicardial
and
cavity
areas
d
=
Truncated
semi-major
axis
from
widest
short
axis
diameter
to
plane
of
mitral
annulus.
Mass
unit
is
grams
and
length
in
cm.
Schiller
NB
et
al:
Recommendations
for
quantification
of
the
left
ventricle
by
two-dimensional
echocardiography,
American
Society
of
Echocardiography
2:364,
1989.
|
|
|
125223
|
4
Point
Segment
Finding
Scale
|
A
four
point,
echocardiographic
numeric
scoring
scheme
of
myocardium
segments
based
on
evaluation
of
wall
motion
and
ventricle
morphology.
Recommendations
for
Quantitation
of
the
Left
Ventricle
by
Two-Dimensional
Echocardiography,
Journal
of
the
American
Society
of
Echocardiography,
2:358-367,
1989
|
|
|
125224
|
5
Point
Segment
Finding
Scale
|
A
five
point,
echocardiographic
numeric
scoring
scheme
of
myocardium
segments
based
on
evaluation
of
wall
motion
and
ventricle
morphology.
Recommendations
for
Quantitation
of
the
Left
Ventricle
by
Two-Dimensional
Echocardiography,
Journal
of
the
American
Society
of
Echocardiography,
2:358-367,
1989
|
|
|
125225
|
5
Point
Segment
Finding
Scale
With
Graded
Hypokinesis
|
A
five
point,
echocardiographic
numeric
scoring
scheme
of
myocardium
segments
based
on
evaluation
of
wall
motion
and
ventricle
morphology,
with
severity
of
hypokinesis
graded.
Recommendations
for
Quantitation
of
the
Left
Ventricle
by
Two-Dimensional
Echocardiography,
Journal
of
the
American
Society
of
Echocardiography,
2:358-367,
1989
|
|
|
125226
|
Single
Plane
Ellipse
|
Method
of
estimating
volume
from
a
planar
ellipse.
Equivalent
to
Biplane
Ellipse
with
an
assumption
that
the
ellipse
in
the
orthogonal
plane
has
identical
major
and
minor
diameters
|
|
|
125227
|
Modified
Simpson
|
Modified
Simpson's
Method
of
estimating
ventricular
volume,
based
on
the
method
of
disks
with
paired
apical
views.
Schiller
NB,
et
al.
"Recommendations
for
quantitation
of
the
left
ventricle
by
two-dimensional
echocardiography.
American
Society
of
Echocardiography
Committee
on
Standards,
Subcommittee
on
Quantitation
of
Two-Dimensional
Echocardiograms".
J
Am
Soc
Echocardiogr.1989
2(5):358-367.
Sep-Oct
|
|
|
125228
|
Bullet
Method
|
Bullet
method
of
estimating
ventricular
volume.
Volume
=
5/6
*
L
*
S
L:
Left
ventricle
long
axis
length
S:
Left
ventricle
area,
SAX
view
at
level
of
Mitral
Valve
|
|
|
125230
|
Power
Doppler
|
Color
coded
ultrasound
images
of
blood
flow,
which
depict
the
amplitude,
or
power,
of
Doppler
signals
|
|
|
125231
|
3D
mode
|
Volumetric
ultrasound
imaging
|
|
|
125233
|
Start
of
drug
dose
administration
|
Onset
of
administration
of
dose
of
a
drug
|
|
|
125234
|
Start
of
contrast
agent
administration
|
Onset
of
contrast
agent
administration
|
|
|
125235
|
Destruction
of
microbubbles
|
Destruction
of
ultrasonic
contrast
microbubbles
by
a
high-energy
ultrasound
pulse
|
|
|
125236
|
Onset
of
exercise
|
Instant
at
which
exercise
begins
|
|
|
125237
|
Cessation
of
exercise
|
Instant
at
which
exercise
ends
|
|
|
125238
|
Onset
of
stimulation
|
Instant
at
which
stimulation
begins
|
|
|
125239
|
Cessation
of
stimulation
|
Instant
at
which
stimulation
ends
|
|
|
125240
|
Line
scan
pattern
|
Ultrasound
transducer
scan
pattern
in
which
information
is
gathered
along
a
line
|
|
|
125241
|
Plane
scan
pattern
|
Ultrasound
transducer
scan
pattern
in
which
information
is
gathered
within
a
plane
|
|
|
125242
|
Volume
scan
pattern
|
Ultrasound
transducer
scan
pattern
in
which
information
is
gathered
within
a
volume
|
|
|
125251
|
Non-imaging
Doppler
ultrasound
transducer
geometry
|
Ultrasound
transducer
geometry
characterized
by
a
single
scan
line
used
for
PW
or
CW
Doppler
scanning
|
|
|
125252
|
Linear
ultrasound
transducer
geometry
|
Ultrasonic
transducer
geometry
characterized
by
parallel
lines
|
|
|
125253
|
Curved
linear
ultrasound
transducer
geometry
|
Ultrasonic
transducer
geometry
characterized
by
radial
lines
normal
to
the
outside
of
a
curved
surface
|
|
|
125254
|
Sector
ultrasound
transducer
geometry
|
Ultrasonic
transducer
geometry
characterized
by
lines
originating
from
a
common
apex
|
|
|
125255
|
Radial
ultrasound
transducer
geometry
|
Ultrasonic
transducer
geometry
characterized
by
lines
emanating
radially
from
a
single
point
|
|
|
125256
|
Ring
ultrasound
transducer
geometry
|
Ultrasonic
transducer
geometry
characterized
by
a
circular
ring
of
transducer
elements
|
|
|
125257
|
Fixed
beam
direction
|
Ultrasonic
steering
technique
consisting
of
a
single
beam
normal
to
the
transducer
face
steered
by
the
orientation
of
the
probe
|
|
|
125258
|
Mechanical
beam
steering
|
Ultrasonic
steering
technique
consisting
of
mechanically
directing
the
beam
|
|
|
125259
|
Phased
beam
steering
|
Ultrasonic
steering
technique
consisting
of
electronically-steered
beams
|
|
|
125261
|
External
Transducer
|
Transducer
is
designed
to
be
placed
onto
the
surface
of
the
subject
|
|
|
125262
|
Transesophageal
Transducer
|
Transducer
is
designed
for
insertion
into
the
esophagus
|
|
|
125263
|
Endovaginal
Transducer
|
Transducer
is
designed
for
insertion
into
the
vagina
|
|
|
125264
|
Endorectal
Transducer
|
Transducer
is
designed
for
insertion
into
the
rectum
|
|
|
125265
|
Intravascular
Transducer
|
Transducer
is
designed
for
insertion
via
a
catheter
|
|
|
125270
|
Left
Ventricle
Mass
by
Area
Length
|
method
to
measure
the
mass
of
the
Left
Ventricle
via
the
ASE
area-length
method
at
end
diastole.
LV
Mass
=
1.05*(5/6*(A1*(L+t))
-
5/6*(A2*L))
A1
=
Left
Ventricle
epicardial
SAX
area
at
the
level
of
the
papillary
muscle
tips
at
end
diastole.
A2
=
Left
Ventricle
endocardial
SAX
area
cavity
area
at
the
level
of
the
papillary
muscle
tips
at
end
diastole.
L
=
Left
Ventricle
apical
view
long
axis
length
at
end
diastole.
t
=
Myocardial
thickness
can
be
computed
as:
t
=
sqrt
(A1/3.14)
-
sqrt
(A2/3.14)
Reference:
1)
Schiller,
N.B.,
et
al.
"Recommendations
for
Quantification
of
the
LV
by
Two-dimensional
Echocardiography."
J
Am
Soc
Echo,
Vol.
2,
No.
5:
358-367,
Sep-Oct
1989.
2)
Reichek,
N.,
et
al.
"Anatomic
Validation
of
Left
Ventricular
Mass
Estimates
from
Clinical
Two-dimensional
Echocardiography:
Initial
Results."
Circulation,
Vol.
67,
No.
2:
348-52,
February
1983
|
|
|
125271
|
Left
Ventricle
Mass
by
M-mode
-
adjusted
by
Height
|
Equation
=
Left
Ventricle
Mass
by
M-mode
(in
gram)
/
(Height
(in
meter))
^2.7
Reference:
Giovanni
De
Simone,
et
al.
"Effect
of
Growth
on
Variability
of
Left
Ventricular
Mass:
Assessment
of
Allometric
Signals
in
Adults
and
Children
and
Their
Capacity
to
Predict
Cardiovascular
Risk".
New
York,
New
York
and
Cincinnati,
Ohio
|
|
|
125272
|
Left
Ventricle
Mass
by
Truncated
Ellipse
-
adjusted
by
Height
|
Equation
=
Left
Ventricle
Mass
by
Truncated
Ellipse
/
Height^2.7
Reference:
Giovanni
De
Simone,
et
al.
"Effect
of
Growth
on
Variability
of
Left
Ventricular
Mass:
Assessment
of
Allometric
Signals
in
Adults
and
Children
and
Their
Capacity
to
Predict
Cardiovascular
Risk".
New
York,
New
York
and
Cincinnati,
Ohio
|
|
|
125273
|
Left
Ventricle
Mass
by
Area
Length
-
adjusted
by
Height
|
Equation
=
Left
Ventricle
Mass
by
Area
Length
/
Height^2.7
Reference:
Giovanni
De
Simone,
et
al.
"Effect
of
Growth
on
Variability
of
Left
Ventricular
Mass:
Assessment
of
Allometric
Signals
in
Adults
and
Children
and
Their
Capacity
to
Predict
Cardiovascular
Risk".
New
York,
New
York
and
Cincinnati,
Ohio
|
|
|
125901
|
CARDIOsphere
|
CARDIOsphere
ultrasonic
contrast
agent
produced
by
POINT
Biomedical
|
|
|
125902
|
Echovist
|
Echovist®
ultrasonic
contrast
agent
produced
by
Schering
AG
|
|
|
125903
|
Imagify
|
Imagify
ultrasonic
contrast
agent
produced
by
Accusphere
Inc
|
|
|
125904
|
Levovist
|
Levovist®
ultrasonic
contrast
agent
produced
by
Schering
AG
|
|
|
125905
|
Sonazoid
|
Sonazoid
ultrasonic
contrast
agent
produced
by
Daiichi
Pharmaceutical
/
General
Electric
|
|
|
125906
|
SonoVue
|
SonoVue
ultrasonic
contrast
agent
produced
by
Bracco
Diagnostics
|
|
|
125907
|
Targestar-B
|
Targestar-B
ultrasonic
contrast
agent
produced
by
Targeson
LLC
|
|
|
125908
|
Targestar-P
|
Targestar-P
ultrasonic
contrast
agent
produced
by
Targeson
LLC
|
|
|
126000
|
Imaging
Measurement
Report
|
A
structured
report
containing
the
quantitative
results
of
human
or
machine
analysis
of
images
|
|
|
126001
|
Oncology
Measurement
Report
|
A
structured
report
containing
the
quantitative
results
of
human
or
machine
analysis
of
images
for
oncology
evaluation
|
|
|
126002
|
Dynamic
Contrast
MR
Measurement
Report
|
A
structured
report
containing
the
quantitative
results
of
human
or
machine
analysis
of
DCE-MR
|
|
|
126003
|
PET
Measurement
Report
|
A
structured
report
containing
the
quantitative
results
of
human
or
machine
analysis
of
PET
images
|
|
|
126010
|
Imaging
Measurements
|
Measurements
made
on
images
|
|
|
126011
|
Derived
Imaging
Measurements
|
Measurements
derived
from
measurements
made
on
images
|
|
|
126020
|
Multiparametric
MRI
|
An
MRI
procedure
in
which
multiple
parameters
including
diffusion,
dynamic
contrast
and
T2
are
measured
|
|
|
126021
|
Multiparametric
MRI
of
prostate
|
An
MRI
procedure
of
the
prostate
in
which
multiple
parameters
including
diffusion,
dynamic
contrast
and
T2
are
measured
|
|
|
126022
|
Multiparametric
MRI
of
whole
body
|
An
MRI
procedure
of
the
whole
body
in
which
multiple
parameters
including
diffusion,
dynamic
contrast
and
T2
are
measured
|
|
|
126030
|
Sum
of
segmented
voxel
volumes
|
The
volume
derived
by
summing
the
volumes
of
all
the
voxels
(and
partial
voxels
if
the
segment
contains
partially
occupied
voxels)
included
in
the
segment
|
|
|
126031
|
Peak
Value
Within
ROI
|
Maximum
average
gray
value
that
is
calculated
from
a
1
cubic
centimeter
sphere
placed
within
the
region
of
interest.
Reference
Wahl
et
al
PERCIST
article
|
|
|
126032
|
Metabolic
Volume
|
The
volume
of
a
lesion
(e.g.
a
tumor)
ascertained
through
information
about
its
metabolic
activity
(e.g.
SUV
on
PET).
Abbreviated
"MV".
Synonymous
with
Metabolic
Tumor
Volume
(MTV)
|
|
|
126033
|
Total
Lesion
Glycolysis
|
The
total
activity
of
a
lesion
obtained
as
the
product
of
its
volume
and
its
glycolytic
activity
(on
FDG-PET).
The
volume
may
be
defined
on
the
same
modality
(e.g.
the
MV
on
FDG-PET
by
some
thresholding
or
other
technique)
or
on
another
spatially
registered
modality
(e.g.
the
lesion
outline
segmented
on
CT
or
MR).
Does
not
apply
to
other
radiopharmaceuticals
than
those
involved
in
glucose
metabolism.
Abbreviated
TLG.
Synonymnous
with
"Tumor
Lesion
Glycolysis"
|
|
|
126034
|
Glycolysis
|
The
amount
glycolytic
activity
summed
across
all
voxels
in
a
defined
region
or
within
a
defined
range
of
SUV
(on
FDG-PET)
|
|
|
126035
|
Total
Lesion
Proliferation
|
The
total
activity
of
a
lesion
obtained
as
the
product
of
its
volume
and
its
proliferative
activity
(on
FLT-PET).
The
volume
may
be
defined
on
the
same
modality
(e.g.
the
MV
on
FDG-PET
by
some
thresholding
or
other
technique)
or
on
another
spatially
registered
modality
(e.g.
the
lesion
outline
segmented
on
CT
or
MR).
Does
not
apply
to
other
radiopharmaceuticals
than
those
involved
in
cellular
proliferation.
Abbreviated
TLP.
Synonymnous
with
"Tumor
Lesion
Proliferation"
|
|
|
126036
|
Proliferative
Activity
|
The
amount
proliferative
activity
summed
across
all
voxels
in
a
defined
region
or
within
a
defined
range
of
SUV
(on
FLT-PET)
|
|
|
126037
|
Standardized
Added
Metabolic
Activity
(SAM)
|
A
background-corrected,
partial
volume
independent
version
of
TLG.
SAM
is
calculated
by
drawing
a
volume
of
interest
(VOI1)
around
the
tumour
and
a
larger
VOI
(VOI2)
around
VOI1.
Subtracting
the
background
activity
in
VOI2-VOI1
from
VOI1
yields
SAM.
See
Mertens
et
al.
"Standardized
added
metabolic
activity
(SAM):
a
partial
volume
independent
marker
of
total
lesion
glycolysis
in
liver
metastases".
Eur
J
Nucl
Med
Mol
Imaging
(2012)
39:1441-1448
|
|
|
126038
|
Standardized
Added
Metabolic
Activity
(SAM)
Background
|
The
background
value
(VOI2-VOI1)
used
to
calculate
Standardized
Added
Metabolic
Activity
(SAM).
SAM
is
calculated
by
drawing
a
volume
of
interest
(VOI1)
around
the
tumour
and
a
larger
VOI
(VOI2)
around
VOI1.
Subtracting
the
background
activity
in
VOI2-VOI1
from
VOI1
yields
SAM.
See
Mertens
et
al.
"Standardized
added
metabolic
activity
(SAM):
a
partial
volume
independent
marker
of
total
lesion
glycolysis
in
liver
metastases".
Eur
J
Nucl
Med
Mol
Imaging
(2012)
39:1441-1448
|
|
|
126039
|
Lesion
to
Background
SUV
Ratio
|
The
ratio
of
the
SUV
within
a
tumor
to
the
SUV
of
a
pre-defined
background
region.
Need
reference(s).
A
more
general
concept
than
Tumor
to
Background
Ratio
(TBR)
|
|
|
126040
|
Background
for
Lesion
to
Background
SUV
Ratio
|
The
SUV
of
a
pre-defined
background
region
used
to
compute
Lesion
to
Background
SUV
Ratio.
Need
reference(s)
|
|
|
126050
|
Fractal
Dimension
|
A
statistical
index
of
complexity
comparing
how
detail
in
a
fractal
pattern
changes
with
the
scale
at
which
it
is
measured;
a
ratio
of
the
change
in
detail
to
the
change
in
scale
|
|
|
126051
|
Skewness
|
Measure
of
the
asymmetry
of
the
probability
distribution
of
a
real-valued
random
variable
about
its
mean
|
|
|
126052
|
Kurtosis
|
Measure
of
the
peakedness
of
the
probability
distribution
of
a
real-valued
random
variable
|
|
|
126060
|
Entropy
of
GLCM
|
The
zero
order
entropy
of
a
Gray
Level
Co-occurrence
Matrix
(GLCM).
A
measure
of
disorder.
See
http://www.fp.ucalgary.ca/mhallbey/equations.htm
|
|
|
126061
|
Energy
of
GLCM
|
The
energy
(uniformity)
(square
root
of
the
Angular
Second
Moment
(ASM))
of
a
Gray
Level
Co-occurrence
Matrix
(GLCM).
A
measure
of
orderliness.
See
http://www.fp.ucalgary.ca/mhallbey/equations.htm
|
|
|
126062
|
Homogeneity
of
GLCM
|
The
Inverse
Difference
Moment
of
a
Gray
Level
Co-occurrence
Matrix
(GLCM).
See
http://www.fp.ucalgary.ca/mhallbey/equations.htm
|
|
|
126063
|
Contrast
of
GLCM
|
The
sum
of
squares
variance
of
a
Gray
Level
Co-occurrence
Matrix
(GLCM).
See
http://www.fp.ucalgary.ca/mhallbey/equations.htm
|
|
|
126064
|
Dissimilarity
of
GLCM
|
The
dissimilarity
of
a
Gray
Level
Co-occurrence
Matrix
(GLCM).
See
http://www.fp.ucalgary.ca/mhallbey/equations.htm
|
|
|
126065
|
ASM
of
GLCM
|
The
Angular
Second
Moment
of
a
Gray
Level
Co-occurrence
Matrix
(GLCM).
See
http://www.fp.ucalgary.ca/mhallbey/equations.htm
|
|
|
126066
|
Correlation
of
GLCM
|
A
measure
of
the
linear
dependency
of
grey
levels
on
those
of
neighbouring
pixels
of
a
Gray
Level
Co-occurrence
Matrix
(GLCM).
See
http://www.fp.ucalgary.ca/mhallbey/equations.htm
|
|
|
126067
|
Gray
Level
Co-occurrence
Matrix
(GLCM)
|
A
tabulation
of
how
often
different
combinations
of
pixel
values
(grey
levels)
occur
in
an
image.
See
http://www.fp.ucalgary.ca/mhallbey/the_glcm.htm
|
|
|
126070
|
Subject
Time
Point
Identifier
|
An
identifier
of
a
specific
time
point
in
a
continuum,
which
is
unique
within
an
appropriate
local
context
(such
as
an
entire
organization,
system
or
treatment
protocol),
which
identifies
the
time
point
for
a
specific
patient
|
|
|
126071
|
Protocol
Time
Point
Identifier
|
An
identifier
of
a
specific
time
point
in
a
continuum,
which
is
unique
within
an
appropriate
local
context
(such
as
an
entire
organization,
system
or
treatment
protocol),
which
identifies
the
time
point
"slot"
within
a
treatment
protocol
using
the
same
value
for
all
patients
in
the
protocol
|
|
|
126072
|
Time
Point
Type
|
A
pre-defined
type
of
a
specific
time
point
in
a
continuum
|
|
|
126073
|
Time
Point
Order
|
A
number
indicating
the
order
of
a
time
point
relative
to
other
time
points
in
the
same
continuum
|
|
|
126074
|
Posttreatment
|
The
time
after
the
treatment
of
interest
|
|
|
126075
|
Eligibility
|
For
the
purpose
of
determining
eligibility
for
a
protocol
|
Similar
but
not
identical
to
(21954-3,
LN,
"Protocol
eligibility
status
Cancer"),
since
not
constrained
to
cancer,
etc.
|
|
126080
|
RECIST
1.0
|
Response
Evaluation
Criteria
in
Solid
Tumors
version
1.0.
See
[RECIST]
in
Normative
References
|
More
specific
than
(112022,
DCM,
"RECIST")
or
(C1709926,
UMLS,
"RECIST")
or
(C49164,
NCIt,
"RECIST")
in
that
a
specific
version
is
specified.
|
|
126081
|
RECIST
1.1
|
Response
Evaluation
Criteria
in
Solid
Tumors
Version
1.1.
See
Eisenhauer
et
al.
"New
Response
Evaluation
Criteria
in
Solid
Tumours:
Revised
RECIST
Guideline
(version
1.1)."
European
Journal
of
Cancer
45,
no.
2
(n.d.):
228-47.
doi:10.1016/j.ejca.2008.10.026.
|
More
specific
than
(112022,
DCM,
"RECIST")
or
(C1709926,
UMLS,
"RECIST")
or
(C49164,
NCIt,
"RECIST")
in
that
a
specific
version
is
specified.
|
|
126100
|
Real
World
Value
Map
used
for
measurement
|
A
reference
to
the
Real
World
Value
Map
applied
to
the
stored
image
pixel
values
before
their
use
for
a
measurement
|
|
|
126200
|
Image
Library
Group
|
A
container
that
groups
common
information
about
a
set
of
images
used
as
evidence
to
produce
a
report
|
|
|
126201
|
Acquisition
Date
|
The
date
the
acquisition
of
data
started
|
|
|
126202
|
Acquisition
Time
|
The
time
the
acquisition
of
data
started
|
|
|
126203
|
PET
Radionuclide
Incubation
Time
|
The
time
between
the
start
of
injection
of
the
PET
radionuclide
and
the
start
of
acquisition
of
the
PET
data
|
|
|
126220
|
R2-Coefficient
|
Coefficient
of
determination,
R2.
An
indication
of
goodness
of
fit
|
|
|
126300
|
Perfusion
analysis
by
Stable
Xenon
CT
technique
|
Perfusion
analysis
by
Stable
Xenon
CT
technique
|
|
|
126301
|
Perfusion
analysis
by
IV
Iodinated
Contrast
CT
technique
|
Perfusion
analysis
by
IV
Iodinated
Contrast
CT
technique
|
|
|
126302
|
Perfusion
analysis
by
Arterial
Spin
Labeling
MR
technique
|
Perfusion
analysis
by
Arterial
Spin
Labeling
(ASL)
MR
technique
|
|
|
126303
|
Perfusion
analysis
by
Susceptibility
MR
technique
|
Perfusion
analysis
by
Susceptibility
(T2*)
MR
technique
|
|
|
126310
|
Least
Mean
Square
(LMS)
deconvolution
|
Least
Mean
Square
(LMS)
deconvolution
|
|
|
126311
|
Singular
Value
Decomposition
(SVD)
deconvolution
|
Singular
Value
Decomposition
(SVD)
deconvolution
|
|
|
126312
|
Ktrans
|
Ktrans,
the
volume
transfer
constant
of
a
tracer
diffusion
kinetic
model,
specifically
the
volume
transfer
constant
between
blood
plasma
and
extravascular
extracellular
space
(EES)
See
Tofts
et
al,
"Estimating
Kinetic
Parameters
From
Dynamic
Contrast-Enhanced
T1-Weighted
MRI
of
a
Diffusable
Tracer:
Standardized
Quantities
and
Symbols",
Journal
of
Magnetic
Resonance
Imaging,
vol.
10,
pp.
223-232,
1999
|
|
|
126313
|
kep
|
kep,
the
rate
constant
between
extravascular
extracellular
space
(EES)
and
blood
plasma
See
Tofts
et
al,
"Estimating
Kinetic
Parameters
From
Dynamic
Contrast-Enhanced
T1-Weighted
MRI
of
a
Diffusable
Tracer:
Standardized
Quantities
and
Symbols",
Journal
of
Magnetic
Resonance
Imaging,
vol.
10,
pp.
223-232,
1999
|
|
|
126314
|
ve
|
ve,
the
fractional
(not
absolute)
volume
of
extravascular
extracellular
space
(EES)
per
unit
volume
of
tissue
See
Tofts
et
al,
"Estimating
Kinetic
Parameters
From
Dynamic
Contrast-Enhanced
T1-Weighted
MRI
of
a
Diffusable
Tracer:
Standardized
Quantities
and
Symbols",
Journal
of
Magnetic
Resonance
Imaging,
vol.
10,
pp.
223-232,
1999
|
|
|
126320
|
IAUC
|
The
intial
area
under
the
contrast
agent
concentration-time
curve
|
|
|
126321
|
IAUC60
|
The
intial
area
under
the
contrast
agent
concentration-time
curve
at
60
seconds
after
the
onset
time
|
|
|
126322
|
IAUC90
|
The
intial
area
under
the
contrast
agent
concentration-time
curve
at
90
seconds
after
the
onset
time
|
|
|
126330
|
tau_m
|
τm.
The
mean
intracellular
water
lifetime
(τi).
Used
in
the
Shutter-Speed
Model
(SSM)
of
tracer
kinetics
|
|
|
126331
|
vp
|
vp.
The
fractional
(not
absolute)
blood
plasma
volume
per
unit
volume
of
tissue.
See
Tofts
et
al,
"Estimating
Kinetic
Parameters
From
Dynamic
Contrast-Enhanced
T1-Weighted
MRI
of
a
Diffusable
Tracer:
Standardized
Quantities
and
Symbols",
Journal
of
Magnetic
Resonance
Imaging,
vol.
10,
pp.
223-232,
1999
|
|
|
126340
|
Standard
Tofts
Model
|
A
tracer
diffusion
kinetic
model
in
which
the
permeability
is
assumed
to
be
isodirectional.
See
P.
Tofts,
"Modeling
tracer
kinetics
in
dynamic
Gd-DTPA
MR
imaging",
Journal
of
Magnetic
Resonance
Imaging,
vol.
7,
pp.
91-101,
1997
|
|
|
126341
|
Extended
Tofts
Model
|
A
tracer
diffusion
kinetic
model
in
which
the
permeability
is
not
assumed
to
be
isodirectional,
and
which
includes
the
contribution
of
tracer
in
the
blood
plasma
to
the
total
tissue
concentration.
See
P.
Tofts,
"Modeling
tracer
kinetics
in
dynamic
Gd-DTPA
MR
imaging",
Journal
of
Magnetic
Resonance
Imaging,
vol.
7,
pp.
91-101,
1997
|
|
|
126342
|
Model-free
concentration-time
quantitification
|
A
semiquantitative
analysis
of
the
contrast-enhancement
concentration
versus
time
curve
that
avoids
the
use
of
a
pharmacokinetic
model;
e.g.
integration
to
compute
the
initial
area
under
the
curve
|
|
|
126343
|
First
Pass
Leakage
Profile
(FPLP)
|
A
tracer
diffusion
kinetic
model
that
accounts
for
the
tumor
leakage
profile
during
the
first
pass
of
contrast.
See
Li,
Ka-Loh,
Xiao
Ping
Zhu,
John
Waterton,
and
Alan
Jackson.
"Improved
3D
Quantitative
Mapping
of
Blood
Volume
and
Endothelial
Permeability
in
Brain
Tumors."
Journal
of
Magnetic
Resonance
Imaging
12,
no.
2
(2000):
347-357.
doi:10.1002/1522-2586(200008)12:2<347::AID-JMRI19>3.0.CO;2-7
|
|
|
126344
|
Shutter-Speed
Model
(SSM)
|
A
tracer
diffusion
kinetic
model
that
does
not
assume
that
intercompartmental
water
molecule
exchange
is
infinitely
fast.
See
Li,
Xin,
Wei
Huang,
Thomas
E.
Yankeelov,
Alina
Tudorica,
William
D.
Rooney,
and
Charles
S.
Springer.
"Shutter-Speed
Analysis
of
Contrast
Reagent
Bolus-Tracking
Data:
Preliminary
Observations
in
Benign
and
Malignant
Breast
Disease."
Magnetic
Resonance
in
Medicine
53,
no.
3
(2005):
724-29.
doi:10.1002/mrm.20405
|
|
|
126350
|
T1
by
Multiple
Flip
Angles
|
T1
measurement
by
Multiple
Flip
Angles
(MFA)
(variable
saturation)
method
|
|
|
126351
|
T1
by
Inversion
Recovery
|
T1
measurement
by
Inversion
Recovery
(IR)
method
|
|
|
126352
|
T1
by
Fixed
Value
|
Calculation
was
performed
using
a
fixed
value
of
T1
rather
than
a
measured
value.
The
value
could
be
encoded
as
the
value
of
(126353,
DCM,
"T1
Used
For
Calculation")
|
|
|
126353
|
T1
Used
For
Calculation
|
The
fixed
value
of
T1
used
for
a
calculation
|
|
|
126360
|
AIF
Ignored
|
No
Arterial
Input
Function
was
used
|
|
|
126361
|
Population
Averaged
AIF
|
A
population-averaged
Arterial
Input
Function
|
|
|
126362
|
User-defined
AIF
ROI
|
An
Arterial
Input
Function
computed
from
a
user-defined
Region
of
Interest
|
|
|
126363
|
Automatically
Detected
AIF
ROI
|
An
Arterial
Input
Function
computed
from
an
automatically
detected
Region
of
Interest
|
|
|
126364
|
Blind
Estimation
of
AIF
|
A
data-driven
blind
source
separation
(BSS)
algorithm
that
estimates
AIF
from
individuals
without
any
presumed
AIF
model
and
initialization.
See
Lin,
Yu-Chun,
Tsung-Han
Chan,
Chong-Yung
Chi,
Shu-Hang
Ng,
Hao-Li
Liu,
Kuo-Chen
Wei,
Yau-Yau
Wai,
Chun-Chieh
Wang,
and
Jiun-Jie
Wang.
"Blind
Estimation
of
the
Arterial
Input
Function
in
Dynamic
Contrast-Enhanced
MRI
Using
Purity
Maximization."
Magnetic
Resonance
in
Medicine
68,
no.
5
(November
1,
2012):
1439-49.
doi:10.1002/mrm.24144
|
|
|
126370
|
Time
of
Peak
Concentration
|
The
time
at
which
the
concentration-time
curve
achieves
its
peak
for
the
first
time.
Used
as
a
concept
name
for
a
value
or
as
a
method;
e.g.
used
as
a
method
of
calculation
for
BAT.
See
Shpilfoygel
Med
Phys
2008.
doi:
10.1118/1.1288669
|
|
|
126371
|
Bolus
Arrival
Time
|
The
nominal
time
at
which
arrival
of
a
contrast
bolus
is
detected,
which
is
used
as
a
reference
point
for
subsequent
calculations.
Used
as
a
concept
name
for
a
value
or
as
a
method.
No
specific
computational
method
is
implied
by
this
general
definition.
Abbreviated
BAT
|
|
|
126372
|
Time
of
Leading
Half-Peak
Concentration
|
The
time
at
which
the
concentration-time
curve
achieves
half
of
its
peak
density
for
the
first
time.
Used
as
a
concept
name
for
a
value
or
as
a
method;
e.g.
used
as
a
method
of
calculation
for
BAT.
See
Shpilfoygel
Med
Phys
2008.
doi:
10.1118/1.1288669
|
|
|
126373
|
Temporal
Derivative
Exceeds
Threshold
|
A
method
of
determining
BAT
that
involves
computing
the
temporal
derivative
of
the
concentration-time
curve
and
selecting
the
time
when
the
temporal
derivative
exceeds
a
specified
threshold.
See
Shpilfoygel
Med
Phys
2008.
doi:
10.1118/1.1288669
|
|
|
126374
|
Temporal
Derivative
Threshold
|
A
threshold
applied
to
the
temporal
derivative
of
the
concentration-time
curve;
e.g.
used
to
establish
BAT.
See
Shpilfoygel
Med
Phys
2008.
doi:
10.1118/1.1288669
|
|
|
126375
|
Maximum
Slope
|
The
maximum
rate
of
signal
intensity
change
within
a
measured
region
of
a
time-activity
curve.
See
Boonsirikamchai,
Piyaporn,
Harmeet
Kaur,
Deborah
A.
Kuban,
Edward
Jackson,
Ping
Hou,
and
Haesun
Choi.
"Use
of
Maximum
Slope
Images
Generated
From
Dynamic
Contrast-Enhanced
MRI
to
Detect
Locally
Recurrent
Prostate
Carcinoma
After
Prostatectomy:
A
Practical
Approach."
American
Journal
of
Roentgenology
198,
no.
3
(March
1,
2012):
W228-W236.
doi:10.2214/AJR.10.6387
|
|
|
126376
|
Maximum
Difference
|
The
maximum
degree
of
signal
intensity
change
within
a
measured
region
of
a
time-activity
curve.
See
Boonsirikamchai,
Piyaporn,
Harmeet
Kaur,
Deborah
A.
Kuban,
Edward
Jackson,
Ping
Hou,
and
Haesun
Choi.
"Use
of
Maximum
Slope
Images
Generated
From
Dynamic
Contrast-Enhanced
MRI
to
Detect
Locally
Recurrent
Prostate
Carcinoma
After
Prostatectomy:
A
Practical
Approach."
American
Journal
of
Roentgenology
198,
no.
3
(March
1,
2012):
W228-W236.
doi:10.2214/AJR.10.6387
|
|
|
126377
|
Tracer
Concentration
|
Tracer
concentration
in
tissue;
e.g.
in
a
DCE-MR
experiment,
the
concentration
of
contrast
agent
in
mmol/l
|
|
|
126380
|
Contrast
Longitudinal
Relaxivity
|
The
degree
to
which
a
paramagnetic
contrast
agent
can
enhance
the
proton
longitudinal
relaxation
rate
constant
(R1,
1/T1),
normalized
to
the
concentration
of
the
contrast
agent.
Also
referred
to
as
r1.
Typically
expressed
in
units
of
l/mmol/s
|
|
|
126390
|
Regional
Blood
Flow
|
The
flow
rate
of
blood
perfusing
a
region
as
volume
per
mass
per
unit
of
time
|
|
|
126391
|
Regional
Blood
Volume
|
The
volume
of
blood
perfusing
a
region
as
volume
per
mass
|
|
|
126392
|
Oxygen
Extraction
Fraction
|
The
percent
of
the
oxygen
removed
from
the
blood
by
tissue
during
its
passage
through
the
capillary
network.
For
example,
as
measured
by
blood
oxygenation
level
dependent
(BOLD)
MR.
See
He,
Xiang,
and
Dmitriy
A.
Yablonskiy.
"Quantitative
BOLD:
Mapping
of
Human
Cerebral
Deoxygenated
Blood
Volume
and
Oxygen
Extraction
Fraction:
Default
State."
Magnetic
Resonance
in
Medicine
57,
no.
1
(2007):
115-26
|
|
|
126393
|
R1
|
The
longitiudinal
relaxation
rate
constant.
The
inverse
of
longitudinal
relaxation
time,
i.e.,
R1
=
1/T1
|
|
|
126394
|
R2
|
The
transverse
relaxation
rate
constant.
The
inverse
of
transverse
relaxation
time,
i.e.,
R2
=
1/T2
|
|
|
126400
|
Standardized
Uptake
Value
|
A
ratio
of
locally
measured
radioactivity
concentration
versus
the
injected
radioactivity
distributed
evenly
throughout
the
whole
body.
This
general
concept
encompasses
all
specific
methods
of
calculating
the
whole
body
volume
of
distribution,
such
as
using
body
weight,
lean
body
mass,
body
surface
area,
etc
|
|
|
126401
|
SUVbw
|
Standardized
Uptake
Value
calculated
using
body
weight.
The
patient
size
correction
factor
for
males
and
females
is
body
weight.
Defined
in
Sugawara
et
al.
Reevaluation
of
the
Standardized
Uptake
Value
for
FDG:
Variations
with
Body
Weight
and
Methods
for
Correction.Radiology,
1999
at
http://radiology.rsna.org/content/213/2/521
|
|
|
126402
|
SUVlbm
|
Standardized
Uptake
Value
calculated
using
lean
body
mass.
The
patient
size
correction
factor
for
males
is
1.10
*
weight
-
120
*
(weight/height)
^2,
and
for
females
is
1.07
*
weight
-
148
*
(weight/height)
^2.
Defined
in
Sugawara
et
al.
Reevaluation
of
the
Standardized
Uptake
Value
for
FDG:
Variations
with
Body
Weight
and
Methods
for
Correction.Radiology,
1999
at
http://radiology.rsna.org/content/213/2/521
|
|
|
126403
|
SUVbsa
|
Standardized
Uptake
Value
calculated
using
body
surface
area.
The
patient
size
correction
factor
for
males
and
females
is
weight^
0.425
*
height^0.725
*
0.007184.
Defined
in
Sugawara
et
al.
Reevaluation
of
the
Standardized
Uptake
Value
for
FDG:
Variations
with
Body
Weight
and
Methods
for
Correction.Radiology,
1999
at
http://radiology.rsna.org/content/213/2/521
|
|
|
126404
|
SUVibw
|
Standardized
Uptake
Value
calculated
using
ideal
body
weight.
The
patient
size
correction
factor
for
males
is
48.0
+
1.06
*
(height
-
152)
and
for
females
is
45.5
+
0.91
*
(height
-
152).
Defined
in
Sugawara
et
al.
Reevaluation
of
the
Standardized
Uptake
Value
for
FDG:
Variations
with
Body
Weight
and
Methods
for
Correction.Radiology,
1999
at
http://radiology.rsna.org/content/213/2/521
|
|
|
126410
|
SUV
body
weight
calculation
method
|
Method
of
calculating
Standardized
Uptake
Value
using
body
weight.
The
patient
size
correction
factor
for
males
and
females
is
body
weight.
Defined
in
Sugawara
et
al.
Reevaluation
of
the
Standardized
Uptake
Value
for
FDG:
Variations
with
Body
Weight
and
Methods
for
Correction.Radiology,
1999
at
http://radiology.rsna.org/content/213/2/521
|
|
|
126411
|
SUV
lean
body
mass
calculation
method
|
Method
of
calculating
Standardized
Uptake
Value
using
lean
body
mass.
The
patient
size
correction
factor
for
males
is
1.10
*
weight
-
120
*
(weight/height)
^2,
and
for
females
is
1.07
*
weight
-
148
*
(weight/height)
^2.
Defined
in
Sugawara
et
al.
Reevaluation
of
the
Standardized
Uptake
Value
for
FDG:
Variations
with
Body
Weight
and
Methods
for
Correction.Radiology,
1999
at
http://radiology.rsna.org/content/213/2/521
|
|
|
126412
|
SUV
body
surface
area
calculation
method
|
Method
of
calculating
Standardized
Uptake
Value
using
body
surface
area.
The
patient
size
correction
factor
for
males
and
females
is
weight^
0.425
*
height^0.725
*
0.007184.
Defined
in
Sugawara
et
al.
Reevaluation
of
the
Standardized
Uptake
Value
for
FDG:
Variations
with
Body
Weight
and
Methods
for
Correction.Radiology,
1999
at
http://radiology.rsna.org/content/213/2/521
|
|
|
126413
|
SUV
ideal
body
weight
calculation
method
|
Method
of
calculating
Standardized
Uptake
Value
using
ideal
body
weight.
The
patient
size
correction
factor
for
males
is
48.0
+
1.06
*
(height
-
152)
and
for
females
is
45.5
+
0.91
*
(height
-
152).
Defined
in
Sugawara
et
al.
Reevaluation
of
the
Standardized
Uptake
Value
for
FDG:
Variations
with
Body
Weight
and
Methods
for
Correction.Radiology,
1999
at
http://radiology.rsna.org/content/213/2/521
|
|
|
126500
|
Pittsburgh
compound
B
C^11^
|
A
beta-amyloid
PET
radiotracer
that
is
an
analog
of
thioflavin
T
|
|
|
126501
|
Florbetaben
F^18^
|
A
beta-amyloid
PET
radiotracer
|
|
|
126502
|
T807
F^18^
|
A
PHF-tau
PET
radiotracer
|
|
|
126503
|
Flubatine
F^18^
|
A
nicotinic
α4β2
receptor
(nAChR)
PET
radiotracer
|
|
|
126510
|
Monoclonal
Antibody
(mAb)
^64^Cu
|
A
Cu
64
Monoclonal
Antibody
(mAb)
PET
Radiotracer
|
|
|
126511
|
Monoclonal
Antibody
(mAb)
^89^Zr
|
A
Zr
89
Monoclonal
Antibody
(mAb)
PET
Radiotracer
|
|
|
126512
|
Trastuzumab
^89^Zr
|
A
Zr
89
Trastuzumab
PET
Radiotracer
|
|
|
126513
|
Cetuximab
^89^Zr
|
A
Zr
89
Cetuximab
PET
Radiotracer
|
|
|
126514
|
J591
^89^Zr
|
A
Zr
89
J591
PET
Radiotracer
|
|
|
126515
|
cU36
^89^Zr
|
A
Zr
89
cU36
PET
Radiotracer
|
|
|
126516
|
Bevacizumab
^89^Zr
|
A
Zr
89
Bevacizumab
PET
Radiotracer
|
|
|
126517
|
cG250-F(ab')(2)
^89^Zr
|
A
Zr
89
cG250-F(ab')(2)
PET
Radiotracer
|
|
|
126518
|
R1507
^89^Zr
|
A
Zr
89
R1507
PET
Radiotracer
|
|
|
126519
|
E4G10
^89^Zr
|
A
Zr
89
E4G10
PET
Radiotracer
|
|
|
126520
|
Df-CD45
^89^Zr
|
A
Zr
89
Df-CD45
PET
Radiotracer
|
|
|
126600
|
^44^Scandium
|
^44^Scandium
|
|
|
126601
|
^51^Manganese
|
^51^Manganese
|
|
|
126602
|
^70^Arsenic
|
^70^Arsenic
|
|
|
126603
|
^90^Niobium
|
^90^Niobium
|
|
|
126604
|
^191m^Iridium
|
^191m^Iridium
|
|
|
126605
|
^43^Scandium
|
^43^Scandium
|
|
|
126606
|
^152^Terbium
|
^152^Terbium
|
|
|
126700
|
ATSM
Cu^60^
|
A
Cu
60
ATSM
PET
radiotracer
|
|
|
126701
|
ATSM
Cu^61^
|
A
Cu
61
ATSM
PET
radiotracer
|
|
|
126702
|
ATSM
Cu^62^
|
A
Cu
62
ATSM
PET
radiotracer
|
|
|
126703
|
Choline
C^11^
|
A
C
11
Choline
PET
radiotracer
|
|
|
126704
|
Fallypride
C^11^
|
A
C
11
Fallypride
PET
radiotracer
|
|
|
126705
|
Fallypride
F^18^
|
An
F
18
Fallypride
PET
radiotracer
|
|
|
126706
|
FLB
457
C^11^
|
A
C
11
FLB
457
PET
radiotracer
|
|
|
126707
|
Fluorotriopride
F^18^
|
An
F
18
Fluorotriopride
PET
radiotracer
|
|
|
126708
|
Fluoromisonidazole
(FMISO)
F^18^
|
An
F
18
Fluoromisonidazole
PET
radiotracer
|
|
|
126709
|
Glutamine
C^11^
|
A
C
11
Glutamine
PET
radiotracer
|
|
|
126710
|
Glutamine
C^14^
|
A
C
14
Glutamine
PET
radiotracer
|
|
|
126711
|
Glutamine
F^18^
|
An
F
18
Glutamine
PET
radiotracer
|
|
|
126712
|
Flubatine
F^18^
|
An
F
18
Flubatine
PET
radiotracer
|
|
|
126713
|
2FA
F^18^
|
An
F
18
2FA
PET
radiotracer
|
|
|
126714
|
Nifene
F^18^
|
An
F
18
Nifene
PET
radiotracer
|
|
|
126715
|
CLR1404
I^124^
|
An
I
124
cancer
targeted
phospholipid
ether
PET
radiotracer
|
|
|
126716
|
CLR1404
I^131^
|
An
I
131
cancer
targeted
phospholipid
ether
PET
radiotracer
|
|
|
126801
|
IEC6127
Patient
Support
Continuous
Angle
|
Patient
Support
Continuous
Angle
in
IEC
PATIENT
SUPPORT
Coordinate
System
[IEC
61217]
|
|
|
126802
|
IEC6127
Table
Top
Continuous
Pitch
Angle
|
Table
Top
Continuous
Pitch
Angle
in
the
direction
of
the
IEC
TABLE
TOP
Coordinate
System
[IEC
61217]
|
|
|
126803
|
IEC6127
Table
Top
Continuous
Roll
Angle
|
Table
Top
Continuous
Roll
Angle
in
the
direction
of
the
IEC
TABLE
TOP
Coordinate
System
[IEC
61217]
|
|
|
126804
|
IEC6127
Table
Top
Eccentric
Axis
Distance
|
Table
Top
Eccentric
Axis
Distance
[IEC
61217]
|
|
|
126805
|
IEC6127
Table
Top
Continuous
Eccentric
Angle
|
Table
Top
Continuous
Eccentric
Angle
in
the
direction
of
the
IEC
TABLE
TOP
ECCENTRIC
Coordinate
System
[IEC
61217]
|
|
|
126806
|
IEC6127
Table
Top
Lateral
Position
|
Table
Top
Lateral
Position
IEC
TABLE
TOP
Coordinate
System
[IEC
61217]
|
|
|
126807
|
IEC6127
Table
Top
Longitudinal
Position
|
Table
Top
Longitudinal
Position
IEC
TABLE
TOP
Coordinate
System
[IEC
61217]
|
|
|
126808
|
IEC6127
Table
Top
Vertical
Position
|
Table
Top
Vertical
Position
in
IEC
TABLE
TOP
Coordinate
System
[IEC
61217]
|
|
|
126809
|
IEC6127
Gantry
Continuous
Roll
Angle
|
Gantry
Continuous
Roll
Angle
in
degrees
of
the
radiation
source,
i.e.,
the
rotation
about
the
Y-axis
of
the
IEC
GANTRY
coordinate
system
[IEC
61217]
|
|
|
126810
|
IEC6127
Gantry
Continuous
Pitch
Angle
|
Gantry
Pitch
Continuous
Angle
in
degrees
of
the
radiation
source,
i.e.,
the
rotation
about
the
X-axis
of
the
IEC
GANTRY
coordinate
system
[IEC
61217]
|
|
|
126811
|
IEC6127
Gantry
Continuous
Yaw
Angle
|
Gantry
Yaw
Continuous
Angle
in
degrees
of
the
radiation
source,
i.e.,
about
the
Z-axis
of
the
IEC
GANTRY
coordinate
system
[IEC
61217]
|
|
Terminology
.
Page
versions:
R4B
R4
R3
|
Propose
a
change